<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006876.pub4" GROUP_ID="STROKE" ID="446906121812502258" MERGED_FROM="" MODIFIED="2015-11-03 13:18:21 +0000" MODIFIED_BY="Hazel Fraser" REVIEW_NO="01230002" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="5.1">
<COVER_SHEET MODIFIED="2015-11-03 13:18:21 +0000" MODIFIED_BY="Hazel Fraser">
<TITLE MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser">Electromechanical and robot-assisted arm training for improving activities of daily living, arm function, and arm muscle strength after stroke</TITLE>
<CONTACT MODIFIED="2015-11-03 13:18:21 +0000" MODIFIED_BY="Hazel Fraser"><PERSON ID="D2C58DF182E26AA201E74FE96B163441" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Jan</FIRST_NAME><LAST_NAME>Mehrholz</LAST_NAME><POSITION>Leiter</POSITION><EMAIL_1>jan.mehrholz@klinik-bavaria.de</EMAIL_1><URL>www.rehabilitationsforschung-kreischa.de</URL><ADDRESS><DEPARTMENT>Wissenschaftliches Institut</DEPARTMENT><ORGANISATION>Private Europäische Medizinische Akademie der Klinik Bavaria in Kreischa GmbH</ORGANISATION><ADDRESS_1>An der Wolfsschlucht 1-2</ADDRESS_1><CITY>Kreischa</CITY><ZIP>01731</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 35206 62054</PHONE_1><FAX_1>+49 35206 63507</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2015-11-03 13:18:21 +0000" MODIFIED_BY="Hazel Fraser"><PERSON ID="D2C58DF182E26AA201E74FE96B163441" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Jan</FIRST_NAME><LAST_NAME>Mehrholz</LAST_NAME><POSITION>Leiter</POSITION><EMAIL_1>jan.mehrholz@klinik-bavaria.de</EMAIL_1><URL>www.rehabilitationsforschung-kreischa.de</URL><ADDRESS><DEPARTMENT>Wissenschaftliches Institut</DEPARTMENT><ORGANISATION>Private Europäische Medizinische Akademie der Klinik Bavaria in Kreischa GmbH</ORGANISATION><ADDRESS_1>An der Wolfsschlucht 1-2</ADDRESS_1><CITY>Kreischa</CITY><ZIP>01731</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 35206 62054</PHONE_1><FAX_1>+49 35206 63507</FAX_1></ADDRESS></PERSON><PERSON ID="1777C72D82E26AA200831C1926A4C9DA" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Marcus</FIRST_NAME><LAST_NAME>Pohl</LAST_NAME><POSITION>Chief of department</POSITION><EMAIL_1>marcus.pohl@helios-kliniken.de</EMAIL_1><ADDRESS><DEPARTMENT>Neurological Rehabilitation</DEPARTMENT><ORGANISATION>Helios Klinik Schloss Pulsnitz</ORGANISATION><ADDRESS_1>Wittgensteiner Str. 1</ADDRESS_1><CITY>Pulsnitz</CITY><ZIP>01896</ZIP><REGION>Saxony</REGION><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 35955 5-1201</PHONE_1><FAX_1>+49 35955 5-1210</FAX_1></ADDRESS></PERSON><PERSON ID="B5C90D8D82E26AA200F0756D4FD96716" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Thomas</FIRST_NAME><LAST_NAME>Platz</LAST_NAME><POSITION>Medical Director and Head of Department</POSITION><EMAIL_1>t.platz@bdh-klinik-greifswald.de</EMAIL_1><ADDRESS><DEPARTMENT>Neurorehabilitation Centre and Spinal Cord Injury Unit, BDH-Klinik Greifswald</DEPARTMENT><ORGANISATION>Ernst-Moritz-Arndt-Universität Greifswald</ORGANISATION><ADDRESS_1>Karl-Liebknecht-Ring 26a</ADDRESS_1><CITY>Greifswald</CITY><ZIP>17491</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 03834 871 201</PHONE_1><FAX_1>+49 03834 871 302</FAX_1></ADDRESS></PERSON><PERSON ID="1774AD2B82E26AA200831C19FEE76BC7" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Joachim</FIRST_NAME><LAST_NAME>Kugler</LAST_NAME><POSITION>Professor</POSITION><EMAIL_1>jokugler@aol.com</EMAIL_1><EMAIL_2>kugler@imib.med.tu-dresden.de</EMAIL_2><URL>http://www.imib.med.tu-dresden.de/imib/imib/public_health/index.html</URL><ADDRESS><DEPARTMENT>Department of Public Health, Dresden Medical School</DEPARTMENT><ORGANISATION>Technical University Dresden</ORGANISATION><ADDRESS_1>Löscherstr. 18</ADDRESS_1><CITY>Dresden</CITY><ZIP>D-01307</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 351 3177 217</PHONE_1><FAX_1>+49 351 3177 33 217</FAX_1></ADDRESS></PERSON><PERSON ID="28690826847602830146110301141953" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Bernhard</FIRST_NAME><LAST_NAME>Elsner</LAST_NAME><POSITION>Research Fellow</POSITION><EMAIL_1>bernhard.elsner@posteo.de</EMAIL_1><ADDRESS><DEPARTMENT>Department of Public Health</DEPARTMENT><ORGANISATION>Faculty of Medicine Carl Gustav Carus, TU Dresden</ORGANISATION><ADDRESS_1>Fetscherstr. 74</ADDRESS_1><CITY>Dresden</CITY><ZIP>01307</ZIP><REGION>Sachsen</REGION><COUNTRY CODE="DE">Germany</COUNTRY></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2015-11-03 13:18:21 +0000" MODIFIED_BY="Hazel Fraser">
<UP_TO_DATE>
<DATE DAY="1" MONTH="6" YEAR="2015"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="9" MONTH="3" YEAR="2015"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="1" MONTH="10" YEAR="2017"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2008"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="2008"/>
<LAST_CITATION_ISSUE ISSUE="11" YEAR="2015"/>
</DATES>
<WHATS_NEW MODIFIED="2015-10-30 14:05:26 +0000" MODIFIED_BY="Hazel Fraser">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2015-10-30 14:05:26 +0000" MODIFIED_BY="Hazel Fraser">
<DATE DAY="2" MONTH="6" YEAR="2015"/>
<DESCRIPTION>
<P>The conclusions of the review have changed. The previous version concluded that people who receive electromechanical and robot-assisted arm training after stroke were more likely to improve their activities of daily living, paretic arm function may improve, but arm strength did not improve.</P>
<P>This updated version concluded that people who receive electromechanical and robot-assisted arm training after stroke are more likely to improve their activities of daily living, arm function, and arm muscle strength.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2015-10-30 12:00:02 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="2" MONTH="6" YEAR="2015"/>
<DESCRIPTION>
<P>We have updated the searches to March 2015, and revised the text as appropriate. We have included 34 trials with 1160 participants in this update compared with 19 trials with 666 participants in the 2011 version of this review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser">
<DATE DAY="27" MONTH="10" YEAR="2011"/>
<DESCRIPTION>
<P>The conclusions of the review have changed. The previous version of this review concluded that people who receive electromechanical and robot-assisted arm training after stroke are not more likely to improve their generic activities of daily living, but arm function and muscle strength of the paretic arm may improve. This updated version of the review concluded that people who receive electromechanical and robot-assisted arm training after stroke are more likely to improve their activities of daily living, and paretic arm function may improve, but not arm strength.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser">
<DATE DAY="9" MONTH="8" YEAR="2011"/>
<DESCRIPTION>
<P>We have updated the searches to July and August 2011, and revised the text as appropriate. We have included 19 trials with 666 participants in this update compared with 11 trials with 328 participants in the 2008 version of this review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser">
<DATE DAY="31" MONTH="3" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2008-07-28 09:37:08 +0100" MODIFIED_BY="Hazel Fraser">
<INTERNAL_SOURCES MODIFIED="2008-07-28 09:37:08 +0100" MODIFIED_BY="Hazel Fraser">
<SOURCE MODIFIED="2008-07-28 09:36:12 +0100" MODIFIED_BY="Hazel Fraser">
<NAME>Wissenschaftliches Institut, Klinik Bavaria Kreischa</NAME>
<COUNTRY CODE="DE">Germany</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2008-07-28 09:36:45 +0100" MODIFIED_BY="Hazel Fraser">
<NAME>Department of Public Health, TU Dresden</NAME>
<COUNTRY CODE="DE">Germany</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2008-07-28 09:37:08 +0100" MODIFIED_BY="Hazel Fraser">
<NAME>SRH Fachhochschule für Gesundheit Gera gGmbH</NAME>
<COUNTRY CODE="DE">Germany</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2015-11-02 12:38:28 +0000" MODIFIED_BY="Hazel Fraser">
<SUMMARY MODIFIED="2015-10-30 14:21:21 +0000" MODIFIED_BY="Hazel Fraser">
<TITLE MODIFIED="2008-06-17 11:07:48 +0100" MODIFIED_BY="Hazel Fraser">Electromechanical-assisted training for improving arm function and disability after stroke</TITLE>
<SUMMARY_BODY MODIFIED="2015-10-30 14:21:21 +0000" MODIFIED_BY="Hazel Fraser">
<P>
<B>Review question</B>
</P>
<P>To assess the effects of electromechanical and robot-assisted arm and hand training for improving arm function in people who have had a stroke.</P>
<P>
<B>Background</B>
</P>
<P>More than two-thirds of people who have had a stroke have difficulties with reduced arm function, which can restrict a person's ability to perform everyday activities, reduce productivity, limit social activities, and lead to economic burden. Electromechanical and robot-assisted arm training uses specialised machines to assist rehabilitation in supporting shoulder, elbow, or hand movements. However, the role of electromechanical and robot-assisted arm training for improving arm function after stroke is unclear.</P>
<P>
<B>Study characteristics</B>
</P>
<P>We identified 34 trials (involving 1160 participants) up to March 2015 and included them in our review. Nineteen different electromechanical devices were described in the trials, which compared electromechanical and robot-assisted arm training with a variety of other interventions. Participants were between 21 to 80 years of age, the duration of the trials ranged from two to 12 weeks, the size of the trials was between eight and 127 participants, and the primary outcome differed between the included trials. Most of the trials were done in rehabilitation facilities in the USA.</P>
<P>
<B>Key results</B>
</P>
<P>Electromechanical and robot-assisted arm and hand training improved activities of daily living in people after stroke and function and muscle strength of the affected arm. As adverse events such as injuries and pain were seldom described, these devices can be applied as a rehabilitation tool, but we still do not know when or how often they should be used.</P>
<P>
<B>Quality of the evidence</B>
</P>
<P>The quality of the evidence was low to very low.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2015-10-30 14:05:57 +0000" MODIFIED_BY="Hazel Fraser">
<ABS_BACKGROUND MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser">
<P>Electromechanical and robot-assisted arm training devices are used in rehabilitation, and may help to improve arm function after stroke.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2015-10-05 11:14:06 +0100" MODIFIED_BY="Hazel Fraser">
<P>To assess the effectiveness of electromechanical and robot-assisted arm training for improving activities of daily living, arm function, and arm muscle strength in people after stroke. We also assessed the acceptability and safety of the therapy.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2015-10-30 14:05:32 +0000" MODIFIED_BY="Hazel Fraser">
<P>We searched the Cochrane Stroke Group's Trials Register (last searched February 2015), the Cochrane Central Register of Controlled Trials (CENTRAL) (the Cochrane Library 2015, Issue 3), MEDLINE (1950 to March 2015), EMBASE (1980 to March 2015), CINAHL (1982 to March 2015), AMED (1985 to March 2015), SPORTDiscus (1949 to March 2015), PEDro (searched April 2015), Compendex (1972 to March 2015), and Inspec (1969 to March 2015). We also handsearched relevant conference proceedings, searched trials and research registers, checked reference lists, and contacted trialists, experts, and researchers in our field, as well as manufacturers of commercial devices.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2015-10-30 14:05:36 +0000" MODIFIED_BY="Hazel Fraser">
<P>Randomised controlled trials comparing electromechanical and robot-assisted arm training for recovery of arm function with other rehabilitation or placebo interventions, or no treatment, for people after stroke.<BR/>
</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2015-10-30 14:05:40 +0000" MODIFIED_BY="Hazel Fraser">
<P>Two review authors independently selected trials for inclusion, assessed trial quality and risk of bias, and extracted data. We contacted trialists for additional information. We analysed the results as standardised mean differences (SMDs) for continuous variables and risk differences (RDs) for dichotomous variables.<BR/>
</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2015-10-30 14:05:49 +0000" MODIFIED_BY="Hazel Fraser">
<P>We included 34 trials (involving 1160 participants) in this update of our review. Electromechanical and robot-assisted arm training improved activities of daily living scores (SMD 0.37, 95% confidence interval (CI) 0.11 to 0.64, P = 0.005, I² = 62%), arm function (SMD 0.35, 95% CI 0.18 to 0.51, P &lt; 0.0001, I² = 36%), and arm muscle strength (SMD 0.36, 95% CI 0.01 to 0.70, P = 0.04, I² = 72%), but the quality of the evidence was low to very low. Electromechanical and robot-assisted arm training did not increase the risk of participant drop-out (RD 0.00, 95% CI -0.02 to 0.03, P = 0.84, I² = 0%) with moderate-quality evidence, and adverse events were rare.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2015-10-30 14:05:57 +0000" MODIFIED_BY="Hazel Fraser">
<P>People who receive electromechanical and robot-assisted arm and hand training after stroke might improve their activities of daily living, arm and hand function, and arm and hand muscle strength. However, the results must be interpreted with caution because the quality of the evidence was low to very low, and there were variations between the trials in the intensity, duration, and amount of training; type of treatment; and participant characteristics.<BR/>
</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2015-11-02 12:38:28 +0000" MODIFIED_BY="Hazel Fraser">
<BACKGROUND MODIFIED="2015-10-30 14:06:39 +0000" MODIFIED_BY="Hazel Fraser">
<P>A stroke is a sudden, non-convulsive loss of neurological function due to an ischaemic or haemorrhagic intracranial vascular event (<LINK REF="REF-WHO-2006" TYPE="REFERENCE">WHO 2006</LINK>). In general, strokes are classified by anatomic location in the brain, vascular distribution, aetiology, age of the affected individual, and haemorrhagic versus non-haemorrhagic nature (<LINK REF="REF-Adams-1993" TYPE="REFERENCE">Adams 1993</LINK>). The prevalence of stroke depends on age and gender, and is estimated to be 1% of the population (<LINK REF="REF-Feigin-2009" TYPE="REFERENCE">Feigin 2009</LINK>; <LINK REF="REF-Vos-2015" TYPE="REFERENCE">Vos 2015</LINK>). Stroke, taken together with ischaemic heart disease, is one of the largest sources of disease burden; in low- and middle-income countries of Europe and Central Asia, these conditions account for more than a quarter of the total disease burden (<LINK REF="REF-Vos-2015" TYPE="REFERENCE">Vos 2015</LINK>).</P>
<P>Stroke is a major cause of chronic impaired arm function and may affect many activities of daily living. At hospital admission after stroke, more than two-thirds of people have arm paresis, resulting in reduced upper extremity function (<LINK REF="REF-J_x00f8_rgensen-1999" TYPE="REFERENCE">Jørgensen 1999</LINK>; <LINK REF="REF-Nakayama-1994" TYPE="REFERENCE">Nakayama 1994</LINK>), and six months after stroke the affected arm of approximately half of all people remains without function (<LINK REF="REF-Kwakkel-2003" TYPE="REFERENCE">Kwakkel 2003</LINK>). Therefore, to reduce this burden, many people receive multidisciplinary rehabilitation soon after stroke. However, despite intensive rehabilitation efforts, only approximately 5% to 20% of people reach complete functional recovery (<LINK REF="REF-Nakayama-1994" TYPE="REFERENCE">Nakayama 1994</LINK>); in other words, four out of five people leave rehabilitation with restricted arm function. Thus, there still exists an urgent need for new inpatient and outpatient rehabilitation and training strategies that match the specific needs of stroke survivors and their relatives (<LINK REF="REF-Barker-2005" TYPE="REFERENCE">Barker 2005</LINK>).</P>
<P>In recent years, new electromechanical-assisted training strategies to improve arm function and activities of daily living have been developed for people after stroke. Examples of electromechanical and robot-assisted arm training devices found in this review are:</P>
<UL>
<LI>Mirror Image Motion Enabler, MIME (<LINK REF="REF-Burgar-2000" TYPE="REFERENCE">Burgar 2000</LINK>);</LI>
<LI>InMotion robot (Massachusetts Institute of Technology, MIT-Manus) (<LINK REF="REF-Krebs-1998" TYPE="REFERENCE">Krebs 1998</LINK>);</LI>
<LI>Assisted Rehabilitation and Measurement (ARM) Guide (<LINK REF="REF-Reinkensmeyer-2000b" TYPE="REFERENCE">Reinkensmeyer 2000b</LINK>);</LI>
<LI>Robotic Rehabilitation System for upper limb motion therapy for the disabled, REHAROB (<LINK REF="STD-Fazekas-2007" TYPE="STUDY">Fazekas 2007</LINK>);</LI>
<LI>Neuro-Rehabilitation-Robot, NeReBot (<LINK REF="STD-Fazekas-2007" TYPE="STUDY">Fazekas 2007</LINK>);</LI>
<LI>Bi-Manu-Track (<LINK REF="REF-Hesse-2003" TYPE="REFERENCE">Hesse 2003</LINK>);</LI>
<LI>Robot-mediated therapy system, GENTLE/s (<LINK REF="REF-Coote-2003" TYPE="REFERENCE">Coote 2003</LINK>);</LI>
<LI>Arm robot, ARMin (<LINK REF="REF-Riener-2005" TYPE="REFERENCE">Riener 2005</LINK>); and</LI>
<LI>Amadeo (<LINK REF="STD-Hwang-2012" TYPE="STUDY">Hwang 2012</LINK>).</LI>
</UL>
<P>Most of these devices provide passive movement of the person's arm. Other devices assist arm movements or provide resistance during training. Some devices may assist active movements of an isolated joint, like in continuous passive motion (<LINK REF="REF-Hesse-2003" TYPE="REFERENCE">Hesse 2003</LINK>), while other devices are able to move multiple segments to perform reaching-like movements (<LINK REF="REF-Burgar-2000" TYPE="REFERENCE">Burgar 2000</LINK>). The progression of therapy with electromechanical devices is possible by, for example, varying the force, decreasing assistance, increasing resistance, and expanding the movement amplitude. Moreover, some devices, such as the Bi-Manu-Track and the MIME, may be used to provide bimanual exercise: the device simultaneously moves (mirrors) the affected limb passively, steered by the non-paretic limb. Broadly considered, most robotic systems incorporate more than one modality into a single device.</P>
<P>Early studies and previous reviews suggested that an advantage of electromechanical and robotic devices, when compared with conventional therapies, may be an increase in repetitions during arm training due to an increase of motivation to train and also the opportunity for independent exercise (<LINK REF="REF-Kwakkel-2008" TYPE="REFERENCE">Kwakkel 2008</LINK>; <LINK REF="REF-Prange-2006" TYPE="REFERENCE">Prange 2006</LINK>). Therefore, electromechanical-assistive training devices allow a therapy paradigm that is intensive, frequent and repetitive, and accords to principles of motor learning.</P>
<P>However, contrary to the remarkable number of publications about electromechanical technologies, scientific evidence for the benefits of these technologies, which could justify costs and effort, is still lacking. We summarised the evidence in our first Cochrane review about this topic in 2008 and in our last update in 2012 (<LINK REF="REF-Mehrholz-2008" TYPE="REFERENCE">Mehrholz 2008</LINK>; <LINK REF="REF-Mehrholz-2012" TYPE="REFERENCE">Mehrholz 2012</LINK>), but many new studies have emerged in recent years. Therefore there is a need for an updated and systematic evaluation of the available literature to assess the effectiveness and acceptability of these electromechanical-assisted training devices.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2015-10-05 11:50:38 +0100" MODIFIED_BY="Hazel Fraser">
<P>To assess the effectiveness of electromechanical and robot-assisted arm training for improving activities of daily living, arm function, and arm muscle strength in people after stroke. We also assessed the acceptability and safety of the therapy.</P>
</OBJECTIVES>
<METHODS MODIFIED="2015-11-02 11:37:40 +0000" MODIFIED_BY="Hazel Fraser">
<SELECTION_CRITERIA MODIFIED="2015-11-02 11:37:40 +0000" MODIFIED_BY="Hazel Fraser">
<CRIT_STUDIES MODIFIED="2015-10-30 14:06:40 +0000" MODIFIED_BY="Hazel Fraser">
<P>We included randomised controlled trials (RCTs) and randomised controlled cross-over trials (we only analysed the first study period as a parallel-group trial).</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2015-10-30 14:06:44 +0000" MODIFIED_BY="Hazel Fraser">
<P>We included studies with participants of either gender over 18 years of age after stroke (using the World Health Organization (WHO) definition of stroke, or a clinical definition of stroke when the WHO definition was not specifically stated) (<LINK REF="REF-WHO-2006" TYPE="REFERENCE">WHO 2006</LINK>), regardless of the duration of illness or level of initial impairment. If we found RCTs with mixed populations (such as traumatic brain injury and stroke), we included only those RCTs with more than 50% of participants with stroke in our analysis.</P>
<P>Although we initially included all studies regardless of the duration of illness in our analysis, we later compared participants in the acute and subacute phase of their stroke (within three months) with participants in the chronic phase (more than three months) in a subgroup analysis.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2015-10-30 14:06:45 +0000" MODIFIED_BY="Hazel Fraser">
<P>We compared electromechanical and robot-assisted arm training for recovery of arm function (such as robot-aided technologies or any other newly developed electromechanical device) with any other intervention for:</P>
<UL>
<LI>improving activities of daily living (main analysis); and</LI>
<LI>improving impairments (secondary analysis).</LI>
</UL>
<P>An example of an eligible robot-assisted intervention is the Mirror Image Motion Enabler, MIME (<LINK REF="REF-Burgar-2000" TYPE="REFERENCE">Burgar 2000</LINK>). An example of an electromechanical-assisted intervention is the Bi-Manu-Track (<LINK REF="REF-Hesse-2003" TYPE="REFERENCE">Hesse 2003</LINK>). Other interventions could include other devices, other rehabilitation or placebo interventions, or no treatment.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2015-11-02 11:37:40 +0000" MODIFIED_BY="Hazel Fraser">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2015-10-30 14:06:50 +0000" MODIFIED_BY="Hazel Fraser">
<P>The primary outcome was activities of daily living. We preferred the Barthel Index, <LINK REF="REF-Wade-1987" TYPE="REFERENCE">Wade 1987</LINK>, and the Functional Independence Measure, <LINK REF="REF-Hamilton-1994" TYPE="REFERENCE">Hamilton 1994</LINK>, (scales were regarded as continuous scaled, higher scores indicate a good outcome) as primary outcome measures, if they were available. However, we accepted other scales that measured activities of daily living.</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2015-11-02 11:37:40 +0000" MODIFIED_BY="Hazel Fraser">
<P>The secondary outcomes were impairments, such as motor function and muscle strength. We measured arm and hand motor function with the Fugl-Meyer score (regarded as continuous scaled, higher scores indicate a good outcome; <LINK REF="REF-Platz-2005" TYPE="REFERENCE">Platz 2005</LINK>) and measured arm and hand muscle strength with the Motricity Index Score (scales were regarded as continuous scaled, higher scores indicate a good outcome; <LINK REF="REF-Collin-1990" TYPE="REFERENCE">Collin 1990</LINK>; <LINK REF="REF-Demeurisse-1980" TYPE="REFERENCE">Demeurisse 1980</LINK>). However, if these scales were not available we accepted other scales that measured arm and hand function and arm and hand muscle strength (in the following we will use the term 'arm function' instead of 'arm and hand function' and also 'arm muscle strength' instead of 'arm and hand muscle strength').</P>
<P>To measure the acceptance of electromechanical and robot-assisted arm training we used withdrawal or dropouts from the study due to any reason (including deaths) during the study period. We investigated the safety of electromechanical and robot-assisted arm training with the incidence of adverse outcomes, such as cardiovascular events, injuries and pain, and any other reported adverse events.</P>
<P>Depending on the aforementioned categories and the availability of variables used in the included trials, all review authors discussed and reached consensus on which outcome measures should be included in the analysis.</P>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2015-10-30 14:23:41 +0000" MODIFIED_BY="Hazel Fraser">
<P>See the 'Specialized register' section in the <A HREF="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/STROKE/frame.html">Cochrane Stroke Group</A> module. We did not restrict our searches by language, publication status, or date, and we arranged for the translation of articles where necessary.
<BR/>

</P>
<ELECTRONIC_SEARCHES MODIFIED="2015-10-30 14:07:01 +0000" MODIFIED_BY="Hazel Fraser">
<P>We searched the Cochrane Stroke Group Trials Register (last searched in February 2015) and the following bibliographic databases:</P>
<UL>
<LI>The Cochrane Central Register of Controlled Trials (CENTRAL) (the Cochrane Library 2015, Issue 3) (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>);</LI>
<LI>MEDLINE (Ovid) (1950 to March 2015) (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>);</LI>
<LI>EMBASE (Ovid) (1980 to March 2015) (<LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>);</LI>
<LI>CINAHL (Ebsco) (1982 to March 2015) (<LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>);</LI>
<LI>AMED (Allied and Complementary Medicine) (Ovid) (1985 to March 2015) (<LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK>);</LI>
<LI>SPORTDiscus (Ebsco) (1949 to March 2015) (<LINK REF="APP-06" TYPE="APPENDIX">Appendix 6</LINK>);</LI>
<LI>Physiotherapy Evidence Database (PEDro, http://www.pedro.org.au/) (searched April 2015);</LI>
<LI>Compendex (1972 to March 2015) and Inspec (1969 to March 2015) (Engineering Village) (<LINK REF="APP-07" TYPE="APPENDIX">Appendix 7</LINK>).</LI>
</UL>
<P>We developed the search strategy for MEDLINE with the help of the Cochrane Stroke Group Trials Search Co-ordinator and modified it for the other databases.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2015-10-30 14:23:41 +0000" MODIFIED_BY="Hazel Fraser">
<P>In an effort to identify further published, unpublished, and ongoing trials not available in the major databases, we:</P>
<OL>
<LI>handsearched the following relevant conference proceedings:</LI>
<OL>
<LI>World Congress for NeuroRehabilitation (WCNR, 1998, 2002, 2006, 2010, and 2014);</LI>
<LI>International Society of Physical and Rehabilitation Medicine World Congress (ISPRM 2001, 2003, 2005, 2007, 2009, and 2011);</LI>
<LI>World Confederation for Physical Therapy (2003, 2007, 2011, and 2015);</LI>
<LI>International Congress on Neurorehabilitation and Neural Repair (2015);</LI>
<LI>Deutsche Gesellschaft für Neurotraumatologie und Klinische Neurorehabilitation (2001 to 2015);</LI>
<LI>Deutsche Gesellschaft für Neurologie (2000 to 2014);</LI>
<LI>Deutsche Gesellschaft für Neurorehabilitation (1999 to 2014);</LI>
</OL>
<LI>screened reference lists of all relevant articles;</LI>
<LI>identified and searched the following ongoing trials and research registers:</LI>
<OL>
<LI>ISRCTN Registry (http://www.isrctn.com/) (searched June 2015);</LI>
<LI>ClinicalTrials.gov (http://clinicaltrials.gov/) (searched June 2015);</LI>
<LI>Stroke Trials Registry (www.strokecenter.org/trials) (searched June 2015);</LI>
</OL>
<LI>contacted trialists, experts, and researchers in our field of study; and</LI>
<LI>contacted the following manufacturers of commercial devices:</LI>
<OL>
<LI>Hocoma (last contact March 2015); and</LI>
<LI>Reha-Stim (last contact May 2015).</LI>
</OL>
</OL>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2015-10-30 14:07:48 +0000" MODIFIED_BY="Hazel Fraser">
<STUDY_SELECTION MODIFIED="2015-10-30 14:07:14 +0000" MODIFIED_BY="Hazel Fraser">
<P>Two review authors (JM and BE) independently read the titles and abstracts (if available) of identified publications and eliminated obviously irrelevant studies. We obtained the full text for the remaining studies, and the same two review authors independently examined potentially relevant studies using our predetermined criteria for including studies. Based on types of studies, participants, aims of interventions, and outcome measures, the review authors independently ranked these studies as relevant, irrelevant, or possibly relevant. We excluded all trials ranked initially as irrelevant, but included all other trials at that stage for further assessment. We excluded all trials of specific treatment components (such as electrical stimulation) as standalone treatment, and continuous passive motion treatment and continuous passive stretching. All review authors resolved disagreements through discussion. If further information was needed to reach consensus, we contacted the study authors.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2015-10-30 14:07:23 +0000" MODIFIED_BY="Hazel Fraser">
<P>Two review authors (JM and MP) independently extracted trial and outcome data from the selected trials. We used checklists to independently record details of the studies. If any review author was involved in any of the selected studies, another member of our review team not involved in the study was asked to handle the study information.</P>
<P>We established the characteristics of unpublished trials through correspondence with the trial co-ordinator or principal investigator. We used checklists to independently record details of the:<BR/>
</P>
<UL>
<LI>methods of generating randomisation schedule;</LI>
<LI>method of concealment of allocation;</LI>
<LI>blinding of assessors;</LI>
<LI>use of an intention-to-treat analysis (all participants initially randomised were included in the analyses as allocated to groups);</LI>
<LI>adverse events and dropouts for all reasons;</LI>
<LI>important imbalance in prognostic factors;</LI>
<LI>participants (country, number of participants, age, gender, type of stroke, time from stroke onset to entry to the study, inclusion and exclusion criteria);</LI>
<LI>comparison (details of the intervention in treatment and control groups, details of co-intervention(s) in both groups, duration of treatment); and</LI>
<LI>outcomes and time points of measures (number of participants in each group and outcome, regardless of compliance).</LI>
</UL>
<P>We checked all of the extracted data for agreement between review authors, with another review author (JK or BE) arbitrating any disagreements. We contacted study authors to request more information, clarification, or missing data if necessary.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2015-10-30 14:07:27 +0000" MODIFIED_BY="Hazel Fraser">
<P>All review authors independently assessed the methodological quality of the included trials using the Cochrane 'Risk of bias' tool, as described in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<P>We checked all methodological quality assessments for agreement between review authors, resolving any disagreements by discussion. Two review authors (MP and JM) were coauthors of one included trial (<LINK REF="STD-Hesse-2005" TYPE="STUDY">Hesse 2005</LINK>); two other review authors (BE and JK) conducted the quality assessment for this trial.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2015-10-30 14:07:32 +0000" MODIFIED_BY="Hazel Fraser">
<P>The primary outcome variables of interest were treated as continuous data and entered as mean and standard deviations (SDs). We calculated a pooled estimate of the mean differences (MDs) with 95% confidence intervals (CIs). If studies used different scales for an outcome variable, or if we obtained only full data of all included studies regarding changes from baseline to study end, we entered data as mean changes and SDs of changes and used the standardised mean difference (SMD) with 95% CI instead of MDs. For all binary outcomes (such as the secondary outcome 'dropouts from all causes'), we calculated risk ratios (RRs) with 95% CIs. If studies reported no events, we calculated risk differences (RDs) with 95% CIs, instead of RRs.</P>
</EFFECT_MEASURES>
<HETEROGENEITY_ASSESSMENT MODIFIED="2015-10-30 14:07:33 +0000" MODIFIED_BY="Hazel Fraser">
<P>We used the I² statistic to assess heterogeneity. We used a random-effects model, regardless of the level of heterogeneity.</P>
</HETEROGENEITY_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2015-10-30 14:07:39 +0000" MODIFIED_BY="Hazel Fraser">
<P>We pooled the results of all eligible studies to present an overall estimate of the effect of electromechanical and robot-assisted arm training (meta-analysis). For all statistical analyses we used the latest version of the Cochrane Review Manager software, RevMan 5.3 (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>). We calculated the overall effects using a random-effects model, regardless of the level of heterogeneity. To test the robustness of the results, we did a sensitivity analysis by leaving out studies that we assessed to be of lower or ambiguous methodological quality (with respect to randomisation procedure, allocation concealment, and blinding of assessors). Clinical diversity and heterogeneity did not contribute to the decision about when to pool trials, but we described clinical diversity, variability in participants, interventions, and outcomes studied in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>.</P>
<P>If studies had three or more intervention groups, for example two treatment groups and one control group, and the results of these intervention groups did not differ significantly, we combined the results of all intervention groups in one (collapsed) group and compared this with the results of the control group.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2015-10-30 14:07:45 +0000" MODIFIED_BY="Hazel Fraser">
<P>We conducted a formal subgroup analysis by splitting all participants into two subgroups: a subgroup of participants in the acute and subacute phase of their stroke (within three months) and a subgroup of participants treated in the chronic phase (more than three months after stroke). In this subgroup analysis, we did a formal comparison between the results of the primary outcome measure of participants treated in the acute and subacute phase of their stroke compared with the results of participants treated in the chronic phase (<LINK REF="REF-Deeks-2011" TYPE="REFERENCE">Deeks 2011</LINK>).</P>
<P>We conducted another subgroup analysis by splitting all participants into two subgroups: a subgroup of participants who received mainly training for the distal arm and the hand (finger, hand, and radio-ulnar joints) and a subgroup of participants who received training mainly of the proximal arm (shoulder and elbow joints) and a subgroup of participants treated in the chronic phase (more than three months after stroke). In this subgroup analysis, we did a formal comparison between the results of the subgroups for the primary outcome measure (activities of daily living) and the secondary outcome measure (arm function). To quantify heterogeneity we used the I² statistic implemented in RevMan 5.3 for all comparisons (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>).</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2015-10-30 14:07:48 +0000" MODIFIED_BY="Hazel Fraser">
<P>In accordance with the description in the <I>Cochrane Handbook for Systematic Reviews of Interentions</I>, we used the methodological features randomisation procedure, concealed allocation, and blinding of assessors to test the robustness of the main results in a sensitivity analysis (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2015-11-02 12:38:28 +0000" MODIFIED_BY="Hazel Fraser">
<STUDY_DESCRIPTION MODIFIED="2015-10-30 16:12:44 +0000" MODIFIED_BY="Hazel Fraser">
<P>See: <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>, <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>, <LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK>, <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK> and <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<SEARCH_RESULTS MODIFIED="2015-10-30 14:08:06 +0000" MODIFIED_BY="Hazel Fraser">
<P>Our updated searches of the electronic bibliographic databases identified 5308 citations (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>). One review author (BE) carried out additional searches of trials registers, commercial websites, conference proceedings, and reference lists, and from these and the search of the Cochrane Stroke Group's Trials Register, we identified three further studies for inclusion. Hence the number of records identified was 5311. After the elimination of duplicates, two review authors (BE and JM) assessed 4471 relevant abstracts and eliminated obviously irrelevant studies from the titles and abstracts alone. We obtained the full text of 49 possibly relevant papers. The same review authors (BE and JM) independently reviewed the full papers and selected 15 studies (30 full texts) that met our inclusion criteria. If necessary due to disagreements or uncertainties, we held consensus discussions involving additional review authors. We carefully considered and discussed a further 10 studies, but did not deem them eligible; we have detailed them in <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>.</P>
<P>We thus identified 15 new studies (30 full texts), and together with 19 studies included in the original review, we have included a total of 34 studies in this update. Five studies are still awaiting classification; we have described these studies in detail in <LINK TAG="CHARACTERISTICS_OF_AWAITING_STUDIES" TYPE="SECTION">Characteristics of studies awaiting classification</LINK>. In addition, we identified 24 ongoing studies, which we have listed in <LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK>.<BR/>
</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2015-10-30 16:12:44 +0000" MODIFIED_BY="Hazel Fraser">
<P>Thirty-four trials, including a total of 1160 participants, met our inclusion criteria and have been included in the analysis (see <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>, <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>, <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>, and <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>).<BR/>
</P>
<SUBSECTION>
<HEADING LEVEL="4">Design</HEADING>
<P>Two trials used a cross-over design with random allocation to the order of treatment sequences (<LINK REF="STD-Amirabdollahian-2007" TYPE="STUDY">Amirabdollahian 2007</LINK>; <LINK REF="STD-Hollenstein-2011" TYPE="STUDY">Hollenstein 2011</LINK>). For <LINK REF="STD-Amirabdollahian-2007" TYPE="STUDY">Amirabdollahian 2007</LINK>, we could not obtain outcome data from the trialists of this study, therefore we could not pool the data for this trial together with the data from other studies. In the study of <LINK REF="STD-Hollenstein-2011" TYPE="STUDY">Hollenstein 2011</LINK>, we used the data of the first period before cross-over. All other studies used a parallel-group design with true randomisation-to-group allocation.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Sample sizes</HEADING>
<P>The sample sizes in the trials ranged from eight participants, in <LINK REF="STD-Mayr-2008" TYPE="STUDY">Mayr 2008</LINK>, to 127 participants, in <LINK REF="STD-Lo-2010" TYPE="STUDY">Lo 2010</LINK> (sample size median = 30 interquartile range = 25). We have provided a more detailed description of trial characteristics in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> and in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK> and <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Setting</HEADING>
<P>Most of the trials were done in rehabilitation facilities in the USA. We have provided a more detailed description of trial characteristics in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Participants</HEADING>
<P>The mean age of participants in the included studies ranged from 21 years, in <LINK REF="STD-McCabe-2015" TYPE="STUDY">McCabe 2015</LINK>, to 80 years, in <LINK REF="STD-Rabadi-2008" TYPE="STUDY">Rabadi 2008</LINK>. We have provided a detailed description of participant characteristics in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>. There were significantly more males than females (66% males with 95% CI 63 to 69), and slightly more participants with left-sided hemiparesis (53% left-sided with 95% CI 49 to 57) included in the studies.</P>
<P>Twenty-three studies provided information about baseline stroke severity (for example Functional Independence Measure, Barthel) or about the deficit of arm motor function (Fugl-Meyer) (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>; <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>).</P>
<P>For inclusion and exclusion criteria of every included study, see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Interventions</HEADING>
<P>The duration of the studies (time frame where experimental interventions were applied) was heterogeneous, ranging from two weeks, in <LINK REF="STD-Hollenstein-2011" TYPE="STUDY">Hollenstein 2011</LINK>, and three weeks, in <LINK REF="STD-Amirabdollahian-2007" TYPE="STUDY">Amirabdollahian 2007</LINK>; <LINK REF="STD-Burgar-2011" TYPE="STUDY">Burgar 2011</LINK>, to 12 weeks (<LINK REF="STD-Brokaw-2014" TYPE="STUDY">Brokaw 2014</LINK>; <LINK REF="STD-Daly-2005" TYPE="STUDY">Daly 2005</LINK>; <LINK REF="STD-Lo-2010" TYPE="STUDY">Lo 2010</LINK>). Most studies (eight out of 34) used a two-, three-, four-, or six-week study period (<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>). The studies described and used 19 different electromechanical devices (see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK> for an overview); the devices used most often were the Bi-Manu-Track (<LINK REF="STD-Hesse-2005" TYPE="STUDY">Hesse 2005</LINK>; <LINK REF="STD-Hesse-2014" TYPE="STUDY">Hesse 2014</LINK>; <LINK REF="STD-Hsieh-2011" TYPE="STUDY">Hsieh 2011</LINK>; <LINK REF="STD-Hsieh-2014" TYPE="STUDY">Hsieh 2014</LINK>; <LINK REF="STD-Liao-2011" TYPE="STUDY">Liao 2011</LINK>; <LINK REF="STD-Wu-2012" TYPE="STUDY">Wu 2012</LINK>), the InMotion (<LINK REF="STD-Conroy-2011" TYPE="STUDY">Conroy 2011</LINK>; <LINK REF="STD-Daly-2005" TYPE="STUDY">Daly 2005</LINK>; <LINK REF="STD-McCabe-2015" TYPE="STUDY">McCabe 2015</LINK>; <LINK REF="STD-Volpe-2008" TYPE="STUDY">Volpe 2008</LINK>), and the MIT-Manus (<LINK REF="STD-Lo-2010" TYPE="STUDY">Lo 2010</LINK>; <LINK REF="STD-Rabadi-2008" TYPE="STUDY">Rabadi 2008</LINK>; <LINK REF="STD-Sale-2014" TYPE="STUDY">Sale 2014</LINK>; <LINK REF="STD-Volpe-2000" TYPE="STUDY">Volpe 2000</LINK>).<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Comparisons</HEADING>
<P>The included trials compared electromechanical and robot-assisted arm training with a variety of other interventions. We only did a formal meta-analysis of studies that measured the same treatment effect. Thus we combined electromechanical and robot-assisted arm training versus placebo (or no additional therapy) (two studies) with electromechanical and robot-assisted arm training combined with physiotherapy versus physiotherapy alone (32 studies), as both estimate the effect of electromechanical and robot-assisted arm training compared with a different treatment. However, we did not combine electromechanical and robot-assisted arm training versus physiotherapy (or no treatment) with electromechanical and robot-assisted arm training A versus electromechanical and robot-assisted arm training B (<LINK REF="STD-Lum-2002" TYPE="STUDY">Lum 2002</LINK>), as these all measure entirely different treatment effects.</P>
<P>One study had four groups: three treatment (robot) groups and one control group (<LINK REF="STD-Lum-2006" TYPE="STUDY">Lum 2006</LINK>). Since the results of these experimental groups did not differ significantly, we combined the results of all experimental groups into one (collapsed, robot) group and compared this with the results of the control group. Nine other studies used three arms: two treatment (robot) groups and one control group or two control and one treatment group (<LINK REF="STD-Ang-2014" TYPE="STUDY">Ang 2014</LINK>; <LINK REF="STD-Burgar-2011" TYPE="STUDY">Burgar 2011</LINK>; <LINK REF="STD-Conroy-2011" TYPE="STUDY">Conroy 2011</LINK>; <LINK REF="STD-Hsieh-2011" TYPE="STUDY">Hsieh 2011</LINK>; <LINK REF="STD-Hsieh-2014" TYPE="STUDY">Hsieh 2014</LINK>; <LINK REF="STD-Lo-2010" TYPE="STUDY">Lo 2010</LINK>; <LINK REF="STD-McCabe-2015" TYPE="STUDY">McCabe 2015</LINK>; <LINK REF="STD-Rabadi-2008" TYPE="STUDY">Rabadi 2008</LINK>; <LINK REF="STD-Wu-2012" TYPE="STUDY">Wu 2012</LINK>). As we were interested in the effects of robot therapy versus any other control intervention, we either combined the results of both experimental groups in one (collapsed) group and compared this with the results of the control group, or we combined the results of both control groups in one (collapsed) group and compared this with the results of the one treatment group.</P>
<P>For most trials the frequency of treatment was five times a week (see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK> for a detailed description of time and frequency for each single study).</P>
<P>The intensity of treatment (in terms of duration of experimental therapy provided) ranged from 20 minutes, in <LINK REF="STD-Masiero-2011" TYPE="STUDY">Masiero 2011</LINK>, or 30 minutes, in <LINK REF="STD-Fazekas-2007" TYPE="STUDY">Fazekas 2007</LINK>, <LINK REF="STD-Hesse-2005" TYPE="STUDY">Hesse 2005</LINK>, and <LINK REF="STD-Masiero-2007" TYPE="STUDY">Masiero 2007</LINK>, to 90 minutes each working day, in <LINK REF="STD-Daly-2005" TYPE="STUDY">Daly 2005</LINK> and <LINK REF="STD-Hsieh-2011" TYPE="STUDY">Hsieh 2011</LINK>, or even 90 to 105 minutes each day (<LINK REF="STD-Hsieh-2014" TYPE="STUDY">Hsieh 2014</LINK>). For some studies, the intensity of the experimental treatment is still unclear (<LINK REF="STD-Amirabdollahian-2007" TYPE="STUDY">Amirabdollahian 2007</LINK>; <LINK REF="STD-Kahn-2006" TYPE="STUDY">Kahn 2006</LINK>; <LINK REF="STD-Lo-2010" TYPE="STUDY">Lo 2010</LINK>). We have provided a detailed description for each single study in <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK> and a more detailed description of the individual therapy in studies in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Outcomes</HEADING>
<P>The primary outcomes of the included studies varied. See <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> for a detailed description of the primary outcomes for each trial.</P>
<P>In our pooled analysis for the primary outcome, activities of daily living, we used the Barthel Index score or the modified Barthel Index (<LINK REF="STD-Hesse-2005" TYPE="STUDY">Hesse 2005</LINK>; <LINK REF="STD-Hesse-2014" TYPE="STUDY">Hesse 2014</LINK>; <LINK REF="STD-Yoo-2013" TYPE="STUDY">Yoo 2013</LINK>), the Functional Independence Measure (<LINK REF="STD-Burgar-2011" TYPE="STUDY">Burgar 2011</LINK>; <LINK REF="STD-Fazekas-2007" TYPE="STUDY">Fazekas 2007</LINK>; <LINK REF="STD-Lum-2006" TYPE="STUDY">Lum 2006</LINK>; <LINK REF="STD-Masiero-2007" TYPE="STUDY">Masiero 2007</LINK>; <LINK REF="STD-Volpe-2000" TYPE="STUDY">Volpe 2000</LINK>), the ABILHAND (<LINK REF="STD-Hsieh-2011" TYPE="STUDY">Hsieh 2011</LINK>; <LINK REF="STD-Liao-2011" TYPE="STUDY">Liao 2011</LINK>), the Stroke Impact Scale 3.0 (motor function and social participation section) (<LINK REF="STD-Kutner-2010" TYPE="STUDY">Kutner 2010</LINK>; <LINK REF="STD-Lo-2010" TYPE="STUDY">Lo 2010</LINK>; <LINK REF="STD-Wu-2012" TYPE="STUDY">Wu 2012</LINK>), the Stroke Impact Scale 2.0 (higher scores indicate a good outcome) (<LINK REF="STD-Volpe-2008" TYPE="STUDY">Volpe 2008</LINK>), and the Frenchay Arm Test (<LINK REF="STD-Masiero-2011" TYPE="STUDY">Masiero 2011</LINK>).<BR/>
</P>
<P>For our secondary outcome arm function, we used the Fugl-Meyer score or the Chedoke-McMaster Stroke Assessment (<LINK REF="STD-Abdullah-2011" TYPE="STUDY">Abdullah 2011</LINK>; <LINK REF="STD-Mayr-2008" TYPE="STUDY">Mayr 2008</LINK>), and in one study the Wolf Motor Function Test for our pooled analysis and conducted a separate analysis for impaired arm function (<LINK REF="STD-Yoo-2013" TYPE="STUDY">Yoo 2013</LINK>). For our secondary outcome arm strength, we accepted measures such as the Motricity Index score or Medical Research Council score (higher scores indicate a good outcome) or grip force.</P>
<P>Eighteen included studies assessed outcomes at the end of the study, but the follow-up assessment varied between three months and nine months after study end (see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK> for a detailed description of time points of assessment for each single study) (<LINK REF="STD-Lo-2010" TYPE="STUDY">Lo 2010</LINK>). As reporting data of follow-up measures were heterogeneous and limited mostly to our primary outcome, we did not conduct separate analyses for immediate data after study end and sustained data from follow-up after study end. We therefore undertook just one analysis (immediately after the end of the intervention).</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2015-10-30 14:51:07 +0000" MODIFIED_BY="Hazel Fraser">
<P>We excluded 22 trials (see <LINK TAG="EXCLUDED_STUDIES_DESCR" TYPE="SECTION">Excluded studies</LINK>). We have excluded 11 trials from the previous version of the review and another 11 trials (19 full texts) from the current update. See <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> for details of reasons for excluding these trials. If there was any doubt about whether or not a study should be excluded, we retrieved the full text of the article. Where the two review authors (BE and JM) disagreed, a third review author (JK) decided on inclusion or exclusion of a study.</P>
<SUBSECTION>
<HEADING LEVEL="4">Ongoing studies</HEADING>
<P>We identified 24 ongoing studies (see <LINK TAG="ONGOING_STUDIES" TYPE="SECTION">Ongoing studies</LINK>), which we have described in <LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK>. Nine of these studies were listed as ongoing studies in the previous version of the review. After we retrieved further information, four of these ongoing studies became included studies; one became a study awaiting classification; and three remained ongoing studies.</P>
</SUBSECTION>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2015-10-30 14:09:11 +0000" MODIFIED_BY="Hazel Fraser">
<P>We have provided all details about the methodological quality of each included study in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
<P>We wrote to the trialists of all the included studies requesting clarification of some design features or missing information in order to complete the quality ratings. The correspondence was via email or letter, and we wrote reminders every month if we did not receive an answer. Most trialists provided some or all of the requested data, but for four trials we did not receive all requested data.</P>
<P>We used the 'Risk of bias' tool to assess the methodological quality of all the included trials for random allocation, concealment of allocation, and blinding of assessors. (See <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> and <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>).</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2015-11-02 12:38:28 +0000" MODIFIED_BY="Hazel Fraser">
<SUBSECTION>
<HEADING LEVEL="3">Electromechanical and robot-assisted arm training versus any other intervention</HEADING>
<P>See <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="4">Activities of daily living at the end of the intervention phase</HEADING>
<P>Eighteen studies with a total of 717 participants compared electromechanical and robot-assisted arm training versus any other intervention and measured activities of daily living. Electromechanical and robot-assisted arm training improved activities of daily living scores. The pooled SMD (random-effects model) for activities of daily living was 0.37 (95% CI 0.11 to 0.64, P = 0.005, level of heterogeneity I² = 62%; <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). We did not find graphical evidence in a funnel plot for publication bias (<LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Activities of daily living at the end of the intervention phase: subgroup analysis comparing the acute and chronic phase</HEADING>
<P>We included eight trials with a total of 320 participants in the acute and subacute phase after stroke. Electromechanical and robot-assisted arm training improved activities of daily living scores in the acute phase after stroke; the SMD (random-effects model) was 0.53 (95% CI 0.09 to 0.96, P = 0.02, level of heterogeneity I² = 69%). We included 10 trials with a total of 397 participants in the chronic phase (more than three months after stroke). Electromechanical and robot-assisted arm training did not improve activities of daily living scores in the chronic phase after stroke; the SMD (random-effects model) was 0.66 (95% CI -0.17 to 1.49, P = 0.12, level of heterogeneity I² = 92%; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). The test for subgroup differences (between acute and subacute phase after stroke versus chronic phase after stroke) revealed no significant difference (P = 0.78, level of heterogeneity I² = 0%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Arm function at the end of the intervention phase</HEADING>
<P>Thirty-one studies with a total of 1078 participants compared electromechanical and robot-assisted arm training versus any other intervention and measured arm function. Electromechanical and robot-assisted arm training improved arm function of the impaired arm. As we received the change data from baseline to study end for all trials that measured arm function, we used SMDs for this comparison. The pooled SMD (random-effects model) for arm function was 0.35 (95% CI 0.18 to 0.51, P &lt; 0.0001, level of heterogeneity I² = 36%; <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>). We did not find graphical evidence in a funnel plot for publication bias (<LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Arm muscle strength at the end of the intervention phase</HEADING>
<P>Sixteen studies with a total of 568 participants compared electromechanical and robot-assisted arm training versus another intervention and measured strength of arm. Electromechanical and robot-assisted arm training improved arm muscle strength. The SMD (random-effects model) for muscle strength was 0.36 (95% CI 0.01 to 0.70, P = 0.04, level of heterogeneity I² = 72%; <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>). We did not find graphical evidence in a funnel plot for publication bias (<LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Acceptability: dropouts during the intervention period</HEADING>
<P>We pooled all reported rates of participants who dropped out from all causes during the trial period. The use of electromechanical and robot-assisted arm training in people after stroke did not increase the risk of participants dropping out. The RD (random-effects model) for dropouts was 0.00 (95% CI -0.02 to 0.03, P = 0.84, level of heterogeneity I² = 0%; <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>).</P>
<P>The drop-out rate for all reasons at the end of the treatment phase was relatively low (all included studies achieved a drop-out rate of less than 16%), but for one study this is still unclear (<LINK REF="STD-Amirabdollahian-2007" TYPE="STUDY">Amirabdollahian 2007</LINK>). Twenty-one out of 34 included studies (62%) reported no dropouts at scheduled study end (<LINK REF="STD-Amirabdollahian-2007" TYPE="STUDY">Amirabdollahian 2007</LINK>; <LINK REF="STD-Ang-2014" TYPE="STUDY">Ang 2014</LINK>; <LINK REF="STD-Burgar-2011" TYPE="STUDY">Burgar 2011</LINK>; <LINK REF="STD-Fazekas-2007" TYPE="STUDY">Fazekas 2007</LINK>; <LINK REF="STD-Hollenstein-2011" TYPE="STUDY">Hollenstein 2011</LINK>; <LINK REF="STD-Hsieh-2011" TYPE="STUDY">Hsieh 2011</LINK>; <LINK REF="STD-Hsieh-2014" TYPE="STUDY">Hsieh 2014</LINK>; <LINK REF="STD-Hwang-2012" TYPE="STUDY">Hwang 2012</LINK>; <LINK REF="STD-Kahn-2006" TYPE="STUDY">Kahn 2006</LINK>; <LINK REF="STD-Liao-2011" TYPE="STUDY">Liao 2011</LINK>; <LINK REF="STD-Lum-2006" TYPE="STUDY">Lum 2006</LINK>; <LINK REF="STD-Masiero-2011" TYPE="STUDY">Masiero 2011</LINK>; <LINK REF="STD-Mayr-2008" TYPE="STUDY">Mayr 2008</LINK>; <LINK REF="STD-McCabe-2015" TYPE="STUDY">McCabe 2015</LINK>; <LINK REF="STD-Rabadi-2008" TYPE="STUDY">Rabadi 2008</LINK>; <LINK REF="STD-Sale-2014" TYPE="STUDY">Sale 2014</LINK>; <LINK REF="STD-Timmermans-2014" TYPE="STUDY">Timmermans 2014</LINK>; <LINK REF="STD-Volpe-2000" TYPE="STUDY">Volpe 2000</LINK>; <LINK REF="STD-Volpe-2008" TYPE="STUDY">Volpe 2008</LINK>; <LINK REF="STD-Wu-2012" TYPE="STUDY">Wu 2012</LINK>; <LINK REF="STD-Yoo-2013" TYPE="STUDY">Yoo 2013</LINK>). The highest drop-out rate in the treatment group was 12% (five dropouts out of 41 participants; <LINK REF="STD-Conroy-2011" TYPE="STUDY">Conroy 2011</LINK>). The highest drop-out rate in the control group was 14% (11 dropouts out of 78 participants; <LINK REF="STD-Lo-2010" TYPE="STUDY">Lo 2010</LINK>) and 16.7% (three dropouts out of 18 participants; <LINK REF="STD-Masiero-2011" TYPE="STUDY">Masiero 2011</LINK>). Only one study in the early acute phase after stroke reported deaths during the treatment period (<LINK REF="STD-Masiero-2007" TYPE="STUDY">Masiero 2007</LINK>). However, as explained by the authors via email correspondence, both deaths occurred in the control group. Other reasons for dropouts were:</P>
<UL>
<LI>personal reasons (treatment group) (<LINK REF="STD-Daly-2005" TYPE="STUDY">Daly 2005</LINK>);</LI>
<LI>personal reasons (control group) (<LINK REF="STD-Housman-2009" TYPE="STUDY">Housman 2009</LINK>);</LI>
<LI>withdrew (treatment group) (<LINK REF="STD-Abdullah-2011" TYPE="STUDY">Abdullah 2011</LINK>; <LINK REF="STD-Klamroth_x002d_Marganska-2014" TYPE="STUDY">Klamroth-Marganska 2014</LINK>);</LI>
<LI>withdrew (control group) (<LINK REF="STD-Klamroth_x002d_Marganska-2014" TYPE="STUDY">Klamroth-Marganska 2014</LINK>);</LI>
<LI>injured arm in daily life (treatment group) (<LINK REF="STD-Housman-2009" TYPE="STUDY">Housman 2009</LINK>);</LI>
<LI>depression (control group) (<LINK REF="STD-Housman-2009" TYPE="STUDY">Housman 2009</LINK>);</LI>
<LI>refusing therapy (treatment group) (<LINK REF="STD-Hesse-2005" TYPE="STUDY">Hesse 2005</LINK> <LINK REF="STD-Klamroth_x002d_Marganska-2014" TYPE="STUDY">Klamroth-Marganska 2014</LINK>);</LI>
<LI>medical complications (treatment group) (<LINK REF="STD-Conroy-2011" TYPE="STUDY">Conroy 2011</LINK>; <LINK REF="STD-Lum-2002" TYPE="STUDY">Lum 2002</LINK>);</LI>
<LI>medical reasons (control group) (<LINK REF="STD-Klamroth_x002d_Marganska-2014" TYPE="STUDY">Klamroth-Marganska 2014</LINK>);</LI>
<LI>exclusion (control group) (<LINK REF="STD-Lum-2002" TYPE="STUDY">Lum 2002</LINK>);</LI>
<LI>lost to follow-up (control group) (<LINK REF="STD-Susanto-2015" TYPE="STUDY">Susanto 2015</LINK>);</LI>
<LI>unable to travel (<LINK REF="STD-Lo-2010" TYPE="STUDY">Lo 2010</LINK>) or transportation difficulties (treatment group) (<LINK REF="STD-Kutner-2010" TYPE="STUDY">Kutner 2010</LINK>);</LI>
<LI>limited data (<LINK REF="STD-Conroy-2011" TYPE="STUDY">Conroy 2011</LINK>; <LINK REF="STD-Hsieh-2014" TYPE="STUDY">Hsieh 2014</LINK>);</LI>
<LI>moved (<LINK REF="STD-Conroy-2011" TYPE="STUDY">Conroy 2011</LINK>; <LINK REF="STD-Housman-2009" TYPE="STUDY">Housman 2009</LINK>);</LI>
<LI>did not met inclusion criteria after study commencement (<LINK REF="STD-Brokaw-2014" TYPE="STUDY">Brokaw 2014</LINK>).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Safety: adverse events during the intervention period</HEADING>
<P>We did not carry out a pooled analysis because the reported rates of adverse events during the intervention period were rare and not related to the therapy (as described by the study authors). The reported adverse events were as described above: death in the control group, which was not related to the therapy (information as published by the study authors; <LINK REF="STD-Masiero-2007" TYPE="STUDY">Masiero 2007</LINK>); and two participants experienced medical complications in the treatment group (information as published by the study authors; <LINK REF="STD-Lum-2002" TYPE="STUDY">Lum 2002</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Sensitivity analysis: by trial methodology</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Activities of daily living</HEADING>
<P>To examine the robustness of the results, we specified variables in a sensitivity analysis that we believed could influence the size of effect observed (randomisation procedure, concealed allocation, and blinding of assessors) (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>). We did not investigate in this sensitivity analysis if selective reporting has an influence on the size of effect observed, because we did not find sufficient information to permit such a judgement.</P>
<SUBSECTION>
<HEADING LEVEL="5">All studies with description of randomisation procedure</HEADING>
<P>We included 11 trials with a total of 481 participants with an adequate description of the randomisation procedure. Electromechanical and robot-assisted arm training improved activities of daily living. The SMD (random-effects model) for activities of daily living was 0.41 (95% CI 0.22 to 0.59, P &lt; 0.0001, level of heterogeneity I² = 0%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">All studies with adequately concealed allocation</HEADING>
<P>We included six trials with a total of 188 participants with adequate concealment of allocation. Electromechanical and robot-assisted arm training improved activities of daily living. The SMD (random-effects model) for activities of daily living was 0.34 (95% CI 0.01 to 0.67, P = 0.04, level of heterogeneity I² = 17%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">All studies with blinded assessors</HEADING>
<P>Sixteen trials with a total of 640 participants had blinded assessors for the primary outcome. Electromechanical and robot-assisted arm training improved activities of daily living. The SMD (random-effects model) for activities of daily living was 0.31 (95% CI 0.07 to 0.54, P = 0.009, level of heterogeneity I² = 45%).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Arm function</HEADING>
<P>To examine the robustness of the results, we specified variables in a sensitivity analysis that we believed could influence the size of effect observed (randomisation procedure, concealed allocation, and blinding of assessors) (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="5">All studies with description of randomisation procedure</HEADING>
<P>We included 21 trials with a total of 737 participants with an adequate description of the randomisation procedure. Electromechanical and robot-assisted arm training improved impaired arm function. The SMD (random-effects model) for arm function was 0.33 (95% CI 0.15 to 0.52, P = 0.0005, level of heterogeneity I² = 28%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">All studies with adequately concealed allocation</HEADING>
<P>We included nine trials with a total of 335 participants with adequate concealment of allocation. Electromechanical and robot-assisted arm training improved impaired arm function. The SMD (random-effects model) for arm function was 0.42 (95% CI 0.14 to 0.69, P = 0.003, level of heterogeneity I² = 30%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">All studies with blinded assessors</HEADING>
<P>We included 28 trials with a total of 993 participants with blinded assessors. Electromechanical and robot-assisted arm training improved impaired arm function. The SMD (random-effects model) for arm function was 0.33 (95% CI 0.15 to 0.51, P = 0.0003, level of heterogeneity I² = 40%).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Subgroup analysis: by treatment approach</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Activities of daily living at the end of intervention phase: subgroup analysis by treatment approach</HEADING>
<P>The test for subgroup differences between a subgroup of participants who received mainly training for the distal arm and the hand (finger, hand, and radio-ulnar joints) and a subgroup of participants who received training mainly of the proximal arm (shoulder and elbow joints) revealed no significant difference (P = 0.47, level of heterogeneity I² = 0%; <LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Arm function at the end of intervention phase: subgroup analysis by treatment approach</HEADING>
<P>The test for subgroup differences between a subgroup of participants who received mainly training for the distal arm and the hand (finger, hand, and radio-ulnar joints) and a subgroup of participants who received training mainly of the proximal arm (shoulder and elbow joints) revealed no significant difference (P = 0.75, level of heterogeneity I² = 0%; <LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2015-10-30 14:54:02 +0000" MODIFIED_BY="Hazel Fraser">
<SUMMARY_OF_RESULTS MODIFIED="2015-10-30 14:09:38 +0000" MODIFIED_BY="Hazel Fraser">
<P>We included 34 trials (involving 1160 participants) in this update of our systematic review of the effects of electromechanical and robot-assisted therapy for improving activities of daily living, arm function, and arm muscle strength. We found that the use of electromechanical-assistive devices in rehabilitation settings may improve activities of daily living, arm function, and arm strength, but the quality of evidence was rated as low to very low. Furthermore, adverse events and dropouts were uncommon and did not appear to be more frequent in those participants who received electromechanical and robot-assisted arm training, graded with moderate-quality evidence. This indicates that the use of electromechanical and robot-assisted arm training devices could be safe and acceptable to most participants included in the trials that this review analysed.</P>
<P>Although the quality of evidence was very limited, there seems to be at least a potential benefit of electromechanical and robot-assisted arm training.</P>
<P>When looking at certain groups of participants, we found significant improvements of activities of daily living in the subgroup of participants treated in the acute and subacute phase. We did not find such improvements for participants treated in the chronic phase. However, our statistical subgroup comparison does not indicate that people in the acute or subacute phase after stroke may improve more than people in the chronic phase with respect to activities of daily living. Participants who received mainly training for the distal arm and the hand (finger, hand, and radio-ulnar joints) and participants who received training mainly of the proximal arm (shoulder and elbow joints) did not differ significantly with regard to activities of daily living and arm function.</P>
<P>Electromechanical and robot-assisted therapy uses devices simply as 'vehicles' to apply an increased intensity in terms of many repetitions of arm training (<LINK REF="REF-Kwakkel-2008" TYPE="REFERENCE">Kwakkel 2008</LINK>; <LINK REF="REF-Kwakkel-2015" TYPE="REFERENCE">Kwakkel 2015</LINK>). It seems unlikely that motor therapy provided by robots will lead to better results than motor therapy provided by humans under the premise that intensity, amount, and frequency of therapy are exactly comparable. The potential advantage of electromechanical devices, when compared with conventional therapies, may be an increase in repetitions during arm training and an increase of motivation to train. Additionally, because people using electromechanical and robot-assistance therapy are able to practise without a therapist, this type of training has the potential to increase the number of repetitions of practise. However, in our analysis of the included studies in this review update, we were not able to compare different amounts of repetitions of arm training. The amount of repetitions and also the exact intensity, time, dose, amount, and frequency of applied therapies were not described in detail in most of the studies included here. However, almost all of the included studies (but not <LINK REF="STD-Yoo-2013" TYPE="STUDY">Yoo 2013</LINK>) had an active control group, and most studies matched the time for therapy between in-treatment and control groups. One could therefore argue that robot-assisted arm therapy after stroke is more effective in improving activities of daily living, arm function, and arm strength than other interventions if the same time of practise is offered. Then again, as mentioned above, it could just be that more repetitions in the same time were applied by robotic-assisted arm training (higher dose). This appears to be an important issue that should be taken into account when discussing the effectiveness of electromechanical and robot-assisted therapy for improving activities of daily living, arm function, and arm muscle strength.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2015-10-30 14:52:59 +0000" MODIFIED_BY="Hazel Fraser">
<P>The results of this review seem to be quite generalisable for settings in industrialised countries and especially for rehabilitation centres with available electromechanical and robot-assisted devices. However, the following factors produce uncertainty.</P>
<UL>
<LI>Most of the studies included participants with first-ever stroke.</LI>
<LI>The majority of participants suffered from ischaemic stroke.</LI>
<LI>Nearly all of the participants were right-handed.</LI>
<LI>The quality of evidence was rated as low to very low.</LI>
<LI>The exclusion of certain patient groups, such as people with unstable cardiovascular conditions, cognitive and communication deficits, or with a limited range of motion in the arm joints at the start of the intervention (it is well known that limited range of motion is common after stroke).</LI>
</UL>
<P>Hence, the results may be of limited applicability for people with recurrent stroke, haemorrhagic stroke, and people who are left-handed. There is currently insufficient moderate- or high-quality evidence to make conclusions about the benefits of robot therapy for improving activities of daily living, arm function, and arm muscle strength. However, as we found no evidence of side effects or harm, further research into this type of therapy appears to be justified.</P>
<P>The relatively tight selection criteria that have been applied to many studies should be considered. For example, the relatively younger age of people who were studied should be recognised, and also many of the people studied had no limitations of passive range of motion or were free of shoulder pain. It is well known in clinical practice that people are older and that the prevalence of comorbidities, such as pain, spasticity, or limitations to range of motion, is expected to be higher than described in the studies included here.</P>
<P>Additionally, electromechanical and robot-assisted training could create additional costs of rehabilitation after stroke. The general applicability of robot therapy might therefore be limited simply due to lack of access of devices, for example in many low-income countries, and there also appears to be fewer opportunities for therapists and patients to access robots in outpatient than in inpatient settings. All these points taken together might limit the applicability of this type of therapy in day-to-day clinical routine.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2015-10-30 14:09:50 +0000" MODIFIED_BY="Hazel Fraser">
<P>We found heterogeneity regarding trial design (parallel-group or cross-over design, two or three or more intervention groups), therapy variables (type of device, bilateral or unilateral assistance, proximal or distal assistance, dosage of therapy), and participant characteristics (age, time poststroke, and severity of arm paresis).</P>
<P>There were enough studies to perform our planned sensitivity analysis examining the effects of methodological quality on the effectiveness of the intervention. We found that the effects of electromechanical-assistive devices for improving activities of daily living and for improving arm function were quite stable and not affected by methodological quality (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>; <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>).</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2015-10-30 14:54:02 +0000" MODIFIED_BY="Hazel Fraser">
<P>The methodological rigour of Cochrane Reviews minimises bias in the process of conducting systematic reviews. A risk of publication bias, however, is present in all systematic reviews.</P>
<P>We searched extensively for relevant literature in databases and handsearched conference abstracts. Additionally, we contacted authors, trialists, and experts in the field for other unpublished and ongoing trials. We were unable to find graphical evidence for publication bias using funnel plots. There was heterogeneity between the trials in terms of trial design (two groups, four groups, parallel-group or cross-over trial, duration of study and follow-up, and selection criteria for participants), characteristics of the therapy interventions (especially device used), and participant characteristics (length of time since stroke onset). There were also methodological differences in the mechanism of randomisation and allocation concealment methods used and blinding of primary outcomes.</P>
<P>After examination of the influence of methodological quality on the observed effect on activities of daily living and arm function, we did not find a change of benefit when we removed trials with unclear randomisation or allocation concealment procedures or unclear blinding.</P>
<P>While the methodological quality of the included trials was in general good to very good, although heterogeneous (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>), trials investigating electromechanical and robot-assisted arm training are subject to potential methodological limitations. These limitations include inability to blind the therapist and participants, so-called contamination (provision of the intervention to the control group), and co-intervention (when the same therapist unintentionally provides additional care to either treatment or comparison group). All these potential methodological limitations introduce the possibility of performance bias. However, as discussed above, our sensitivity analyses by methodological quality did not support this.</P>
<P>Some of the statistical analyses used in the review are based on parametric statistics. However, one could argue that it might not be appropriate to treat some scores for activities of daily living (for example Barthel Index score ranging from 0 to 100) and arm function (for example Fugl-Meyer score ranging from 0 to 66) included in this review with this approach. Most of these scores were used in the included trials as continuous scales, and by others as ordinal scaled scores. However, it is unclear how this has led to an over- or underestimation of our described treatment effects.</P>
<P>As is always the case in systematic reviews, a so-called publication bias could have potentially affected our results. The visual inspection of funnel plots for our main outcomes did not show evidence of publication bias (<LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>; <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>; <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>), however this does not mean the complete absence of publication bias. Publication bias could therefore potentially be an issue, but it is unclear if this has led to an overestimation of our described treatment effects.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2015-10-30 14:10:06 +0000" MODIFIED_BY="Hazel Fraser">
<P>As far as we know, no other systematic reviews of RCTs about electromechanical and robot-assisted therapy for improving activities of daily living, arm function, and arm muscle strength have been conducted in the last three years. The most recent systematic review of this topic was done in 2008 (<LINK REF="REF-Kwakkel-2008" TYPE="REFERENCE">Kwakkel 2008</LINK>). However, there are other systematic reviews within the context of our review.</P>
<P>A systematic review about the evidence of physiotherapy also searched for the effect of robotic training of different segments of the arm (<LINK REF="REF-Veerbeek-2014" TYPE="REFERENCE">Veerbeek 2014</LINK>). The authors found 22 studies including a total of 648 participants investigating robotic arm training. Veerbeek and colleagues found small-to-moderate effect sizes for bilateral elbow-wrist robotic training (four studies) compared with studies with robotic training for the shoulder, elbow, wrist, and hand. The study authors classified robotic devices on the basis of the joints they target: 1) shoulder-elbow robots, 2) elbow-wrist robots, and 3) shoulder-elbow-wrist-hand robots, but they did not compare effect sizes (<LINK REF="REF-Veerbeek-2014" TYPE="REFERENCE">Veerbeek 2014</LINK>). In our review, compared to <LINK REF="REF-Veerbeek-2014" TYPE="REFERENCE">Veerbeek 2014</LINK>, the corresponding effect sizes and the differences in effect sizes between the different treatment approaches were lower. However, we were able to identify 34 trials including a total of 1160 participants. We therefore believe that our review has used a more sensitive search and hence shows a more comprehensive picture of the evidence.</P>
<P>Another up-to-date review also included trials using robotic training in combination with other interventions for people with stroke (<LINK REF="REF-Laver-2015" TYPE="REFERENCE">Laver 2015</LINK>). However, the authors specifically investigated the efficacy of virtual reality compared with an alternative intervention or no intervention on upper limb function and activity.</P>
<P>
<BR/>
</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2015-10-30 14:10:14 +0000" MODIFIED_BY="Hazel Fraser">
<IMPLICATIONS_PRACTICE MODIFIED="2015-10-30 14:10:09 +0000" MODIFIED_BY="Hazel Fraser">
<P>We found that people after stroke who receive electromechanical or robot-assisted arm training are more likely to show improvement in their activities of daily living, arm function, and muscle strength of the paretic arm, but we rated the quality of evidence as low to very low.</P>
<P>In practice, electromechanical or robot-assisted arm training could increase the intensity of arm therapy. Perhaps more repetitions in the same time of therapy can be achieved if electromechanical and robot-assisted therapy is given. Electromechanical devices could therefore be used as an adjunct to conventional therapies.</P>
<P>However, it is still not clear if the difference between electromechanical or robot-assisted arm training and other interventions is clinically meaningful for most people. Perhaps one main difference between electromechanical or robot-assisted arm training and other interventions could be an improvement in motivation due to the feedback of the device, or the novelty of a robotic device, or both. However, we can only speculate about this.<BR/>
</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2015-10-30 14:10:14 +0000" MODIFIED_BY="Hazel Fraser">
<P>There is still a need for well-designed, large-scale, multicentre studies to evaluate benefits and harms of electromechanical-assisted arm training after stroke. Further research should count the amount of repetitions in time and address specific questions about the type, timing, frequency, and duration of electromechanical and robot-assisted arm training. Further research should also investigate whether or not there is any benefit over and above the amount of practice, for example if it would be useful or not if a robot prevents 'incorrect learning or movements'. Additionally, improved reporting of trial methods and the use of published reporting guidelines for trials are essential.</P>
<P>It may be useful if future studies could use arm function-specific outcome measures and measures of repetitions during training to gain a better understanding of the explicit effects of this special form of training.</P>
<P>The heterogeneity of training dose could be seen as a limitation of this review. Future studies should therefore describe the total training time and dose and should also describe the personnel supervising participants during training.</P>
<P>Future studies should also investigate the most severely affected people and groups, who are not reflected so far in the existing trials.</P>
<P>We found a drop-out rate of less than 5%. Future studies could determine their sample size calculations based on this drop-out rate.<BR/>
</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2015-10-30 14:10:20 +0000" MODIFIED_BY="Hazel Fraser">
<P>We thank Brenda Thomas for her help in developing the search strategy and providing us with relevant trials and systematic reviews from MEDLINE, EMBASE, CINAHL, AMED, SPORTDiscus, Compendex, and Inspec; Hazel Fraser for her helpful support in proofreading the manuscript and providing us with relevant trials and systematic reviews from the Cochrane Stroke Group Trials Register; Gabi Voigt for providing us with many useful studies. We thank all the authors and investigators who provided us with additional or unpublished information about their trials. We thank the German federal Competence Network Stroke (www.kompetenznetz-schlaganfall.de).</P>
<P>We are grateful to the editors, the consumer reviewers (Kedar K Mate and Heather Goodare), and the peer reviewers (Professor Peter Langhorne, Dr Alex Pollock, Dr Valentina Assi, Brenda Thomas, Dr Gerald Fluet, and Dr Hanna Persson) for their comments on this updated review.<BR/>
</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2015-10-30 14:10:33 +0000" MODIFIED_BY="Hazel Fraser">
<P>Jan Mehrholz: was a co-author of one included trial (<LINK REF="STD-Hesse-2005" TYPE="STUDY">Hesse 2005</LINK>). He did not participant in the quality assessment or data extraction of this study.<BR/>Marcus Pohl: was a co-author of one included trial (<LINK REF="STD-Hesse-2005" TYPE="STUDY">Hesse 2005</LINK>). He did not participant in the quality assessment or data extraction of this study.<BR/>Thomas Platz: none known.<BR/>Joachim Kugler: none known.<BR/>Bernhard Elsner: none known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2015-10-30 14:10:31 +0000" MODIFIED_BY="Hazel Fraser">
<P>Jan Mehrholz contributed to the conception and design of the protocol and approved the final manuscript. He searched electronic databases and conference proceedings, screened titles and abstracts of publications identified by the search, selected and assessed trials, extracted trial and outcome data, guided the analysis and interpretation of the data, and contributed to and approved the final manuscript of the review.</P>
<P>Marcus Pohl extracted trial and outcome data, contributed to the conception and design of the review, and drafted the protocol. Together with Jan Mehrholz, he contacted trialists about unpublished data and also entered the data, carried out statistical analysis, helped with the interpretation of the data, drafted the review, and approved the final manuscript of the review.</P>
<P>Thomas Platz contributed to the interpretation of the data and approved the final manuscript of the review.</P>
<P>Joachim Kugler assessed and extracted trial and outcome data, assessed the methodological quality of selected trials, contributed to the interpretation of the data, and contributed to and approved the final manuscript of the review.</P>
<P>Bernhard Elsner searched electronic databases and conference proceedings, screened titles and abstracts of publications identified by the search, selected and assessed trials, extracted trial data, guided the analysis and the interpretation of the data, and contributed to and approved the final manuscript of the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2015-10-30 14:10:45 +0000" MODIFIED_BY="Hazel Fraser">
<P>In our protocol we stated that we would use the PEDro scale to assess the methodological quality of the included trials. However, in Chapter 8 of the latest edition of the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>), it is suggested that scales that yield a summary score should be avoided. We therefore have not used the PEDro scale to assess the methodological quality of the included trials, but used the Cochrane 'Risk of bias' tool instead.</P>
<P>In our protocol we planned to quantify heterogeneity with the I² statistic and to use a cutoff of I² = 50% for all comparisons. Additonally, we planned to calculate the overall effects using a random-effects model instead of a fixed-effect model when we found substantial heterogeneity. However, in this update we calculated the overall effects using a random-effects model regardless of the level of heterogeneity.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2015-11-02 12:24:55 +0000" MODIFIED_BY="Hazel Fraser">
<STUDIES MODIFIED="2015-11-02 12:24:55 +0000" MODIFIED_BY="Hazel Fraser">
<INCLUDED_STUDIES MODIFIED="2015-11-02 11:45:56 +0000" MODIFIED_BY="Hazel Fraser">
<STUDY DATA_SOURCE="PUB" ID="STD-Abdullah-2011" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="Abdullah 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-05-29 09:16:25 +0100" MODIFIED_BY="Jan Mehrholz" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Abdullah HA, Tarry C, Lambert C, Barreca S, Allen BO</AU>
<TI>Results of clinicians using a therapeutic robotic system in an inpatient stroke rehabilitation unit</TI>
<SO>Journal of NeuroEngineering and Rehabilitation</SO>
<YR>2011</YR>
<VL>8</VL>
<PG>50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;RP - NOT IN FILE&lt;br&gt;M1 - 101232233 L2 - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;amp;PAGE=reference&amp;amp;D=medl&amp;amp;NEWS=N&amp;amp;AN=21871095&lt;/p&gt;" NOTES_MODIFIED="2015-10-30 14:18:34 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Tarry C, Lambert C, Barreca S, Allen BO</AU>
<TI>Results of clinicians using a therapeutic robotic system in an inpatient stroke rehabilitation unit</TI>
<SO>Journal of NeuroEngineering and Rehabilitation</SO>
<YR>2011</YR>
<VL>8</VL>
<PG>50</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1399"/>
<IDENTIFIER TYPE="OTHER" VALUE="1743-0003"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Amirabdollahian-2007" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="Amirabdollahian 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Amirabdollahian F, Loureiro R, Gradwell E, Collin C, Harwin W, Johnson G</AU>
<TI>Multivariate analysis of the Fugl-Meyer outcome measures assessing the effectiveness of GENTLE/S robot-mediated stroke therapy</TI>
<SO>Journal of NeuroEngineering and Rehabilitation</SO>
<YR>2007</YR>
<VL>4</VL>
<PG>4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-06 14:09:52 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Coote S, Murphy BT, Stokes EK</AU>
<TI>The effect of robot mediated therapy on upper extremity function post stroke</TI>
<SO>14th International Congress of the World Confederation for Physical Therapy, Barcelona, Spain</SO>
<YR>2003</YR>
<PB>World Confederation for Physical Therapy</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Coote S, Stokes EK</AU>
<TI>The effect of robot mediated therapy on upper extremity function following stroke - initial results</TI>
<SO>Irish Journal of Medical Science</SO>
<YR>2003</YR>
<VL>172</VL>
<NO>2</NO>
<PG>26-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ang-2014" MODIFIED="2015-10-06 14:11:56 +0100" MODIFIED_BY="Hazel Fraser" NAME="Ang 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-10-06 14:11:30 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;Cochrane ID: CN-00998848 EMBASE 2014514907 Journal: Article Record Available: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/848/CN-00998848/frame.html&lt;br&gt;RP - NOT IN FILE&lt;/p&gt;" NOTES_MODIFIED="2015-10-06 14:11:30 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="OTHER">
<AU>Ang KK, Guan C, Phua KS, Wang C, Zhou L, Tang KY, et al</AU>
<TI>Brain-computer interface-based robotic end effector system for wrist and hand rehabilitation: Results of a three-armed randomized controlled trial for chronic stroke</TI>
<SO>Frontiers in Neuroengineering.</SO>
<YR>2014</YR>
<VL>7</VL>
<PG>30</PG>
<IDENTIFIERS MODIFIED="2015-10-06 14:11:30 +0100" MODIFIED_BY="Hazel Fraser"/>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-06 14:11:56 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;SERC Grant No: 092 148 0066&lt;br&gt;January 2011&lt;br&gt;June 2013&lt;/p&gt;" NOTES_MODIFIED="2015-10-06 14:11:56 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01287975</AU>
<TI>Brain computer interface (BCI) technology for stroke hand rehabilitation</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT01287975</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brokaw-2014" MODIFIED="2015-10-06 14:12:35 +0100" MODIFIED_BY="Hazel Fraser" NAME="Brokaw 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-10-06 14:12:20 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Brokaw EB, Nichols D, Holley RJ, Lum PS</AU>
<TI>Robotic therapy provides a stimulus for upper limb motor recovery after stroke that is complementary to and distinct from conventional therapy</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2014</YR>
<VL>28</VL>
<NO>4</NO>
<PG>367-76</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-06 14:12:35 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;B4719-R&lt;br&gt;June 2010&lt;br&gt;May 2012&lt;/p&gt;" NOTES_MODIFIED="2015-10-06 14:12:35 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT00995774</AU>
<TI>Extension of the MIME robotic system for stroke rehabilitation</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT00995774</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burgar-2011" MODIFIED="2015-10-06 14:13:09 +0100" MODIFIED_BY="Hazel Fraser" NAME="Burgar 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-04-10 09:16:55 +0100" MODIFIED_BY="Bernhard Elsner" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Burgar CG, Lum PS, Scremin AM, Garber SL, Van der Loos HF, Kenney D, et al</AU>
<TI>Robot-assisted upper-limb therapy in acute rehabilitation setting following stroke: Department of Veterans Affairs multisite clinical trial</TI>
<SO>Journal of Rehabilitation Research and Development</SO>
<YR>2011</YR>
<VL>48</VL>
<NO>4</NO>
<PG>445-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-06 14:13:09 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;B2156&lt;br&gt;January 2000&lt;br&gt;December 2003&lt;/p&gt;" NOTES_MODIFIED="2015-10-06 14:13:09 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT00011583</AU>
<TI>Robot assisted upper limb neuro-rehabilitation</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT00011583</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Conroy-2011" MODIFIED="2015-04-10 09:17:21 +0100" MODIFIED_BY="Bernhard Elsner" NAME="Conroy 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-04-10 09:17:21 +0100" MODIFIED_BY="Bernhard Elsner" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Conroy SS, Whitall J, Dipietro L, Jones-Lush LM, Zhan M, Finley MA, et al</AU>
<TI>Effect of gravity on robot-assisted motor training after chronic stroke: a randomized trial</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2011</YR>
<VL>92</VL>
<NO>11</NO>
<PG>1754-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-03-31 08:57:42 +0100" MODIFIED_BY="Jan Mehrholz" PRIMARY="NO" TYPE="OTHER">
<AU>NCT00333983</AU>
<TI>Evaluation of robotic arm rehabilitation in stroke patients</TI>
<SO>http://clinicaltrials.gov/ct2/show/NCT00333983</SO>
<YR>(accessed 1 August 2011)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Daly-2005" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="Daly 2005" YEAR="2005">
<REFERENCE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;0748-7711 (Print)&lt;/p&gt;" NOTES_MODIFIED="2015-10-30 14:18:34 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Daly JJ, Hogan N, Perepezko EM, Krebs HI, Rogers JM, Goyal KS, et al</AU>
<TI>Response to upper-limb robotics and functional neuromuscular stimulation following stroke</TI>
<SO>Journal of Rehabilitation Research and Development</SO>
<YR>2005</YR>
<VL>42</VL>
<NO>6</NO>
<PG>723-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fazekas-2007" MODIFIED="2012-03-15 14:19:24 +0000" MODIFIED_BY="Hazel Fraser" NAME="Fazekas 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-03-15 14:19:24 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fazekas G, Horvath M, Troznai T, Toth A</AU>
<TI>Robot-mediated upper limb physiotherapy for patients with spastic hemiparesis: a preliminary study</TI>
<SO>Journal of Rehabilitation Medicine</SO>
<YR>2007</YR>
<VL>39</VL>
<NO>7</NO>
<PG>580-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hesse-2005" MODIFIED="2008-07-11 13:48:25 +0100" MODIFIED_BY="Hazel Fraser" NAME="Hesse 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-07-11 13:48:25 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;1524-4628 (Electronic)&lt;/p&gt;" NOTES_MODIFIED="2008-07-11 13:48:25 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hesse S, Werner C, Pohl M, Rueckriem S, Mehrholz J, Lingnau ML</AU>
<TI>Computerized arm training improves the motor control of the severely affected arm after stroke: a single-blinded randomized trial in two centers</TI>
<SO>Stroke</SO>
<YR>2005</YR>
<VL>36</VL>
<NO>9</NO>
<PG>1960-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hesse-2014" MODIFIED="2015-10-30 09:48:18 +0000" MODIFIED_BY="[Empty name]" NAME="Hesse 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-10-30 09:48:18 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;Cochrane ID: CN-00995423 EMBASE 2014425107 Journal: Article Record Available: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/423/CN-00995423/frame.html&lt;br&gt;RP - NOT IN FILE&lt;/p&gt;" NOTES_MODIFIED="2015-10-30 09:48:18 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Hesse S, Buschfort R, Hess A, Kabbert N, Werner C</AU>
<TI>Effect on arm function and cost of robot-assisted group therapy in subacute patients with stroke and a moderately to severely affected arm: A randomized controlled trial [German]</TI>
<SO>Neurologie und Rehabilitation</SO>
<YR>2014</YR>
<VL>20</VL>
<NO>2</NO>
<PG>67-73</PG>
<IDENTIFIERS MODIFIED="2015-10-30 09:48:18 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="MEDLINE" VALUE="9"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-06 14:15:22 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;Accession Number: 96423545; Author: Hesse, Stefan: 1 Author: He*Y, Anke: 2 Author: Werner C, Cordula: 1 Author: Kabbert, Nadine: 1 Author: Buschfort, R**diger: 2 ; Author Affiliation: 1 Medical Park Berlin, Department of Neurological Rehabilitation, Charit** University, Berlin, Germany: 2 Klinik am Stein, Zentrum f**r NeuroGeriatrie und Rehabilitationsmedizin, Olsberg, Germany; No. of Pages: 11; Language: English; Publication Type: Article; Update Code: 20140612&lt;br&gt;RP - NOT IN FILE&lt;/p&gt;" NOTES_MODIFIED="2015-10-06 14:15:22 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="OTHER">
<AU>Hesse S, Heß A, Werner C, Kabbert N, Buschfort RÇ</AU>
<TI>Effect on arm function and cost of robot-assisted group therapy in subacute patients with stroke and a moderately to severely affected arm: a randomized controlled trial</TI>
<SO>Clinical Rehabilitation</SO>
<YR>2014</YR>
<VL>28</VL>
<NO>7</NO>
<PG>637-47</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="2874"/>
<IDENTIFIER TYPE="OTHER" VALUE="02692155"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hollenstein-2011" MODIFIED="2015-10-06 14:15:55 +0100" MODIFIED_BY="Hazel Fraser" NAME="Hollenstein 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-10-06 14:15:55 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hollenstein C, Cabri C</AU>
<TO>Zusatztherapie mit computerunterstütztem Trainingssystem im Vergleich zu ergotherapeutischer Armgruppentherapie</TO>
<SO>Neuroreha</SO>
<YR>2011</YR>
<VL>3</VL>
<NO>1</NO>
<PG>40-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Housman-2009" MODIFIED="2015-10-30 09:52:17 +0000" MODIFIED_BY="[Empty name]" NAME="Housman 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-03-15 14:19:24 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Housman SJ, Scott KM, Reinkensmeyer DJ</AU>
<TI>A randomized controlled trial of gravity-supported, computer-enhanced arm exercise for individuals with severe hemiparesis</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2009</YR>
<VL>23</VL>
<NO>5</NO>
<PG>505-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hsieh-2011" MODIFIED="2015-10-06 14:16:06 +0100" MODIFIED_BY="Hazel Fraser" NAME="Hsieh 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-10-06 14:16:06 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hsieh YW, Wu CY, Liao WW, Lin KC, Wu KY, Lee CY</AU>
<TI>Effects of treatment intensity in upper limb robot-assisted therapy for chronic stroke: a pilot randomized controlled trial</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2011</YR>
<VL>25</VL>
<NO>6</NO>
<PG>503-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hsieh-2014" MODIFIED="2015-10-06 14:16:30 +0100" MODIFIED_BY="Hazel Fraser" NAME="Hsieh 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-10-06 14:16:30 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hsieh YW, Lin KC, Horng YS, Wu CY, Wu TC, Ku FL</AU>
<TI>Sequential combination of robot-assisted therapy and constraint-induced therapy in stroke rehabilitation: a randomized controlled trial</TI>
<SO>Journal of Neurology</SO>
<YR>2014</YR>
<VL>261</VL>
<NO>5</NO>
<PG>1037-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hwang-2012" MODIFIED="2015-10-06 14:17:13 +0100" MODIFIED_BY="Hazel Fraser" NAME="Hwang 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-10-06 14:16:54 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;Cochrane ID: CN-00970874 PUBMED 22261813 Journal Article Randomized Controlled Trial Record Available: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/874/CN-00970874/frame.html&lt;br&gt;RP - NOT IN FILE&lt;/p&gt;" NOTES_MODIFIED="2015-10-06 14:16:54 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="OTHER">
<AU>Hwang CH, Seong JW, Son DS</AU>
<TI>Individual finger synchronized robot-assisted hand rehabilitation in subacute to chronic stroke: a prospective randomized clinical trial of efficacy</TI>
<SO>Clinical Rehabilitation</SO>
<YR>2012</YR>
<VL>26</VL>
<NO>8</NO>
<PG>696-704</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="137"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-06 14:17:13 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;Cochrane ID: CN-00856504 CC: SR-STROKE Record Available: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/504/CN-00856504/frame.html&lt;br&gt;RP - NOT IN FILE&lt;/p&gt;" NOTES_MODIFIED="2015-10-06 14:17:13 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Hwang CH</AU>
<TI>Individual-finger-synchronized-robot-assisted hand rehabilitation in sub-acute to chronic stroke; a prospective randomized clinical trial of efficacy</TI>
<SO>Brain Injury</SO>
<YR>2012</YR>
<VL>26</VL>
<NO>4-5</NO>
<PG>444-5</PG>
<IDENTIFIERS MODIFIED="2015-04-08 12:02:49 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER TYPE="MEDLINE" VALUE="223"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kahn-2006" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="Kahn 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-03-15 14:19:24 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="BOOK_SECTION">
<AU>Kahn L, Averbuch M, Rymer W, Reinkensmeyer J</AU>
<TI>Comparison of robot-assisted reaching to free reaching in promoting recovery from chronic stroke</TI>
<SO>Integration of Assistive Technology in the Information Age</SO>
<YR>2001</YR>
<PG>39-44</PG>
<ED>Mokhtari M</ED>
<PB>IOS Press</PB>
<CY>Amsterdam</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kahn L, Zygman M, Rymer W, Reinkensmeyer D</AU>
<TI>Robot-assisted reaching exercise promotes arm recovery in chronic hemiparetic stroke: a randomized controlled pilot study</TI>
<SO>Journal of NeuroEngineering and Rehabilitation</SO>
<YR>2006</YR>
<VL>3</VL>
<PG>12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Klamroth_x002d_Marganska-2014" MODIFIED="2015-11-02 10:47:04 +0000" MODIFIED_BY="Hazel Fraser" NAME="Klamroth-Marganska 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Klamroth-Marganska V, Blanco J, Campen K, Curt A, Dietz V, Ettlin T, et al</AU>
<TI>Three-dimensional, task-specific robot therapy of the arm after stroke: a multicentre, parallel-group randomised trial</TI>
<SO>The Lancet Neurology</SO>
<YR>2014</YR>
<VL>13</VL>
<NO>2</NO>
<PG>159-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-11-02 10:24:41 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;SNF ARMin III -1|SNF 325200-120621|EK-39/2007&lt;br&gt;July 2008&lt;br&gt;September 2012&lt;/p&gt;" NOTES_MODIFIED="2015-11-02 10:24:41 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT00719433</AU>
<TI>Functional recovery in stroke patients with task-specific robot-aided arm therapy</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT00719433</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-11-02 10:47:04 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Riener R</AU>
<TI>Exoskeletal arm robotics for stroke rehabilitation: what are the chances?</TI>
<SO>1st European NeuroRehabilitation Congress, 20-22 October, 2011</SO>
<YR>2011</YR>
<PG>32</PG>
<PB>ENCR</PB>
<CY>Merano, Italy</CY>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="NCT00719433"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kutner-2010" MODIFIED="2015-11-02 11:06:42 +0000" MODIFIED_BY="Hazel Fraser" NAME="Kutner 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-03-31 09:05:09 +0100" MODIFIED_BY="Jan Mehrholz" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kutner NG, Zhang R, Butler AJ, Wolf SL, Alberts JL</AU>
<TI>Quality-of-life change associated with robotic-assisted therapy to improve hand motor function in patients with subacute stroke: a randomized clinical trial</TI>
<SO>Physical Therapy</SO>
<YR>2010</YR>
<VL>90</VL>
<NO>4</NO>
<PG>493-504</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-11-02 11:06:42 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT00729625</AU>
<TI>Air muscle and task practice in upper limb stroke rehab</TI>
<SO>clinicaltrials.gov/show/NCT00729625</SO>
<YR>(accessed 1 August 2011)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-03-31 09:03:53 +0100" MODIFIED_BY="Jan Mehrholz" PRIMARY="NO" TYPE="OTHER">
<AU>Stein J</AU>
<TI>Air muscle and task practice in upper limb stroke rehab. Study of neurological recovery with robotic aids</TI>
<SO>http://www.strokecenter.org/trials/clinicalstudies/air-muscle-and-task-practice-in-upper-limb-stroke-rehab</SO>
<YR>(accessed 1 August 2011)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liao-2011" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="Liao 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;Cochrane ID: CN-00812250 PUBMED 21436390 Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't CC: SR-STROKE DOI: 10.1177/1545968310394871 Record Available: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/250/CN-00812250/frame.html&lt;br&gt;RP - NOT IN FILE&lt;/p&gt;" NOTES_MODIFIED="2015-10-30 14:18:34 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Hsieh YW, Wu CY, Liao WW, Lin KC, Wu KY, Lee CY</AU>
<TI>Effects of treatment intensity in upper limb robot-assisted therapy for chronic stroke: a pilot randomized controlled trial</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2011</YR>
<VL>25</VL>
<NO>6</NO>
<PG>503-11</PG>
<IDENTIFIERS MODIFIED="2015-04-08 11:53:23 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER TYPE="MEDLINE" VALUE="254"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-06 14:20:49 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;RP - NOT IN FILE&lt;br&gt;M1 - cr7, 8802181 L2 - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;amp;PAGE=reference&amp;amp;D=medl&amp;amp;NEWS=N&amp;amp;AN=21840917&lt;/p&gt;" NOTES_MODIFIED="2015-10-06 14:20:49 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="OTHER">
<AU>Liao WW, Wu CY, Hsieh YW, Lin KC, Chang WY</AU>
<TI>Effects of robot-assisted upper limb rehabilitation on daily function and real-world arm activity in patients with chronic stroke: a randomized controlled trial</TI>
<SO>Clinical Rehabilitation</SO>
<YR>2012</YR>
<VL>26</VL>
<NO>2</NO>
<PG>111-20</PG>
<IDENTIFIERS MODIFIED="2015-04-08 11:53:23 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER TYPE="MEDLINE" VALUE="1321"/>
<IDENTIFIER TYPE="OTHER" VALUE="1477-0873"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lo-2010" MODIFIED="2015-11-02 11:07:33 +0000" MODIFIED_BY="Hazel Fraser" NAME="Lo 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lo AC, Guarino PD, Richards LG, Haselkorn JK, Wittenberg GF, Federman DG, et al</AU>
<TI>Robot-assisted therapy for long-term upper-limb impairment after stroke</TI>
<SO>The New England Journal of Medicine</SO>
<YR>2010</YR>
<VL>362</VL>
<NO>19</NO>
<PG>1772-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-11-02 11:07:33 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT00372411</AU>
<TI>Robotic assisted upper-limb neurorehabilitation in stroke patients</TI>
<SO>http://clinicaltrials.gov/ct2/show/NCT00372411</SO>
<YR>(accessed 1 August 2011)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lum-2002" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="Lum 2002" YEAR="2002">
<REFERENCE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;Ref 5799&lt;/p&gt;" NOTES_MODIFIED="2015-10-30 14:18:34 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burgar C, Lum P, Shor P, Van der Loos H</AU>
<TI>Development of robots for rehabilitation therapy: the Palo Alto VA/Stanford experience</TI>
<SO>Journal of Rehabilitation Research and Development</SO>
<YR>2000</YR>
<VL>37</VL>
<NO>6</NO>
<PG>663-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;0003-9993 (Print)&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lum PS, Burgar CG, Shor PC, Majmundar M, Van der Loos M</AU>
<TI>Robot-assisted movement training compared with conventional therapy techniques for the rehabilitation of upper-limb motor function after stroke</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2002</YR>
<VL>83</VL>
<NO>7</NO>
<PG>952-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lum-2006" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="Lum 2006" YEAR="2006">
<REFERENCE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;0748-7711 (Print)&lt;/p&gt;" NOTES_MODIFIED="2015-10-30 14:18:34 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lum PS, Burgar CG, Van der Loos M, Shor PC, Majmundar M, Yap R</AU>
<TI>MIME robotic device for upper-limb neurorehabilitation in subacute stroke subjects: a follow-up study</TI>
<SO>Journal of Rehabilitation Research and Development</SO>
<YR>2006</YR>
<VL>43</VL>
<NO>5</NO>
<PG>631-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Masiero-2007" MODIFIED="2015-10-06 14:22:08 +0100" MODIFIED_BY="Hazel Fraser" NAME="Masiero 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-10-06 14:22:08 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;0003-9993 (Print)&lt;/p&gt;" NOTES_MODIFIED="2015-10-06 14:22:08 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Masiero S, Celia A, Rosati G, Armani M</AU>
<TI>Robotic-assisted rehabilitation of the upper limb after acute stroke</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2007</YR>
<VL>88</VL>
<NO>2</NO>
<PG>142-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Masiero-2011" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="Masiero 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;Cochrane ID: CN-01005273 EMBASE 70767200 Journal: Conference Abstract Record Available: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/273/CN-01005273/frame.html&lt;br&gt;RP - NOT IN FILE&lt;/p&gt;" NOTES_MODIFIED="2015-10-30 14:18:34 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Masiero S, Armani M, Ferlini G, Chiasera A, Rosati G, Rossi A, et al</AU>
<TI>A novel robot-assisted upper-limb rehabilitation program in acute management of post-stroke patients: a randomized controlled trial</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2012</YR>
<VL>26</VL>
<NO>4</NO>
<PG>401</PG>
<IDENTIFIERS MODIFIED="2015-04-08 12:25:08 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER TYPE="MEDLINE" VALUE="177"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-06 14:22:52 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;RP - NOT IN FILE&lt;br&gt;M1 - dxy, 100892086 L2 - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;amp;PAGE=reference&amp;amp;D=medl&amp;amp;NEWS=N&amp;amp;AN=24316679&lt;/p&gt;" NOTES_MODIFIED="2015-10-06 14:22:52 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="OTHER">
<AU>Masiero S, Armani M, Ferlini G, Rosati G, Rossi A</AU>
<TI>Randomized trial of a robotic assistive device for the upper extremity during early inpatient stroke rehabilitation</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2014</YR>
<VL>28</VL>
<NO>4</NO>
<PG>377-86</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="964"/>
<IDENTIFIER TYPE="OTHER" VALUE="1552-6844"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-04-10 09:52:34 +0100" MODIFIED_BY="Bernhard Elsner" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Masiero S, Armani M, Rosati G</AU>
<TI>Upper-limb robot-assisted therapy in rehabilitation of acute stroke patients: focused review and results of new randomized controlled trial</TI>
<SO>Journal of Rehabilitation Research and Development</SO>
<YR>2011</YR>
<VL>48</VL>
<NO>4</NO>
<PG>355-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-06 14:23:18 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;FIN-TN-2007&lt;br&gt;October 2008&lt;br&gt;June 2011&lt;/p&gt;" NOTES_MODIFIED="2015-10-06 14:23:18 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01102309</AU>
<TI>Robot-assisted rehabilitation of the upper limb in acute and subacute post-stroke patients</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT01102309</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mayr-2008" MODIFIED="2012-01-26 15:43:32 +0000" MODIFIED_BY="[Empty name]" NAME="Mayr 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-01-26 15:43:32 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mayr A, Kofler M, Saltuari L</AU>
<TI>ARMOR: an electromechanical robot for upper limb training following stroke. A prospective randomised controlled pilot study</TI>
<SO>Handchirurgie, Mikrochirurgie, Plastische Chirurgie</SO>
<YR>2008</YR>
<VL>40</VL>
<NO>1</NO>
<PG>66-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McCabe-2015" MODIFIED="2015-10-06 14:24:34 +0100" MODIFIED_BY="Hazel Fraser" NAME="McCabe 2015" YEAR="2015">
<REFERENCE MODIFIED="2015-05-29 07:53:15 +0100" MODIFIED_BY="Jan Mehrholz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Daly JJ, Rogers J, McCabe J, Monkiewicz M, Burdsall R, Pundik S</AU>
<TI>Recovery of actual functional tasks in response to motor learning, robotics, and functional electrical stimulation</TI>
<SO>Stroke</SO>
<YR>2010</YR>
<VL>41</VL>
<NO>4</NO>
<PG>e355-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-06 14:24:34 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>McCabe J, Monkiewicz M, Holcomb J, Pundik S, Daly JJ</AU>
<TI>Comparison of robotics, functional electrical stimulation, and motor learning methods for treatment of persistent upper extremity dysfunction after stroke: a randomized controlled trial</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2015</YR>
<VL>96</VL>
<NO>6</NO>
<PG>981-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rabadi-2008" MODIFIED="2015-10-06 14:25:30 +0100" MODIFIED_BY="Hazel Fraser" NAME="Rabadi 2008" YEAR="2008">
<REFERENCE MODIFIED="2015-10-06 14:25:12 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;BRC-357&lt;br&gt;April 2005&lt;br&gt;May 2006&lt;/p&gt;" NOTES_MODIFIED="2015-10-06 14:25:12 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT00343304</AU>
<TI>Pilot study - comparison of upper body ergometer vs. robot in upper extremity motor recovery post-stroke</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT00343304</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-06 14:25:30 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Rabadi M, Galgano M, Lynch D, Akerman M, Lesser M, Volpe B</AU>
<TI>A pilot study of activity-based therapy in the arm motor recovery post stroke: a randomized controlled trial</TI>
<SO>Clinical Rehabilitation</SO>
<YR>2008</YR>
<VL>22</VL>
<PG>1071-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sale-2014" MODIFIED="2015-11-02 11:08:59 +0000" MODIFIED_BY="Hazel Fraser" NAME="Sale 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;RP - NOT IN FILE&lt;br&gt;M1 - 101232233 L2 - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;amp;PAGE=reference&amp;amp;D=medl&amp;amp;NEWS=N&amp;amp;AN=24946799&lt;/p&gt;" NOTES_MODIFIED="2015-10-30 14:18:34 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Franceschini M, Mazzoleni S, Palma E, Agosti M, Posteraro F</AU>
<TI>Effects of upper limb robot-assisted therapy on motor recovery in subacute stroke patients</TI>
<SO>Journal of NeuroEngineering and Rehabilitation</SO>
<YR>2014</YR>
<VL>11</VL>
<PG>104</PG>
<IDENTIFIERS MODIFIED="2015-04-08 12:42:14 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER TYPE="MEDLINE" VALUE="978"/>
<IDENTIFIER TYPE="OTHER" VALUE="1743-0003"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-11-02 11:08:59 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Franceschini M</AU>
<TI>Robot-aided therapy for upper limb in sub-acute stroke patients: a randomized control trial</TI>
<SO>1st European NeuroRehabilitation Congress, 20-22 October, 2011</SO>
<YR>2011</YR>
<VL>1</VL>
<PG>32</PG>
<PB>ENCR</PB>
<CY>Merano, Italy</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-06 14:27:50 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - CONF&lt;br&gt;Compilation and indexing terms, Copyright 2015 Elsevier Inc&lt;br&gt;RP - NOT IN FILE&lt;br&gt;U1 - 20145100347042&lt;br&gt;U2 - Chronic stroke;Clinical measure;Kinematic parameters;Motor impairments;Robot-assisted therapies;Robotic systems;Upper limbs&lt;/p&gt;" NOTES_MODIFIED="2015-10-06 14:27:50 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Mazzoleni S, Buono L, Dario P, Posteraro F</AU>
<TI>Upper limb robot-assisted therapy in subacute and chronic stroke patients: preliminary results on initial exposure based on kinematic measures</TI>
<SO>5th IEEE RAS and EMBS International Conference on Biomedical Robotics and Biomechatronics, BioRob, 12-15 August</SO>
<YR>2014</YR>
<PG>265-9</PG>
<IDENTIFIERS MODIFIED="2015-04-10 11:02:15 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER TYPE="MEDLINE" VALUE="4006"/>
<IDENTIFIER TYPE="OTHER" VALUE="21551774"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-06 14:28:15 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;MIT02012EEG&lt;br&gt;July 2012&lt;br&gt;August 2014&lt;/p&gt;" NOTES_MODIFIED="2015-10-06 14:28:15 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01658111</AU>
<TI>Robot-aided therapy in stroke patients for upper limb rehabilitation</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT01658111</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Sale P, Franceschini M, Mazzoleni S, Palma E, Agosti M, Posteraro F</AU>
<TI>Effects of upper limb robot-assisted therapy on motor recovery in subacute stroke patients</TI>
<SO>Journal of NeuroEngineering and Rehabilitation</SO>
<YR>2014</YR>
<VL>11</VL>
<PG>104</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-06 14:28:47 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;Compilation and indexing terms, Copyright 2015 Elsevier Inc&lt;br&gt;RP - NOT IN FILE&lt;br&gt;U1 - 20143418088043&lt;br&gt;U2 - Experimental groups;Hand function;Medical research councils;Modified Ashworth scale;randomized-controlled trial;Robot-assisted therapies;Robotic rehabilitation;stroke&lt;/p&gt;" NOTES_MODIFIED="2015-10-06 14:28:47 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Sale P, Mazzoleni S, Lombardi V, Galafate D, Massimiani MP, Posteraro F, et al</AU>
<TI>Recovery of hand function with robot-assisted therapy in acute stroke patients: a randomized-controlled trial</TI>
<SO>International Journal of Rehabilitation Research</SO>
<YR>2014</YR>
<VL>37</VL>
<NO>3</NO>
<PG>236-42</PG>
<IDENTIFIERS MODIFIED="2015-04-08 12:33:57 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER TYPE="MEDLINE" VALUE="4901"/>
<IDENTIFIER TYPE="OTHER" VALUE="03425282"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Susanto-2015" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="Susanto 2015" YEAR="2015">
<REFERENCE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Susanto EA, Tong RK, Ockenfeld C, Ho NS</AU>
<TI>Efficacy of robot-assisted fingers training in chronic stroke survivors: a pilot randomized-controlled trial</TI>
<SO>Journal of NeuroEngineering and Rehabilitation</SO>
<YR>2015</YR>
<VL>12</VL>
<NO>1</NO>
<PG>42</PG>
<IDENTIFIERS MODIFIED="2015-05-18 14:17:46 +0100" MODIFIED_BY="Jan Mehrholz">
<IDENTIFIER MODIFIED="2015-05-18 14:17:46 +0100" MODIFIED_BY="Jan Mehrholz" TYPE="DOI" VALUE="10.1186/s12984-015-0033-5"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Timmermans-2014" MODIFIED="2015-11-02 11:45:56 +0000" MODIFIED_BY="Hazel Fraser" NAME="Timmermans 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-10-06 15:02:26 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>ISRCTN82787126</AU>
<TI>Technology-supported task-oriented training of arm-hand function in persons with chronic stroke</TI>
<SO>http://www.isrctn.com/ISRCTN82787126</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-11-02 11:45:56 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;Cochrane ID: CN-00992773 EMBASE 2014354403 Journal: Article Record Available: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/773/CN-00992773/frame.html&lt;br&gt;RP - NOT IN FILE&lt;/p&gt;" NOTES_MODIFIED="2015-11-02 11:45:56 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lemmens RJM, Timmermans AAA, Janssen-Potten YJM, Pulles SANT, Geers RPJ, Bakx WGM, et al</AU>
<TI>Accelerometry measuring the outcome of robot-supported upper limb training in chronic stroke: a randomized controlled trial</TI>
<SO>PLoS One</SO>
<YR>2014</YR>
<VL>9</VL>
<NO>5</NO>
<PG>e96414</PG>
<IDENTIFIERS MODIFIED="2015-04-08 12:46:09 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER TYPE="MEDLINE" VALUE="17"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;RP - NOT IN FILE&lt;br&gt;M1 - 101232233 L2 - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;amp;PAGE=reference&amp;amp;D=medl&amp;amp;NEWS=N&amp;amp;AN=24684808&lt;/p&gt;" NOTES_MODIFIED="2015-10-30 14:18:34 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="OTHER">
<AU>Timmermans AA, Lemmens RJM, Monfrance M, Geers RPJ, Bakx W, Smeets RJEM, et al</AU>
<TI>Effects of task-oriented robot training on arm function, activity, and quality of life in chronic stroke patients: a randomized controlled trial</TI>
<SO>Journal of NeuroEngineering and Rehabilitation</SO>
<YR>2014</YR>
<VL>11</VL>
<PG>45</PG>
<IDENTIFIERS MODIFIED="2015-04-08 12:46:09 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER TYPE="MEDLINE" VALUE="1001"/>
<IDENTIFIER TYPE="OTHER" VALUE="1743-0003"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Volpe-2000" MODIFIED="2012-03-15 14:19:24 +0000" MODIFIED_BY="[Empty name]" NAME="Volpe 2000" YEAR="2000">
<REFERENCE MODIFIED="2012-03-15 14:19:24 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fasoli SE, Krebs HI, Ferraro M, Hogan N, Volpe BT</AU>
<TI>Does shorter rehabilitation limit potential recovery poststroke?</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2004</YR>
<VL>18</VL>
<PG>88-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;0028-3878 (Print)&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Volpe BT, Krebs HI, Hogan N, Edelstein OL, Diels C, Aisen M</AU>
<TI>A novel approach to stroke rehabilitation: robot-aided sensorimotor stimulation</TI>
<SO>Neurology</SO>
<YR>2000</YR>
<VL>54</VL>
<NO>10</NO>
<PG>1938-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Volpe-2008" MODIFIED="2012-01-26 15:43:37 +0000" MODIFIED_BY="Hazel Fraser" NAME="Volpe 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-01-26 15:43:37 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Volpe BT, Lynch D, Rykman-Berland A, Ferraro M, Galgano M, Hogan N, et al</AU>
<TI>Intensive sensorimotor arm training mediated by therapist or robot improves hemiparesis in patients with chronic stroke</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2008</YR>
<VL>22</VL>
<NO>3</NO>
<PG>305-10</PG>
<IDENTIFIERS MODIFIED="2008-05-22 14:20:10 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wu-2012" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="Wu 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-10-06 15:04:26 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;99-0832B|NHRI-EX100-10010PI&lt;br&gt;January 2011&lt;br&gt;December 2015&lt;/p&gt;" NOTES_MODIFIED="2015-10-06 15:04:26 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01525979</AU>
<TI>Comparative efficacy research of uni- vs bi-lateral arm training poststroke</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT01525979</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-06 15:43:47 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - ELEC&lt;br&gt;RP - NOT IN FILE&lt;br&gt;VL - 26&lt;/p&gt;" NOTES_MODIFIED="2015-10-06 15:43:47 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Wu C-Y, Chen M-D, Chen Y-T, Wu L-L, Lin K-C</AU>
<TI>Unilateral and bilateral robot-assisted arm training had differential effects on upper limb function in chronic stroke survivors</TI>
<SO>Brain Injury</SO>
<YR>2012</YR>
<VL>26</VL>
<NO>4-5</NO>
<PG>362-3</PG>
<IDENTIFIERS MODIFIED="2015-04-08 12:00:33 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER TYPE="MEDLINE" VALUE="2573"/>
<IDENTIFIER TYPE="OTHER" VALUE="0269-9052"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-06 15:45:07 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;Cochrane ID: CN-01029164 EMBASE 70951166 Journal: Conference Abstract Record Available: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/164/CN-01029164/frame.html&lt;br&gt;RP - NOT IN FILE&lt;/p&gt;" NOTES_MODIFIED="2015-10-06 15:45:07 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Wu C-Y, Chuang L-L, Chen M-D, Chen Y-T, Lin K-C</AU>
<TI>Therapist-based and robot-assisted physical training have differential effects on motor control of upper limb and quality of life after chronic stroke</TI>
<SO>Circulation</SO>
<YR>2012</YR>
<VL>125</VL>
<NO>10 Suppl 1</NO>
<PG>Abst. P289</PG>
<IDENTIFIERS MODIFIED="2015-04-08 12:00:33 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER TYPE="MEDLINE" VALUE="172"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;Accession Number: 78565078; Author: Ching-yi Wu: 1 Author: Chieh-ling Yang: 2 Author: Li-ling Chuang: 3 Author: Keh-chung Lin: 4 email: kehchunglin@ntu.edu.tw. Author: Hsieh-ching Chen: 5 Author: Ming-de Chen: 2 Author: Wan-chien Huang: 6 ; Author Affiliation: 1 Department of Occupational Therapy and Graduate Institute of Behavioral Sciences, Chang Gung University, Taoyuan, Taiwan: 2 Department of Occupational Therapy and Graduate Institute of Behavioral Sciences, Chang Gung University: 3 School of Occupational Therapy, College of Medicine, National Taiwan University, Taipei, Taiwan: 4 School of Occupational Therapy, College of Medicine, National Taiwan University, and Division of Occupational Therapy, Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital, 17, F4, Xu Zhou Road, Taipei, Taiwan: 5 Department of Graduate Institute of Industrial Engineering and Management, National Taipei University of Technology, Taipei, Taiwan: 6 Division of Occupational Therapy, Department of Physical Medicine and Rehabilitation, En Chu Kong Hospital, New Taipei City, Taiwan; No. of Pages: 11; Language: English; Publication Type: Article; Update Code: 20120816&lt;br&gt;RP - NOT IN FILE&lt;/p&gt;" NOTES_MODIFIED="2015-10-30 14:18:34 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Wu CY, Yang CL, Chuang LL, Lin KC, Chen HC, Chen MD, et al</AU>
<TI>Effect of therapist-based versus robot-assisted bilateral arm training on motor control, functional performance, and quality of life after chronic stroke: a clinical trial</TI>
<SO>Physical Therapy</SO>
<YR>2012</YR>
<VL>92</VL>
<NO>8</NO>
<PG>1006-16</PG>
<IDENTIFIERS MODIFIED="2015-04-08 12:00:33 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER TYPE="MEDLINE" VALUE="2921"/>
<IDENTIFIER TYPE="OTHER" VALUE="00319023"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yoo-2013" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="Yoo 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - ELEC&lt;br&gt;RP - NOT IN FILE&lt;br&gt;VL - 25&lt;/p&gt;" NOTES_MODIFIED="2015-10-30 14:18:34 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Yoo DH, Cha YJ, Kim SK, Lee JS</AU>
<TI>Effect of three-dimensional robot-assisted therapy on upper limb function of patients with stroke</TI>
<SO>Journal of Physical Therapy Science</SO>
<YR>2013</YR>
<VL>25</VL>
<NO>4</NO>
<PG>407-9</PG>
<IDENTIFIERS MODIFIED="2015-04-08 12:35:12 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER TYPE="MEDLINE" VALUE="2789"/>
<IDENTIFIER TYPE="OTHER" VALUE="0915-5287"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2015-11-02 12:24:55 +0000" MODIFIED_BY="Hazel Fraser">
<STUDY DATA_SOURCE="PUB" ID="STD-Abdollahi-2014" MODIFIED="2015-10-07 11:13:15 +0100" MODIFIED_BY="Hazel Fraser" NAME="Abdollahi 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-10-07 11:13:15 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;Abdollahi, Farnaz&lt;br&gt;Case Lazarro, Emily D&lt;br&gt;Listenberger, Molly&lt;br&gt;Kenyon, Robert V&lt;br&gt;Kovic, Mark&lt;br&gt;Bogey, Ross A&lt;br&gt;Hedeker, Donald&lt;br&gt;Jovanovic, Borko D&lt;br&gt;Patton, James L&lt;br&gt;H133E0700 13/PHS HHS/United States&lt;br&gt;R01 NS053606/NS/NINDS NIH HHS/United States&lt;br&gt;Clinical Trial&lt;br&gt;Randomized Controlled Trial&lt;br&gt;Research Support, N.I.H., Extramural&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;United States&lt;br&gt;Neurorehabilitation and neural repair&lt;br&gt;Neurorehabil Neural Repair. 2014 Feb;28(2):120-8. doi: 10.1177/1545968313498649. Epub 2013 Aug 8.&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:13:15 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Abdollahi F, Case Lazarro ED, Listenberger M, Kenyon RV, Kovic M, Bogey RA, et al</AU>
<TI>Error augmentation enhancing arm recovery in individuals with chronic stroke: a randomized crossover design</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2014</YR>
<VL>28</VL>
<NO>2</NO>
<PG>120-8</PG>
<IDENTIFIERS MODIFIED="2015-10-07 11:13:15 +0100" MODIFIED_BY="Hazel Fraser">
<IDENTIFIER MODIFIED="2015-10-07 11:13:15 +0100" MODIFIED_BY="Hazel Fraser" TYPE="OTHER" VALUE="1552-6844"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Aisen-1997" NAME="Aisen 1997" YEAR="1997">
<REFERENCE NOTES="&lt;p&gt;0003-9942 (Print)&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aisen ML, Krebs HI, Hogan N, McDowell F, Volpe BT</AU>
<TI>The effect of robot-assisted therapy and rehabilitative training on motor recovery following stroke</TI>
<SO>Archives of Neurology</SO>
<YR>1997</YR>
<VL>54</VL>
<NO>4</NO>
<PG>443-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dodakian-2013" MODIFIED="2015-10-07 11:13:47 +0100" MODIFIED_BY="Hazel Fraser" NAME="Dodakian 2013" YEAR="2009">
<REFERENCE MODIFIED="2015-05-29 08:12:53 +0100" MODIFIED_BY="Jan Mehrholz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Der-Yeghiaian L, Sharp KG, See J, Abidi NS, Mai K, Le VH, et al</AU>
<TI>Robotic therapy after stroke and the influence of baseline motor status</TI>
<SO>Stroke</SO>
<YR>2009</YR>
<VL>40</VL>
<NO>4</NO>
<PG>e169</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-07 11:13:47 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Dodakian L, Sharp KG, See J, Abidi NS, Mai K, Fling BW, et al</AU>
<TI>Targeted engagement of a dorsal premotor circuit in the treatment of post-stroke paresis</TI>
<SO>NeuroRehabilitation</SO>
<YR>2013</YR>
<VL>33</VL>
<NO>1</NO>
<PG>13-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fasoli-2003" MODIFIED="2012-03-15 14:19:24 +0000" MODIFIED_BY="[Empty name]" NAME="Fasoli 2003" YEAR="2003">
<REFERENCE MODIFIED="2011-10-26 09:33:15 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;0003-9993 (Print)&lt;/p&gt;" NOTES_MODIFIED="2011-10-26 09:33:15 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Fasoli SE, Krebs HI, Stein J, Frontera WR, Hogan N</AU>
<TI>Effects of robotic therapy on motor impairment and recovery in chronic stroke</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2003</YR>
<VL>84</VL>
<NO>4</NO>
<PG>477-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-03-15 14:19:24 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stein J, Krebs HI, Frontera WR, Fasoli SE, Hughes R, Hogan N</AU>
<TI>Comparison of two techniques of robot-aided upper limb exercise training after stroke</TI>
<SO>American Journal of Physical Medicine and Rehabilitation</SO>
<YR>2004</YR>
<VL>83</VL>
<NO>9</NO>
<PG>720-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fluet-2012" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="Fluet 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - THES&lt;br&gt;Accession Number: 2012250379. Language: English. Entry Date: 20130913. Publication Type: doctoral dissertation; randomized controlled trial; research. Special Interest: Physical Therapy. Instrumentation: Wolf motor test; Jebsen test of hand function; Nine-Hole Peg Test (NHPT)&lt;br&gt;RP - NOT IN FILE&lt;br&gt;AV - UMI Order AAI3515747.&lt;br&gt;M1 - Ph.D.&lt;/p&gt;" NOTES_MODIFIED="2015-10-30 14:18:34 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="BOOK">
<AU>Fluet G</AU>
<SO>Robotically Facilitated Virtual Rehabilitation of Arm Transport Integrated With Finger Movement Versus Isolated Training of the Arm and Hand in Persons With Hemiparesis [Dissertation]</SO>
<YR>2012</YR>
<PB>University of Medicine and Dentistry of New Jersey</PB>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="3869"/>
<IDENTIFIER TYPE="OTHER" VALUE="978-1-267-42769-4"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hesse-2007" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="Hesse 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Hesse S</AU>
<TI>Transcranial direct current stimulation (tDCS) of the lesioned or non-lesioned hemisphere plus computer-assisted arm trainer: a randomized, placebo-controlled double-blind multi-centre study in patients with severe arm paresis early after stroke</TI>
<SO>https://clinicaltrials.gov/show/NCT00407667</SO>
<YR>(accessed 1 December 2007)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-10-30 11:07:49 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-10-30 11:07:49 +0000" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT00407667"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hill-2011" MODIFIED="2015-11-02 11:11:08 +0000" MODIFIED_BY="Hazel Fraser" NAME="Hill 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-11-02 11:11:08 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - ELEC&lt;br&gt;RP - NOT IN FILE&lt;br&gt;VL - 92&lt;/p&gt;" NOTES_MODIFIED="2015-11-02 11:11:08 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Hill V, Page S</AU>
<TI>The efficacy of using a combined regimen of portable robotics and a repetitive task specific practice to increase motor function in the upper arm</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2011</YR>
<VL>92</VL>
<NO>10</NO>
<PG>1718</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="2591"/>
<IDENTIFIER TYPE="OTHER" VALUE="0003-9993"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-07 11:14:53 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;Cochrane ID: CN-01030989 EMBASE 70880208 Journal: Conference Abstract Record Available: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/989/CN-01030989/frame.html&lt;br&gt;RP - NOT IN FILE&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:14:53 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Page S, Hill V, White S</AU>
<TI>Portable upper extremity robotics is as efficacious as upper extremity rehabilitative therapy</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2012</YR>
<VL>93</VL>
<NO>10</NO>
<PG>E21</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="211"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-07 11:15:17 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;RP - NOT IN FILE&lt;br&gt;M1 - cr7, 8802181 L2 - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;amp;PAGE=reference&amp;amp;D=medl&amp;amp;NEWS=N&amp;amp;AN=23147552&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:15:17 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="OTHER">
<AU>Page S, Hill V, White S</AU>
<TI>Portable upper extremity robotics is as efficacious as upper extremity rehabilitative therapy: a randomized controlled pilot trial</TI>
<SO>Clinical Rehabilitation</SO>
<YR>2013</YR>
<VL>27</VL>
<NO>6</NO>
<PG>494-503</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1122"/>
<IDENTIFIER TYPE="OTHER" VALUE="1477-0873"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hu-2015" MODIFIED="2015-11-02 11:13:44 +0000" MODIFIED_BY="Hazel Fraser" NAME="Hu 2015" YEAR="2015">
<REFERENCE MODIFIED="2015-11-02 11:13:44 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hu XL, Tong RK, Ho NS, Xue JJ, Rong W, Li LS</AU>
<TI>Wrist rehabilitation assisted by an electromyography-driven neuromuscular electrical stimulation robot after stroke</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2015</YR>
<VL>29</VL>
<NO>8</NO>
<PG>767-76</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jackson-2013" MODIFIED="2015-11-02 12:24:55 +0000" MODIFIED_BY="Hazel Fraser" NAME="Jackson 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-10-07 11:17:03 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>ISRCTN16472838</AU>
<TI>iPAM (robot) Stroke Intervention Trial (iSIT) for arm weakness</TI>
<SO>http://www.isrctn.com/ISRCTN16472838</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="10.1186/ISRCTN16472838"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-11-02 12:24:25 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - CONF&lt;br&gt;RP - NOT IN FILE&lt;br&gt;U1 - 13879602&lt;br&gt;U2 - iPAM MkII system;randomized control trial;acute stroke patients;intelligent pneumatic arm movement;dual robot system;assistive upper-limb exercise&lt;/p&gt;" NOTES_MODIFIED="2015-11-02 12:24:25 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="OTHER">
<AU>Jackson AE, Levesley MC, Makower SG, Cozens JA, Bhakta BB</AU>
<TI>Development of the iPAM MkII system and description of a randomized control trial with acute stroke patients</TI>
<SO>2013 IEEE 13th International Conference on Rehabilitation Robotics (ICORR 2013), 24-26 June 2013, Seattle, Washington, USA</SO>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="4610"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Krebs-2000" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="Krebs 2000" YEAR="2000">
<REFERENCE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;0748-7711 (Print)&lt;/p&gt;" NOTES_MODIFIED="2015-10-30 14:18:34 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Krebs HI, Volpe BT, Aisen ML, Hogan N</AU>
<TI>Increasing productivity and quality of care: robot-aided neuro-rehabilitation</TI>
<SO>Journal of Rehabilitation Research and Development</SO>
<YR>2000</YR>
<VL>37</VL>
<NO>6</NO>
<PG>639-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Luft-2004" MODIFIED="2012-02-13 15:44:15 +0000" MODIFIED_BY="[Empty name]" NAME="Luft 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-02-13 15:44:15 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;1538-3598 (Electronic)&lt;/p&gt;" NOTES_MODIFIED="2012-02-13 15:44:15 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Luft AR, McCombe-Waller S, Whitall J, Forrester LW, Macko R, Sorkin JD, et al</AU>
<TI>Repetitive bilateral arm training and motor cortex activation in chronic stroke: a randomized controlled trial</TI>
<SO>JAMA</SO>
<YR>2004</YR>
<VL>292</VL>
<NO>15</NO>
<PG>1853-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lum-2004a" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="Lum 2004a" YEAR="2004">
<REFERENCE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;0748-7711 (Print)&lt;/p&gt;" NOTES_MODIFIED="2015-10-30 14:18:34 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lum PS, Taub E, Schwandt D, Postman M, Hardin P, Uswatte G</AU>
<TI>Automated constraint-induced therapy extension (AutoCITE) for movement deficits after stroke</TI>
<SO>Journal of Rehabilitation Research and Development</SO>
<YR>2004</YR>
<VL>41</VL>
<NO>3A</NO>
<PG>249-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lum-2004b" MODIFIED="2012-02-13 15:44:51 +0000" MODIFIED_BY="Hazel Fraser" NAME="Lum 2004b" YEAR="2004">
<REFERENCE MODIFIED="2012-02-13 15:44:51 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;1534-4320 (Print)&lt;/p&gt;" NOTES_MODIFIED="2012-02-13 15:44:51 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lum PS, Burgar CG, Shor PC</AU>
<TI>Evidence for improved muscle activation patterns after retraining of reaching movements with the MIME robotic system in subjects with post-stroke hemiparesis</TI>
<SO>IEEE Transactions on Neural Systems and Rehabilitation Engineering</SO>
<YR>2004</YR>
<VL>12</VL>
<NO>2</NO>
<PG>186-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Page-2012" MODIFIED="2015-10-07 11:17:41 +0100" MODIFIED_BY="Hazel Fraser" NAME="Page 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-10-07 11:17:41 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;Cochrane ID: CN-00970754 PUBMED 22289227 Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Record Available: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/754/CN-00970754/frame.html&lt;br&gt;RP - NOT IN FILE&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:17:41 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Page SJ, Levin L, Hermann V, Dunning K, Levine P</AU>
<TI>Longer versus shorter daily durations of electrical stimulation during task-specific practice in moderately impaired stroke</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2012</YR>
<VL>93</VL>
<NO>2</NO>
<PG>200-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="200"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Prange-2015" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="Prange 2015" YEAR="2014">
<REFERENCE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Prange GB, Kottink AIR, Buurke JH, Eckhardt MMEM, Keulen-Rouweler BJ, Ribbers GM, et al</AU>
<TI>The effect of arm support combined with rehabilitation games on upper-extremity function in subacute stroke: a randomized controlled trial</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2015</YR>
<VL>29</VL>
<PG>174-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-07 11:18:36 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;Cochrane ID: CN-01023494 EMBASE 71665549 Journal: Conference Abstract Record Available: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/494/CN-01023494/frame.html&lt;br&gt;RP - NOT IN FILE&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:18:36 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Rietman JS, Prange G, Kottink A, Ribbers G, Buurke J</AU>
<TI>The effect of an arm supporting training device in sub-acute stroke patients: randomized clinical trial</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2014</YR>
<VL>95</VL>
<NO>10</NO>
<PG>e8</PG>
<IDENTIFIERS MODIFIED="2015-04-08 13:23:08 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER TYPE="MEDLINE" VALUE="25"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reinkensmeyer-2000a" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="Reinkensmeyer 2000a" YEAR="2000">
<REFERENCE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;0748-7711 (Print)&lt;/p&gt;" NOTES_MODIFIED="2015-10-30 14:18:34 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reinkensmeyer DJ, Kahn LE, Averbuch M, McKenna-Cole A, Schmit BD, Rymer WZ</AU>
<TI>Understanding and treating arm movement impairment after chronic brain injury: progress with the ARM guide</TI>
<SO>Journal of Rehabilitation Research and Development</SO>
<YR>2000</YR>
<VL>37</VL>
<NO>6</NO>
<PG>653-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Takahashi-2008" MODIFIED="2008-06-17 11:27:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Takahashi 2008" YEAR="2008">
<REFERENCE MODIFIED="2008-06-17 11:27:24 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Takahashi CD, Der-Yeghiaian L, Le V, Motiwala RR, Cramer SC</AU>
<TI>Robot-based handmotor therapy after stroke</TI>
<SO>Brain</SO>
<YR>2008</YR>
<VL>131</VL>
<PG>425-37</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Takebayashi-2013" MODIFIED="2015-11-02 11:16:26 +0000" MODIFIED_BY="Hazel Fraser" NAME="Takebayashi 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-10-07 11:19:09 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - ELEC&lt;br&gt;RP - NOT IN FILE&lt;br&gt;VL - 35&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:19:09 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Takahashi K, Amano S, Domen K, Hachisuka K, Kimura T, Takebayashi T</AU>
<TI>Which stroke patients benefit from robotic therapy for the upper extremities?</TI>
<SO>Cerebrovascular Diseases</SO>
<YR>2013</YR>
<PG>145</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1660"/>
<IDENTIFIER TYPE="OTHER" VALUE="1015-9770"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-11-02 11:16:26 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;Cochrane ID: CN-00784632 CC: SR-STROKE Record Available: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/632/CN-00784632/frame.html&lt;br&gt;RP - NOT IN FILE&lt;/p&gt;" NOTES_MODIFIED="2015-11-02 11:16:26 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Takahashi K, Domen K, Hachisuka K, Sakamoto T, Toshima M, Otaka Y, et al</AU>
<TI>Upper extremity robotic therapy is effective in post-stroke hemiplegia: a randomized controlled trial</TI>
<SO>In: Proceedings of the International Stroke Conference 2011. 8-11 February 2011; Los Angeles, USA</SO>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="329"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-07 11:35:10 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - ELEC&lt;br&gt;RP - NOT IN FILE&lt;br&gt;VL - 27&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:35:10 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="OTHER">
<AU>Takebayashi T, Koyama T, Amano S, Hanada K, Tabusadani M, Hosomi M, et al</AU>
<TI>A 6-month follow-up after constraint-induced movement therapy with and without transfer package for patients with hemiparesis after stroke: a pilot quasi-randomized controlled trial</TI>
<SO>Clinical Rehabilitation</SO>
<YR>2013</YR>
<VL>27</VL>
<NO>5</NO>
<PG>418-26</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1506"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-07 11:20:28 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;Cochrane ID: CN-00886999 CC: SR-STROKE Record Available: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/999/CN-00886999/frame.html&lt;br&gt;RP - NOT IN FILE&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:20:28 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Takebayashi T, Takahashi K, Amano S, Domen K, Hachisuka K, Kimura T</AU>
<TI>Which stroke patients benefit from robotic therapy for the upper extremities?</TI>
<SO>Cerebrovascular Diseases</SO>
<YR>2013</YR>
<VL>35 Suppl 3</VL>
<PG>145</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="117"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thorsen-2013" MODIFIED="2015-10-07 11:21:57 +0100" MODIFIED_BY="Hazel Fraser" NAME="Thorsen 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-10-07 11:21:57 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - ELEC&lt;br&gt;RP - NOT IN FILE&lt;br&gt;VL - 50&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:21:57 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thorsen R, Cortesi M, Jonsdottir J, Carpinella I, Morelli D, Casiraghi A, et al</AU>
<TI>Myoelectrically driven functional electrical stimulation may increase motor recovery of upper limb in poststroke subjects: a randomized controlled pilot study</TI>
<SO>Journal of Rehabilitation Research and Development</SO>
<YR>2013</YR>
<VL>50</VL>
<NO>6</NO>
<PG>785-94</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="2044"/>
<IDENTIFIER TYPE="OTHER" VALUE="0748-7711"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tropea-2013" MODIFIED="2015-10-07 11:22:55 +0100" MODIFIED_BY="Hazel Fraser" NAME="Tropea 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-10-07 11:22:55 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;RP - NOT IN FILE&lt;br&gt;U1 - 13689003&lt;br&gt;U2 - error-enhancing robot-mediated treatment;active assistive robot-mediated treatment;robotic-aided rehabilitation treatment;upper limb related capability recovery;chronic post stroke patients;six-week therapy program;horizontal pointing movements;robot-generated divergent force field;trajectory error;active assistive approach;robotic therapy;therapy treatment;active arm control;time 6 week&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:22:55 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tropea P, Cesqui B, Monaco V, Aliboni S, Posteraro F, Micera S</AU>
<TI>Effects of the alternate combination of error-enhancing and active assistive robot-mediated treatments on stroke patients</TI>
<SO>IEEE Journal of Translational Engineering in Health and Medicine</SO>
<YR>2013</YR>
<VL>1</VL>
<PG>2100-9</PG>
<IDENTIFIERS MODIFIED="2015-04-10 11:00:37 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER TYPE="MEDLINE" VALUE="4640"/>
<IDENTIFIER TYPE="OTHER" VALUE="2168-2372"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Volpe-1999" NAME="Volpe 1999" YEAR="1999">
<REFERENCE NOTES="&lt;p&gt;0028-3878 (Print)&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Volpe BT, Krebs HI, Hogan N, Edelsteinn L, Diels CM, Aisen ML</AU>
<TI>Robot training enhanced motor outcome in patients with stroke maintained over 3 years</TI>
<SO>Neurology</SO>
<YR>1999</YR>
<VL>53</VL>
<NO>8</NO>
<PG>1874-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Whitall-2000" MODIFIED="2008-06-17 11:32:25 +0100" MODIFIED_BY="Hazel Fraser" NAME="Whitall 2000" YEAR="2000">
<REFERENCE NOTES="&lt;p&gt;1524-4628 (Electronic)&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Whitall J, McCombe Waller S, Silver KH, Macko RF</AU>
<TI>Repetitive bilateral arm training with rhythmic auditory cueing improves motor function in chronic hemiparetic stroke</TI>
<SO>Stroke</SO>
<YR>2000</YR>
<VL>31</VL>
<NO>10</NO>
<PG>2390-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser">
<STUDY DATA_SOURCE="PUB" ID="STD-AIAS" MODIFIED="2015-06-12 12:28:10 +0100" MODIFIED_BY="Bernhard Elsner" NAME="AIAS" YEAR="2009">
<REFERENCE MODIFIED="2015-06-12 12:28:08 +0100" MODIFIED_BY="Bernhard Elsner" PRIMARY="NO" TYPE="OTHER">
<AU>ISRCTN33421390</AU>
<TI>Arm Intervention After Stroke (AIAS): a feasibility study</TI>
<SO>http://www.isrctn.com/ISRCTN33421390</SO>
<YR>(accessed 12 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chisari-2014" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="Chisari 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - ELEC&lt;br&gt;RP - NOT IN FILE&lt;br&gt;VL - 40&lt;/p&gt;" NOTES_MODIFIED="2015-10-30 14:18:34 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chisari C, Frisoli A, Sotgiu E, Procopio C, Bertolucci F, Bergamasco M, et al</AU>
<TI>Training and assessment of upper limb motor function with a robotic exoskeleton in chronic stroke patients</TI>
<SO>Gait and Posture</SO>
<YR>2014</YR>
<VL>40</VL>
<PG>S27-8</PG>
<MD>(Frisoli, Sotgiu, Procopio, Bergamasco) PERCRO Lab, TeCIP Scuola Superiore Sant'Anna, Pisa, Italy;(Chisari, Bertolucci, Rossi) Neurorehabilitation Department, Azienda Ospedaliera Universitaria, Pisa, Italy</MD>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1549"/>
<IDENTIFIER TYPE="OTHER" VALUE="0966-6362"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Faran-2008" MODIFIED="2015-10-07 11:37:09 +0100" MODIFIED_BY="Hazel Fraser" NAME="Faran 2008" YEAR="2008">
<REFERENCE MODIFIED="2015-10-07 11:37:09 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Faran S, Van Kaick S, Eickhoff C, Mahoney R, Mauritz KH</AU>
<TI>An active and repetitive robot assisted training improves functional motor recovery of the arm in sub-acute stroke patients</TI>
<SO>Stroke</SO>
<YR>2008</YR>
<VL>39</VL>
<NO>2</NO>
<PG>617</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT00435617" MODIFIED="2015-10-30 11:06:56 +0000" MODIFIED_BY="[Empty name]" NAME="NCT00435617" YEAR="2004">
<REFERENCE MODIFIED="2015-10-07 11:37:21 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT00435617</AU>
<TI>Study of hand therapy 3 to 24 months after stroke. Clinical assessment of a massed practice therapy device - study of hand therapy 3 to 24 months after stroke</TI>
<SO>http://clinicaltrials.gov/ct2/show/NCT00435617</SO>
<YR>(accessed 27 May 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-10-30 11:06:56 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="CTG" VALUE="NCT00435617"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reinkensmeyer-2012" MODIFIED="2015-10-07 11:37:46 +0100" MODIFIED_BY="Hazel Fraser" NAME="Reinkensmeyer 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-10-07 11:37:46 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reinkensmeyer DJ, Wolbrecht ET, Chan V, Chou C, Cramer SC, Bobrow JE</AU>
<TI>Comparison of three-dimensional, assist-as-needed robotic arm/hand movement training provided with Pneu-WREX to conventional tabletop therapy after chronic stroke</TI>
<SO>American Journal of Physical Medicine and Rehabilitation</SO>
<YR>2012</YR>
<VL>91</VL>
<NO>11 Suppl</NO>
<PG>s232-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2015-10-30 11:12:35 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="MIX" ID="STD-Krebs-2007" MODIFIED="2015-10-07 11:37:53 +0100" MODIFIED_BY="Hazel Fraser" NAME="Krebs 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-10-07 11:37:53 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Krebs HI, Volpe BT, Williams D, Celestino J, Charles SK, Lynch D, et al</AU>
<TI>Robot-aided neurorehabilitation: a robot for wrist rehabilitation</TI>
<SO>IEEE Transactions on Neural Systems and Rehabilitation Engineering</SO>
<YR>2007</YR>
<VL>15</VL>
<NO>3</NO>
<PG>327-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Linder-2013" MODIFIED="2015-10-07 11:38:16 +0100" MODIFIED_BY="Hazel Fraser" NAME="Linder 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-10-07 11:38:16 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;RP - NOT IN FILE&lt;br&gt;M1 - 101274068 L2 - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;amp;PAGE=reference&amp;amp;D=medl&amp;amp;NEWS=N&amp;amp;AN=23280269&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:38:16 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Linder SM, Rosenfeldt AB, Reiss A, Buchanan S, Sahu K, Bay CR, et al</AU>
<TI>The home stroke rehabilitation and monitoring system trial: a randomized controlled trial</TI>
<SO>International Journal of Stroke</SO>
<YR>2013</YR>
<VL>8</VL>
<NO>1</NO>
<PG>46-53</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1167"/>
<IDENTIFIER TYPE="OTHER" VALUE="1747-4949"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-NCT00272259" MODIFIED="2015-10-07 11:38:32 +0100" MODIFIED_BY="Hazel Fraser" NAME="NCT00272259" YEAR="2006">
<REFERENCE MODIFIED="2015-10-07 11:38:32 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT00272259</AU>
<TI>Robots for stroke survivors</TI>
<SO>http://clinicaltrials.gov/ct2/show/NCT00272259</SO>
<YR>(accessed 29 May 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2012-03-09 03:07:07 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-03-09 03:07:07 +0000" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT00272259"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT00343304" MODIFIED="2015-10-07 11:39:07 +0100" MODIFIED_BY="Hazel Fraser" NAME="NCT00343304" YEAR="2006">
<REFERENCE MODIFIED="2015-10-07 11:39:07 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;BRC-357&lt;br&gt;April 2005&lt;br&gt;May 2006&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:39:07 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT00343304</AU>
<TI>Pilot study - comparison of upper body ergometer vs. robot in upper extremity motor recovery post-stroke</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT00343304</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-06-11 14:26:44 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER MODIFIED="2015-06-11 14:26:44 +0100" MODIFIED_BY="Bernhard Elsner" TYPE="CTG" VALUE="NCT00343304"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT00453843" MODIFIED="2015-10-07 11:39:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="NCT00453843" YEAR="2004">
<REFERENCE MODIFIED="2015-10-07 11:39:24 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT00453843</AU>
<TI>Shoulder, or elbow, or wrist: what should we train first after a stroke? The effect of proximal and distal training on stroke recovery</TI>
<SO>http://clinicaltrials.gov/ct2/show/NCT00453843</SO>
<YR>(accessed 29 May 2015 )</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2012-03-09 03:08:56 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-03-09 03:08:56 +0000" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT00453843"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT00785343" MODIFIED="2015-10-07 11:39:49 +0100" MODIFIED_BY="Hazel Fraser" NAME="NCT00785343" YEAR="2009">
<REFERENCE MODIFIED="2015-10-07 11:39:49 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;R-618-08&lt;br&gt;September 2008&lt;br&gt;null&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:39:49 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT00785343</AU>
<TI>Study of robot-assisted arm therapy for acute stroke patients</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT00785343</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-06-11 14:27:05 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER MODIFIED="2015-06-11 14:27:05 +0100" MODIFIED_BY="Bernhard Elsner" TYPE="CTG" VALUE="NCT00785343"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT00878085" MODIFIED="2015-10-07 11:40:23 +0100" MODIFIED_BY="Hazel Fraser" NAME="NCT00878085" YEAR="2014">
<REFERENCE MODIFIED="2015-10-07 11:40:23 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;HR|NIH 1K25NS058577 - 01A1&lt;br&gt;November 2008&lt;br&gt;June 2013&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:40:23 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT00878085</AU>
<TI>Functional magnetic resonance imaging (fMRI) and robot-assisted practice of activities of daily living</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT00878085</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT01117194" MODIFIED="2015-10-07 11:40:57 +0100" MODIFIED_BY="Hazel Fraser" NAME="NCT01117194" YEAR="2010">
<REFERENCE MODIFIED="2015-10-07 11:40:57 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01117194</AU>
<TI>Rehabilitation robot for upper limbs, component project 5: effect on shoulder training using rehabilitation robot for stroke patients</TI>
<SO>https://clinicaltrials.gov/show/NCT01117194</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-06-11 14:26:24 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER MODIFIED="2015-06-11 14:26:24 +0100" MODIFIED_BY="Bernhard Elsner" TYPE="CTG" VALUE="NCT01117194"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT01253018" MODIFIED="2015-10-07 11:41:18 +0100" MODIFIED_BY="Hazel Fraser" NAME="NCT01253018" YEAR="2015">
<REFERENCE MODIFIED="2015-10-07 11:41:18 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;B6935-R&lt;br&gt;April 2011&lt;br&gt;June 2015&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:41:18 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01253018</AU>
<TI>Evaluation of robot assisted neuro-rehabilitation</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT01253018</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-06-11 14:27:19 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER MODIFIED="2015-06-11 14:27:19 +0100" MODIFIED_BY="Bernhard Elsner" TYPE="CTG" VALUE="NCT01253018"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT01552733" MODIFIED="2015-10-07 11:41:38 +0100" MODIFIED_BY="Hazel Fraser" NAME="NCT01552733" YEAR="2012">
<REFERENCE MODIFIED="2015-10-07 11:41:38 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;GN12MT023|R12/A141&lt;br&gt;March 2012&lt;br&gt;March 2015&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:41:38 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01552733</AU>
<TI>Robotic therapy early after stroke events</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT01552733</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-06-11 14:27:29 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER MODIFIED="2015-06-11 14:27:29 +0100" MODIFIED_BY="Bernhard Elsner" TYPE="CTG" VALUE="NCT01552733"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT01655446" MODIFIED="2015-10-07 11:42:22 +0100" MODIFIED_BY="Hazel Fraser" NAME="NCT01655446" YEAR="2012">
<REFERENCE MODIFIED="2015-10-07 11:42:01 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;201012131RB&lt;br&gt;August 2011&lt;br&gt;July 2014&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:42:01 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="OTHER">
<AU>NCT01655446</AU>
<TI>Effects of RR and MT on patients with stroke</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT01655446</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-07 11:42:22 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;201003058R&lt;br&gt;August 2011&lt;br&gt;July 2014&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:42:22 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01724164</AU>
<TI>Robot- versus mirror-assisted rehabilitation in stroke patients</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT01724164</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-06-11 14:27:42 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER MODIFIED="2015-06-11 14:27:42 +0100" MODIFIED_BY="Bernhard Elsner" TYPE="CTG" VALUE="NCT01655446"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT01767480" MODIFIED="2015-10-07 11:43:06 +0100" MODIFIED_BY="Hazel Fraser" NAME="NCT01767480" YEAR="2013">
<REFERENCE MODIFIED="2015-10-07 11:43:06 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01767480</AU>
<TI>Effects and mechanisms of intensive robot-assisted therapy in patients with subacute stroke: outcomes in brain/movement reorganization, sensorimotor and daily functions, and physiological markers</TI>
<SO>https://clinicaltrials.gov/show/NCT01767480</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-06-03 13:25:00 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER MODIFIED="2015-06-03 13:25:00 +0100" MODIFIED_BY="Bernhard Elsner" TYPE="CTG" VALUE="NCT01767480"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT01907139" MODIFIED="2015-10-07 11:43:35 +0100" MODIFIED_BY="Hazel Fraser" NAME="NCT01907139" YEAR="2014">
<REFERENCE MODIFIED="2015-10-07 11:43:35 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;01-M07-072&lt;br&gt;August 2013&lt;br&gt;July 2016&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:43:35 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01907139</AU>
<TI>Comparative efficacy research of robot-assisted therapy with and without constraint-induced therapy in stroke rehabilitation</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT01907139</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT01939041" MODIFIED="2015-10-07 11:44:16 +0100" MODIFIED_BY="Hazel Fraser" NAME="NCT01939041" YEAR="2014">
<REFERENCE MODIFIED="2015-10-07 11:44:16 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;101-5194A3&lt;br&gt;August 2013&lt;br&gt;July 2016&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:44:16 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01939041</AU>
<TI>Efficacy of unilateral versus bilateral approach to robot-assisted rehabilitation in patients with subacute stroke</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT01939041</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02077439" MODIFIED="2015-10-30 11:12:35 +0000" MODIFIED_BY="[Empty name]" NAME="NCT02077439" YEAR="2014">
<REFERENCE MODIFIED="2015-10-30 11:12:35 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02077439</AU>
<TI>Trial: Interactive intention-driven upper-limb training robotic system</TI>
<SO>https://clinicaltrials.gov/show/NCT02077439</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS MODIFIED="2015-10-30 11:12:35 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-06-03 13:27:33 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER MODIFIED="2015-06-03 13:27:33 +0100" MODIFIED_BY="Bernhard Elsner" TYPE="CTG" VALUE="NCT02077439"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02079779" MODIFIED="2015-10-07 11:45:07 +0100" MODIFIED_BY="Hazel Fraser" NAME="NCT02079779" YEAR="2014">
<REFERENCE MODIFIED="2015-10-07 11:45:07 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT0279779</AU>
<TI>Efficacy study of an interactive robot for the rehabilitation of the upper limb in acute stroke patients</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT02079779</SO>
<YR>(accessed 28 May 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-04-10 11:05:38 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER MODIFIED="2015-04-10 11:05:38 +0100" MODIFIED_BY="Bernhard Elsner" TYPE="CTG" VALUE="NCT02079779"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02096445" MODIFIED="2015-10-07 11:45:25 +0100" MODIFIED_BY="Hazel Fraser" NAME="NCT02096445" YEAR="2015">
<REFERENCE MODIFIED="2015-10-07 11:45:25 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;CIV-13-02-009921|2013-MD-0002&lt;br&gt;April 2013&lt;br&gt;December 2016&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:45:25 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02096445</AU>
<TI>Neurocognitive robot-assisted rehabilitation of hand function after stroke</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT02096445</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-06-11 14:27:57 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER MODIFIED="2015-06-11 14:27:57 +0100" MODIFIED_BY="Bernhard Elsner" TYPE="CTG" VALUE="NCT02096445"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02188628" MODIFIED="2015-10-07 11:45:47 +0100" MODIFIED_BY="Hazel Fraser" NAME="NCT02188628" YEAR="2015">
<REFERENCE MODIFIED="2015-10-07 11:45:47 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;2014/00122&lt;br&gt;July 2014&lt;br&gt;September 2016&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:45:47 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02188628</AU>
<TI>Refinement and clinical evaluation of the H-Man for arm rehabilitation after stroke</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT02188628</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-06-11 14:28:07 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER MODIFIED="2015-06-11 14:28:07 +0100" MODIFIED_BY="Bernhard Elsner" TYPE="CTG" VALUE="NCT02188628"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02228863" MODIFIED="2015-10-07 11:46:07 +0100" MODIFIED_BY="Hazel Fraser" NAME="NCT02228863" YEAR="2014">
<REFERENCE MODIFIED="2015-10-07 11:46:07 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;NRC-2014-01-005&lt;br&gt;March 2014&lt;br&gt;null&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:46:07 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02228863</AU>
<TI>Upper extremity rehabilitation using robot and botulinum toxin</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT02228863</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-06-11 14:28:15 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER MODIFIED="2015-06-11 14:28:15 +0100" MODIFIED_BY="Bernhard Elsner" TYPE="CTG" VALUE="NCT02228863"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02254343" MODIFIED="2015-10-07 11:46:33 +0100" MODIFIED_BY="Hazel Fraser" NAME="NCT02254343" YEAR="2015">
<REFERENCE MODIFIED="2015-10-07 11:46:33 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;103-3564A3&lt;br&gt;September 2014&lt;br&gt;September 2017&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:46:33 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02254343</AU>
<TI>Effects of proximal and distal robot-assisted therapy combined with functional training</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT02254343</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-06-11 14:28:24 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER MODIFIED="2015-06-11 14:28:24 +0100" MODIFIED_BY="Bernhard Elsner" TYPE="CTG" VALUE="NCT02254343"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02319785" MODIFIED="2015-10-07 11:46:59 +0100" MODIFIED_BY="Hazel Fraser" NAME="NCT02319785" YEAR="2014">
<REFERENCE MODIFIED="2015-10-07 11:46:59 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;CathayGH&lt;br&gt;August 2014&lt;br&gt;December 2018&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:46:59 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02319785</AU>
<TI>Effects of robot-assisted combined therapy in upper limb rehabilitation in stroke patients</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT02319785</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-06-11 14:28:34 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER MODIFIED="2015-06-11 14:28:34 +0100" MODIFIED_BY="Bernhard Elsner" TYPE="CTG" VALUE="NCT02319785"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02323061" MODIFIED="2015-10-07 11:47:47 +0100" MODIFIED_BY="Hazel Fraser" NAME="NCT02323061" YEAR="2014">
<REFERENCE MODIFIED="2015-10-07 11:47:18 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;4055037&lt;br&gt;January 2015&lt;br&gt;December 2016&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:47:18 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="OTHER">
<AU>NCT02323061</AU>
<TI>Brain Computer Interface (BCI) system for stroke rehabilitation</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT02323061</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-07 11:47:47 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;CUHK 525513&lt;br&gt;January 2014&lt;br&gt;December 2016&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:47:47 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02323074</AU>
<TI>Brain training system using electroencephalography (EEG) for neurorehabilitation of hand function after stroke</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT02323074</SO>
<YR>(accessed 3 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-06-11 14:28:43 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER MODIFIED="2015-06-11 14:28:43 +0100" MODIFIED_BY="Bernhard Elsner" TYPE="CTG" VALUE="NCT02323061"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NTR3669" MODIFIED="2015-10-07 11:48:07 +0100" MODIFIED_BY="Hazel Fraser" NAME="NTR3669" YEAR="2012">
<REFERENCE MODIFIED="2015-10-07 11:48:07 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NTR3669</AU>
<TI>Feasibility of supervised care &amp; rehabilitation involving personal tele-robotics for arm/hand function of chronic stroke patients</TI>
<SO>http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=3669</SO>
<YR>(accessed 12 June 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-06-12 11:25:57 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER MODIFIED="2015-06-12 11:25:57 +0100" MODIFIED_BY="Bernhard Elsner" OTHERTYPE="NTR" TYPE="OTHER" VALUE="3669"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RATULS" MODIFIED="2015-10-07 11:48:27 +0100" MODIFIED_BY="Hazel Fraser" NAME="RATULS" YEAR="2013">
<REFERENCE MODIFIED="2015-10-07 11:48:27 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;Cochrane ID: CN-00991233 CC: SR-STROKE Record Available: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/233/CN-00991233/frame.html&lt;br&gt;RP - NOT IN FILE&lt;/p&gt;" NOTES_MODIFIED="2015-10-07 11:48:27 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Stroke Research Group</AU>
<TI>RATULS: Robot Assisted Training for the Upper Limb after Stroke</TI>
<SO>https://research.ncl.ac.uk/ratuls/</SO>
<YR>(accessed 28 May 2015)</YR>
<IDENTIFIERS MODIFIED="2015-04-10 11:03:51 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER TYPE="MEDLINE" VALUE="106"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-04-10 11:04:41 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER MODIFIED="2015-04-10 11:04:41 +0100" MODIFIED_BY="Bernhard Elsner" TYPE="ISRCTN" VALUE="69371850"/>
</IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2015-11-02 11:19:05 +0000" MODIFIED_BY="Hazel Fraser">
<ADDITIONAL_REFERENCES MODIFIED="2015-11-02 11:19:05 +0000" MODIFIED_BY="Hazel Fraser">
<REFERENCE ID="REF-Adams-1993" MODIFIED="2008-07-23 22:59:50 +0100" MODIFIED_BY="[Empty name]" NAME="Adams 1993" TYPE="JOURNAL_ARTICLE">
<AU>Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al</AU>
<TI>Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment</TI>
<SO>Stroke</SO>
<YR>1993</YR>
<VL>24</VL>
<NO>1</NO>
<PG>35-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Barker-2005" MODIFIED="2008-07-23 22:59:50 +0100" MODIFIED_BY="[Empty name]" NAME="Barker 2005" TYPE="JOURNAL_ARTICLE">
<AU>Barker RN, Brauer SG</AU>
<TI>Upper limb recovery after stroke: the stroke survivors' perspective</TI>
<SO>Disability and Rehabilitation</SO>
<YR>2005</YR>
<VL>30</VL>
<NO>20</NO>
<PG>1213-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Burgar-2000" MODIFIED="2012-03-15 14:19:24 +0000" MODIFIED_BY="[Empty name]" NAME="Burgar 2000" TYPE="JOURNAL_ARTICLE">
<AU>Burgar CG, Lum PS, Shor PC, Machiel Van der Loos HF</AU>
<TI>Development of robots for rehabilitation therapy: the Palo Alto VA/Stanford experience</TI>
<SO>Journal of Rehabilitation Research and Development</SO>
<YR>2000</YR>
<VL>37</VL>
<NO>6</NO>
<PG>663-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Collin-1990" MODIFIED="2012-01-26 13:16:52 +0000" MODIFIED_BY="[Empty name]" NAME="Collin 1990" TYPE="JOURNAL_ARTICLE">
<AU>Collin C, Wade D</AU>
<TI>Assessing motor impairment after stroke: a pilot reliability study</TI>
<SO>Journal of Neurology, Neurosurgery and Psychiatry</SO>
<YR>1990</YR>
<VL>53</VL>
<NO>7</NO>
<PG>576-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Coote-2003" MODIFIED="2012-03-26 16:31:15 +0100" MODIFIED_BY="[Empty name]" NAME="Coote 2003" TYPE="CONFERENCE_PROC">
<AU>Coote S, Stokes EK</AU>
<TI>A Gentle Robot &#8211; attitudes to the first European prototype of a robot mediated therapy system</TI>
<SO>Proceedings of the World Congress of Physical Therapy; 2003 June 7-12 Barcelona, Spain</SO>
<YR>2003</YR>
<PG>RR-PL-1940</PG>
<PB>WCPT</PB>
<CY>Barcelona, Spain</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deeks-2011" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="Deeks 2011" TYPE="OTHER">
<AU>Deeks JJ, Higgins JPT, Altman DG (editors)</AU>
<TI>Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Demeurisse-1980" MODIFIED="2008-07-23 22:59:50 +0100" MODIFIED_BY="[Empty name]" NAME="Demeurisse 1980" TYPE="JOURNAL_ARTICLE">
<AU>Demeurisse G, Demol O, Robaye E</AU>
<TI>Motor evaluation in vascular hemiplegia</TI>
<SO>European Neurology</SO>
<YR>1980</YR>
<VL>19</VL>
<NO>6</NO>
<PG>382-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Feigin-2009" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="Feigin 2009" TYPE="JOURNAL_ARTICLE">
<AU>Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V</AU>
<TI>Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review</TI>
<SO>The Lancet Neurology</SO>
<YR>2009</YR>
<VL>8</VL>
<NO>4</NO>
<PG>355-69</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hamilton-1994" MODIFIED="2008-07-23 22:59:50 +0100" MODIFIED_BY="[Empty name]" NAME="Hamilton 1994" TYPE="JOURNAL_ARTICLE">
<AU>Hamilton BB, Laughlin JA, Fiedler RC, Granger CV</AU>
<TI>Interrater reliability of the 7-level functional independence measure (FIM)</TI>
<SO>Scandinavian Journal of Rehabilitation Medicine</SO>
<YR>1994</YR>
<VL>26</VL>
<NO>3</NO>
<PG>115-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hesse-2003" MODIFIED="2008-07-23 22:59:50 +0100" MODIFIED_BY="[Empty name]" NAME="Hesse 2003" TYPE="JOURNAL_ARTICLE">
<AU>Hesse S, Schmidt H, Werner C, Bardeleben A</AU>
<TI>Upper and lower extremity robotic devices for rehabilitation and for studying motor control</TI>
<SO>Current Opinion in Neurology</SO>
<YR>2003</YR>
<VL>16</VL>
<NO>6</NO>
<PG>705-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2012-03-15 14:19:24 +0000" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Altman DG and Sterne JAC (editors)</AU>
<TI>Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-J_x00f8_rgensen-1999" MODIFIED="2015-10-30 11:21:38 +0000" MODIFIED_BY="[Empty name]" NAME="Jørgensen 1999" TYPE="JOURNAL_ARTICLE">
<AU>Jørgensen HS, Nakayama H, Raaschou HO, Olsen TS</AU>
<TI>Stroke. Neurologic and functional recovery. The Copenhagen Stroke Study</TI>
<SO>Physical Medicine and Rehabilitation Clinics of North America</SO>
<YR>1999</YR>
<VL>10</VL>
<NO>4</NO>
<PG>887-906</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Krebs-1998" MODIFIED="2012-02-13 15:59:18 +0000" MODIFIED_BY="[Empty name]" NAME="Krebs 1998" TYPE="JOURNAL_ARTICLE">
<AU>Krebs HI, Hogan N, Aisen ML, Volpe BT</AU>
<TI>Robot-aided neurorehabilitation</TI>
<SO>IEEE Transactions on Rehabilitation Engineering</SO>
<YR>1998</YR>
<VL>6</VL>
<NO>1</NO>
<PG>75-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kwakkel-2003" MODIFIED="2012-03-15 14:19:24 +0000" MODIFIED_BY="[Empty name]" NAME="Kwakkel 2003" TYPE="JOURNAL_ARTICLE">
<AU>Kwakkel G, Kollen BJ, Van der Grond J, Prevo AJ</AU>
<TI>Probability of regaining dexterity in the flaccid upper limb: impact of severity of paresis and time since onset in acute stroke</TI>
<SO>Stroke</SO>
<YR>2003</YR>
<VL>34</VL>
<NO>9</NO>
<PG>2181-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kwakkel-2008" MODIFIED="2015-10-30 11:23:15 +0000" MODIFIED_BY="[Empty name]" NAME="Kwakkel 2008" TYPE="JOURNAL_ARTICLE">
<AU>Kwakkel G, Kollen BJ, Krebs HI</AU>
<TI>Effects of robot-assisted therapy on upper limb recovery after stroke: a systematic review</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2008</YR>
<VL>22</VL>
<NO>2</NO>
<PG>111-21</PG>
<IDENTIFIERS MODIFIED="2015-10-30 11:23:15 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-10-30 11:23:15 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1177/1545968307305457"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kwakkel-2015" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="Kwakkel 2015" TYPE="JOURNAL_ARTICLE">
<AU>Kwakkel G, van Wegen EE, Meskers CM</AU>
<TI>Invited commentary on comparison of robotics, functional electrical stimulation, and motor learning methods for treatment of persistent upper extremity dysfunction after stroke: a randomized controlled trial</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2015</YR>
<VL>96</VL>
<PG>991&#8211;3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Laver-2015" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="Laver 2015" TYPE="COCHRANE_REVIEW">
<AU>Laver KE, George S, Thomas S, Deutsch JE, Crotty M</AU>
<TI>Virtual reality for stroke rehabilitation</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2015</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2015-08-25 10:23:43 +0100" MODIFIED_BY="Jan Mehrholz">
<IDENTIFIER MODIFIED="2015-08-25 10:23:43 +0100" MODIFIED_BY="Jan Mehrholz" TYPE="DOI" VALUE="10.1002/14651858.CD008349.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Nakayama-1994" MODIFIED="2008-07-23 22:59:50 +0100" MODIFIED_BY="[Empty name]" NAME="Nakayama 1994" TYPE="JOURNAL_ARTICLE">
<AU>Nakayama H, Jørgensen HS, Raaschou HO, Olsen TS</AU>
<TI>Recovery of upper extremity function in stroke patients: the Copenhagen Stroke Study</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>1994</YR>
<VL>75</VL>
<NO>4</NO>
<PG>394-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Platz-2005" MODIFIED="2012-02-13 16:00:21 +0000" MODIFIED_BY="[Empty name]" NAME="Platz 2005" TYPE="JOURNAL_ARTICLE">
<AU>Platz T, Pinkowski C, Van Wijck F, Kim IH, Di Bella P, Johnson G</AU>
<TI>Reliability and validity of arm function assessment with standardized guidelines for the Fugl-Meyer Test, Action Research Arm Test and Box and Block Test: a multicentre study</TI>
<SO>Clinical Rehabilitation</SO>
<YR>2005</YR>
<VL>19</VL>
<NO>4</NO>
<PG>404-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Prange-2006" MODIFIED="2008-07-23 22:59:50 +0100" MODIFIED_BY="[Empty name]" NAME="Prange 2006" TYPE="JOURNAL_ARTICLE">
<AU>Prange GB, Jannink MJ, Groothuis-Oudshoorn CG, Hermens HJ, Ijzerman MJ</AU>
<TI>Systematic review of the effect of robot-aided therapy on recovery of the hemiparetic arm after stroke</TI>
<SO>Journal of Rehabilitation Research and Development</SO>
<YR>2006</YR>
<VL>43</VL>
<NO>2</NO>
<PG>171-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Reinkensmeyer-2000b" MODIFIED="2012-02-13 16:00:49 +0000" MODIFIED_BY="[Empty name]" NAME="Reinkensmeyer 2000b" TYPE="JOURNAL_ARTICLE">
<AU>Reinkensmeyer DJ, Kahn LE, Averbuch M, McKenna-Cole A, Schmit BD, Rymer WZ</AU>
<TI>Understanding and treating arm movement impairment after chronic brain injury: progress with the ARM Guide</TI>
<SO>Journal of Rehabilitation Research and Development</SO>
<YR>2000</YR>
<VL>37</VL>
<NO>6</NO>
<PG>653-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2014" MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser" NAME="RevMan 2014" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2014</YR>
<EN>5.1</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Riener-2005" MODIFIED="2012-03-15 14:19:24 +0000" MODIFIED_BY="[Empty name]" NAME="Riener 2005" TYPE="JOURNAL_ARTICLE">
<AU>Riener R, Nef T, Colombo G</AU>
<TI>Robot-aided neurorehabilitation of the upper extremities</TI>
<SO>Medical and Biological Engineering and Computing</SO>
<YR>2005</YR>
<VL>43</VL>
<NO>1</NO>
<PG>2-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Veerbeek-2014" MODIFIED="2015-10-07 11:52:21 +0100" MODIFIED_BY="Hazel Fraser" NAME="Veerbeek 2014" TYPE="JOURNAL_ARTICLE">
<AU>Veerbeek JM, van Wegen E, van Peppen R, van der Wees PJ, Hendriks E, Rietberg M</AU>
<TI>What is the evidence for physical therapy poststroke? A systematic review and meta-analysis</TI>
<SO>PLoS One</SO>
<YR>2014</YR>
<VL>9</VL>
<NO>2</NO>
<PG>e87987</PG>
<IDENTIFIERS MODIFIED="2015-08-25 10:17:40 +0100" MODIFIED_BY="Jan Mehrholz">
<IDENTIFIER MODIFIED="2015-08-25 10:17:40 +0100" MODIFIED_BY="Jan Mehrholz" TYPE="DOI" VALUE="10.1371/journal.pone.0087987"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Vos-2015" MODIFIED="2015-11-02 11:19:05 +0000" MODIFIED_BY="Hazel Fraser" NAME="Vos 2015" TYPE="JOURNAL_ARTICLE">
<AU>Vos T, Barber RM, Ryan M, Bell B, Bertozzi-Villa A, Amelia IR, et al</AU>
<TI>Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013</TI>
<SO>The Lancet</SO>
<YR>2015</YR>
<VL>386</VL>
<NO>9995</NO>
<PG>743&#8211;800</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wade-1987" MODIFIED="2012-03-15 14:19:24 +0000" MODIFIED_BY="[Empty name]" NAME="Wade 1987" TYPE="JOURNAL_ARTICLE">
<AU>Wade DT, Hewer RL</AU>
<TI>Functional abilities after stroke: measurement, natural history and prognosis</TI>
<SO>Journal of Neurology, Neurosurgery and Psychiatry</SO>
<YR>1987</YR>
<VL>50</VL>
<NO>2</NO>
<PG>177-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2006" MODIFIED="2012-03-26 16:31:39 +0100" MODIFIED_BY="[Empty name]" NAME="WHO 2006" TYPE="OTHER">
<AU>World Health Organization</AU>
<TI>Cerebrovascular accident, stroke</TI>
<SO>http://www.who.int/topics/cerebrovascular_accident/en/</SO>
<YR>(accessed 1 July 2007)</YR>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser">
<REFERENCE ID="REF-Mehrholz-2008" MODIFIED="2012-01-26 12:50:59 +0000" MODIFIED_BY="[Empty name]" NAME="Mehrholz 2008" TYPE="COCHRANE_REVIEW">
<AU>Mehrholz J, Platz T, Kugler J, Pohl M</AU>
<TI>Electromechanical and robot-assisted arm training for improving arm function and activities of daily living after stroke</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2012-01-25 08:57:17 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-01-25 08:57:17 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006876.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Mehrholz-2012" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="Mehrholz 2012" TYPE="COCHRANE_REVIEW">
<AU>Mehrholz J, Hädrich A, Platz T, Kugler J and Pohl M</AU>
<TI>Electromechanical and robot-assisted arm training for improving generic activities of daily living, arm function, and arm muscle strength after stroke</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>6</NO>
<IDENTIFIERS MODIFIED="2015-06-02 07:27:38 +0100" MODIFIED_BY="Jan Mehrholz">
<IDENTIFIER MODIFIED="2015-06-02 07:27:38 +0100" MODIFIED_BY="Jan Mehrholz" TYPE="DOI" VALUE="10.1002/14651858.CD006876.pub3"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser">
<REFERENCE ID="REF-Carmeli-2011" MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser" NAME="Carmeli 2011" NOTES="&lt;p&gt;TY - JOUR&lt;br&gt;RP - NOT IN FILE&lt;br&gt;M1 - 9612022, cws L2 - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;amp;PAGE=reference&amp;amp;D=medl&amp;amp;NEWS=N&amp;amp;AN=20740477&lt;/p&gt;" NOTES_MODIFIED="2015-08-31 10:28:01 +0100" NOTES_MODIFIED_BY="Hazel Fraser" TYPE="OTHER">
<AU>Carmeli E, Peleg S, Bartur G, Elbo E, Vatine JJ</AU>
<TI>HandTutor enhanced hand rehabilitation after stroke--a pilot study</TI>
<SO>Physiotherapy research international : the journal for researchers and clinicians in physical therapy</SO>
<YR>2011</YR>
<VL>16</VL>
<NO>4</NO>
<PG>191-200</PG>
<PB>Carmeli,Eli. Physical Therapy Department, Sackler Faculty of Medicine, Stanley Steyer School of Health Professions, Tel Aviv University, Ramat Aviv, Israel. elie@post.tau.ac.il</PB>
<CY>United States</CY>
<IDENTIFIERS MODIFIED="2015-04-10 11:06:28 +0100" MODIFIED_BY="Bernhard Elsner">
<IDENTIFIER TYPE="MEDLINE" VALUE="1377"/>
<IDENTIFIER TYPE="OTHER" VALUE="1471-2865"/>
</IDENTIFIERS>
</REFERENCE>
</PENDING_REFERENCES>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2015-10-30 15:59:10 +0000" MODIFIED_BY="Hazel Fraser">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2015-10-30 15:37:51 +0000" MODIFIED_BY="Hazel Fraser" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2015-10-30 14:10:46 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Abdullah-2011">
<CHAR_METHODS MODIFIED="2015-10-05 14:06:52 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-05 14:08:20 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: Canada</P>
<P>Sample size: 20 participants (9 in treatment group, 11 in control group)</P>
<P>Inclusion criteria: first single, unilateral stroke; informed consent; age between 16 and 90 years; 2 to 8 weeks after stroke; motor arm impairment between stages 1 and 4 measured by CMSA</P>
<P>Exclusion criteria: shoulder pain between 1 and 3 as measured by CMSA pain inventory scale; presence of other condition in the affected shoulder or elbow</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-05 14:09:37 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>robotic-mediated therapy for 45 minutes, 3 times a week for 8 to 11 weeks</LI>
<LI>conventional arm therapy for 45 minutes, 3 times a week for 8 to 11 weeks</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:10:46 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcome measures were assessed at baseline and at the end of intervention period</P>
<P>Primary outcome measure: Chedoke Arm and Hand Activity Inventory (CAHAI-7)</P>
<P>Secondary outcome measures: CMSA, client satisfaction using a 10-point Likert scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:10:51 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Amirabdollahian-2007">
<CHAR_METHODS MODIFIED="2012-02-07 14:45:07 +0000" MODIFIED_BY="[Empty name]">
<P>Cross-over RCT<BR/>Method of randomisation: selecting a sealed envelope<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:10:49 +0000" MODIFIED_BY="Hazel Fraser">
<P>Countries: UK and Republic of Ireland<BR/>Sample size: 31 participants (16 in treatment group, 15 in control group)<BR/>Inclusion criteria: medically stable; first stroke; over 60 years of age; able to give informed consent; a score higher than 24 in the Short Orientation-Memory-Concentration Test<BR/>Exclusion criteria: people with pacemakers</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-05 14:11:03 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>group ABC: 3 weeks baseline (Phase A) then 3 weeks robot-mediated therapy (Phase B) then 3 weeks sling suspension (Phase C)</LI>
<LI>group ACB: 3 weeks baseline (Phase A) then 3 weeks sling suspension (Phase C) then 3 weeks robot-mediated therapy (Phase B)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:10:50 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded before and after baseline, after 3 weeks of therapy and again 3 weeks later (after each cross-over)</P>
<P>Fugl-Meyer scale (0 to 66)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-10-30 14:10:51 +0000" MODIFIED_BY="Hazel Fraser">
<P>We planned to use Phase B data for group 1 (experimental) and Phase C data for group 2 (control) in the analysis</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:10:59 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Ang-2014">
<CHAR_METHODS MODIFIED="2015-10-05 14:12:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:10:53 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Singapore</P>
<P>Sample size: 21 participants (7 in treatment group brain computer interface with haptic knob device (BCI-HK); 8 in treatment group HK; 7 in control group)</P>
<P>Inclusion criteria: first-ever stroke, confirmed by neuroimaging; age 21 to 80 years; time since stroke &gt; 4 months; FMA-score 10 to 50 points (moderate to severe arm impairment); motor power grade 2 to 5 MRC shoulder abduction, grade 2 to 5 MRC elbow flexion, and grade 1 to 3 MRC in wrist dorsiflexion and finger flexion</P>
<P>Exclusion criteria: medical instability; postural hypotension; terminal illness; severe aphasia; inattention; hemispatial neglect; severe visual impairment; epilepsy; severe depression; psychiatric disorders; recurrent stroke; skull defect; severe spasticity; fixed joint contractures; skin lesions</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:10:58 +0000" MODIFIED_BY="Hazel Fraser">
<P>3 groups:</P>
<OL>
<LI>robot-mediated therapy with the haptic knob robot and a brain computer interface for 60 minutes + therapist-assisted arm mobilisation for 30 minutes</LI>
<LI>robot-mediated therapy with the haptic knob robot alone for 60 minutes + therapist-assisted arm mobilisation for 30 minutes</LI>
<LI>standard arm therapy for 60 minutes + therapist-assisted arm mobilisation for 30 minutes</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:10:58 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were measured at baseline (week 0), at mid-intervention (week 3), at the end of intervention period (week 6), 6 weeks' follow-up (week 12), and 18 weeks' follow-up (week 24)</P>
<P>Primary outcome: total FMA score</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-10-30 14:10:59 +0000" MODIFIED_BY="Hazel Fraser">
<P>We combined the results of both HK groups in 1 (collapsed) group and compared this collapsed group with the results of the standard arm therapy group</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:11:01 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Brokaw-2014">
<CHAR_METHODS MODIFIED="2015-10-05 14:14:40 +0100" MODIFIED_BY="Hazel Fraser">
<P>Randomised cross-over trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:10:59 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: USA</P>
<P>Sample size: 12 participants</P>
<P>Inclusion criteria: adult with ischaemic/haemorrhagic stroke at least 6 months before; persistent hemiparesis (score 1 to 2 on the National Institutes of Health Stroke Scale); voluntary wrist and finger extension; shoulder elevation</P>
<P>Exclusion criteria: a score of less than 24 on the Mini-Mental State Examination; hemispatial neglect; severe sensory loss; excessive pain in any joint of the affected hemisphere or upper extremity injury</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:11:00 +0000" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>group AB: 12 hours of robotic training within a month (A) and 12 hours of conventional therapy within a month (B), separated by a month of wash-out period</LI>
<LI>group BA: 12 hours of conventional therapy within a month (B) and 12 hours of robotic training within a month (A), separated by a month of wash-out period</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:11:01 +0000" MODIFIED_BY="Hazel Fraser">
<P>FMA</P>
<P>ARAT</P>
<P>BBT</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:11:07 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Burgar-2011">
<CHAR_METHODS MODIFIED="2012-02-07 14:46:20 +0000" MODIFIED_BY="[Empty name]">
<P>Prospective, single-blinded RCT<BR/>Method of randomisation: stratified random number table</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:11:03 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: USA</P>
<P>Sample size: 54 participants (19 in the first treatment group, 17 in the second treatment group, and 18 in the control group)</P>
<P>Inclusion criteria: primary diagnosis of stroke</P>
<P>Exclusion criteria: people were excluded if they exhibited upper limb joint pain that restricted normal movement, had absent proprioception at the elbow or shoulder joints, or scored less than 22 on the Mini Mental State Examination. People with cardiovascular, orthopaedic, or neurological conditions that would have precluded exercise in short-duration, moderate-workload trials were also excluded</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:11:05 +0000" MODIFIED_BY="Hazel Fraser">
<P>3 groups:</P>
<OL>
<LI>Robot-Lo: received up to 15 1-hour therapy sessions over a 3-week period with the MIME system</LI>
<LI>Robot-Hi: received up to 30 1-hour therapy sessions over a 3-week period with the MIME system</LI>
<LI>Control group: received up to 15 1-hour therapy sessions over a 3-week period</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:11:07 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline, just after completion of training (after 3 weeks), and 6 months later (follow-up)</P>
<UL>
<LI>FMA (maximum 66 points)</LI>
<LI>FIM (upper limb, maximum 63 points)</LI>
<LI>Motor Power (maximum 70*)</LI>
<LI>Ashworth (MAS maximum 5 points)</LI>
<LI>WMFT Functional Ability Scale (maximum 5 and time in seconds)</LI>
</UL>
<P>*The strength of 14 shoulder and elbow muscle groups was assessed by performing manual muscle testing of isolated joint actions and applying the MRC Motor Power grading scale (0 to 5) with a maximum possible score of 70 (scapular abduction/upward rotation, scapular elevation, adduction, adduction/depression, adduction/downward rotation, flexion, extension, abduction, horizontal adduction, horizontal abduction, external rotation, internal rotation, elbow flexion, elbow extension)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:11:12 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Conroy-2011">
<CHAR_METHODS MODIFIED="2012-03-15 14:14:26 +0000" MODIFIED_BY="[Empty name]">
<P>Prospective, single-blinded RCT<BR/>Method of randomisation: choosing a sealed envelope</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:11:10 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: USA</P>
<P>Sample size: 62 participants (41 in the treatment group and 21 in the control group)</P>
<P>Inclusion criteria: diagnosis of clinically defined, unilateral hemiparetic stroke with radiologic exclusion of other possible diagnoses; onset of stroke 6 months before randomisation for ischaemic stroke, 12 months for haemorrhagic stroke; manual muscle testing of grade 3 or lower for at least 1 muscle of the affected arm; &gt; 18 years of age</P>
<P>Exclusion criteria: serious complicating medical illness or stroke occurring within the previous 6 months (or both); contractures or orthopaedic problems limiting the range of joint movement in the potential study arm; visual loss limiting the ability to see the test patterns on the robot monitor; Botox injection of the affected arm 3 months before study onset or during the study</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:11:11 +0000" MODIFIED_BY="Hazel Fraser">
<P>3 groups:</P>
<OL>
<LI>group A: received robot-assisted planar reaching tasks with the InMotion 2.0 shoulder/arm over 6 weeks, 3 sessions per week for 1 hour</LI>
<LI>group B: received robot-assisted planar and vertical reaching tasks with the InMotion Linear Robot over the same time and frequency</LI>
<LI>group C: participants received intensive conventional arm exercise, which includes, for example, 40 minutes of repetitive arm motion using an arm ergometer, or task specific and functional reaching tasks (cones), in addition to 10 minutes of passive and guided stretching and 10 minutes of repositioning and rest between activities</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:11:11 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded 3 times at baseline and after 6 weeks and 3 months later (follow-up)</P>
<UL>
<LI>FMA</LI>
<LI>WMFT</LI>
<LI>SIS</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-10-30 14:11:12 +0000" MODIFIED_BY="Hazel Fraser">
<P>We combined the results of both the planar group and the planar and vertical group in 1 (collapsed) group and compared this collapsed group with the results of the control group</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:11:14 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Daly-2005">
<CHAR_METHODS MODIFIED="2012-02-07 14:52:45 +0000" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Method of randomisation: drawing of tickets from envelopes by a person not involved in or aware of the allocation process<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:11:13 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: USA<BR/>Sample size: 13 participants (7 in treatment group, 6 in control group)<BR/>Inclusion criteria: &gt; 12 months after stroke, at least grade 1 muscle contraction in wrist extensors, and a score of &gt; 10 on the Fugl-Meyer upper-limb score (0 to 66)<BR/>Exclusion criteria: not stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:11:13 +0000" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>control group trained arms with functional neuromuscular stimulation 5 hours a day, 5 days a week for 12 weeks</LI>
<LI>experimental group (robotics and motor learning) had the same amount and frequency of treatment, but during 1.5 hours of the daily treatment session participants used the InMotion robot for practising shoulder/elbow movements</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:11:14 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after 4 weeks and 3 months later</P>
<UL>
<LI>AMAT</LI>
<LI>FMA (0 to 66)</LI>
<LI>the motor control measures of target accuracy, smoothness of movement</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:11:15 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Fazekas-2007">
<CHAR_METHODS MODIFIED="2012-02-07 14:53:54 +0000" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Method of randomisation: by a person not involved in the study<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-07 14:54:06 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Hungary<BR/>Sample size: 30 participants (15 in treatment group, 15 in control group; 22 after stroke and 8 after traumatic brain injury)<BR/>Inclusion criteria: hemiparesis after stroke or traumatic brain injury<BR/>Exclusion criteria: not stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:11:14 +0000" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<OL>
<LI>control group received 30 minutes of Bobath therapy sessions on 20 consecutive workdays</LI>
<LI>treatment group received same therapy as control group, but an additional 30 minutes of robot therapy</LI>
</OL>
<P>
<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:11:15 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after the 10th session and at the end of the training</P>
<UL>
<LI>MAS of shoulder adductors and elbow flexors</LI>
<LI>range of motion of shoulder and elbow</LI>
<LI>FMA (shoulder and elbow subsection; 0 to 36)</LI>
<LI>Rivermead Motor Assessment, arm score</LI>
<LI>FIM, self care subsection</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:11:24 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Hesse-2005">
<CHAR_METHODS MODIFIED="2015-10-30 14:11:16 +0000" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: participant drew a lot out of the sealed envelope presented by an independent person<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:11:23 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Germany<BR/>Sample size: 44 participants (22 in treatment group, 22 in control group)<BR/>Inclusion criteria: first-time supratentorial stroke; stroke interval before study onset 4 to 8 weeks; severe arm paresis with no or only a palpable volitional activity of the wrist and finger extensors (i.e. MRC 0 or 1); an initial Fugl-Meyer arm motor score (0 to 66) of less then 18; absent or moderate elbow, wrist, and finger spasticity; able to understand the meaning of the study; and written informed consent to participate in the approved study<BR/>Exclusion criteria: apraxia (i.e. 1 fault in the tasks waving goodbye, saluting, and making a fist with the non-affected hand after verbal instruction and demonstration, and using an eraser, comb, and screwdriver with the objects handed to the person and verbally instructed); shoulder pain insensitive to standard therapy; hand swelling sufficient to prevent fist formation; painful arthritis of the wrist or finger joints; and forearm skin ulcers</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-05 14:18:53 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>control group received in addition to their standard inpatient rehabilitation programme 5 times a week for 6 weeks (if possible EMG-initiated) functional electrical stimulation for wrist extension</LI>
<LI>experimental group received in addition to their standard inpatient rehabilitation programme for the same time and frequency as the control group therapy with the Bi-Manu-Track robotic arm trainer</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:11:24 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after 6 weeks and 3 months later</P>
<UL>
<LI>FMA (0 to 66)</LI>
<LI>MRC score (0 to 5) muscle strength of the shoulder abductors, flexors, and extensors of the elbow, the wrist, the fingers, and the thumb. A total MRC sum score (0 to 45) included a proximal (MRC proximal subscore) (0 to 15) and a MRC distal subscore (0 to 30)</LI>
<LI>MAS (0 to 5) assessed the tone of the shoulder adductors, the flexors of the elbow, wrist, fingers, and the thumb. A total MAS score (0 to 25), a proximal MAS score (0 to 10), and a distal MAS score (0 to 15) were calculated</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:11:27 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Hesse-2014">
<CHAR_METHODS MODIFIED="2015-10-05 14:19:23 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:11:26 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Germany</P>
<P>Sample size: 50 (25 in the experimental group and 25 in the control group)</P>
<P>Inclusion criteria: first-time supratentorial stroke; time since stroke more than 8 weeks; aged between 18 and 90 years; being able to get out of bed and mobilised in a wheelchair or being able to walk; Fugl-Meyer score &lt; 35</P>
<P>Exlusion criteria: severe arm spasticity; hemiparetic shoulder pain; swollen hand impeding closing the fist</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-05 14:19:56 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>robot-assisted group therapy for 30 minutes + individual arm therapy for 30 minutes, each workday for 4 weeks</LI>
<LI>individual arm therapy for 2 x 30 minutes each workday for 4 weeks</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:11:27 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline, after 4 weeks at the end of intervention period, and at 3 months' follow-up</P>
<P>Primary outcome: FMA</P>
<P>Secondary outcomes: ARAT, BBT, MRC (upper limb muscles), MAS (upper limbs), Barthel Index</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 15:11:43 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Hollenstein-2011">
<CHAR_METHODS MODIFIED="2015-10-05 14:58:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Cross-over RCT</P>
<P>A cross-over design was used (only the first period before cross-over was used for data analysis)</P>
<P>Methods of randomisation: described as follows: "subjects were randomly assigned by lottery of the supervising therapist"</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:11:27 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Germany<BR/>Sample size: 13 participants (7 in treatment group, 6 in control group)<BR/>Inclusion criteria: first-time stroke, affected arm and first rehabilitation</P>
<P>Exclusion criteria: none described</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 15:11:43 +0000" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>group A: received robot-mediated therapy with the Armeo device 5 times a week for 30 minutes over 2 weeks (10 times)</LI>
<LI>group B: received an arm group programme (without device) delivered by an occupational therapist for the same time and frequency as group A</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded before and after 10 treatment sessions</P>
<UL>
<LI>FMA</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-04-10 10:28:05 +0100" MODIFIED_BY="Bernhard Elsner">
<P>This study was published in German</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 15:14:38 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Housman-2009">
<CHAR_METHODS MODIFIED="2015-10-30 14:11:28 +0000" MODIFIED_BY="Hazel Fraser">
<P>RCT</P>
<P>Methods of randomisation: participants were randomly assigned by a supervising therapist</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 15:14:38 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: USA</P>
<P>Sample size: 34 participants (17 in treatment group, 17 in control group)</P>
<P>Inclusion criteria: single ischaemic or haemorrhagic stroke at least 6 months prior to participation, moderate to severe upper extremity hemiparesis (characterised by arm motor Fugl-Meyer scores &gt; 10 and &lt; 30)</P>
<P>Exclusion criteria: significant pain or shoulder instability, current enrolment in ongoing upper extremity therapy, severe cognitive dysfunction, aphasia, hemispatial neglect, or apraxia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-05 14:21:39 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>group A: received robot-mediated therapy with the T-WREX device 3 times a week for 1 hour over 8 to 9 weeks, over the first 3 sessions the participants received direct training with an occupational therapist, and after that the participants exercised with intermittent supervision</LI>
<LI>group B: received the same treatment programme for the same time and frequency but without the device</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:11:29 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded before and after every treatment session and 6 months after treatment completion</P>
<UL>
<LI>FMA</LI>
<LI>Rancho Functional Test (functional use of the affected arm during activities of daily living)</LI>
<LI>MAL to evaluate the quality of movement and the amount of use of the affected arm during activities of daily living, used as a self report measurement</LI>
<LI>handheld dynamometer</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-10-27 12:27:58 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:11:40 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Hsieh-2011">
<CHAR_METHODS MODIFIED="2015-10-30 14:11:29 +0000" MODIFIED_BY="Hazel Fraser">
<P>Pilot RCT</P>
<P>Methods of randomisation: by using a random-number table, a sealed envelope was given to the therapists after a new eligible participant was registered, to deliver therapy accordingly</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:11:35 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Taiwan</P>
<P>Sample size: 18 participants (6 in higher-intensity robot-assisted group, 6 in lower-intensity robot-assisted group, 6 in conventional rehabilitation group)</P>
<P>Inclusion criteria: unilateral stroke onset at least 6 months prior to study; an initial upper extremity subsection of the Fugl-Meyer Assessment score of 30 to 56, indicating moderate to mild motor impairment; no excessive spasticity in elbow and wrist finger joints of the affected upper extremity (MAS &lt; 3); ability to follow study instructions and perform study tasks (Mini-Mental State Examination &gt; 24); no upper limb fracture within 3 months; no participation in any experimental rehabilitation or drug studies during the study period; and written informed consent</P>
<P>Exclusion criteria: painful arthritis of the elbow, wrist, or finger joints; severe neuropsychologic impairments; physician-determined major medical problems or poor physical condition that would interfere with participation; and cerebellar or brain stem lesions to limit potential interference of other symptoms or signs with task accomplishment</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:11:40 +0000" MODIFIED_BY="Hazel Fraser">
<P>3 groups:</P>
<OL>
<LI>higher-intensity RT group: Bi-Manu-Track used in this study for 20 training sessions for 90 to 105 minutes, 5 days per week for 4 weeks, within this group each participant practiced 600 to 800 repetitions of mode 1 (15 minutes), 600 to 800 repetitions of mode 2 (15 to 20 minutes), and 150 to 200 repetitions of mode 3 (5 minutes) for the forearm and wrist movement, after the RT participants received 15 to 20 minutes of functional activities training to help them transfer the acquired motor ability into ADL</LI>
<LI>lower-intensity RT group: with the Bi-Manu-Track the participants received over the same time a different frequency of 300 to 400 repetitions of mode 1 (15 minutes), 300 to 400 repetitions of mode 2 (15 to 20 minutes), and 70 to 100 repetitions of mode 3 (5 minutes) for the forearm and wrist movement, and after that they received the same treatment of functional abilities as the higher-intensity group</LI>
<LI>conventional rehabilitation group: these participants received a structured protocol using conventional occupational therapy techniques including passive range-of-motion exercises for 15 to 20 minutes, fine-motor dexterity training for 20 minutes, gross-motor training for 20 minutes, muscle strengthening of the affected upper limb for 15 to 20 minutes, activities of daily living for 15 to 20 minutes</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:11:40 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and post-treatment</P>
<UL>
<LI>FMA</LI>
<LI>MRC</LI>
<LI>MAL</LI>
<LI>ABILHAND scale to measure bimanual ability</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-10-29 21:59:31 +0000" MODIFIED_BY="[Empty name]">
<P>We combined the results of both the planar and the planar + vertical in 1 (collapsed) group and compared this collapsed group with the results of the control group</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 15:20:09 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Hsieh-2014">
<CHAR_METHODS MODIFIED="2015-06-02 11:24:43 +0100" MODIFIED_BY="Jan Mehrholz">
<P>RCT</P>
<P>Methods of randomisation: random-number table</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:11:43 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Taiwan</P>
<P>Sample size: 48</P>
<P>Inclusion criteria: at least 6 months after onset of a unilateral stroke, an initial score of the FMA arm assessment of 20 to 50 (SD 25), minimal hand function (i.e. extension of the wrist &#8805; 10°, extension of at least 2 fingers &gt; 0° and &gt; 10°, and abduction of thumb &#8805; 10°, no excessive spasticity in any of the joints of the affected arm (MAS &#8805; 4), no arm fracture within 3 months or painful arthritis of the joints, and able to follow study instructions and perform study tasks (Mini-Mental State Examination score &#8805; 22)</P>
<P>Exlusion criteria: none described</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 15:20:09 +0000" MODIFIED_BY="Hazel Fraser">
<P>3 groups:</P>
<OL>
<LI>RT + CIT group (robot-assisted arm therapy (Bi-Manu-Track) + constraint-induced therapy)</LI>
<LI>RT group (robot-assisted arm therapy (Bi-Manu-Track))</LI>
<LI>CT group (received a therapist-mediated intervention using conventional occupational therapy techniques, including neurodevelopmental techniques, functional task practice, fine-motor training, arm exercises or gross-motor training, and muscle strengthening)</LI>
</OL>
<P>Participants in each group received 20 training sessions of 90 to 105 min/day, 5 days/week for 4 weeks. In addition to the intervention provided in the clinics, all participants were encouraged to use their affected upper limb during activities in their daily life situations (e.g. at home)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:11:52 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and post-treatment after 4 weeks</P>
<UL>
<LI>FMA</LI>
<LI>WMFT</LI>
<LI>MAL</LI>
<LI>accelerometers (actigraphy activity monitor)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-10-30 14:11:53 +0000" MODIFIED_BY="Hazel Fraser">
<P>We combined the results of both the RT + CIT group and the RT group (collapsed) group and compared this collapsed group with the results of the CT group</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:11:58 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Hwang-2012">
<CHAR_METHODS MODIFIED="2015-10-30 14:11:55 +0000" MODIFIED_BY="Hazel Fraser">
<P>RCT</P>
<P>Methods of randomisation: random allocation of participants to 2 groups was performed using a random-assignments generator (Wichmann&#8211;Hill random-number generator)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:11:56 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Republic of Korea</P>
<P>Sample size: 15</P>
<P>Inclusion criteria: &#8805; 18 years old, more than 3 months after stroke, &gt; 10° voluntary range of motion of the second metacarpophalangeal joint, a FMA arm motor scale of 2 to 20 for the wrist and hand subportion and requiring a &gt; 25% longer time to finish the 9-hole pegboard test with the affected arm compared with the contralateral arm.</P>
<P>Exlusion criteria: apraxia (&#8804; 2 on the Alexander scale), impaired consciousness (&#8805; 1 for the NIH Stroke Scale question Ia&#8211;c), sensory impairment (&lt; 75% of the contralateral score on the Nottingham Sensory Scale), increased spasticity (4 on the Ashworth scale), aphasia (&#8805; 2 for the NIH Stroke Scale question IX) or depression (&#8805; 8 on the Geriatric Depression Scale), with a combined disabling disease on the hemiparetic hand, or who refused to participate</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:11:57 +0000" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>4 weeks (20 sessions) of active robot-assisted intervention (full-term intervention) group</LI>
<LI>2 weeks (10 sessions) of early passive therapy, followed by 2 weeks (10 sessions) of active robot-assisted intervention (the half-term intervention) group</LI>
</OL>
<P>The robot-assisted therapy included individual finger synchronisation (Amadeo, Tyromotion, Austria)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:11:58 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and at 2, 4, and 8 weeks after starting therapy</P>
<UL>
<LI>FMA</LI>
<LI>Jebsen-Taylor test</LI>
<LI>MAS</LI>
<LI>9-hole pegboard test</LI>
<LI>hand motor subscale of the SIS (involving 12 questions regarding hand function while activities of daily living, with a minimum score of 12 and maximum score of 60)</LI>
<LI>grasping force test</LI>
<LI>pinching force test</LI>
<LI>second metacarpophalangeal joint active range of motion</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-10-05 14:31:43 +0100" MODIFIED_BY="Hazel Fraser">
<P>We used the data from the first 2 weeks of intervention</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:12:00 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Kahn-2006">
<CHAR_METHODS MODIFIED="2012-02-07 15:11:52 +0000" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Method of randomisation: not stated<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:11:59 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: USA<BR/>Sample size: 19 participants (10 in treatment group, 9 in control group)<BR/>Inclusion criteria: unilateral stroke at least 1 year previously, CMSA 3 to 5 points scale<BR/>Exclusion criteria: not stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:12:00 +0000" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>control group received "free reaching training" that involved unconstrained, unassisted repetitive voluntary reaching in an 8-week therapy programme involving a total of 24 exercise sessions. Each session lasted 45 minutes</LI>
<LI>treatment group used robot-guided active-assist training with the ARM Guide for the same time and frequency</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after end of training</P>
<UL>
<LI>biomechanical examination of the impaired limb with the ARM Guide</LI>
<LI>CMSA</LI>
<LI>FMA</LI>
<LI>Rancho Los Amigos Functional Test for the hemiparetic upper extremity</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:12:13 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Klamroth_x002d_Marganska-2014">
<CHAR_METHODS MODIFIED="2015-10-30 14:12:00 +0000" MODIFIED_BY="Hazel Fraser">
<P>RCT</P>
<P>Methods of randomisation: computer-generated list of random numbers was used that paired a unique sequential number with a treatment type (robotic or conventional). Pairs were sealed in tamper-evident envelopes by the study co-ordinator</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:12:12 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Switzerland</P>
<P>Sample size: 77</P>
<P>Inclusion criteria: diagnosis of 1, first-ever cerebrovascular accident verified by brain imaging (magnetic resonance imaging or computed tomography); chronic impairment after stroke (minimum 6 months); moderate to severe arm paresis as indicated by a score of 8 to 38 on arm section of FMA (which has a maximum of 66 points); aged &#8805; 18 years; stable recovery stage; able to sit in a chair without any additional support and without leaning on the back rest; passive range of motion in the shoulder as assessed with the neutral zero method: anteversion/retroversion 80°/0°/20°, abduction/adduction 60°/0°/10°, inner and outer rotation 20°/0°/20°; passive range of motion in the elbow as assessed with the neutral zero method: flexion/extension 100°/40°/40°</P>
<P>Exlusion criteria: excessive spasticity of the affected arm (MAS &#8804; 3); serious medical or psychiatric disorder as assessed by their physician; participation in any clinical investigation within previous 4 weeks; participation in any therapeutic treatment (apart from assigned therapy) done with the paretic arm during the therapy phase of the study; anticipated need for any major surgery during the study; pregnancy or breastfeeding; orthopaedic, rheumatological, or other disease restricting movements of therapeutic arm; shoulder subluxation (palpation &lt; 2 fingers); skin ulcerations at the paretic arm; not able to communicate effectively with the examiner such that the validity of the participant&#8217;s data could not be compromised; cyber sickness (e.g. nausea when looking at a screen or playing computer games); pacemaker or other implanted electric devices; bodyweight above 120 kg; serious cognitive defects or aphasia preventing effective use of ARMin</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:12:13 +0000" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>robotic therapy with ARMin, each of 3 therapy modes (mobilisation, games, and training for activities of daily living) had to be done for at least 10 minutes</LI>
<LI>conventional therapy: receiving common neurorehabilitation treatment given to participants after stroke in outpatient facilities, namely occupational therapy or physiotherapy. Therapists were asked to give regular therapy, usually including mobilisation, games, activities of daily living, or any combination of the 3</LI>
</OL>
<P>Therapy was given 3 times a week for a period of 8 weeks (sum of 24 sessions). Minimum session time (excluding time for preparation, diagnostics, and documentation) was 45 minutes</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:12:13 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and post-treatment every 2 weeks</P>
<UL>
<LI>FMA</LI>
<LI>WMFT</LI>
<LI>quality of movement section of the MAL</LI>
<LI>Stroke Impact Scale (SIS 2.0)</LI>
<LI>Goal Attainment Scale</LI>
<LI>MAS</LI>
<LI>grip strength (handheld dynamometer)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-05-18 11:12:37 +0100" MODIFIED_BY="Jan Mehrholz"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:12:19 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Kutner-2010">
<CHAR_METHODS MODIFIED="2015-10-05 14:36:19 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT</P>
<P>Methods of randomisation: sealed envelope method</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:12:17 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: USA</P>
<P>Sample size: 21 participants (11 in experimental group and 10 in combined therapy group)</P>
<P>Inclusion criteria: first clinical stroke diagnosis; time since stroke between 3 and 9 months; Mini-Mental State Examination score of &gt; 24; being able to stand for 2 minutes; passive range of motion &#8805; 45° for shoulder abduction, flexion, or external rotation and pronation of the forearm; active wrist extension &#8805; 10°; active thumb extension and &#8805; 10° of extension in at least 2 additional digits</P>
<P>Exlusion criteria: not described</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:12:18 +0000" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>60 hours of repetitive task training over the course of 3 weeks</LI>
<LI>30 hours of repetitive task training plus 30 hours of robotic-assisted training with the Hand Mentor device over the course of 3 weeks</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:12:19 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline, at the end of intervention, and at 2 months postintervention</P>
<P>Primary outcome measure: health-related quality of life (SIS)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-05-18 11:12:45 +0100" MODIFIED_BY="Jan Mehrholz"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:12:25 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Liao-2011">
<CHAR_METHODS MODIFIED="2015-10-30 14:12:19 +0000" MODIFIED_BY="Hazel Fraser">
<P>Prospective RCT</P>
<P>Methods of randomisation: participants were randomly assigned to either the treatment or control group in accordance with a random-number table, then a sealed envelope was given to the therapists to deliver therapy accordingly</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:12:22 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Taiwan</P>
<P>Sample size: 20 participants (10 in treatment group and 10 in control group)</P>
<P>Inclusion criteria: clinical diagnosis of the first cortical or subcortical stroke, more than 6 months poststroke, initial upper limb FMA score of 28 to 56 (0 to 66), Mini-Mental State examination &gt; 22, no excessive spasticity in elbow or wrist joints of the affected arm (MAS &lt; 3)</P>
<P>Exclusion criteria: stroke lesions in other than brain areas (cerebellum or brainstem), comorbidity with other severe neurological diseases (epilepsy), severe shoulder pain or painful arthritis of the elbow, wrist, or finger joints, unable to follow treatment instructions</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:12:24 +0000" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>group A: participants received robot-assisted therapy (with the Bi-Manu-Track) over 4 weeks, 5 days a week for 90 to 105 minutes per session, with 600 to 800 repetitions of mode 1 (passive-passive mode) and mode 2 (passive-active mode), and 150 to 200 repetitions of mode 3 (active-active or resistance mode). If the participants were able to perform actively forearm pronation-supination or wrist flexion-extension, then mode 2 was adjusted to mode 4 (active-passive mode, but the affected arm would actively execute the training cycle). After robot-training participants received 15 minutes of training in functional activities that were selected by participants and therapists, e.g. twisting a towel</LI>
<LI>group B: participants received active control therapy that senior occupational therapists designed for protocol-based occupational therapy techniques such as neurodevelopmental techniques with emphasis on functional training, e.g. muscle strengthening of the affected arm and ADL or functional task training. The control group received the same amount of therapy hours as the treatment group (dose-matched comparison group), after the active control therapy session the participants also received 15 minutes of training in functional activities that were selected by the participants and the therapists</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:12:25 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and immediately after the 4 weeks of intervention</P>
<UL>
<LI>arm activity ratio of the accelerometer data (ratio of activity between the affected and the unaffected limb) measured by the MicroMini-Motionlogger activity monitor (Ambulatory Monitoring, New York, NY, USA)</LI>
<LI>FMA</LI>
<LI>FIM</LI>
<LI>MAL</LI>
<LI>ABILHAND</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 15:22:29 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Lo-2010">
<CHAR_METHODS MODIFIED="2015-10-30 14:12:25 +0000" MODIFIED_BY="Hazel Fraser">
<P>Multicentre RCT</P>
<P>Method of randomisation: a permuted-block design that was stratified according to site</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:12:27 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: USA</P>
<P>Sample size: 127 participants (49 in intensive robot-assisted group, 50 in intensive comparison group, and 28 in usual-care group)</P>
<P>Inclusion criteria: age 18 years and older; stroke that occurred at least 6 months prior to enrolment to the study; long-term, moderate to severe motor impairment of the upper limb (described as a score between 7 and 38 of the Fugl-Meyer score); and written informed consent from all participants</P>
<P>Exclusion criteria: all patients with a baseline Fugl-Meyer score outside the required range of 7 to 38</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-05 14:40:37 +0100" MODIFIED_BY="Hazel Fraser">
<P>3 groups:</P>
<OL>
<LI>group A: the participants received intensive robot-assisted therapy for a maximum of 36 sessions over a period of 12 weeks</LI>
<LI>group B: the participants received intensive comparison therapy, which matched the robot-assisted therapy in schedule and in form of intensity of movements</LI>
<LI>group C: the participants received customary care (i.e. medical management, clinic visits needed, and in some cases rehabilitation services). After the final study visit the participants in the usual-care group were offered to choose between robot-assisted therapy or intensive comparison therapy</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:12:28 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline, then 6 and 12 weeks after randomisation, then again 6 months and 9 months after treatment completion</P>
<UL>
<LI>FMA</LI>
<LI>WMFT</LI>
<LI>Stroke Impact Scale (SIS 3.0)</LI>
<LI>MAS</LI>
<LI>measure of pain with a scale from 0 to 10</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-10-30 15:22:29 +0000" MODIFIED_BY="Hazel Fraser"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:12:33 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Lum-2002">
<CHAR_METHODS MODIFIED="2012-02-14 13:43:16 +0000" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Method of randomisation: list of random numbers</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:12:33 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: USA<BR/>Sample size: 30 participants (15 in treatment group, 15 in control group)<BR/>Inclusion criteria: diagnosis of a single stroke, more than 6 months post-stroke, obvious deficit in upper-limb motor function as a result of the stroke, had completed all formal outpatient therapy but continued with any home-based exercise regimen or community-based stroke programmes they were enrolled in at the time of intake into the study<BR/>Exclusion criteria: upper-extremity joint pain or range-of-motion limitations that would affect their ability to complete the protocols; any unstable cardiovascular, orthopaedic, or neurologic conditions; cognitive impairments if people were unable to co-operate with the study tasks<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-05 14:40:59 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>control group received 55 minutes of physiotherapy for the arm and 5 minutes of robot training for each of the 24 sessions over a 2-month period</LI>
<LI>experimental group received bimanual and passive robot therapy by the MIME robot for the same time and frequency</LI>
</OL>
<P>
<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:12:33 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after 4 and 8 weeks (end of training) and 8 months after baseline</P>
<UL>
<LI>FMA</LI>
<LI>Barthel Index</LI>
<LI>FIM</LI>
<LI>strength</LI>
<LI>reach</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-10-30 14:12:33 +0000" MODIFIED_BY="Hazel Fraser">
<P>Incorporates results of <LINK REF="REF-Burgar-2000" TYPE="REFERENCE">Burgar 2000</LINK>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:12:37 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Lum-2006">
<CHAR_METHODS MODIFIED="2012-02-14 13:43:49 +0000" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Method of randomisation: list of random numbers<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:12:37 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: USA<BR/>Sample size: 30 participants (9 in the robot-unilateral group, 10 in the robot-bilateral group, 5 in the robot-combined group, and 6 in the control group)<BR/>Inclusion criteria: diagnosis of stroke, 1 to 5 months poststroke<BR/>Exclusion criteria: any upper-limb joint pain or range-of-motion limitations that would affect their ability to complete the protocols; any unstable cardiovascular, orthopaedic, or neurological conditions; cognitive impairments (scored &lt; 21 of the Folstein Mini-Mental State Examination)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-05 14:42:13 +0100" MODIFIED_BY="Hazel Fraser">
<P>4 groups:</P>
<OL>
<LI>robot-unilateral group performed exercises with the MIME device that progressed from the easiest exercise modes (passive) to the most challenging (active-constrained); no bilateral exercise was performed</LI>
<LI>robot-bilateral group practised the same 12 reaching movements as in group 1, but only in bilateral mode with the MIME device</LI>
<LI>robot-combined group spent approximately half the treatment time in the unilateral mode (as in group 1) and the other half in the bilateral mode with the MIME device</LI>
<LI>control group received an equivalent intensity and duration of conventional therapy targeting proximal upper-limb function based on neurodevelopmental treatment</LI>
</OL>
<P>Groups 1 to 3 were collapsed to 1 robot treatment group (pooled as 1 group) in our analysis</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 01:01:44 +0000" MODIFIED_BY="[Empty name]">
<P>Outcomes were recorded immediately before treatment started, immediately post-treatment, and 6 months after treatment ended</P>
<UL>
<LI>FMA</LI>
<LI>Motor Status Score</LI>
<LI>FIM</LI>
<LI>Motor Power examination to assess arm strength</LI>
<LI>MAS</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:12:38 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Masiero-2007">
<CHAR_METHODS MODIFIED="2012-02-14 13:44:33 +0000" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Method of randomisation: not stated<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:12:38 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Italy<BR/>Sample size: 35 participants (17 in treatment group, 18 in control group)<BR/>Inclusion criteria: first, single unilateral ischaemic stroke using the World Health Organization definition of stroke<BR/>Exclusion criteria: neurologic or cardiovascular instability contraindicating exercise (e.g. uncontrolled hypertension), early severe spasticity, multiple cerebrovascular lesions, severe neuropsychologic impairment (global aphasia, severe attention deficit or neglect), not able to follow instructions</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-05 14:42:36 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>treatment group received additional early sensorimotor robotic training with the NeReBot, robot training treatment twice a day, 5 days a week, for at least 5 weeks</LI>
<LI>control group received similar exposure to the robot (30 minutes twice per week) except that the exercises were performed with the unimpaired arm</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:12:38 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after 1.5, 3, and 8 months</P>
<UL>
<LI>FMA</LI>
<LI>MRC score to measure the strength of shoulder abduction, elbow flexion, and wrist flexion</LI>
<LI>FIM (motor component)</LI>
<LI>Trunk Control Test</LI>
<LI>MAS</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:12:42 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Masiero-2011">
<CHAR_METHODS MODIFIED="2012-02-14 13:45:42 +0000" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Method of randomisation: sequence of computer-generated random numbers</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:12:42 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Italy</P>
<P>Sample size: 21 participants (11 in treatment group, 10 in control group)</P>
<P>Inclusion criteria: (1) diagnosis of recent single-sided stroke (ischaemic or haemorrhagic) demonstrated by brain computerised axial tomography or nuclear magnetic resonance, (2) sufficient cognitive and language capacities to understand the operator&#8217;s instructions (Modified Mini-Mental State Examination score &gt; 18), (3) paralysis or paresis (Motor Power score between 8 and 12) with no ability for active movement against gravity or weak resistance</P>
<P>Exclusion criteria: (1) cardiovascular instability (severe uncontrolled hypertension, severe coronary artery disease, etc.) or orthopaedic or neurological conditions, (2) multiple cerebrovascular lesions, (3) &gt; 3 points Ashworth Scale, (4) upper-limb joint pain or limitations to range of motion that would have affected the participant&#8217;s ability to complete the protocols, (5) severe neuropsychological impairment (global aphasia, severe attention deficit, or severe space inattention), (6) age &gt; 85 years or &lt; 18 years</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 01:05:29 +0000" MODIFIED_BY="[Empty name]">
<P>2 groups:</P>
<OL>
<LI>treatment group received robotic training with the NeReBot, robot training twice a day for 20 minutes, and 40 minutes conventional training, 5 days a week, for at least 5 weeks</LI>
<LI>control group received conventional functional rehabilitation for 80 minutes a day (including proprioceptive exercises, functional re-education, gait training, occupational therapy, and passive and active-assisted mobilisation of the hand and wrist) but without specifically exercising the proximal paretic arm</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:12:42 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline, 5 weeks after treatment onset, and after 3-month follow-up:</P>
<UL>
<LI>MRC</LI>
<LI>FMA</LI>
<LI>Motor subsection of Functional Independence Measure (m-FIM)</LI>
<LI>MAS</LI>
<LI>Frenchay Arm Test</LI>
<LI>BBT</LI>
<LI>Tolerability of treatment: evaluated by noting the number of medical complications in the 2 groups (shoulder-hand syndrome, shoulder pains) and the degree of acceptance of the robotic training rated on a visual analogue scale (0 = poor acceptance and 10 = maximum acceptance)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:12:44 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Mayr-2008">
<CHAR_METHODS MODIFIED="2012-02-14 13:48:19 +0000" MODIFIED_BY="[Empty name]">
<P>Cross-over RCT</P>
<P>Method of randomisation: not stated</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:12:43 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Austria</P>
<P>Sample size: 8 (4 in treatment group, 4 in control group)</P>
<P>Inclusion criteria: &lt; 3 months poststroke with severe to moderate upper-limb paresis, sufficient communication abilities to complete the study, and written informed consent</P>
<P>Exclusion criteria: painful arthritis of the wrist and finger or physician-determined major medical problems</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-05 14:44:04 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>group AB: the participants received over 2 weeks, 5 times per week robot-assisted therapy with the ARMOR device, then 2 weeks with no intervention, and then over 2 weeks, 5 times per week EMG-initiated functional electrical stimulation</LI>
<LI>group BA: the participants received 5 times per week over 2 weeks EMG-initiated functional electrical stimulation, then 2 weeks no intervention, and then 5 times per week over 2 weeks robot-assisted therapy</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:12:44 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and then after each cross-over (after 2, 4, and 6 weeks since baseline)</P>
<UL>
<LI>CMSA</LI>
<LI>MAS</LI>
<LI>Jamar dynamometer to measure hand-force</LI>
<LI>Functional Dexterity Test</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:12:48 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-McCabe-2015">
<CHAR_METHODS MODIFIED="2015-10-30 14:12:44 +0000" MODIFIED_BY="Hazel Fraser">
<P>RCT</P>
<P>Method of randomisation: not described</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-05 14:44:33 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: USA</P>
<P>Sample size: 39 participants (12 in the experimental and 27 in the control group)</P>
<P>Inclusion criteria: single unilateral stroke; &gt; 1 year upper extremity impairment; a trace muscle contraction in the wrist extensors; mobility and function sufficient for independent performance of activities; stable medical condition; not other neurologic condition; ability to follow 2-step commands; informed consent</P>
<P>Exlusion criteria: not explicitly stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:12:44 +0000" MODIFIED_BY="Hazel Fraser">
<P>3 groups:</P>
<OL>
<LI>Motor Learning Programme in a 1:3 group paradigm for 5 hours per day for 12 weeks</LI>
<LI>Motor Learning Programme 1:3 group paradigm for 3.5 hours per day + functional electric stimulation for 1.5 hours per day for 12 weeks</LI>
<LI>Motor Learning Programme 1:3 group paradigm for 3.5 hours per day + robotic-assisted arm training with the InMotion2 Shoulder-Elbow Robot 1.5 hours per day for 12 weeks</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:12:48 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and post-treatment every 2 weeks</P>
<P>Primary outcome: AMAT</P>
<P>Secondary outcomes: AMAT subscale wrist/hand; AMAT subscale shoulder/elbow; FMA (shoulder/elbow and wrist/hand subscales); AMAT (function scale)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-05-18 11:13:02 +0100" MODIFIED_BY="Jan Mehrholz"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 15:24:13 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Rabadi-2008">
<CHAR_METHODS MODIFIED="2015-10-30 14:12:49 +0000" MODIFIED_BY="Hazel Fraser">
<P>RCT</P>
<P>Method of randomisation: sealed, opaque envelopes</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 15:24:13 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: USA</P>
<P>Sample size: 30 participants (10 in experimental group and 20 in control groups)</P>
<P>Inclusion criteria: First acute stroke; time since stroke &lt; 4 weeks; admission to an inpatient rehabilitation facility; arm weakness as defined by Medical Research Council grade &lt; 2 in the shoulder joint; informed consent</P>
<P>Exlusion criteria: Anterior or severe inferior shoulder subluxation (&#8805; 3 cm) of the affected arm; shoulder pain on passive range of 60° forward flexion and 60° abduction of the weak arm; trophic skin changes and significant oedema (shoulder-hand syndrome); prior rotator cuff surgery; bursitis or biceps tendonitis; recent cardiac event; medications enhancing motor recovery such as Botox or d-amphetamine</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:12:52 +0000" MODIFIED_BY="Hazel Fraser">
<P>3 groups:</P>
<OL>
<LI>standard occupational and physical therapy for 3 hours per day + 12 additional sessions of 40 minutes of occupational therapy 5 days per week</LI>
<LI>standard occupational and physical therapy for 3 hours per day + 12 additional sessions of 40 minutes of arm ergometry 5 days per week</LI>
<LI>standard occupational and physical therapy for 3 hours per day + 12 additional sessions of 40 minutes of robotic-assisted arm training with the MIT-Manus 5 days per week</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:12:54 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and at discharge</P>
<P>Primary outcomes:</P>
<UL>
<LI>Shoulder/elbow subscales of FMA wrist/hand subscales</LI>
<LI>Motor Status Scale</LI>
<LI>FIM (including motor and cognition subscale)</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>Motor Power Scale for muscle strength</LI>
<LI>ARAT</LI>
<LI>MAS</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-05-18 11:13:20 +0100" MODIFIED_BY="Jan Mehrholz"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:12:58 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Sale-2014">
<CHAR_METHODS MODIFIED="2015-10-30 14:12:55 +0000" MODIFIED_BY="Hazel Fraser">
<P>RCT</P>
<P>Method of randomisation: Lehmer's algorithm</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:12:55 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Italy</P>
<P>Sample size: 53</P>
<P>Inclusion criteria: subacute first-ever stroke, unilateral paresis, ability to understand and follow simple instructions, ability to remain in a sitting posture</P>
<P>Exlusion criteria: bilateral impairment, severe sensory deficits in the paretic upper limb, cognitive impairment or behavioural dysfunction that would influence the ability to comprehend or perform the experiment, refusal or inability to provide informed consent, other current severe medical problems<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:12:56 +0000" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>performed 30 sessions of robot-assisted therapy (5 days a week for 6 weeks, goal-directed, planar reaching tasks, which emphasised shoulder and elbow movements, moving from the centre target to each of the 8 peripheral targets MIT-Manus/InMotion2 robot)</LI>
<LI>30 sessions (5 days a week for 6 weeks) of conventional rehabilitative treatment, matching robot-assisted therapy of the same duration, such as assisted stretching, shoulder and arm exercises, and functional reaching tasks provided by experienced physiotherapists</LI>
</OL>
<P>Experimental and control therapies were applied in addition to usual rehabilitation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:12:58 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline, after 3 weeks and post-treatment after 6 weeks</P>
<UL>
<LI>FMA</LI>
<LI>MAS-Shoulder and Elbow</LI>
<LI>passive range of motion</LI>
<LI>Motricity Index</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-05-28 12:10:48 +0100" MODIFIED_BY="Jan Mehrholz"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:13:02 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Susanto-2015">
<CHAR_METHODS MODIFIED="2015-10-30 14:12:59 +0000" MODIFIED_BY="Hazel Fraser">
<P>RCT</P>
<P>Method of randomisation: random-number generator</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:13:02 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: China</P>
<P>Sample size: 19</P>
<P>Inclusion criteria: primary stroke 6 to 24 months prior to the beginning of the intervention, moderate stroke condition (50 &gt; FMA score &gt; 20), ability to understand simple commands (Mini-Mental State Examination score &gt; 21), and ability to differentiate sensation on 1 finger from the other fingers</P>
<P>Exclusion criteria: recurrent stroke; other neurological, neuromuscular, or orthopaedic disease; or shoulder or arm contracture/pain</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-05 14:49:06 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>hand exoskeleton robot-assisted group</LI>
<LI>control group (non-assisted group)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:13:02 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline (within 2 weeks from the first training session, within 1 week from the first session), within 3 days after the last session, and at 6 months' follow-up</P>
<UL>
<LI>ARAT</LI>
<LI>WMFT</LI>
<LI>FMA</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:13:11 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Timmermans-2014">
<CHAR_METHODS MODIFIED="2015-10-30 14:13:04 +0000" MODIFIED_BY="Hazel Fraser">
<P>RCT</P>
<P>Method of randomisation: blocked randomisation, using opaque envelopes</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:13:09 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: the Netherlands</P>
<P>Sample size: 22</P>
<P>Inclusion criteria: first-ever stroke, age between 18 and 85 years, clinically diagnosed with a central paresis of the arm/hand (strength: MRC grade 2 to 4 at entry into study), poststroke time &#8805; 12 months, fair to good cognitive level (Mini-Mental State Examination score &#8805; 26), able to read and understand the Dutch language, unable to fully perform at least 2 of the following skills: drinking from a cup, eating with knife and fork, taking money from a purse and using a tray, motivated to train at least 2 of the above-mentioned skills.</P>
<P>(At the start of the last 6 months of the inclusion period, inclusion criteria were adjusted to poststroke time &#8805; 8 months, to facilitate participant inclusion)</P>
<P>Exclusion criteria: severe neglect (Bell Test, Letter Cancellation Test: minimum omission score of 15%), hemianopsia, severe spasticity (MAS total arm &gt; 3, severe additional neurological, orthopaedic, or rheumatoid impairments prior to stroke that could interfere with task performance, Broca's aphasia, Wernicke's aphasia, global aphasia (determined by the Akense Afasie Test), apraxia (apraxia test of Van Heugten), and attending another study or therapy to improve arm-hand function</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:13:09 +0000" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>robotic-assisted training with the end-effector robot HapticMaster</LI>
<LI>arm-hand training program (control group)</LI>
</OL>
<P>Training was provided during 8 weeks, 4 times/week, twice a day for 30 minutes (separated by 0.5 hour to 1 hour of rest)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:13:11 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and post-treatment every 2 weeks</P>
<UL>
<LI>FMA</LI>
<LI>ARAT</LI>
<LI>MAL (quality of use (QU) and amount of use (AU))</LI>
<LI>EuroQol-5D (visual analogue scale)</LI>
<LI>SF-36</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-05-18 11:12:49 +0100" MODIFIED_BY="Jan Mehrholz"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:13:14 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Volpe-2000">
<CHAR_METHODS MODIFIED="2012-02-14 13:49:08 +0000" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Method of randomisation: not stated<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:13:11 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: USA<BR/>Sample size: 56 participants (30 in treatment group, 26 in control group)<BR/>Ambulatory at study onset<BR/>Inclusion criteria: first, single stroke, hemiparesis or hemiplegia of the upper and lower extremity, to be able to follow simple instructions, written informed consent<BR/>Exclusion criteria: not stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:13:12 +0000" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>treatment group used the MIT-Manus device for arm training for 1 hour per day, 5 days a week (for at least 25 sessions)</LI>
<LI>control group had similar initial exposure to the robot with the exception that half the tasks were performed with the unimpaired arm, and when the participant could not perform the task with the affected limb, the unimpaired limb was used to complete the task or the technician assisted the movement. The robot never actively moved the limbs of participants in the control group. Participants were exposed to the robot 1 hour per week</LI>
</OL>
<P>
<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:13:14 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded before and after end of treatment</P>
<UL>
<LI>FMA</LI>
<LI>Motor Power Score (0 to 20)</LI>
<LI>Motor Status Score for shoulder and elbow (0 to 40)</LI>
<LI>Motor Status Score for wrist and hand (0 to 42)</LI>
<LI>FIM (motor and cognition score)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-10-05 14:53:11 +0100" MODIFIED_BY="Hazel Fraser">
<P>
<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:13:15 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Volpe-2008">
<CHAR_METHODS MODIFIED="2012-02-14 13:49:56 +0000" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Method of randomisation: not stated<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-03-15 14:16:14 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: USA<BR/>Sample size: 21 participants (11 in treatment group, 10 in control group)<BR/>Inclusion criteria: people after stroke with impaired arm and hand mobility for at least 6 months<BR/>Exclusion criteria: not able to follow simple instructions, minimally impaired (Fugl-Meyer shoulder-elbow section &gt; 33 points), neurosurgical procedure, second stroke, fixed contracture</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:13:15 +0000" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>control group: intensive movement protocol with a trained physiotherapist</LI>
<LI>treatment group: robotic training with the InMotion2 robot (the commercial version of MIT-Manus)</LI>
</OL>
<P>All participants had an identical number of treatment sessions, and the sessions were of the same duration (1 hour per session, 3 times a week for 6 weeks)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:13:15 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at 3 preliminary evaluations (Pre1, Pre2, Pre3), at midpoint, at discharge, and at 3-month follow-up</P>
<UL>
<LI>FMA</LI>
<LI>Motor Power Scale for shoulder/elbow (0 to 70)</LI>
<LI>MAS</LI>
<LI>Stroke Impact Scale (SIS 2.0)</LI>
<LI>ARAT</LI>
<LI>shoulder dislocation (joint stability; maximum cm of displacement = 9)</LI>
<LI>pain scale from the FMA (0 to 24)</LI>
<LI>Beck Depression Scale (maximum = 63)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 15:37:51 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Wu-2012">
<CHAR_METHODS MODIFIED="2015-10-30 14:13:15 +0000" MODIFIED_BY="Hazel Fraser">
<P>RCT</P>
<P>Method of randomisation: not described</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 15:33:52 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Taiwan</P>
<P>Sample size: 42</P>
<P>Inclusion criteria: unilateral stroke at least 6 months previously, mild to moderate motor impairment (total score of 26 to 66 on the upper extremity part of the FMA, no severe spasticity in the paretic arm (MAS score of 2 in any joint), no serious cognitive deficits (Mini-Mental State Examination score of 22), no other neurologic, neuromuscular, or orthopaedic disease and no participation within the previous 3 months in any experimental rehabilitation or drug studies</P>
<P>Exlusion criteria: none described</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:13:19 +0000" MODIFIED_BY="Hazel Fraser">
<P>3 groups:</P>
<OL>
<LI>therapist-mediated bilateral arm training (TBAT Group)</LI>
<LI>robot-assisted (Bi-Manu-Track) arm trainer (RBAT Group)</LI>
<LI>CT involved weight bearing, stretching, strengthening of the paretic arms, co-ordination, unilateral and bilateral fine-motor tasks, balance, and compensatory practice on functional tasks</LI>
</OL>
<P>Each group received treatment for 90 to 105 minutes per session, 5 sessions on weekdays, for 4 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 15:37:51 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and post-treatment after 4 weeks</P>
<UL>
<LI>Kinematic analysis</LI>
<LI>FMA</LI>
<LI>MAL (Quality of use and Amount of use)</LI>
<LI>SIS</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-10-05 14:55:59 +0100" MODIFIED_BY="Hazel Fraser">
<P>We combined the results of both the TBAT and the CT Group (collapsed) group and compared this collapsed group with the results of the RBAT group</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-30 14:13:21 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Yoo-2013">
<CHAR_METHODS MODIFIED="2015-10-30 14:13:19 +0000" MODIFIED_BY="Hazel Fraser">
<P>RCT</P>
<P>Method of randomisation: not clearly described</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:13:20 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: South Korea</P>
<P>Sample size: 22</P>
<P>Inclusion criteria: no visual neglect or impaired cognitive function (Mini-Mental State Examination score &gt; 24 points), written informed consent</P>
<P>Exlusion criteria: none</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:13:20 +0000" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>3-dimensional robot-assisted therapy (RAT) and conventional rehabilitation therapy (CRT) for a total of 90 minutes (RAT: 30 minutes, CRT: 60 minutes) a day with 10 minutes rest halfway through the session, received training 3 days a week for 6 weeks</LI>
<LI>the control group received only CRT for 60 minutes a day on the same days as the first group</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:13:21 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and post-treatment after 6 weeks</P>
<UL>
<LI>WMFT</LI>
<LI>BBT</LI>
<LI>modified Barthel Index</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-05-18 11:13:29 +0100" MODIFIED_BY="Jan Mehrholz"/>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ADL: activities of daily living<BR/>AMAT: Arm Motor Ability Test<BR/>ARAT: Action Research Arm Test<BR/>BBT: Box and Block Test<BR/>CG: control group<BR/>CMSA: Chedoke-McMaster Stroke Assessment<BR/>EG: experimental group<BR/>EMG: electromyography<BR/>FIM: Functional Independence Measure<BR/>FMA: Fugl-Meyer Assessment<BR/>MAL: Motor Activity Log<BR/>MAS: Modified Ashworth Scale<BR/>MIME: mirror image motion enabler<BR/>MRC: Medical Research Council<BR/>NIH: National Institutes of Health<BR/>RCT: randomised controlled trial<BR/>RT: robot training<BR/>SD: standard deviation<BR/>SIS: Stroke Impact Scale<BR/>WMFT: Wolf Motor Function Test</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2015-10-30 14:13:28 +0000" MODIFIED_BY="Hazel Fraser" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2015-10-05 15:01:02 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Abdollahi-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-05 15:01:02 +0100" MODIFIED_BY="Hazel Fraser">
<P>Compared 2 different approaches of robotic training</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-05 15:01:11 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Aisen-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-05 15:01:11 +0100" MODIFIED_BY="Hazel Fraser">
<P>Not an RCT; participants were allocated by stratification not by randomisation; inclusion criteria not fulfilled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-05 15:01:34 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Dodakian-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-05 15:01:34 +0100" MODIFIED_BY="Hazel Fraser">
<P>Not an RCT; participants were allocated using an approach that kept age and baseline motor deficits matched across the 2 groups</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-05 15:01:39 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Fasoli-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-05 15:01:39 +0100" MODIFIED_BY="Hazel Fraser">
<P>All included participants received a kind of robotic therapy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-30 14:13:24 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Fluet-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-30 14:13:24 +0000" MODIFIED_BY="Hazel Fraser">
<P>Irrelevant comparison: 2 different approaches of robotic training tested</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-05 15:01:51 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Hesse-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-05 15:01:51 +0100" MODIFIED_BY="Hazel Fraser">
<P>All participants received the same robotic therapy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-05 15:01:58 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Hill-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-05 15:01:58 +0100" MODIFIED_BY="Hazel Fraser">
<P>Not an electromechanical-assistive device; used functional electrical stimulation only</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-30 14:13:24 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Hu-2015">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-30 14:13:24 +0000" MODIFIED_BY="Hazel Fraser">
<P>Irrelevant comparison: 2 different approaches of robotic training tested</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-05 15:02:18 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Jackson-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-05 15:02:18 +0100" MODIFIED_BY="Hazel Fraser">
<P>Not an RCT; description of a project/plan for RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-05 15:02:23 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Krebs-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-05 15:02:23 +0100" MODIFIED_BY="Hazel Fraser">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-03-15 14:16:27 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Luft-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-03-15 14:16:27 +0000" MODIFIED_BY="Hazel Fraser">
<P>Inclusion criteria of robot-aided or electromechanical-assisted technology not fulfilled; device used is a mechanical device without robot aid and without an electromechanical-assisted technology</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-05 15:02:33 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Lum-2004a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-05 15:02:33 +0100" MODIFIED_BY="Hazel Fraser">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-17 15:31:36 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Lum-2004b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-17 15:31:36 +0100" MODIFIED_BY="Hazel Fraser">
<P>This trial was excluded after correspondence with the study authors because it overlaps with another trial included in the analysis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-30 14:13:25 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Page-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-30 14:13:25 +0000" MODIFIED_BY="Hazel Fraser">
<P>Not an electromechanical-assistive device; used functional electrical stimulation only</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-30 14:13:25 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Prange-2015">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-30 14:13:25 +0000" MODIFIED_BY="Hazel Fraser">
<P>Not an electromechanical-assistive device; used sling support and feedback only</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-05 15:02:52 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Reinkensmeyer-2000a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-05 15:02:52 +0100" MODIFIED_BY="Hazel Fraser">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-03-15 14:16:29 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Takahashi-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-03-15 14:16:29 +0000" MODIFIED_BY="Hazel Fraser">
<P>No strict randomisation process; inclusion criteria not fulfilled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-05 15:03:02 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Takebayashi-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-05 15:03:02 +0100" MODIFIED_BY="Hazel Fraser">
<P>Not a genuine RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-18 14:03:27 +0100" MODIFIED_BY="Jan Mehrholz" STUDY_ID="STD-Thorsen-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-18 14:03:27 +0100" MODIFIED_BY="Jan Mehrholz">
<P>Investigated myoelectrically controlled functional electrical stimulation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-05 15:03:16 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Tropea-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-05 15:03:16 +0100" MODIFIED_BY="Hazel Fraser">
<P>Irrelevant comparison: 2 different approaches of robotic training were tested</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-05 15:03:20 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Volpe-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-05 15:03:20 +0100" MODIFIED_BY="Hazel Fraser">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-30 14:13:27 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Whitall-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-30 14:13:27 +0000" MODIFIED_BY="Hazel Fraser">
<P>Inclusion criteria of robot-aided or electromechanical-assisted technology not fulfilled; device used is a mechanical device without robot aid and without an electromechanical-assisted technology</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>RCT: randomised controlled trial</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2015-10-30 14:13:40 +0000" MODIFIED_BY="Hazel Fraser" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2015-10-30 14:13:33 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-AIAS">
<CHAR_METHODS MODIFIED="2015-06-12 12:29:04 +0100" MODIFIED_BY="Bernhard Elsner">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:13:30 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: UK</P>
<P>Participants: estimated enrolment n = 18</P>
<P>Inclusion criteria: age above 18 years; clinical diagnosis of stroke; Medical Research Council Scale for arm impairment between 1 and 4; medically stable; informed consent; ability to understand and follow simple instructions; sitting balance sufficient to use Armeo arm orthosis safely</P>
<P>Exclusion criteria: orthosis cannot be fitted to affected limb; bone instability of hemiparetic upper limb; pre-existing upper limb deficits; pronounced, fixed contractures of hemiparetic upper limb; shoulder instability or excessive pain; severe spasticity; severe spontaneous movements; confused; non-co-operative; requiring isolation due to infection; severe visual, perceptual, or cognitive problems precluding participation in study protocol; involved in any other intervention study</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-05 15:04:30 +0100" MODIFIED_BY="Hazel Fraser">
<P>Experimental group 1: standard care + ArmeoSpring arm orthosis intervention for 60 minutes per day, 5 days a week for 2 weeks or discharge (whichever is sooner)</P>
<P>Experimental group 2: standard care + ArmeoSpring arm orthosis intervention for 40 minutes per day, 3 days a week for 2 weeks or discharge (whichever is sooner)</P>
<P>Control group (active): standard care, provided by physiotherapists or occupational therapists</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:13:33 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes will be collected at the end of intervention period and at 3-month follow-up</P>
<P>Primary outcome measure: feasibility of experimental intervention (number of per-protocol interventions recorded at the end of intervention period; reasons for non-compliance recorded at end of intervention period); acceptability/satisfaction of experimental intervention: informal interviews with participants completed at the end of intervention period</P>
<P>Secondary outcome measures: arm pain (5-point scale); shoulder subluxation (clinical report); fatigue (Borg Scale of Perceived Exertion); all adverse events; ARAT; FMA; disability (Barthel Index)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2015-10-30 14:13:35 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Chisari-2014">
<CHAR_METHODS MODIFIED="2015-05-29 07:46:54 +0100" MODIFIED_BY="Jan Mehrholz">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:13:34 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Italy</P>
<P>Sample size: 18</P>
<P>Inclusion criteria: chronic stroke</P>
<P>Exclusion criteria: not described</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:13:34 +0000" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>robotic therapy delivered with a robotic exoskeleton</LI>
<LI>manual physical therapy</LI>
</OL>
<P>The treatments were matched in terms of intensity, duration, and tasks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:13:35 +0000" MODIFIED_BY="Hazel Fraser">
<UL>
<LI>FMA</LI>
<LI>Modified Ashworth Scale</LI>
<LI>Bimanual Activity Test</LI>
<LI>execution time and smoothness index</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-05-29 07:50:24 +0100" MODIFIED_BY="Jan Mehrholz"/>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2015-10-30 14:13:35 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Faran-2008">
<CHAR_METHODS MODIFIED="2012-02-14 13:58:39 +0000" MODIFIED_BY="[Empty name]">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:13:35 +0000" MODIFIED_BY="Hazel Fraser">
<P>Countries: USA, Germany</P>
<P>20 participants between 3 weeks and 3 months poststroke</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-06 11:00:49 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 groups, 20 sessions of either Reo-Therapy system (Motorika USA Inc, NJ) or air splint therapy</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-05 15:06:31 +0100" MODIFIED_BY="Hazel Fraser">
<UL>
<LI>FMA</LI>
<LI>ARAT</LI>
<LI>Motor Power Score</LI>
<LI>Motor Status Score</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-14 13:59:07 +0000" MODIFIED_BY="[Empty name]"/>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2015-10-30 14:13:36 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT00435617">
<CHAR_METHODS MODIFIED="2015-03-31 08:57:24 +0100" MODIFIED_BY="Jan Mehrholz">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:13:36 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: USA<BR/>Inclusion criteria: 3 to 12 months post-stroke; able to extend wrist and fingers at least 10°; functional hearing and vision; able to follow instructions; lives at home, not institution; stable medications for 3 months<BR/>Exclusion criteria: excessive cognitive impairments; taking/receiving medicines/shots to make arm/hand less stiff; severe pain in the impaired arm; stroke was more than 12 months ago</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:13:36 +0000" MODIFIED_BY="Hazel Fraser">
<P>Experimental group: electromechanical-assisted hand therapy at home for 6 weeks (device: Hand Mentor)<BR/>Control group: not described</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser">
<P>Primary outcome: WMFT<BR/>Secondary outcomes: compliance with recommended use, FMA, SIS</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-03-31 08:57:24 +0100" MODIFIED_BY="Jan Mehrholz">
<P>Estimated enrolment: 70 participants</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2015-10-30 14:13:39 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Reinkensmeyer-2012">
<CHAR_METHODS MODIFIED="2015-06-12 12:46:06 +0100" MODIFIED_BY="Bernhard Elsner">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-07 11:56:08 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: USA</P>
<P>Sample size: 27</P>
<P>Inclusion criteria: single ischaemic or haemorrhagic stroke; time since stroke at least 3 months; upper extremity FMA between 10 to 35 out of 66; written informed consent</P>
<P>Exclusion criteria: significant pain; instability or subluxation of the affected shoulder; cognitive dysfunction interfering with the study tasks; visual deficits; severe neglect or apraxia; current other upper extremity therapy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:13:39 +0000" MODIFIED_BY="Hazel Fraser">
<P>Experimental group: 24 x 1-hour treatment sessions with the Pneu-WREX device, 3 times a week for 8 to 9 weeks</P>
<P>Control group (active): conventional exercises typical of home exercise programs, including self range-of-motion stretches, active range-of-motion strengthening exercises, and ADL tasks plus 30 minutes training on the Pneu-WREX per week</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:13:39 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were collected at baseline, at the end of intervention phase, and at 3-month follow-up</P>
<P>Primary outcome measures: FMA</P>
<P>Other outcome measures: Rancho Functional Test for the Hemiplegic/Paretic Upper Extremity; MAL; BBT; Nottingham Sensory Assessment</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</AWAITING_CHAR>
<FOOTNOTES>
<P>ADL: activities of daily living<BR/>ARAT: Action Research Arm Test<BR/>BBT: Box and Block Test<BR/>FMA: Fugl-Meyer Assessment<BR/>MAL: Motor Activity Log<BR/>RCT: randomised controlled trial<BR/>SIS: Stroke Impact Scale<BR/>WMFT: Wolf Motor Function Test<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2015-10-30 15:59:10 +0000" MODIFIED_BY="Hazel Fraser" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2015-10-30 14:13:44 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Krebs-2007">
<CHAR_STUDY_NAME MODIFIED="2008-06-17 15:48:48 +0100" MODIFIED_BY="Hazel Fraser">
<P>Robot-aided neurorehabilitation: a robot for wrist rehabilitation</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2012-02-14 14:08:08 +0000" MODIFIED_BY="Hazel Fraser">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:13:41 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: USA<BR/>Inclusion criteria: first, single focal unilateral lesion with diagnosis verified by brain imaging (MRI or CT scans) that occurred at least 6 months prior; cognitive function sufficient to understand the experiments and follow instructions (Mini-Mental State score of 22 or higher or interview for aphasic participants), Motor Power Score 1/5 and 4/5 (neither hemiplegic nor fully recovered motor function in the muscles of the shoulder and elbow and wrist), never experienced robot-assisted therapy, given informed written consent to participate in the study<BR/>Exclusion criteria: fixed contraction deformity in the affected limb</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:13:44 +0000" MODIFIED_BY="Hazel Fraser">
<P>4 groups:</P>
<OL>
<LI>6 weeks of robot-delivered wrist therapy followed by 6 weeks of robot-delivered shoulder-and-elbow training (3 times per week; 36 sessions in total)</LI>
<LI>6 weeks of shoulder-and-elbow training followed by 6 weeks of wrist training (3 times per week; 36 sessions in total)</LI>
<LI>12 weeks of alternating days of shoulder-and-elbow and wrist training (with at least 24 hours between alternations) using the planar and wrist robots in stand-alone mode (3 times per week; 36 sessions in total)</LI>
<LI>12 weeks of training with half of the day&#8217;s session focusing on shoulder-and-elbow training and half of the session focusing on wrist training (3 times per week; 36 sessions in total) using the planar and wrist robots in stand-alone mode</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-06 12:15:47 +0100" MODIFIED_BY="Hazel Fraser">
<P>Primary outcomes: FMA (shoulder/elbow and wrist/hand subsections); motor power</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2008-06-17 15:51:30 +0100" MODIFIED_BY="Hazel Fraser">
<P>Not described</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-02-14 14:09:06 +0000" MODIFIED_BY="Hazel Fraser">
<P>Principal Investigator: Hermano Igo Krebs, PhD, Principal Research Scientist &amp; Lecturer, Massachusetts Institute of Technology, Mechanical Engineering Department, 77 Massachusetts Ave, 3-137 Cambridge, MA 02139 USA, Tel: +1 617 253 8112, Fax: +1 617 258 7018, hikrebs@mit.edu<BR/>
</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2008-06-17 15:52:04 +0100" MODIFIED_BY="Hazel Fraser">
<P>Estimated enrolment: 160 participants<BR/>
</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-30 14:13:46 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Linder-2013">
<CHAR_STUDY_NAME MODIFIED="2015-05-29 08:30:53 +0100" MODIFIED_BY="Jan Mehrholz">
<P>The home stroke rehabilitation and monitoring system trial</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-10-30 14:13:44 +0000" MODIFIED_BY="Hazel Fraser">
<P>RCT</P>
<P>Method of randomisation: adaptive, stratified, computer-driven minimisation procedure</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:13:46 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: USA</P>
<P>Sample size: 96</P>
<P>Inclusion criteria: age &#8805; 18, unilateral ischaemic or haemorrhagic stroke within 6 months confirmed with neuroimaging, persistent hemiparesis with UE voluntary activity as indicated by a score of 11&#8211;55 on the FMA, limited access to an organised stroke rehabilitation programme, preserved cognitive function as indicated by a score of &#8804; 3 on the Short Portable Mental Status Questionnaire, and no UE injury or condition that limited function of the more-affected side before the stroke<BR/>
</P>
<P>Exlusion criteria: inability to provide informed consent, not independent before the stroke as determined by a score of &gt; 1 on the Modified Rankin Scale, sensory loss &#8805; 2 on the sensory item of the NIHSS, hemispatial neglect as determined by asymmetry &gt; 3 errors on the Star Cancellation Test, spastic hypertonus of hemiparetic hand or wrist musculature &#8805; 3 on MAS, Botox injection in hemiparetic upper extremity within 6 months of enrolment, and life expectancy &#8804; 1 year</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-06 11:06:10 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>Robotic-assisted therapy with Hand Mentor Pro and home exercise program (HEP)</LI>
<LI>HEP only</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-06 11:06:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and post-treatment every 2 weeks</P>
<UL>
<LI>ARAT</LI>
<LI>WMFT</LI>
<LI>FMA</LI>
<LI>SIS</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-05-29 08:34:48 +0100" MODIFIED_BY="Jan Mehrholz">
<P>Not described</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-10-06 11:06:39 +0100" MODIFIED_BY="Hazel Fraser">
<P>Jay L Alberts: albertj@ccf.org</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-05-18 13:55:09 +0100" MODIFIED_BY="Jan Mehrholz"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-30 14:13:46 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT00272259">
<CHAR_STUDY_NAME MODIFIED="2008-06-17 15:56:00 +0100" MODIFIED_BY="Hazel Fraser">
<P>Robots for stroke survivors</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2012-02-14 14:03:26 +0000" MODIFIED_BY="Hazel Fraser">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:13:46 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: USA<BR/>Inclusion criteria: 1 year poststroke and difficulties with picking up small objects<BR/>Exclusion criteria: not described<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-06-17 15:40:40 +0100" MODIFIED_BY="Hazel Fraser">
<P>Not described</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-02-14 14:20:51 +0000" MODIFIED_BY="Hazel Fraser">
<P>Primary outcomes: not described</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2008-06-17 15:41:13 +0100" MODIFIED_BY="Hazel Fraser">
<P>Not described</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-02-14 14:22:01 +0000" MODIFIED_BY="Hazel Fraser">
<P>Bambi Brewer, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA, Tel: +1 412-241-9423, <A HREF="mailto:bambi@andrew.cmu.edu?subject=NCT00272259,%20NSF%200238204:%20-%20%20Robots%20for%20Stroke%20Survivors">bambi@andrew.cmu.edu</A>
</P>
<P>Study chairs or principal investigators:</P>
<UL>
<LI>Yoky Matsuoka, PhD, Principal Investigator, Carnegie Mellon University   </LI>
<LI>Roberta Klatzky, PhD, Study Director, Carnegie Mellon University   </LI>
</UL>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-10-06 11:07:09 +0100" MODIFIED_BY="Hazel Fraser">
<P>Assessed on 27 May 2015</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-30 14:13:49 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT00343304">
<CHAR_STUDY_NAME MODIFIED="2015-10-30 14:13:46 +0000" MODIFIED_BY="Hazel Fraser">
<P>Pilot study - Comparison of upper body ergometer versus robot in upper extremity motor recovery post-stroke</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-06-03 11:16:00 +0100" MODIFIED_BY="Bernhard Elsner">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:13:49 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: USA</P>
<P>Participants: estimated enrolment n = 30</P>
<P>Inclusion criteria: age between 19 and 90 years; stroke in the last 4 weeks; UE plegia (MRC grade &#8804; 2 at the shoulder joint); written informed consent; being able to follow simple directions</P>
<P>Exclusion criteria: anterior or severe inferior shoulder subluxation (&#8805; 3 cms) of the plegic arm; no shoulder pain on passive range of 75° forward flexion and 75° abduction of the plegic arm; trophic skin changes and significant oedema; prior rotator cuff surgery; people with bursitis or biceps tendonitis, or both; recent cardiac events</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-03 11:16:00 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Experimental group: unilateral arm training with a robot</P>
<P>Control group: bilateral arm training with upper body ergometer</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-03 11:16:00 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Not described</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-06-03 11:16:00 +0100" MODIFIED_BY="Bernhard Elsner"/>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-06-03 11:16:00 +0100" MODIFIED_BY="Bernhard Elsner"/>
<CHAR_NOTES MODIFIED="2015-10-06 11:09:08 +0100" MODIFIED_BY="Hazel Fraser">
<P>This study has been completed. No study results posted</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-30 14:13:51 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT00453843">
<CHAR_STUDY_NAME MODIFIED="2008-06-17 15:46:18 +0100" MODIFIED_BY="Hazel Fraser">
<P>The effect of proximal and distal training on stroke recovery</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2012-02-14 14:07:18 +0000" MODIFIED_BY="Hazel Fraser">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:13:51 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: USA</P>
<P>Estimated enrolment: 160 participants<BR/>Inclusion criteria: never experienced robot-assisted therapy; first, single focal unilateral lesion with diagnosis verified by brain imaging (MRI or CT scans) that occurred at least 6 months prior; cognitive function sufficient to understand the experiments and follow instructions (Mini-Mental State score of 22 and higher or interview for aphasic participants); average Motor Power score &#8805; 1/5 or &#8804; 3/5 (neither hemiplegic nor fully recovered motor function in 6 muscles of the shoulder, elbow, and wrist); informed written consent to participate in the study</P>
<P>Exclusion criteria: fixed contraction deformity in the affected limb</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-14 14:07:42 +0000" MODIFIED_BY="Hazel Fraser">
<P>Robotic arm training; no further description</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser">
<P>Primary outcome measures: FMA, Motor Power<BR/>Secondary outcomes: WMFT, SIS</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2008-05-06 13:57:01 +0100" MODIFIED_BY="[Empty name]">
<P>June 2004</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-02-14 14:08:01 +0000" MODIFIED_BY="Hazel Fraser">
<P>Principal Investigator: Hermano Igo Krebs, PhD, Principal Research Scientist &amp; Lecturer, Massachusetts Institute of Technology, Mechanical Engineering Department, 77 Massachusetts Ave, 3-137 Cambridge, MA 02139, USA, Tel: +1 617 253 8112, Fax: +1 617 258 7018, hikrebs@mit.edu<BR/>
</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-06-12 10:11:48 +0100" MODIFIED_BY="Bernhard Elsner">
<P>
<BR/>
</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-30 14:13:55 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT00785343">
<CHAR_STUDY_NAME MODIFIED="2015-10-06 11:09:41 +0100" MODIFIED_BY="Hazel Fraser">
<P>Effectiveness of adding robotic therapy to conventional therapy for acute stroke patients with upper extremity paresis</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:13:54 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: USA</P>
<P>Participants: estimated enrolment n = 40</P>
<P>Inclusion criteria: age between 65 and 84 years; right-hemispheric unilateral ischaemic stroke; time since stroke &lt; 15 days; arm weakness; right-handedness; MRC grade &#8805; 2; being able to follow 2-3 step commands; head, neck, and trunk control; maintain upright posture for at least 45 minutes; some synergistic movements at shoulder flexion or abduction &gt; 30°; &#8805; 45° elbow flexion</P>
<P>Exclusion criteria: previous stroke; haemorrhagic, cerebellar stroke or subarachnoid haemorrhage; contractures in the involved upper extremity; moderate to severe muscle tone in the involved upper extremity; full, active isolated movement of the involved upper extremity; corrected visual acuity worse than 20/50 for distance; cognitive or other deficits that would negatively affect their ability to follow directions or track visual targets; unstable cardiovascular, orthopaedic, or neurological conditions that would preclude exercise in short-duration, high-workload trials</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:13:55 +0000" MODIFIED_BY="Hazel Fraser">
<P>Experimental group: ReoGo robotic arm trainer additional to conventional therapy</P>
<P>Control group: conventional therapy</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:13:55 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes will be collected at baseline and at study end</P>
<P>Primary outcomes: FMA</P>
<P>Secondary outcomes: EMG - muscle activation and co-contraction index</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>September 2008</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Lauren McDonagh, PT; lmcdonagh@KESSLER-REHAB.com</P>
<P>Christine Post, OT; CHPost@selectmedicalcorp.com</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-30 15:40:08 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT00878085">
<CHAR_STUDY_NAME MODIFIED="2015-10-06 11:11:00 +0100" MODIFIED_BY="Hazel Fraser">
<P>fMRI and robot-assisted practice of activities of daily living</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 15:40:08 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: USA</P>
<P>Participants: estimated enrolment n = 61</P>
<P>Inclusion criteria: age between 30 to 85 years; right-handedness; unilateral ischaemic stroke in the motor control area with resulting hemiparesis in the arm; time since stroke at least 6 months; residual movement of at least 15° shoulder flexion or adduction and 15° active elbow flexion and extension; no claustrophobia; not depressed; passes the fMRI scanner; being able to understand the instructions and complete the tracking tasks; no history of neurological disorders</P>
<P>Exclusion criteria: brainstem stroke; spasticity &gt; 3 at elbow or fingers on Ashworth Scale; visuospatial, language, or attention deficits of a severity that prevents understanding of the task; shoulder pain or joint pain during movements; decline to participate; will not comply with full protocol; pregnant; allergic to Gore-Tex and conductivity gel</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:13:58 +0000" MODIFIED_BY="Hazel Fraser">
<P>Experimental group: robot therapy with ADLs 3 times a week for 4 weeks</P>
<P>Control group: occupational therapy 3 times a week for 4 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:14:11 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes will be collected at baseline, at the end of study, and at follow-up</P>
<P>Primary outcomes:</P>
<UL>
<LI>FMA</LI>
<LI>functional hand evaluation (ADL)</LI>
<LI>Jebsen-Taylor</LI>
<LI>movement time</LI>
<LI>grasp aperture</LI>
<LI>movement smoothness</LI>
<LI>BOLD response (activation)</LI>
<LI>laterality index</LI>
<LI>fractional anisotropy</LI>
<LI>fiber density index</LI>
<LI>secondary outcomes</LI>
<LI>joint range of motion</LI>
<LI>manual muscle test</LI>
<LI>spasticity</LI>
<LI>pain</LI>
<LI>exertion</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>November 2008</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Michel Torbey, MD; Medical College of Wisconsin</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-10-06 11:12:29 +0100" MODIFIED_BY="Hazel Fraser">
<P>This study has been completed. No study results posted</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-30 14:14:15 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT01117194">
<CHAR_STUDY_NAME MODIFIED="2015-10-06 11:12:56 +0100" MODIFIED_BY="Hazel Fraser">
<P>Rehabilitation robot for upper limbs, component project 5: effect on shoulder training using rehabilitation robot for stroke patients</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-06-08 14:18:47 +0100" MODIFIED_BY="Bernhard Elsner">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-06 11:13:03 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: Taiwan</P>
<P>Participants: estimated enrolment n = 12</P>
<P>Inclusion criteria: not described</P>
<P>Exclusion criteria: not described</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:14:12 +0000" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>Experimental group: shoulder training with the (self developed) NTUH Model One device</LI>
<LI>Control group: no intervention</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:14:15 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes will be measured at 1-year follow-up</P>
<P>Primary outcomes:</P>
<OL>
<LI>Barthel Index</LI>
<LI>MAS</LI>
<LI>Stroke Rehabilitation Assessment of Movement Measure</LI>
<LI>Postural Assessment Scale for Stroke Patients</LI>
<LI>secondary outcomes</LI>
<LI>shoulder range of motion</LI>
<LI>visual analogue scale</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-06-11 13:38:18 +0100" MODIFIED_BY="Bernhard Elsner">
<P>January 2010</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-10-30 14:14:15 +0000" MODIFIED_BY="Hazel Fraser">
<P>Wen-Shiang Chen, MD, PhD; wenshiang@gmail.com</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-06-08 14:18:47 +0100" MODIFIED_BY="Bernhard Elsner"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-30 14:14:19 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT01253018">
<CHAR_STUDY_NAME MODIFIED="2015-10-06 11:14:11 +0100" MODIFIED_BY="Hazel Fraser">
<P>Evaluation of robot assisted neuro-rehabilitation (SRT3)</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:14:16 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: USA</P>
<P>Participants: estimated enrolment n = 75</P>
<P>Inclusion criteria: age over 21 years; clinically defined unilateral hemiparetic stroke (radiologically confirmed); adequate language and cognitive function to participate in training, testing, and informed consent; FMA score with a range of 7 to 38 in the study arm; stroke onset at least 6 months for ischaemic and at least 1 year for haemorrhagic stroke</P>
<P>Exclusion criteria: seizures or treatment with anticonvulsants in the past 10 years (for transcranial magnetic stimulation testing); any medication known to interfere with brain stimulation; serious complicating medical conditions, contractures, or orthopaedic problems in the study arm limiting the range of motion for study positions; serious visual loss; Botox injection 3 months prior to enrolment; any change in the exercise regimen involving the study arm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:14:18 +0000" MODIFIED_BY="Hazel Fraser">
<P>Experimental group: 12 weeks of robot therapy consisting of a progression through 3 robot modules: wrist, planar, and alternating wrist and planar robot. The progression will be sequential, with 4 weeks of training on each robotic device</P>
<P>Control group: 12 weeks of task-specific practise of functional activities using the hemiparetic arm</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:14:19 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes will be collected at baseline and at the end of study</P>
<P>Primary outcomes: FMA</P>
<P>Secondary outcomes: motor cortex excitability via transcranial magnetic stimulation</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>April 2011</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Christopher Bever, MD; Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-30 14:14:22 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT01552733">
<CHAR_STUDY_NAME MODIFIED="2015-10-06 11:16:43 +0100" MODIFIED_BY="Hazel Fraser">
<P>Robotic therapy early after stroke events</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:14:19 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: UK</P>
<P>Participants: estimated enrolment n = 80</P>
<P>Inclusion criteria: age above 18 years; confirmed diagnosis of stroke; randomisation by 7 days; upper limb impairment (FMA score &lt; 50 at randomisation); being able to comply with requirements of the protocol</P>
<P>Exclusion criteria: other significant upper limb impairment; diagnosis likely to interfere with rehabilitation or outcome assessments; participation in other stroke rehabilitation trial</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:14:20 +0000" MODIFIED_BY="Hazel Fraser">
<P>Experimental group: robotic therapy using InMotion device plus standard care for up to 12 1-hourly sessions</P>
<P>Control group: rehabilitation therapy according to local guidelines</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:14:22 +0000" MODIFIED_BY="Hazel Fraser">
<P>Primary outcomes will be collected at 1-month follow-up, and secondary outcomes will be collected at 3-month follow-up</P>
<P>Primary outcomes:</P>
<UL>
<LI>FMA</LI>
<LI>feasibility</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>FMA</LI>
<LI>Modified Rankin Scale score</LI>
<LI>BI</LI>
<LI>SIS</LI>
<LI>NIHSS</LI>
<LI>ARAT</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>March 2012</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Jesse Dawson, MD; jesse.dawson@glasgow.ac.uk</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-30 14:14:35 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT01655446">
<CHAR_STUDY_NAME MODIFIED="2015-10-06 11:18:25 +0100" MODIFIED_BY="Hazel Fraser">
<P>Randomized trial of robotic rehabilitation, mirror therapy, and dose-matched control intervention for upper-limb rehabilitation in patients with chronic stroke: comparative efficacy and clinimetric study</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>RCT with factorial assignment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:14:23 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Taiwan</P>
<P>Participants: estimated enrolment n = 100</P>
<P>Inclusion criteria: unilateral stroke; onset more than 6 months; written informed consent; initial scores on the upper extremity FMA score of 25 to 56 or 18 to 50; Mini-Mental State Examination &#8805; 24 points; no upper limb fracture in the last 3 months</P>
<P>Exclusion criteria: recurrent stroke or seizures during the intervention; serious or continuous pain on affected upper extremity; history of other neurological disease or severe orthopaedic condition</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:14:24 +0000" MODIFIED_BY="Hazel Fraser">
<P>Experimental group 1: robotic rehabilitation combined functional electrical stimulation (5 to 10 minutes of warm-up, 1 hour of robotic rehabilitation with combined functional electrical stimulation, and 15 to 20 minutes of functional-activities training 5 days a week for 4 weeks)</P>
<P>Experimental group 2: mirror therapy (1 hour mirror therapy and 0.5 hour functional training per day, 5 days a week for 4 weeks); focuses on symmetrical bimanual movements and simultaneously observing the mirror visual feedback reflected by the unaffected upper extremity</P>
<P>Experimental group 3: robotic rehabilitation (5 to 10 minutes of warm-up, 1 hour of robotic rehabilitation, and 15 to 20 minutes of functional-activities training 5 days a week for 4 weeks)</P>
<P>Control group 1 (active): conventional rehabilitation (participants in this group received a structured protocol based on occupational therapy such as neurodevelopmental techniques and task-oriented approach for 1.5 hours per day, 5 days a week for 4 weeks)</P>
<P>Control group 2 (placebo): like experimental group 1 but without any electrical current applied for 1.5 hours per day, 5 days a week for 4 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:14:35 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes will be collected at baseline and at 4, 8, 16, and 28 weeks</P>
<P>Primary outcomes:</P>
<UL>
<LI>FMA</LI>
<LI>MAS</LI>
<LI>FIM</LI>
<LI>movement smoothness (movement units)</LI>
<LI>trajectory smoothness (total displacement)</LI>
<LI>pre-motor planning ability (percentage of peak velocity)</LI>
<LI>speed of motor planning (reaction time)</LI>
<LI>ARAT</LI>
<LI>MRC</LI>
<LI>Muscle tone (Myoton-3)</LI>
<LI>amount of the impaired arm movement outside the laboratory (accelerometer)</LI>
<LI>produced force (peak velocity)</LI>
<LI>trunk-related kinematic variables</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>MAL</LI>
<LI>ABILHAND questionnaire</LI>
<LI>SIS 3.0</LI>
<LI>Nottingham Extended Activities of Daily Living Scale</LI>
<LI>revised Nottingham Sensory Assessment</LI>
<LI>FMA Sensory</LI>
<LI>oxidative stress</LI>
<LI>Multidimensional Fatigue Symptom Inventory</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>August 2011</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Keh-chung Lin, ScD; kehchunglin@ntu.edu.tw</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-30 14:14:45 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT01767480">
<CHAR_STUDY_NAME MODIFIED="2015-10-06 11:34:15 +0100" MODIFIED_BY="Hazel Fraser">
<P>Effects and mechanisms of intensive robot-assisted therapy in patients with subacute stroke: outcomes in brain/movement reorganization, sensorimotor and daily functions, and physiological markers</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-06-08 14:18:52 +0100" MODIFIED_BY="Bernhard Elsner">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:14:36 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Taiwan</P>
<P>Participants: estimated enrolment n = 90</P>
<P>Inclusion criteria: age between 20 and 75 years; first-ever unilateral stroke; time since stroke &lt; 3 months; initial motor part of upper limb FMA score ranging from 10 to 40; Mini-Mental State Examination score &gt; 23)</P>
<P>Exclusion criteria: pregnant or breastfeeding; aphasia interfering with understanding of instructions; major health problems or poor physical condition; current participation in other research; contraindications to fMRI</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:14:40 +0000" MODIFIED_BY="Hazel Fraser">
<P>Experimental group 1 (higher-intensity robotic training group; 1200 to 1800 repetitions during robot-assisted functional rehabilitation with the Bi-Manu-Track device): 90 to 120 minutes per day for 5 days a week for 4 consecutive weeks</P>
<P>Experimental group 2 (lower-intensity robotic training group; 600 to 900 repetitions during robot-assisted functional rehabilitation with the Bi-Manu-Track device): 90 to 120 minutes per day for 5 days a week for 4 consecutive weeks</P>
<P>Control group (active): Neurodevelopmental techniques with emphasis on functional tasks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:14:45 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes will be measured at baseline and at the end of study</P>
<P>Primary outcomes:</P>
<UL>
<LI>FMA</LI>
<LI>Motor Status Scale</LI>
<LI>MAS</LI>
<LI>MyotonPRO</LI>
<LI>Muscle metabolism (near-infrared spectroscopy)</LI>
<LI>BBT</LI>
<LI>Revised Nottingham Sensory Assessment</LI>
<LI>FIM</LI>
<LI>MAL</LI>
<LI>ABILHAND questionnaire</LI>
<LI>Adelaide Activites Profile</LI>
<LI>EQ-5D-5L</LI>
<LI>accelerometers</LI>
<LI>fMRI</LI>
<LI>kinematic analysis</LI>
<LI>inflammatory markers</LI>
<LI>oxidative stress markers</LI>
<LI>erythrocyte deformability</LI>
<LI>blood glucose indicators</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-06-11 14:15:31 +0100" MODIFIED_BY="Bernhard Elsner">
<P>January 2013</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-06-11 14:15:45 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Ching-Yi Wu, ScD; cywu@mail.cgu.edu.tw</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-06-08 14:18:52 +0100" MODIFIED_BY="Bernhard Elsner"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-30 14:14:52 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT01907139">
<CHAR_STUDY_NAME MODIFIED="2015-10-06 11:36:03 +0100" MODIFIED_BY="Hazel Fraser">
<P>Comparative efficacy research of robot-assisted therapy with and without constraint-induced therapy in stroke rehabilitation: does the combined therapy improve outcomes compared with monotherapy?</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>RCT with factorial assignment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:14:47 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Taiwan</P>
<P>Participants: estimated enrolment n = 80</P>
<P>Inclusion criteria: aged between 20 to 80 years; unilateral first-ever stroke; 6 months from onset; initial upper extremity FMA score of 20 to 56; minimal motor criteria to receive constraint-induced therapy (i.e. &#8805; 100 wrist extension and &#8805; 100 extension at the thumb and any other 2 digits); MAS &#8804; 3 of the affected upper extremity; no upper limb fracture within the last 3 months; Mini-Mental State Examination &#8805; 24 points; written informed consent</P>
<P>Exclusion criteria: major medical problems or poor physical condition that would interfere with participation; excessive pain in any joint that might limit participation</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-06 11:37:32 +0100" MODIFIED_BY="Hazel Fraser">
<P>Experimental group 1: distributed constraint-induced therapy (placement of the hand in a mitt for 6 hours/day and intensive training of the affected upper limb in functional tasks for 1.5 hours/weekday over 4 weeks)</P>
<P>Control group (active): dose-matched control therapy for 1.5 hours/weekday over 4 weeks</P>
<P>Experimental group 2: robot-assisted therapy (ArmeoSpring) for 1.5 hours/weekday over 4 weeks</P>
<P>Experimental group 3: robot-assisted therapy (ArmeoSpring) for 1.5 hours/weekday over 2 weeks plus distributed constraint-induced therapy for 1.5 hours/weekday over 2 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:14:52 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes will be collected at baseline and at 2 and 4 weeks</P>
<P>Primary outcomes:</P>
<UL>
<LI>FMA</LI>
<LI>WMFT</LI>
<LI>FIM</LI>
<LI>MAL</LI>
<LI>SIS 3.0</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>MRC</LI>
<LI>MAS</LI>
<LI>Revised Nottingham Sensory Assessment</LI>
<LI>muscle tone (MyotonPRO)</LI>
<LI>activity (actigraphy)</LI>
<LI>visual analogue scale for assessing postexertional fatigue and pain</LI>
<LI>urinary 8-hydroxydeoxyguanosine</LI>
<LI>kinematic analysis</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>August 2013</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Keh-chung Lin, ScD; School of Occupational Therapy, College of Medicine, National Taiwan University, Taiwan</P>
<P>Yi-shiung Horng, PhD; Buddhist Tzu Chi General Hospital Taipei Branch</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-30 14:14:57 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT01939041">
<CHAR_STUDY_NAME MODIFIED="2015-10-06 11:38:55 +0100" MODIFIED_BY="Hazel Fraser">
<P>Efficacy of unilateral versus bilateral approach to robot-assisted rehabilitation on motor control/performance, daily functions, and physiological responses in patients with subacute stroke</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:14:54 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Taiwan</P>
<P>Participants: estimated enrolment n = 84</P>
<P>Inclusion criteria: first stroke; time since stroke less than 6 months and more than 2 weeks; initial motor impairment between 24 to 52 points on the upper extremity FMA; Mini-Mental State Examination &#8805; 24 points</P>
<P>Exclusion criteria: aphasia that might limit ability to understand instructions; chronic inflammatory, autoimmune, or haematological disorders; intake of anti-inflammatory drugs; major health problems or poor physical condition that might interfere with participation; current enrolment in other research</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-06 11:39:34 +0100" MODIFIED_BY="Hazel Fraser">
<P>Experimental group 1: robot-assisted therapy with InMotion3 for 90 minutes per day, 5 days a week for 4 weeks</P>
<P>Experimental group 2: robot-assisted therapy with Bi-Manu-Track for 90 minutes per day, 5 days a week for 4 weeks</P>
<P>Control group (active): control intervention for 90 minutes per day, 5 days a week for 4 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:14:57 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes will be collected at baseline, at study end, and at 6-month follow-up</P>
<P>Primary outcomes:</P>
<UL>
<LI>change of kinematic analysis</LI>
<LI>FMA</LI>
<LI>MAS</LI>
<LI>MyotonPRO</LI>
<LI>MRC</LI>
<LI>grip strength (Jamar dynamometer)</LI>
<LI>ARAT</LI>
<LI>MAL</LI>
<LI>ABILHAND questionnaire</LI>
<LI>Accelerometer</LI>
<LI>Adelaide Activities Profile</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>inflammatory markers</LI>
<LI>oxidative stress markers</LI>
<LI>erythrocyte deformability</LI>
<LI>blood glucose indicators</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>August 2013</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Ching-Yi Wu, ScD; cywu@mail.cgu.edu.tw</P>
<P>Chia-Ling Chen, PhD, MD; clingchen@gmail.com</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-30 14:15:00 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT02077439">
<CHAR_STUDY_NAME MODIFIED="2015-10-06 11:40:17 +0100" MODIFIED_BY="Hazel Fraser">
<P>Interactive intention-driven upper-limb training robotic system</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-06-08 14:18:55 +0100" MODIFIED_BY="Bernhard Elsner">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-06 11:40:20 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: China</P>
<P>Participants: estimated enrolment n = 70</P>
<P>Inclusion criteria: age above 18 years; pure unilateral motor paresis after ischaemic or haemorrhagic stroke; sufficient cognition to understand instructions; being able to sit upright for 1 hour</P>
<P>Exclusion criteria: excessive spasticity of the affected arm; involvement in any other therapy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:14:59 +0000" MODIFIED_BY="Hazel Fraser">
<P>Experimental group 1: hand robotic training for 20 1-hourly sessions, 3 to 5 times per week</P>
<P>Experimental group 2: hand and arm robotic training for 20 1-hourly sessions, 3 to 5 times per week</P>
<P>Control therapy (active): conventional therapy for 20 1-hourly sessions, 3 to 5 times per week</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:15:00 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes will be measured at baseline, at the end of study, and at 3- and 6-months follow-up</P>
<P>Primary outcomes:</P>
<UL>
<LI>FMA</LI>
<LI>ARAT</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>WMFT</LI>
<LI>MAS</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-06-11 14:25:37 +0100" MODIFIED_BY="Bernhard Elsner">
<P>January 2014</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-06-11 14:25:54 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Raymond KY Tong, PhD; k.y.tong@polyu.edu.hk</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-06-08 14:18:55 +0100" MODIFIED_BY="Bernhard Elsner"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-30 14:15:04 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT02079779">
<CHAR_STUDY_NAME MODIFIED="2015-10-06 11:41:04 +0100" MODIFIED_BY="Hazel Fraser">
<P>Efficacy study of an interactive robot for the rehabilitation of the upper limb in acute stroke patients</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-05-29 08:43:49 +0100" MODIFIED_BY="Jan Mehrholz">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:15:01 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Belgium<BR/>Inclusion criteria:</P>
<UL>
<LI>first stroke</LI>
<LI>acute stroke (less than 1 month)</LI>
<LI>unilateral localisation of the stroke</LI>
<LI>moderate to severe upper limb impairments (7 &lt; FMA score &lt; 50/66)</LI>
</UL>
<P>Exclusion criteria:</P>
<UL>
<LI>brainstem or cerebellum stroke</LI>
<LI>an unstable clinical condition contraindicating the upper limb rehabilitation treatments</LI>
<LI>cognitive disorders preventing understanding of the instructions</LI>
<LI>other neurological or orthopaedic pathology affecting the upper limb</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-06 11:41:32 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 groups:</P>
<OL>
<LI>robotic-assisted therapy</LI>
<LI>classical therapy</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:15:04 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and post-treatment every 2 weeks</P>
<UL>
<LI>kinematic</LI>
<LI>FMA</LI>
<LI>Stroke Impairment Assessment Set</LI>
<LI>BBT</LI>
<LI>MRC</LI>
<LI>MAS</LI>
<LI>Bells Test</LI>
<LI>WMFT</LI>
<LI>ABILHAND</LI>
<LI>ACTIVLIM</LI>
<LI>SIS</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-05-29 08:44:17 +0100" MODIFIED_BY="Jan Mehrholz">
<P>Not described</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-05-29 09:00:44 +0100" MODIFIED_BY="Jan Mehrholz">
<P>Thierry Lejeune, Professor: thierry.lejeune@uclouvain.be</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-05-29 08:44:17 +0100" MODIFIED_BY="Jan Mehrholz"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-30 14:15:09 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT02096445">
<CHAR_STUDY_NAME MODIFIED="2015-10-06 11:41:53 +0100" MODIFIED_BY="Hazel Fraser">
<P>Neurocognitive robot-assisted rehabilitation of hand function after stroke</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:15:04 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Switzerland</P>
<P>Participants: estimated enrolment n = 20</P>
<P>Inclusion criteria: aged between 18 and 90 years; first stroke with resulting hemiparesis; time since stroke less than 6 weeks</P>
<P>Exclusion criteria: insufficient state of consciousness; severe aphasia; severe cognitive deficits; severe pathologies of the upper extremity of traumatic or rheumatic nature; severe pain in the affected arm; people with metal implants</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Experimental group: robot-assisted neurocognitive therapy (ReHapticKnob) for 45 minutes 4 times per week</P>
<P>Control group: conventional neurocognitive therapy (Perfetti) for 45 minutes 4 times per week</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:15:09 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes will be collected at baseline, at 4 and 8 weeks, and at 6 months</P>
<P>Primary outcomes:</P>
<UL>
<LI>FMA</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>FMA</LI>
<LI>BBT</LI>
<LI>MAS</LI>
<LI>tactile and proprioceptive sensory function of the upper limb (Erasmus Medical Center Nottingham Sensory Assessment)</LI>
<LI>neglect (Albert's test of neglect)</LI>
<LI>cognitive impairment (Mini-Mental State Examination)</LI>
<LI>frontal lobe function (Frontal Assessment Battery)</LI>
<LI>aphasia (Aachen Aphasia Test)</LI>
<LI>attention</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>April 2013</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Daria Dinacci, MD; d.dinacci@clinica-hildebrand.ch</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-30 14:15:15 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT02188628">
<CHAR_STUDY_NAME MODIFIED="2015-10-06 11:42:56 +0100" MODIFIED_BY="Hazel Fraser">
<P>Refinement and clinical evaluation of the H-Man: a novel, portable, inexpensive planar robot for arm rehabilitation after stroke</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:15:13 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Singapore</P>
<P>Participants: estimated enrolment n = 60</P>
<P>Inclusion criteria: age between 21 and 85 years; first-ever clinical stroke confirmed by imaging; time since stroke between 3 and 24 months; hemiplegic pattern of motor impairment with MRC motor power of shoulder and elbow flexion grade &#8805; 3; FMA score of the affected upper limb between 20 and 50 points; motor inco-ordination or motor ataxia</P>
<P>Exclusion criteria: other causes of arm motor impairment; severe medical conditions; palliative care; severe arm pain; inability to sit for 90 minutes; local fractures; spasticity of MAS grades 3 to 4; skin wounds; shoulder pain &gt; 5/10 visual analogue scale; severe sensory impairment of affected limb; severe visual impairment; hemispatial neglect or homonymous hemianopia; cognitive impairments or uncontrolled behaviour; Mini-Mental State Examination &lt; 26/28</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:15:15 +0000" MODIFIED_BY="Hazel Fraser">
<P>Experimental group: H-Man (end-effector upper limb robot; dosage not stated)</P>
<P>Control group: additional conventional therapy (repetitive goals-based arm therapy; dosage not stated)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:15:15 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes will be collected at baseline and at 3, 6, 12, and 24 weeks after start of the intervention</P>
<P>Primary outcomes:</P>
<UL>
<LI>FMA</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>ARAT</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>July 2014</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Chua SG Sui Geok; karen_chua@ttsh.com.sg</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-30 14:15:28 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT02228863">
<CHAR_STUDY_NAME MODIFIED="2015-10-06 11:59:04 +0100" MODIFIED_BY="Hazel Fraser">
<P>Upper extremity rehabilitation using robot and botulinum toxin</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:15:16 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Republic of Korea</P>
<P>Participants: estimated enrolment n = 348</P>
<P>Inclusion criteria: first-ever stroke; shoulder or elbow flexor spasticity &#8805; MAS 1+; being able to follow instructions from the investigator</P>
<P>Exclusion criteria: history of surgery or fracture of affected upper limb; Botox injection within the last 6 months</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:15:20 +0000" MODIFIED_BY="Hazel Fraser">
<P>Experimental group: early InMotion and Botox (robotic rehabilitation with the InMotion device and Botox for 8 weeks; dosage not stated)</P>
<P>Control group 1: Botox, then InMotion (robotic rehabilitation 4 weeks after botulinum toxin injection; dosage not stated)</P>
<P>Control group 2: InMotion, then Botox (robotic rehabilitation from the baseline, then Botox injection at 4 weeks after baseline; dosage not stated)</P>
<P>Control group 3: late Inmotion and Botox (no intervention, then robotic rehabilitation and Botox injection at 4 weeks after baseline; dosage not stated)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:15:28 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes will be collected at baseline and 4, 8, and 12 weeks from baseline</P>
<P>Primary outcomes:</P>
<UL>
<LI>FMA</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>kinematic data (InMotion)</LI>
<LI>spasticity of elbow and shoulder joint (Modified Tardieu Scale)</LI>
<LI>MRC of elbow and shoulder joint strength</LI>
<LI>painless range of motion of elbow and shoulder joint</LI>
<LI>numeric rating scale of pain of elbow and shoulder joint</LI>
<LI>associated reaction rating scale</LI>
<LI>surface electromyography data from bilateral upper extremities</LI>
<LI>behavioural activation system/behavioral inhibition system scale</LI>
<LI>Controlled Oral Word Association Test</LI>
<LI>FMA</LI>
<LI>SIS</LI>
<LI>Beck Depression Inventory</LI>
<LI>satisfaction about the intervention</LI>
<LI>adverse events</LI>
<LI>digit span test</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>March 2014</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Joon-Ho Shin, MS; asfreelyas@gmail.com</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-30 15:59:10 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT02254343">
<CHAR_STUDY_NAME MODIFIED="2015-10-06 12:00:25 +0100" MODIFIED_BY="Hazel Fraser">
<P>Effects of proximal and distal robot-assisted therapy combined with functional training on stroke rehabilitation</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:15:28 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Taiwan</P>
<P>Participants: estimated enrolment n = 92</P>
<P>Inclusion criteria: unilateral stroke, radiologically confirmed; time since onset more than 6 months; upper extremity FMA score between 10 and 50; Mini-Mental State Examination &gt; 24 points; being able to follow commands</P>
<P>Exclusion criteria: serious visual or visual perception problems; orthopaedic or other neurological problems in the last 6 months prior to enrolment; participation in other studies in the last 3 months</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:15:29 +0000" MODIFIED_BY="Hazel Fraser">
<P>Experimental group 1: proximal robot-assisted therapy (InMotion2 device); dosage not described</P>
<P>Experimental group 2: distal robot-assisted therapy (InMotion3 device); dosage not described</P>
<P>Experimental group 3: combined robot-assisted therapy (InMotion2 and InMotion3 devices); dosage not described</P>
<P>Control group (active): dose-matched, individualised intensive therapy; dosage not described</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 15:59:10 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes will be collected at baseline, 2 weeks, and 4 weeks</P>
<P>Primary outcomes:</P>
<UL>
<LI>FMA</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>BBT</LI>
<LI>ARAT</LI>
<LI>MRC</LI>
<LI>MAS</LI>
<LI>Myoton</LI>
<LI>WMFT</LI>
<LI>Chedoke Arm and Hand Activity Inventory</LI>
<LI>FIM</LI>
<LI>SIS 3.0</LI>
<LI>EuroQol Quality of Life Scale (EQ-5D)</LI>
<LI>hand strength</LI>
<LI>MAL</LI>
<LI>ABILHAND questionnaire</LI>
<LI>10-meter walking test</LI>
<LI>Nottingham Extended ADL Questionnaire</LI>
<LI>Adelaide Activities Profile</LI>
<LI>Montreal Cognitive Assessment</LI>
<LI>Number Stroop test</LI>
<LI>accelerometer</LI>
<LI>Revised Nottingham Sensory Assessmen</LI>
<LI>algometer</LI>
<LI>kinematic analysis</LI>
<LI>adverse effects</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>September 2014</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Ching-Yi Wu, ScD; cywu@mail.cgu.edu.tw</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-30 14:15:36 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT02319785">
<CHAR_STUDY_NAME MODIFIED="2015-10-06 12:01:30 +0100" MODIFIED_BY="Hazel Fraser">
<P>Effects of robot-assisted combined therapy in upper limb rehabilitation in stroke patients</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Randomised cross-over trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:15:34 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Taiwan</P>
<P>Participants: estimated enrolment n = 120</P>
<P>Inclusion criteria: age 18 to 80 years; first-ever unilateral stroke &gt; 3 months after onset; upper extremity FMA score between 18 to 56 points; no excessive spasticity in the affected upper extremity; being able to follow study instructions and to perform study tasks; written informed consent</P>
<P>Exclusion criteria: neural or psychological problems that may interfere with study; severe joint pain; upper limb fracture within the last 3 months; participation in any other research</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Experimental group 1: robot-assisted therapy and neuromuscular electrical stimulation for 1.5 hours per day, 5 days a week for 4 weeks</P>
<P>Experimental group 2: robot-assisted therapy and mirror therapy for 1.5 hours per day, 5 days a week for 4 weeks</P>
<P>Experimental group 3: mirror therapy for 1.5 hours per day, 5 days a week for 4 weeks</P>
<P>Experimental group 4: unilateral robot-assisted therapy (InMotion device) for 1.5 hours per day, 5 days a week for 4 weeks</P>
<P>Experimental group 5: bilateral robot-assisted therapy (Bi-Manu-Track) for 1.5 hours per day, 5 days a week for 4 weeks</P>
<P>Control group (active): conventional rehabilitation for 1.5 hours per day, 5 days a week for 4 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:15:36 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes will be collected at baseline and at the end of study at 4 weeks</P>
<P>Primary outcomes:</P>
<UL>
<LI>kinematic analyses</LI>
<LI>FMA</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>10-meter walk test</LI>
<LI>WMFT</LI>
<LI>FIM</LI>
<LI>ARAT</LI>
</UL>
<P>Other outcome measures:</P>
<UL>
<LI>MRC</LI>
<LI>Functional Ambulation Categories</LI>
<LI>MAS</LI>
<LI>MAL</LI>
<LI>ABILHAND questionnaire</LI>
<LI>SIS 3.0</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>August 2014</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-10-06 12:03:05 +0100" MODIFIED_BY="Hazel Fraser">
<P>Keh-Chung Lin; kehchunglin@ntu.edu.tw</P>
<P>Chung-Shan Hung; f00429003@ntu.edu.tw</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-30 14:15:40 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT02323061">
<CHAR_STUDY_NAME MODIFIED="2015-10-30 14:15:37 +0000" MODIFIED_BY="Hazel Fraser">
<P>Brain Computer Interface (BCI) System for stroke rehabilitation</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:15:38 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: China</P>
<P>Participants: estimated enrolment n = 60</P>
<P>Inclusion criteria: age above 18 years; hemiparesis resulting from a single unilateral lesion of the brain; at least 6 months after onset; subcortical ischaemic lesion within the territory of the middle cerebral artery; being able to follow simple instructions; understand purpose and content of the experiment; moderate to severe motor disability in the paretic upper limb</P>
<P>Exclusion criteria: severe hand spasticity; open hand wound or hand deformity; visual-field defects; aphasia; neglect; apraxia; participation in any therapeutic treatment outside the study; history of substance abuse; bilateral infarctions; uncontrolled medical problems; serious cognitive deficits; other MRI contraindications</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:15:39 +0000" MODIFIED_BY="Hazel Fraser">
<P>Experimental group 1: EEG-guided robotic training based on ipsilesional EEG signals for 30 sessions</P>
<P>Experimental group 2: EEG-guided training based on both ipsilesional and contralesional EEG signals for 30 sessions</P>
<P>Control group: placebo comparator robot for 30 sessions</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:15:40 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes will be collected at 3-month follow-up</P>
<P>Primary outcomes:</P>
<UL>
<LI>FMA</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>ARAT</LI>
<LI>MAS</LI>
<LI>MRI</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>May 2015</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Raymond Tong, PhD; +852 3943 8454</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-06-03 11:16:17 +0100" MODIFIED_BY="Bernhard Elsner"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-30 14:15:44 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NTR3669">
<CHAR_STUDY_NAME MODIFIED="2015-10-06 12:04:33 +0100" MODIFIED_BY="Hazel Fraser">
<P>Feasibility of supervised care and rehabilitation involving personal telerobotics for arm/hand function of chronic stroke patients</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-06-12 13:09:03 +0100" MODIFIED_BY="Bernhard Elsner">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-30 14:15:42 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: the Netherlands</P>
<P>Participants: estimated enrolment n = 20</P>
<P>Inclusion criteria: age between 18 and 80 years; unilateral and ischaemic or haemorrhagic stroke; time since stroke between 6 and 12 months; clinical diagnosis of central paresis of arm or hand with 15° active elbow flexion; 1/4 range of active finger flexion; ability to complete measurements and training sessions; discharged from medical centre; living at home and having Internet access; having a carer who is co-resident or closely involved in care; ability to read, understand, and follow instructions; device fits to the person; written informed consent</P>
<P>Exclusion criteria: receiving additional therapy to the affected upper extremity during the study; not eligible to join normal rehabilitation; other severe comorbidities; severe sensory impairments; severe neglect; visual impairments; cognitive impairment</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:15:43 +0000" MODIFIED_BY="Hazel Fraser">
<P>Experimental group: 60 minutes of technology-assisted arm/hand training for 18 sessions during 6 weeks (consisting of computerised gaming wearing the SCRIPT hand device to support hand opening and the SaeboMAS for gravity compensation)</P>
<P>Control group: 60 minutes of technology-assisted arm/hand training for 18 sessions during 6 weeks of conventional home training (standard arm and hand exercises)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:15:44 +0000" MODIFIED_BY="Hazel Fraser">
<P>Primary outcomes:</P>
<UL>
<LI>user acceptance (usability, satisfaction, motivation, compliance)</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>ARAT</LI>
<LI>FMA</LI>
<LI>BBT</LI>
<LI>MAL</LI>
<LI>SIS</LI>
<LI>kinematics</LI>
<LI>EMG</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-06-12 13:25:12 +0100" MODIFIED_BY="Bernhard Elsner">
<P>January 2013</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-06-12 13:25:51 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Sharon Nijenhuis, MSc; s.nijenhuis@rrd.nl</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-30 14:15:46 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-RATULS">
<CHAR_STUDY_NAME MODIFIED="2015-10-30 06:38:48 +0000" MODIFIED_BY="[Empty name]">
<P>Robot Assisted Training for the Upper Limb after Stroke (RATULS)</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-10-06 12:05:57 +0100" MODIFIED_BY="Hazel Fraser">
<P>Multicentre RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-06 12:05:58 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: UK</P>
<P>Inclusion criteria: adults with acute or chronic stroke causing moderate to severe upper limb functional limitation</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-30 14:15:45 +0000" MODIFIED_BY="Hazel Fraser">
<P>3 groups:</P>
<OL>
<LI>robot-assisted training using the InMotion robotic gym system</LI>
<LI>enhanced upper limb therapy</LI>
<LI>usual care</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-30 14:15:46 +0000" MODIFIED_BY="Hazel Fraser">
<P>Primary outcome: upper limb function measured by ARAT at 3 months' postrandomisation</P>
<P>Secondary outcomes: upper limb impairment, activities of daily living, quality of life, resource use, and adverse events measured at 3 and 6 months' postrandomisation</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-05-29 09:13:52 +0100" MODIFIED_BY="Jan Mehrholz">
<P>April 2014</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-05-29 09:15:35 +0100" MODIFIED_BY="Jan Mehrholz">
<P>https://research.ncl.ac.uk/ratuls/contact%20us/</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-05-29 09:15:39 +0100" MODIFIED_BY="Jan Mehrholz">
<P>Sample size: 720 participants</P>
<P>Study duration: 57 months</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES>
<P>ADL: activities of daily living<BR/>ARAT: Action Research Arm Test<BR/>BBT: Box and Block Test<BR/>BOLD: blood oxygenation level dependent<BR/>BI: Barthel Index<BR/>CT: computerised tomography<BR/>EEG: electroencephalogram<BR/>EMG: electromyography<BR/>FIM: Functional Independence Measure<BR/>FMA: Fugl-Meyer Assessment<BR/>fMRI: functional magnetic resonance imaging<BR/>MAL: Motor Activity Log<BR/>MAS: Modified Ashworth Scale<BR/>MRC: Medical Research Council<BR/>MRI: magnetic resonance imaging<BR/>NIHSS: National Institutes of Health Stroke Scale<BR/>RCT: randomised controlled trial<BR/>SIS: Stroke Impact Scale<BR/>UE: upper extremity<BR/>WMFT: Wolf Motor Function Test</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2015-10-30 14:13:21 +0000" MODIFIED_BY="Hazel Fraser">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2015-10-30 14:13:21 +0000" MODIFIED_BY="Hazel Fraser" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-13 08:15:19 +0100" MODIFIED_BY="Bernhard Elsner" RESULT="YES" STUDY_ID="STD-Abdullah-2011">
<DESCRIPTION>
<P>Quote: "A physiotherapist unrelated to the study randomized the participants into one of two groups using a random number table."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-11-29 11:56:38 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Amirabdollahian-2007">
<DESCRIPTION>
<P>Random sequence generation not exactly stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:14:25 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Ang-2014">
<DESCRIPTION>
<P>Quote: "The randomization block size was 3 and the allocation sequence was 1:1:1 generated using STATA software"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:15:54 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Brokaw-2014">
<DESCRIPTION>
<P>Quote: "Randomization was done using a random number generator function in Matlab (MathWorks Inc, Natick, MA) that generated a list of numbers (1-10) randomly ordered"<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-30 14:11:07 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Burgar-2011">
<DESCRIPTION>
<P>Random-number table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-15 14:14:33 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Conroy-2011">
<DESCRIPTION>
<P>Stratified randomisation by a computer scheme</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:39:17 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Daly-2005">
<DESCRIPTION>
<P>The investigators describe a stratified randomisation, but there is insufficient information about the sequence generation process</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:39:25 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fazekas-2007">
<DESCRIPTION>
<P>Insufficient information about the sequence generation process</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:39:37 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hesse-2005">
<DESCRIPTION>
<P>Sequence generation was done by shuffling envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-13 10:16:50 +0100" MODIFIED_BY="Bernhard Elsner" RESULT="YES" STUDY_ID="STD-Hesse-2014">
<DESCRIPTION>
<P>Quote: "The allocation of patients to the two groups (robot-assisted group therapy or individual arm therapy) was conducted online by using a web-based randomization tool (http://www.randomizer.at)."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-10 11:54:13 +0100" MODIFIED_BY="Bernhard Elsner" RESULT="YES" STUDY_ID="STD-Hollenstein-2011">
<DESCRIPTION>
<P>Randomly assigned by lottery of the supervising therapist</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:39:58 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Housman-2009">
<DESCRIPTION>
<P>Randomly assigned by lottery of the supervising therapist</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-30 14:11:41 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Hsieh-2011">
<DESCRIPTION>
<P>By random-number table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-30 14:11:53 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Hsieh-2014">
<DESCRIPTION>
<P>Randomisation assignments were generated from a random-number table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-30 14:11:59 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Hwang-2012">
<DESCRIPTION>
<P>Random allocation of participants into 2 groups was performed using a random-assignments generator (Wichmann&#8211;Hill random-number generator)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:40:42 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kahn-2006">
<DESCRIPTION>
<P>Insufficient information about the sequence generation process</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:58:49 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Klamroth_x002d_Marganska-2014">
<DESCRIPTION>
<P>Quote: "computer-generated list of random numbers was used, which paired a unique sequential number with a treatment type (robotic or conventional)"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:39:25 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Kutner-2010">
<DESCRIPTION>
<P>Quote: "participants were randomly assigned by the sealed envelope method"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:40:53 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liao-2011">
<DESCRIPTION>
<P>Random assignment in accordance with a number table to either treatment or control group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-30 14:12:29 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Lo-2010">
<DESCRIPTION>
<P>Random assignment with a permuted-block design that was according to participants stratified to 1 or the other site of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-14 14:52:17 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lum-2002">
<DESCRIPTION>
<P>Participants were randomly assigned to either group based on a list of random numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:41:28 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lum-2006">
<DESCRIPTION>
<P>Insufficient information about the sequence generation process</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:41:35 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Masiero-2007">
<DESCRIPTION>
<P>Insufficient information about the sequence generation process</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:41:45 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Masiero-2011">
<DESCRIPTION>
<P>Randomisation was achieved with use of a sequence of computer-generated random numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:41:55 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mayr-2008">
<DESCRIPTION>
<P>Insufficient information about the sequence generation process</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-27 09:39:53 +0100" MODIFIED_BY="Bernhard Elsner" RESULT="UNKNOWN" STUDY_ID="STD-McCabe-2015">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-27 10:23:24 +0100" MODIFIED_BY="Bernhard Elsner" RESULT="YES" STUDY_ID="STD-Rabadi-2008">
<DESCRIPTION>
<P>Quote: "Patients who consented were randomized by sealed, opaque envelopes in blocks of six (two patients in each group) at a time."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:59:46 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Sale-2014">
<DESCRIPTION>
<P>Quote: "A Lehemer algorithm was applied to achieve a balanced allocation in the EG and CG groups. Therapists were randomly assigned to patients within each group using the same algorithm."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-30 14:13:03 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Susanto-2015">
<DESCRIPTION>
<P>Random-number generator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-30 14:13:11 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Timmermans-2014">
<DESCRIPTION>
<P>Quote: "participants were randomly allocated to ... using blocked randomization (block size = 2). The randomization procedure was performed by an independent researcher using 2 opaque envelopes with in each envelope a training condition code."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:42:06 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Volpe-2000">
<DESCRIPTION>
<P>Insufficient information about the sequence generation process</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:42:16 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Volpe-2008">
<DESCRIPTION>
<P>Insufficient information about the sequence generation process</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:56:03 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Wu-2012">
<DESCRIPTION>
<P>Exact method not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-30 14:13:21 +0000" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Yoo-2013">
<DESCRIPTION>
<P>Quote: "Subjects were randomly assigned to..." The method of randomisation is not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2015-10-30 14:13:11 +0000" MODIFIED_BY="Hazel Fraser" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-13 08:16:15 +0100" MODIFIED_BY="Bernhard Elsner" RESULT="UNKNOWN" STUDY_ID="STD-Abdullah-2011">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:38:46 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Amirabdollahian-2007">
<DESCRIPTION>
<P>Insufficient information about the sequence generation process</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-13 09:04:03 +0100" MODIFIED_BY="Bernhard Elsner" RESULT="UNKNOWN" STUDY_ID="STD-Ang-2014">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-13 09:29:38 +0100" MODIFIED_BY="Bernhard Elsner" RESULT="UNKNOWN" STUDY_ID="STD-Brokaw-2014">
<DESCRIPTION>
<P>Quote: "The first 5 listed subject numbers received conventional therapy first and the second set received robot therapy first."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:39:01 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burgar-2011">
<DESCRIPTION>
<P>Unclear, not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:39:12 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Conroy-2011">
<DESCRIPTION>
<P>Insufficient information about the sequence generation process</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:39:19 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Daly-2005">
<DESCRIPTION>
<P>Insufficient information about the sequence generation process</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:39:27 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fazekas-2007">
<DESCRIPTION>
<P>Insufficient information about the concealment of allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:39:41 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hesse-2005">
<DESCRIPTION>
<P>Using sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-29 10:02:41 +0100" MODIFIED_BY="Jan Mehrholz" RESULT="UNKNOWN" STUDY_ID="STD-Hesse-2014">
<DESCRIPTION>
<P>Quote: "The allocation of patients to the two groups (robot-assisted group therapy or individual arm therapy) was conducted online by using a web-based randomization tool (http://www.randomizer.at)."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-10 11:54:45 +0100" MODIFIED_BY="Bernhard Elsner" RESULT="UNKNOWN" STUDY_ID="STD-Hollenstein-2011">
<DESCRIPTION>
<P>Insufficient information about the concealment of allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:22:04 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Housman-2009">
<DESCRIPTION>
<P>The treating therapist and participants were blinded to assignment until each participant had consented and was enrolled in the project<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:40:35 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hsieh-2011">
<DESCRIPTION>
<P>Sealed envelopes to accordingly deliver the intervention to the registered participant</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-30 14:11:54 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Hsieh-2014">
<DESCRIPTION>
<P>Sequentially numbered, sealed, and opaque envelopes and a blinded investigator assigned each participant to a treatment group<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:32:00 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Hwang-2012">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:40:44 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kahn-2006">
<DESCRIPTION>
<P>Insufficient information about the concealment of allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:58:51 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Klamroth_x002d_Marganska-2014">
<DESCRIPTION>
<P>Quote: "Pairs were sealed in tamper-evident envelopes by the study co-ordinator."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:39:27 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Kutner-2010">
<DESCRIPTION>
<P>It was not described whether the sealed envelopes were opaque</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:40:58 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liao-2011">
<DESCRIPTION>
<P>By sealed opaque envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:41:10 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lo-2010">
<DESCRIPTION>
<P>Insufficient information about the concealment of allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:41:19 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lum-2002">
<DESCRIPTION>
<P>Insufficient information about the concealment of allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:41:30 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lum-2006">
<DESCRIPTION>
<P>Insufficient information about the concealment of allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:41:38 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Masiero-2007">
<DESCRIPTION>
<P>Insufficient information about the concealment of allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:41:48 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Masiero-2011">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:41:58 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mayr-2008">
<DESCRIPTION>
<P>No concealment of allocation was provided (information provided by the investigator)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-27 09:39:57 +0100" MODIFIED_BY="Bernhard Elsner" RESULT="UNKNOWN" STUDY_ID="STD-McCabe-2015">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:46:32 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Rabadi-2008">
<DESCRIPTION>
<P>Quote: "Envelopes were identical for the three groups of patients. These sealed envelopes were kept in a locked place. Participants were assigned to one of the three groups by a designated nurse on the unit not associated with the study."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:59:47 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Sale-2014">
<DESCRIPTION>
<P>Quote: "The random allocation to treatment was concealed and based upon dedicated software."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:49:18 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Susanto-2015">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-30 14:13:11 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Timmermans-2014">
<DESCRIPTION>
<P>Quote: "The randomization procedure was performed by an independent researcher using 2 opaque envelopes within each envelope a training condition code."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:42:08 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Volpe-2000">
<DESCRIPTION>
<P>Insufficient information about the concealment of allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 15:42:17 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Volpe-2008">
<DESCRIPTION>
<P>Insufficient information about the concealment of allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:56:18 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Wu-2012">
<DESCRIPTION>
<P>Quote: "The allocation to group was concealed from the investigators"<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:57:37 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Yoo-2013">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2015-10-30 14:13:03 +0000" MODIFIED_BY="Hazel Fraser" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1" REF_IDS="CMP-001.01">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-05-13 08:16:02 +0100" MODIFIED_BY="Bernhard Elsner" RESULT="YES" STUDY_ID="STD-Abdullah-2011">
<DESCRIPTION>
<P>Quote: "An occupational therapist blinded to patient allocation administered the CAHAI-7 and the CMSA at admission and discharge."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-01-26 15:38:49 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Amirabdollahian-2007">
<DESCRIPTION>
<P>Blinding procedure not exactly stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-05-13 09:05:00 +0100" MODIFIED_BY="Bernhard Elsner" RESULT="YES" STUDY_ID="STD-Ang-2014">
<DESCRIPTION>
<P>Quote: "As subject blinding was not feasible, all outcome assessments for this study were performed by occupational therapist DXD who was blinded to allocation."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-05 14:15:58 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Brokaw-2014">
<DESCRIPTION>
<P>Quote: "The OT performing recruitment and clinical evaluations was not aware of the randomization order, so was blinded to group assignment."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-07 14:49:57 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Burgar-2011">
<DESCRIPTION>
<P>A second therapist at each site, blinded to group assignment, performed a clinical assessment battery just before study initiation, just after completion of training, and again at the 6-month follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-01-26 15:39:14 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Conroy-2011">
<DESCRIPTION>
<P>Assessment was performed by a single experienced evaluator blinded to group assignment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-03-15 14:14:39 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Daly-2005">
<DESCRIPTION>
<P>Author stated that a blinded examiner scored the primary outcome measure from a videotape<BR/>
<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-03-15 14:14:44 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fazekas-2007">
<DESCRIPTION>
<P>Author stated that assessment was performed by a blinded physiotherapist</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-05 14:19:17 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Hesse-2005">
<DESCRIPTION>
<P>A blinded therapist rated the videos of all participants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-05-13 10:43:19 +0100" MODIFIED_BY="Bernhard Elsner" RESULT="YES" STUDY_ID="STD-Hesse-2014">
<DESCRIPTION>
<P>Quote: "The test was videographed with a mirror placed behind the patient to ensure later blind rating by an external experienced therapist."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-04-10 11:54:46 +0100" MODIFIED_BY="Bernhard Elsner" RESULT="UNKNOWN" STUDY_ID="STD-Hollenstein-2011">
<DESCRIPTION>
<P>Insufficient information about the concealment of allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-07 15:00:48 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Housman-2009">
<DESCRIPTION>
<P>A single-blinded rater performed the clinical assessments</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-30 14:11:41 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Hsieh-2011">
<DESCRIPTION>
<P>All clinical measures were administered to the participants by the same blinded rater</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-05 14:28:25 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Hsieh-2014">
<DESCRIPTION>
<P>Blinded assessor</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-05 14:58:38 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Hwang-2012">
<DESCRIPTION>
<P>Authors quote: "assessor-blinded"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-01-26 15:40:48 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kahn-2006">
<DESCRIPTION>
<P>By a blinded evaluator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-05 14:58:53 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Klamroth_x002d_Marganska-2014">
<DESCRIPTION>
<P>Quote: "Assessors were masked to treatment allocation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-05-22 13:48:25 +0100" MODIFIED_BY="Bernhard Elsner" RESULT="YES" STUDY_ID="STD-Kutner-2010">
<DESCRIPTION>
<P>Quote: "Research staff blinded to treatment assignment conducted interview-based outcome assessments."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-01-26 15:41:01 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liao-2011">
<DESCRIPTION>
<P>Blinded assessor</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-01-26 15:41:12 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lo-2010">
<DESCRIPTION>
<P>Trained blinded raters</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-14 14:52:30 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lum-2002">
<DESCRIPTION>
<P>An occupational therapist blinded to group assignment tested all participants with a battery of clinical evaluations</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-02-14 14:52:44 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lum-2006">
<DESCRIPTION>
<P>An occupational therapist blinded to group assignment tested all participants with a battery of clinical evaluations</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-30 14:12:38 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Masiero-2007">
<DESCRIPTION>
<P>Assessments were performed for all participants by the same blinded clinician</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-05 14:43:38 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Masiero-2011">
<DESCRIPTION>
<P>All participant assessments were performed by the same blinded clinician, who had previously attended a training course qualifying him or her to use the scales, was not directly involved in the delivery of either robot-aided or standard rehabilitation therapy within the study, and did not know which participants had been enrolled in the EG and the CG</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-01-26 15:42:00 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mayr-2008">
<DESCRIPTION>
<P>Assessors were not blinded (information provided by the investigator)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-05-27 09:39:47 +0100" MODIFIED_BY="Bernhard Elsner" RESULT="YES" STUDY_ID="STD-McCabe-2015">
<DESCRIPTION>
<P>Quote: "There was 1 assessor, who was blinded to the group assignment of the subject."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-05 14:59:40 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Rabadi-2008">
<DESCRIPTION>
<P>Quote: "The outcome measures were recorded at baseline and on discharge by an evaluator (LD) blinded to treatment allocation."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-05 14:59:48 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Sale-2014">
<DESCRIPTION>
<P>Quote: "The clinical assessments were carried out by blinded assessors..."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-30 14:13:03 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Susanto-2015">
<DESCRIPTION>
<P>Quote: "single-blinded so the assessors were of no knowledge of the grouping."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-05 15:00:18 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Timmermans-2014">
<DESCRIPTION>
<P>Quote: "Persons involved in data collection were blinded for group allocation."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-05 14:53:18 +0100" MODIFIED_BY="Hazel Fraser" RESULT="NO" STUDY_ID="STD-Volpe-2000">
<DESCRIPTION>
<P>Participants and the medical and rehabilitation team providing the clinical care were "masked" to the group assignment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-01-26 15:42:19 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Volpe-2008">
<DESCRIPTION>
<P>No blinding of outcome assessment was done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-05 14:56:39 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Wu-2012">
<DESCRIPTION>
<P>Quote: "the participants were blinded to the study hypotheses." and "Clinical outcome measures were administered ... by ... therapists blinded to the participant group."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-05 15:00:30 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Yoo-2013">
<DESCRIPTION>
<P>Quote: "Patients and investigators were blind to the test results and intervention grouping because this study used a double-blinded design."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2011-08-09 07:22:09 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2011-08-09 07:22:09 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1" REF_IDS="CMP-001.01">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2015-10-30 14:11:25 +0000" MODIFIED_BY="Hazel Fraser" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:10:34 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Abdullah-2011">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:12:10 +0100" MODIFIED_BY="Hazel Fraser" RESULT="NO" STUDY_ID="STD-Amirabdollahian-2007">
<DESCRIPTION>
<P>One or more outcomes are reported incompletely</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:14:31 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Ang-2014">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:16:02 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Brokaw-2014">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:16:40 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Burgar-2011">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:17:35 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Conroy-2011">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:18:02 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Daly-2005">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:18:26 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Fazekas-2007">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-30 14:11:25 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Hesse-2005">
<DESCRIPTION>
<P>Study protocol is available and all of the study&#8217;s prespecified (primary and secondary) outcomes that are of interest in the review have been reported in the prespecified way</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:20:47 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Hesse-2014">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:21:26 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Hollenstein-2011">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:21:52 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Housman-2009">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:23:40 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Hsieh-2011">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:28:43 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Hsieh-2014">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:32:04 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Hwang-2012">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:32:36 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Kahn-2006">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:36:15 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Klamroth_x002d_Marganska-2014">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:39:33 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Kutner-2010">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-05 14:40:12 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Liao-2011">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Lo-2010">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Lum-2002">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Lum-2006">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Masiero-2007">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Masiero-2011">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Mayr-2008">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-McCabe-2015">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Rabadi-2008">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Sale-2014">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Susanto-2015">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Timmermans-2014">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Volpe-2000">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Volpe-2008">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Wu-2012">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Yoo-2013">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2015-11-02 12:41:51 +0000" MODIFIED_BY="Hazel Fraser">
<SOF_TABLE ID="SOF-01" MODIFIED="2015-11-02 12:41:51 +0000" MODIFIED_BY="Hazel Fraser" NO="1" READONLY="YES">
<TITLE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser">Electromechanical and robotic-assisted training versus all other interventions for improving activities of daily living, arm function, and arm muscle strength after stroke</TITLE>
<TABLE COLS="6" ROWS="14">
<TR>
<TD COLSPAN="6">
<P>
<B>Electromechanical and robotic-assisted training versus all other interventions for improving activities of daily living, arm function, and arm muscle strength after stroke</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="6">
<P>
<B>Patient or population:</B> people after stroke<BR/>
<B>Settings: </B>rehabilitation facilities<BR/>
<B>Intervention:</B> electromechanical and robotic-assisted training versus all other interventions<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>No of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Control</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Electromechanical and robotic-assisted training versus all other interventions</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Activities of daily living at the end of intervention phase - all studies</B>
<BR/>Measures of activities. Scale from: 0 to inf</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>The mean activities of daily living at the end of intervention phase - all studies in the control groups was<BR/>
<B>NA</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>The mean activities of daily living at the end of intervention phase - all studies in the intervention groups was<BR/>
<B>0.37 SDs higher</B>
<BR/>(0.11 to 0.64 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>717<BR/>(18 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>1,2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD 0.37 (0.11 to 0.64)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Activities of daily living at the end of intervention phase: subgroup analysis comparing acute and chronic phase - particpants treated in the acute and subacute phase of their stroke (within 3 months)</B>
<BR/>Measures of activities. Scale from: 0 to inf</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>The mean activities of daily living at the end of intervention phase: subgroup analysis comparing acute and chronic phase - participants treated in the acute and subacute phase of their stroke (within 3 months) in the control groups was<BR/>
<B>NA</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>The mean activities of daily living at the end of intervention phase: subgroup analysis comparing acute and chronic phase - participants treated in the acute and subacute phase of their stroke (within 3 month) in the intervention groups was<BR/>
<B>0.53 SDs higher</B>
<BR/>(0.09 to 0.96 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>320<BR/>(8 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD 0.53 (0.09 to 0.96)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Activities of daily living at the end of intervention phase: subgroup analysis comparing acute and chronic phase - participants treated in the chronic phase (more than 3 months)</B>
<BR/>Measures of activities. Scale from: 0 to inf</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>The mean activities of daily living at the end of intervention phase: subgroup analysis comparing acute and chronic phase - participants treated in the chronic phase (more than 3 months) in the control groups was<BR/>
<B>NA</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>The mean activities of daily living at the end of intervention phase: subgroup analysis comparing acute and chronic phase - participants treated in the chronic phase (more than 3 months) in the intervention groups was<BR/>
<B>0.66 SDs higher</B>
<BR/>(-0.17 lower to 1.49 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>397<BR/>(10 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>1,2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD 0.66 (-0.08 to 1.41)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Arm function at the end of intervention phase</B>
<BR/>Measures of arm function. Scale from: 0 to inf</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>The mean arm function at the end of intervention phase in the control groups was<BR/>
<B>NA</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>The mean arm function at the end of intervention phase in the intervention groups was<BR/>
<B>0.35 SDs higher</B>
<BR/>(0.18 to 0.51 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>1078<BR/>(31 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>1,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD 0.35 (0.18 to 0.51)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Arm muscle strength at the end of intervention phase</B>
<BR/>Measures of arm muscle strength. Scale from: 0 to inf</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>The mean arm muscle strength at the end of intervention phase in the control groups was<BR/>
<B>NA</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>The mean arm muscle strength at the end of intervention phase in the intervention groups was<BR/>
<B>0.36 SDs higher</B>
<BR/>(0.01 to 0.7 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>568<BR/>(16 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>1,2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD 0.36 (0.01 to 0.7)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Acceptability: dropouts during intervention period</B>
<BR/>Rate of dropouts and adverse events</P>
</TD>
<TH ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="BOTTOM">
<P>
<B>Study population</B>
</P>
</TH>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>1160<BR/>(34 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Risks were calculated from pooled risk differences</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>42 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>45 per 1000</B>
<BR/>(22 to 72)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="6">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>NA:</B> Not applicable; <B>RR:</B> Risk ratio; <B>SD:</B> Standard deviation; <B>SMD:</B> Standardised mean difference</P>
</TD>
</TR>
<TR>
<TD COLSPAN="6">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Downgraded due to several ratings with 'high risk of bias'.<BR/>
<SUP>2</SUP> Downgraded due to considerable differences in effect sizes and unexplained heterogeneity.<BR/>
<SUP>3</SUP> Upper or lower confidence limit crosses an effect size of 0.5 in either direction.</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2015-11-02 12:25:42 +0000" MODIFIED_BY="Hazel Fraser">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2015-11-02 12:25:42 +0000" MODIFIED_BY="Hazel Fraser" NO="1">
<TITLE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser">Participant characteristics in studies</TITLE>
<TABLE COLS="11" ROWS="35">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Study ID</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Age, mean (SD) EXP</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Age, mean (SD) CON</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Time poststroke EXP</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Time poststroke CON</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Gender EXP</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Gender CON</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Side-paresis EXP</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Side-paresis CON</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Stroke severity</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Aetiology (ischaemic/haemorrhagic)</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Abdullah-2011" TYPE="STUDY">Abdullah 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>76 (6) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>70 (16) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 (2) weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 (2) weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 F, 5 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 F, 3 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 L, 5 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 L, 4 R, 1 both</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Stage 1-3 CMSA</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Amirabdollahian-2007" TYPE="STUDY">Amirabdollahian 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>67 (7) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>68 (9) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>17 (12) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>31 (22) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9 F, 7 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 F, 10 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9 L, 7 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7 L, 8 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Ang-2014" TYPE="STUDY">Ang 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>52 (7) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>58 (19) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>350 (131) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>455 (110) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 F, 10 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 F, 4 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean 27 points FMA upper extremity</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11/10</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Brokaw-2014" TYPE="STUDY">Brokaw 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>57 (12) years</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>3 (2) years</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>3 F, 9 M</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>7 L, 5 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean 22 points FMA upper extremity</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Burgar-2011" TYPE="STUDY">Burgar 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>60 (2) years*</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>68 (3) years*</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>17 (3) days*</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 (1) days*</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>18 L, 18 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 L, 13 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean 27 points FIM upper limb</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Conroy-2011" TYPE="STUDY">Conroy 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>59 (13) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>56 (6) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 (5) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 (6) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>23 F, 18 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 F, 10 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean 72 points score on SIS, ADL</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>51/6</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Daly-2005" TYPE="STUDY">Daly 2005</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&gt; 12 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&gt; 12 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0 F, 6 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 F, 3 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11/1</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Fazekas-2007" TYPE="STUDY">Fazekas 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>57 years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>56 years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>23 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 F, 7 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 F, 10 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7 L, 8 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 L, 9 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean 30 points FIM self-care</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated: also included people after head trauma</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Hesse-2005" TYPE="STUDY">Hesse 2005</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>65 (12) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>64 (12) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 (1) weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 (1) weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 F, 10 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 F, 10 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>14 L, 8 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 L, 11 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean 42 of 100 Barthel points</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>40/4</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Hesse-2014" TYPE="STUDY">Hesse 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>71 (16) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>70 (17) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 (2) weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 (1) weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 F, 13 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 F, 15 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>14 L, 11 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13 L, 12 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean 27 of 100 Barthel points</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>41/9</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Hollenstein-2011" TYPE="STUDY">Hollenstein 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>71 (8) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>75 (11) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>33 (14) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>29 (10) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 F, 3 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 F, 1 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 L, 3 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 L, 3 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Housman-2009" TYPE="STUDY">Housman 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>54 (12) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>56 (11) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&gt; 12 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&gt; 12 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 F, 11 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7 F, 7 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 L, 4 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 L, 4 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>17/9; 2 unknown</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Hsieh-2011" TYPE="STUDY">Hsieh 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>54 (8) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>54 (8) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>17 (7) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>28 (20) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 F, 8 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 F, 5 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 L, 6 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 L, 2 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>15/3</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Hsieh-2014" TYPE="STUDY">Hsieh 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>53 (10) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>54 (10) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>22 (14) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>28 (19) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 F, 22 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 F, 12 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>19 L, 13 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7 L, 9 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean 34 points FMA upper extremity</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>27/21</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Hwang-2012" TYPE="STUDY">Hwang 2012</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50 (4) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>51 (3) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7 (6) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 (6) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 F, 5 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 F, 4 M</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean 43 (16) SIS activities</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Kahn-2006" TYPE="STUDY">Kahn 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>56 (12) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>56 (12) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>76 (46) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>103 (48) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 F, 4 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 F, 7 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 L, 5 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 L, 3 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Klamroth_x002d_Marganska-2014" TYPE="STUDY">Klamroth-Marganska 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>55 (13) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>58 (14) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>52 (44) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>40 (45) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>17 F, 21 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 F, 25 M</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean SIS total score 63 (11)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Kutner-2010" TYPE="STUDY">Kutner 2010</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>62 (13) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>51 (11) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>270 (111) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>184 (127) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 F, 5 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 F, 5 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>SIS ADL mean 59 and 68 for EXP and CTL groups, respectively</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12/5</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Liao-2011" TYPE="STUDY">Liao 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>55 (11) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>54 (8) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>23 (13) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>22 (17) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 F, 6 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 F, 7 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 L, 6 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 L, 7 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean 116 points FIM self-care</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Lo-2010" TYPE="STUDY">Lo 2010</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>66 (11) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>64 (11) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 (4) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 (4) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 F, 47 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 F, 75 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean 49 points score on SIS</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>108/19</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Lum-2002" TYPE="STUDY">Lum 2002</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>63 (4) years*</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>66 (2) years*</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30 (6) months*</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>29 (6) months*</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 F, 12 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 F, 8 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 L, 9 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 L, 10 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean 87 of 100 Barthel points</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Lum-2006" TYPE="STUDY">Lum 2006</LINK>#</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>67 years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>60 years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 F, 16 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 F, 4 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 L, 13 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 L, 4 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Masiero-2007" TYPE="STUDY">Masiero 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>63 (13) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>67 (12) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7 F, 10 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7 F, 11 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 L, 11 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 L, 10 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Masiero-2011" TYPE="STUDY">Masiero 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>72 (7) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>76 (5) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 (5) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13 (5) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 F, 9 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 F, 7 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9 L, 2 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 L, 2 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean total FIM 30 points</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>18/3</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Mayr-2008" TYPE="STUDY">Mayr 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 L</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 L</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6/2</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-McCabe-2015" TYPE="STUDY">McCabe 2015</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>21-49 years: n = 2; 50-81 years: n = 10</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>21-49 years: n = 5; 50-81 years: n = 18</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1-3 years: n = 9; &#8805;4 years: n = 3</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1-3 years: n = 18; &#8805;4 years: n = 5</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 F, 10 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 F, 13 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>23 (6) FMA upper extremity points</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Rabadi-2008" TYPE="STUDY">Rabadi 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>80 (6) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>69 (11) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 (4) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>14 (13) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 F, 5 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 F, 14 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean FIM score 39 (11)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3/0</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Sale-2014" TYPE="STUDY">Sale 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>68 (14) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>68 (14) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 F, 15 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 F, 16 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>16 L, 10 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13 L, 14 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean CMSA 3 (1)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>53/0</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Susanto-2015" TYPE="STUDY">Susanto 2015</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>51 (9) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>55 (11) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>16 (6) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>16 (5) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 F, 7 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 F, 7 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 L, 3 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 L, 4 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean FMA 33 (9)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8/11</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Timmermans-2014" TYPE="STUDY">Timmermans 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>62 (7) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>57 (6) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 (3) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 (3) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 F, 8 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 F, 8 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7 L, 4 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 L, 3 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean FMA 52</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Volpe-2000" TYPE="STUDY">Volpe 2000</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>62 (2) years*</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>67 (2) years*</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>23 (1) days*</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>26 (1) days*</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>14 F, 16 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 F, 14 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>17 L, 13 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>14 L, 12 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>49/7</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Volpe-2008" TYPE="STUDY">Volpe 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>62 (3) years*</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>60 (3) years*</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>35 (7) months*</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>40 (11) months*</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 F, 8 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 F, 7 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 L, 6 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 L, 5 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean 17 points NIHSS</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>20/1</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Wu-2012" TYPE="STUDY">Wu 2012</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>56 (11) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>51 (6) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>18 (11) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>18 (10) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 F, 22 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 F, 22 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>16 L, 12 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 L, 4 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean FMA 44 (10) points</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Yoo-2013" TYPE="STUDY">Yoo 2013</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>51 (11) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50 (9) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>46 (42) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>42 (33) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 F, 7 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 F, 6 M</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 L, 5 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 L, 7 R</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean Barthel Index 76 (5)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>15/7</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>*SE instead of SD<BR/>#EXP: all robot groups<BR/>ADL: activities of daily living<BR/>CMSA: Chedoke-McMaster Stroke Assessment<BR/>CON: control group<BR/>EXP: experimental group<BR/>F: female<BR/>FIM: Functional Independence Measure<BR/>FMA: Fugl-Meyer AssessmentL: left<BR/>M: male<BR/>NIHSS: National Institutes of Health Stroke ScaleR: right<BR/>SD: standard deviation<BR/>SE: standard error<BR/>SIS: Stroke Impact Scale<BR/>
</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2015-10-30 16:23:18 +0000" MODIFIED_BY="Hazel Fraser" NO="2">
<TITLE MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser">Details of study interventions</TITLE>
<TABLE COLS="5" ROWS="35">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Study ID</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Duration of study</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Frequency and intensity of treatment</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Follow-up</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Device used</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Abdullah-2011" TYPE="STUDY">Abdullah 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 to 11 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 times a week (groups received the same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Adapted 5 DOF industrial robot</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Amirabdollahian-2007" TYPE="STUDY">Amirabdollahian 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 times a week (groups received the same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>GENTLE/s</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Ang-2014" TYPE="STUDY">Ang 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 times a week for 90 minutes (groups received the same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 weeks and 18 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Haptic Knob and Haptic Knob with Brain-Computer Interface</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Brokaw-2014" TYPE="STUDY">Brokaw 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 hours within a month (groups received the same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>ARMin III, HandSOME</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Burgar-2011" TYPE="STUDY">Burgar 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 experimental group and the control group had 15 x 1-hour therapy sessions over a 3-week period (1 robot group received 30 1-hour therapy sessions over a 3-week period)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>MIME</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Conroy-2011" TYPE="STUDY">Conroy 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 sessions per week for 1 hour (groups received the same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>InMotion 2.0 Shoulder/Arm Robot</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Daly-2005" TYPE="STUDY">Daly 2005</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 hours a day, 5 days a week (groups received the same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>InMotion</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Fazekas-2007" TYPE="STUDY">Fazekas 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Control group received 30-minute sessions on 20 consecutive workdays (Bobath, Kabat)<BR/>Experimental group received same therapy as the control group, but also additional 30 minutes of robot therapy</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>REHAROB</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Hesse-2005" TYPE="STUDY">Hesse 2005</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30 minutes, 5 times a week (groups received the same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bi-Manu-Track</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Hesse-2014" TYPE="STUDY">Hesse 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30 minutes, 5 times a week (groups received the same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bi-Manu-Track, Reha-Digit, Reha-Slide, Reha-Slide Duo</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Hollenstein-2011" TYPE="STUDY">Hollenstein 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 times a week for 30 minutes (groups received the same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Armeo</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Housman-2009" TYPE="STUDY">Housman 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 to 9 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 times a week for 1 hour (groups received the same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>T-WREX</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Hsieh-2011" TYPE="STUDY">Hsieh 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Higher-intensity robotic training group: 20 sessions for 90 to 105 minutes, 5 days per week</P>
<P>Lower-intensity robotic training group: same amount, but had only half of the repetitions by the device as in first group</P>
<P>Conventional treatment group: same amount as in the other groups (groups received the same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bi-Manu-Track</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Hsieh-2014" TYPE="STUDY">Hsieh 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Participants in each group received 20 training sessions of 90 to 105 minutes/day, 5 days/week for 4 weeks. In addition to the intervention provided in the clinics, all participants were encouraged to use their affected upper limb during activities in their daily life situations (e.g. at home)</P>
<P>RT + CIT group (received 2 weeks robot-assisted arm therapy (Bi-Manu-Track 40 to 55 minutes plus 15 to 20 minutes conventional therapy without robot), afterwards 2 weeks constraint-induced therapy 90 to 105 minutes therapy a day and 6 hours constraint daily)</P>
<P>RT group (received robot-assisted arm therapy (Bi-Manu-Track) as above)</P>
<P>CT group (received a therapist-mediated intervention using conventional occupational therapy techniques, including neurodevelopmental techniques, functional task practice, fine-motor training, arm exercises or gross-motor training, and muscle strengthening)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bi-Manu-Track</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Hwang-2012" TYPE="STUDY">Hwang 2012</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 weeks (20 sessions) of active robot-assisted intervention versus 2 weeks (10 sessions) of early passive therapy followed by 2 weeks (10 sessions) of active robot-assisted intervention (groups received the same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Amadeo</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Kahn-2006" TYPE="STUDY">Kahn 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>24 sessions for 45 minutes (groups received the same time and frequency)<BR/>
<BR/>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>ARM Guide</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Klamroth_x002d_Marganska-2014" TYPE="STUDY">Klamroth-Marganska 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Robotic training or conventional therapy 3 times a week for at least 45 minutes (groups received the same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>26 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>ARMin</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Kutner-2010" TYPE="STUDY">Kutner 2010</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1) 60 hours of repetitive-task training over the course of 3 weeks</P>
<P>2) 30 hours of repetitive-task training plus 30 hours of robotic-assisted training with the Hand Mentor device over the course of 3 weeks (groups received the same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Hand Mentor</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Liao-2011" TYPE="STUDY">Liao 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 days a week for 90 to 105 minutes per session (groups received the same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bi-Manu-Track</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Lo-2010" TYPE="STUDY">Lo 2010</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Group A: a maximum of 36 sessions over a period of 12 weeks</P>
<P>Group B: same time and frequency</P>
<P>Group C: usual care at different time and frequency</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3, 6, 9 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>MIT-Manus</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Lum-2002" TYPE="STUDY">Lum 2002</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Control group received 55 minutes of physiotherapy for the arm and 5 minutes of robot training at each of the 24 sessions<BR/>Experimental group received robot therapy for the same time and frequency</P>
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>MIME</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Lum-2006" TYPE="STUDY">Lum 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>All groups received 15 1-hour treatment sessions (all groups had same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>MIME</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Masiero-2007" TYPE="STUDY">Masiero 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Experimental group received additional robotic training twice a day, 5 days a week<BR/>Control group received similar exposure to the robot but with the unimpaired arm</P>
<P>(both groups had same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 and 8 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>NeReBot</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Masiero-2011" TYPE="STUDY">Masiero 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Experimental group received robotic training twice a day for 20 minutes, and 40 minutes conventional training, 5 days a week<BR/>Control group received conventional functional rehabilitation for 80 minutes a day</P>
<P>(groups received the same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>NeReBot</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Mayr-2008" TYPE="STUDY">Mayr 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 times per week (both groups received the same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>ARMOR</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-McCabe-2015" TYPE="STUDY">McCabe 2015</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 hours per day for 12 weeks (all groups received the same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>InMotion2 Shoulder/Elbow Robot</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Rabadi-2008" TYPE="STUDY">Rabadi 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Standard occupational and physical therapy for 3 hours per day + 12 additional sessions of 40 minutes of either occupational therapy, arm ergometry, or robotic-assisted training for 5 days per week</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>MIT-Manus</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Sale-2014" TYPE="STUDY">Sale 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30 sessions of robot-assisted therapy (5 days a week for 6 weeks) versus 30 sessions (5 days a week for 6 weeks) of conventional rehabilitative treatment</P>
<P>Experimental and control therapies were applied in addition to usual rehabilitation</P>
<P>(groups received the same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>MIT-Manus/InMotion2</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Susanto-2015" TYPE="STUDY">Susanto 2015</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Hand exoskeleton robot-assisted training for 20 1-hour sessions versus control group (non-assisted group) for 20 1-hour sessions (groups received the same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Self designed hand exoskeleton robot</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Timmermans-2014" TYPE="STUDY">Timmermans 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Robotic-assisted training with the end-effector robot HapticMaster versus arm-hand training program during 8 weeks, 4 times/week, twice a day for 30 minutes (groups received the same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 month</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>HapticMaster</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Volpe-2000" TYPE="STUDY">Volpe 2000</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 hour per day, 5 days a week (for at least 25 sessions) (both groups received the same time and frequency)<BR/>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>MIT-Manus</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Volpe-2008" TYPE="STUDY">Volpe 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 hour per session, 3 times a week (both groups received the same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>InMotion2</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Wu-2012" TYPE="STUDY">Wu 2012</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Therapist-mediated bilateral arm training (TBAT group) versus robot-assisted (Bi-Manu-Track) arm trainer (RBAT group) versus conventional therapy (involved weight bearing, stretching, strengthening of the paretic arms, co-ordination, unilateral and bilateral fine-motor tasks, balance, and compensatory practice on functional tasks; CT group). Each group received treatment for 90 to 105 minutes per session, 5 sessions on weekdays, for 4 weeks (groups received the same time and frequency)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bi-Manu-Track</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Yoo-2013" TYPE="STUDY">Yoo 2013</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3-dimensional robot-assisted therapy (RAT) and conventional rehabilitation therapy (CRT) for a total of 90 minutes (RAT: 30 minutes, CRT: 60 minutes) a day with 10 minutes rest halfway through the session, received training 3 days a week for 6 weeks. The control group received only CRT for 60 minutes a day on the same days as the first group</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>ReoGo</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>DOF: Degrees of Freedom<BR/>MIME: mirror image motion enabler</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2015-11-02 11:19:33 +0000" MODIFIED_BY="Hazel Fraser">
<COMPARISON ID="CMP-001" MODIFIED="2015-11-02 11:19:33 +0000" MODIFIED_BY="Hazel Fraser" NO="1">
<NAME>Electromechanical and robotic assisted training versus all other intervention</NAME>
<CONT_OUTCOME CHI2="44.25906028687778" CI_END="0.6350336284857266" CI_START="0.11328849330723445" CI_STUDY="95" CI_TOTAL="95" DF="17" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.37416106089648055" ESTIMABLE="YES" I2="61.58978548164007" I2_Q="0.0" ID="CMP-001.01" MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser" NO="1" P_CHI2="3.1363488733593403E-4" P_Q="1.0" P_Z="0.004937048002601889" Q="0.0" RANDOM="YES" SCALE="2.73" SORT_BY="STUDY" STUDIES="18" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.18562939192331757" TOTALS="YES" TOTAL_1="366" TOTAL_2="351" UNITS="" WEIGHT="99.99999999999999" Z="2.8111127611128337">
<NAME>Activities of daily living at the end of intervention phase</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.0380024373648842" CI_START="-0.10814800700190896" EFFECT_SIZE="0.4649272151814876" ESTIMABLE="YES" MEAN_1="19.6" MEAN_2="15.9" MODIFIED="2015-07-30 11:55:31 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="74" SD_1="8.47" SD_2="6.36" SE="0.29239069018805486" STUDY_ID="STD-Burgar-2011" TOTAL_1="36" TOTAL_2="18" WEIGHT="6.534259111221847"/>
<CONT_DATA CI_END="1.1507506471231492" CI_START="0.07547143196899198" EFFECT_SIZE="0.6131110395460706" ESTIMABLE="YES" MEAN_1="3.98" MEAN_2="-3.19" MODIFIED="2015-07-30 11:55:31 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="62" SD_1="11.94" SD_2="10.72" SE="0.2743109627615156" STUDY_ID="STD-Conroy-2011" TOTAL_1="41" TOTAL_2="21" WEIGHT="6.790889898420388"/>
<CONT_DATA CI_END="-0.3120300825451786" CI_START="-1.860101658277956" EFFECT_SIZE="-1.0860658704115673" ESTIMABLE="YES" MEAN_1="12.07" MEAN_2="25.53" MODIFIED="2015-07-30 11:55:31 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="9.26" SD_2="14.32" SE="0.39492347511070824" STUDY_ID="STD-Fazekas-2007" TOTAL_1="15" TOTAL_2="15" WEIGHT="5.186214580327776"/>
<CONT_DATA CI_END="0.9453307469415558" CI_START="-0.24643832635851426" EFFECT_SIZE="0.3494462102915208" ESTIMABLE="YES" MEAN_1="22.45" MEAN_2="17.27" MODIFIED="2015-07-30 11:55:31 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="15.14" SD_2="13.95" SE="0.30402830937216" STUDY_ID="STD-Hesse-2005" TOTAL_1="22" TOTAL_2="22" WEIGHT="6.37115332164788"/>
<CONT_DATA CI_END="1.2389432899259827" CI_START="0.09714309978213664" EFFECT_SIZE="0.6680431948540597" ESTIMABLE="YES" MEAN_1="25.2" MEAN_2="16.0" MODIFIED="2015-07-30 11:55:31 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="135" SD_1="11.0" SD_2="15.7" SE="0.29128091106525944" STUDY_ID="STD-Hesse-2014" TOTAL_1="25" TOTAL_2="25" WEIGHT="6.549907729777241"/>
<CONT_DATA CI_END="0.9520381577866032" CI_START="-0.3997153806708117" EFFECT_SIZE="0.27616138855789574" ESTIMABLE="YES" MEAN_1="0.2" MEAN_2="0.1" MODIFIED="2015-07-30 11:55:31 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="60" SD_1="0.4" SD_2="0.3" SE="0.3448414228832454" STUDY_ID="STD-Housman-2009" TOTAL_1="17" TOTAL_2="17" WEIGHT="5.817135382222243"/>
<CONT_DATA CI_END="1.265099905567385" CI_START="-0.7057379833459232" EFFECT_SIZE="0.2796809611107309" ESTIMABLE="YES" MEAN_1="0.13" MEAN_2="0.06" MODIFIED="2015-07-30 11:55:31 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="57" SD_1="0.19" SD_2="0.32" SE="0.502774006170273" STUDY_ID="STD-Hsieh-2011" TOTAL_1="12" TOTAL_2="6" WEIGHT="4.040909356097336"/>
<CONT_DATA CI_END="0.7134875883073168" CI_START="-1.001985630241621" EFFECT_SIZE="-0.14424902096715214" ESTIMABLE="YES" MEAN_1="6.89" MEAN_2="8.49" MODIFIED="2015-07-30 11:55:31 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="142" SD_1="9.995" SD_2="11.33" SE="0.43762876054875793" STUDY_ID="STD-Kutner-2010" TOTAL_1="11" TOTAL_2="10" WEIGHT="4.697301766148572"/>
<CONT_DATA CI_END="1.84094759135064" CI_START="-0.021588700935392335" EFFECT_SIZE="0.9096794452076238" ESTIMABLE="YES" MEAN_1="0.25" MEAN_2="0.03" MODIFIED="2015-07-30 11:55:31 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="49" SD_1="0.17" SD_2="0.28" SE="0.47514554016744204" STUDY_ID="STD-Liao-2011" TOTAL_1="10" TOTAL_2="10" WEIGHT="4.306298071300414"/>
<CONT_DATA CI_END="0.7711305899067029" CI_START="0.04926402680540454" EFFECT_SIZE="0.4101973083560537" ESTIMABLE="YES" MEAN_1="6.31" MEAN_2="1.37" MODIFIED="2015-07-30 11:55:31 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="53" SD_1="11.76" SD_2="12.1" SE="0.18415301729911612" STUDY_ID="STD-Lo-2010" TOTAL_1="49" TOTAL_2="78" WEIGHT="8.06944321251842"/>
<CONT_DATA CI_END="0.624373679078866" CI_START="-1.1709634921881498" EFFECT_SIZE="-0.27329490655464184" ESTIMABLE="YES" MEAN_1="2.85" MEAN_2="3.2" MODIFIED="2015-07-30 11:55:31 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="1.21" SD_2="1.4" SE="0.45800259224873674" STUDY_ID="STD-Lum-2006" TOTAL_1="24" TOTAL_2="6" WEIGHT="4.480522147063414"/>
<CONT_DATA CI_END="1.4561515539012915" CI_START="0.07671920946610333" EFFECT_SIZE="0.7664353816836974" ESTIMABLE="YES" MEAN_1="32.6" MEAN_2="25.5" MODIFIED="2015-07-30 11:55:31 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="7.2" SD_2="10.5" SE="0.3519024725239786" STUDY_ID="STD-Masiero-2007" TOTAL_1="17" TOTAL_2="18" WEIGHT="5.724656955649658"/>
<CONT_DATA CI_END="1.5975928473079857" CI_START="-0.1799721623230024" EFFECT_SIZE="0.7088103424924916" ESTIMABLE="YES" MEAN_1="1.83" MEAN_2="1.0" MODIFIED="2015-07-30 11:55:31 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="80" SD_1="1.4" SD_2="0.7" SE="0.45346879423606606" STUDY_ID="STD-Masiero-2011" TOTAL_1="11" TOTAL_2="10" WEIGHT="4.527844320024991"/>
<CONT_DATA CI_END="0.37113285169722676" CI_START="-1.162162290668966" EFFECT_SIZE="-0.3955147194858696" ESTIMABLE="YES" MEAN_1="25.49" MEAN_2="28.29" MODIFIED="2015-07-30 11:55:31 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="113" SD_1="7.23" SD_2="6.72" SE="0.39115390753621726" STUDY_ID="STD-Rabadi-2008" TOTAL_1="10" TOTAL_2="20" WEIGHT="5.231596294457542"/>
<CONT_DATA CI_END="2.285499037956927" CI_START="1.0547178671309285" EFFECT_SIZE="1.6701084525439278" ESTIMABLE="YES" MEAN_1="9.1" MEAN_2="4.4" MODIFIED="2015-07-30 11:55:31 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="3.3" SD_2="2.0" SE="0.31398055794245294" STUDY_ID="STD-Volpe-2000" TOTAL_1="30" TOTAL_2="26" WEIGHT="6.233276977449952"/>
<CONT_DATA CI_END="1.0561774100325412" CI_START="-0.6616701356394454" EFFECT_SIZE="0.19725363719654784" ESTIMABLE="YES" MEAN_1="67.1" MEAN_2="65.5" MODIFIED="2015-07-30 11:55:31 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="7.96" SD_2="7.59" SE="0.43823446737341826" STUDY_ID="STD-Volpe-2008" TOTAL_1="11" TOTAL_2="10" WEIGHT="4.690703579939638"/>
<CONT_DATA CI_END="1.3400812297186222" CI_START="0.02105250408261261" EFFECT_SIZE="0.6805668669006174" ESTIMABLE="YES" MEAN_1="3.26" MEAN_2="-2.88" MODIFIED="2015-07-30 11:55:31 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="150" SD_1="7.16" SD_2="9.56" SE="0.33649310294483464" STUDY_ID="STD-Wu-2012" TOTAL_1="14" TOTAL_2="28" WEIGHT="5.927850064900149"/>
<CONT_DATA CI_END="0.8952070323354057" CI_START="-0.7767025872918843" EFFECT_SIZE="0.05925222252176064" ESTIMABLE="YES" MEAN_1="0.4" MEAN_2="0.1" MODIFIED="2015-07-30 11:55:31 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="151" SD_1="6.1" SD_2="3.2" SE="0.4265153933478114" STUDY_ID="STD-Yoo-2013" TOTAL_1="11" TOTAL_2="11" WEIGHT="4.820037230832542"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="141.40929139843493" CI_END="0.9406139886003282" CI_START="0.16849074790276702" CI_STUDY="95" CI_TOTAL="95" DF="17" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.5545523682515476" ESTIMABLE="YES" I2="87.9781591210292" I2_Q="0.0" ID="CMP-001.02" MODIFIED="2015-11-02 11:19:33 +0000" MODIFIED_BY="Hazel Fraser" NO="2" P_CHI2="0.0" P_Q="0.7804196862012058" P_Z="0.004872253182557758" Q="0.07771391938154511" RANDOM="YES" SCALE="5.78" SORT_BY="STUDY" STUDIES="18" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.9460003543405106" TOTALS="SUB" TOTAL_1="366" TOTAL_2="351" UNITS="" WEIGHT="200.0" Z="2.815360585008382">
<NAME>Activities of daily living at the end of intervention phase: subgroup analysis comparing acute and chronic phase</NAME>
<GROUP_LABEL_1>Favours treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Favours control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="22.927515057900276" CI_END="0.961432230332371" CI_START="0.09030241172935688" DF="7" EFFECT_SIZE="0.525867321030864" ESTIMABLE="YES" I2="69.46899835275447" ID="CMP-001.02.01" MODIFIED="2015-11-02 11:19:33 +0000" MODIFIED_BY="Hazel Fraser" NO="1" P_CHI2="0.0017548652242773688" P_Z="0.01796645935290191" STUDIES="8" TAU2="0.2689368980558025" TOTAL_1="175" TOTAL_2="145" WEIGHT="100.0" Z="2.3663086439169443">
<NAME>Participants treated in the acute and subacute phase of their stroke (within 3 months)</NAME>
<CONT_DATA CI_END="1.0380024373648842" CI_START="-0.10814800700190896" EFFECT_SIZE="0.4649272151814876" ESTIMABLE="YES" MEAN_1="19.6" MEAN_2="15.9" MODIFIED="2011-10-25 09:16:54 +0100" MODIFIED_BY="[Empty name]" ORDER="76" SD_1="8.47" SD_2="6.36" SE="0.29239069018805486" STUDY_ID="STD-Burgar-2011" TOTAL_1="36" TOTAL_2="18" WEIGHT="13.934136959086732"/>
<CONT_DATA CI_END="0.9453307469415558" CI_START="-0.24643832635851426" EFFECT_SIZE="0.3494462102915208" ESTIMABLE="YES" MEAN_1="22.45" MEAN_2="17.27" ORDER="94" SD_1="15.14" SD_2="13.95" SE="0.30402830937216" STUDY_ID="STD-Hesse-2005" TOTAL_1="22" TOTAL_2="22" WEIGHT="13.666501620283363"/>
<CONT_DATA CI_END="1.2389432899259827" CI_START="0.09714309978213664" EFFECT_SIZE="0.6680431948540597" ESTIMABLE="YES" MEAN_1="25.2" MEAN_2="16.0" MODIFIED="2015-05-29 09:31:34 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="135" SD_1="11.0" SD_2="15.7" SE="0.29128091106525944" STUDY_ID="STD-Hesse-2014" TOTAL_1="25" TOTAL_2="25" WEIGHT="13.95964928826606"/>
<CONT_DATA CI_END="0.624373679078866" CI_START="-1.1709634921881498" EFFECT_SIZE="-0.27329490655464184" ESTIMABLE="YES" MEAN_1="2.85" MEAN_2="3.2" ORDER="92" SD_1="1.21" SD_2="1.4" SE="0.45800259224873674" STUDY_ID="STD-Lum-2006" TOTAL_1="24" TOTAL_2="6" WEIGHT="10.316756725852263"/>
<CONT_DATA CI_END="1.4561515539012915" CI_START="0.07671920946610333" EFFECT_SIZE="0.7664353816836974" ESTIMABLE="YES" MEAN_1="32.6" MEAN_2="25.5" ORDER="93" SD_1="7.2" SD_2="10.5" SE="0.3519024725239786" STUDY_ID="STD-Masiero-2007" TOTAL_1="17" TOTAL_2="18" WEIGHT="12.573864954112166"/>
<CONT_DATA CI_END="1.5975928473079857" CI_START="-0.1799721623230024" EFFECT_SIZE="0.7088103424924916" ESTIMABLE="YES" MEAN_1="1.83" MEAN_2="1.0" MODIFIED="2011-10-25 09:41:42 +0100" MODIFIED_BY="[Empty name]" ORDER="81" SD_1="1.4" SD_2="0.7" SE="0.45346879423606606" STUDY_ID="STD-Masiero-2011" TOTAL_1="11" TOTAL_2="10" WEIGHT="10.406592092092792"/>
<CONT_DATA CI_END="0.37113285169722676" CI_START="-1.162162290668966" EFFECT_SIZE="-0.3955147194858696" ESTIMABLE="YES" MEAN_1="25.49" MEAN_2="28.29" MODIFIED="2015-03-24 11:42:14 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="113" SD_1="7.23" SD_2="6.72" SE="0.39115390753621726" STUDY_ID="STD-Rabadi-2008" TOTAL_1="10" TOTAL_2="20" WEIGHT="11.704710074891732"/>
<CONT_DATA CI_END="2.285499037956927" CI_START="1.0547178671309285" EFFECT_SIZE="1.6701084525439278" ESTIMABLE="YES" MEAN_1="9.1" MEAN_2="4.4" ORDER="95" SD_1="3.3" SD_2="2.0" SE="0.31398055794245294" STUDY_ID="STD-Volpe-2000" TOTAL_1="30" TOTAL_2="26" WEIGHT="13.437788285414895"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="113.06613599707424" CI_END="1.4934535777613795" CI_START="-0.17412095910342873" DF="9" EFFECT_SIZE="0.6596663093289754" ESTIMABLE="YES" I2="92.04005698025013" ID="CMP-001.02.02" MODIFIED="2015-10-06 12:18:01 +0100" MODIFIED_BY="Hazel Fraser" NO="2" P_CHI2="9.992007221626409E-16" P_Z="0.1209827128159819" STUDIES="10" TAU2="1.6488322142834215" TOTAL_1="191" TOTAL_2="206" WEIGHT="100.0" Z="1.5506619698452122">
<NAME>Participants treated in the chronic phase (more than 3 months)</NAME>
<CONT_DATA CI_END="3.3710768719629347" CI_START="1.9425978908335115" EFFECT_SIZE="2.656837381398223" ESTIMABLE="YES" MEAN_1="3.94" MEAN_2="-3.19" MODIFIED="2011-08-22 09:22:48 +0100" MODIFIED_BY="[Empty name]" ORDER="63" SD_1="2.74" SD_2="2.46" SE="0.3644145995531253" STUDY_ID="STD-Conroy-2011" TOTAL_1="41" TOTAL_2="21" WEIGHT="10.157732399859107"/>
<CONT_DATA CI_END="-0.3120300825451786" CI_START="-1.860101658277956" EFFECT_SIZE="-1.0860658704115673" ESTIMABLE="YES" MEAN_1="12.07" MEAN_2="25.53" ORDER="89" SD_1="9.26" SD_2="14.32" SE="0.39492347511070824" STUDY_ID="STD-Fazekas-2007" TOTAL_1="15" TOTAL_2="15" WEIGHT="10.027346736265235"/>
<CONT_DATA CI_END="0.9520381577866032" CI_START="-0.3997153806708117" EFFECT_SIZE="0.27616138855789574" ESTIMABLE="YES" MEAN_1="0.2" MEAN_2="0.1" MODIFIED="2011-08-22 09:25:17 +0100" MODIFIED_BY="[Empty name]" ORDER="66" SD_1="0.4" SD_2="0.3" SE="0.3448414228832454" STUDY_ID="STD-Housman-2009" TOTAL_1="17" TOTAL_2="17" WEIGHT="10.237502622654608"/>
<CONT_DATA CI_END="1.265099905567385" CI_START="-0.7057379833459232" EFFECT_SIZE="0.2796809611107309" ESTIMABLE="YES" MEAN_1="0.13" MEAN_2="0.06" MODIFIED="2011-08-22 09:24:45 +0100" MODIFIED_BY="[Empty name]" ORDER="65" SD_1="0.19" SD_2="0.32" SE="0.502774006170273" STUDY_ID="STD-Hsieh-2011" TOTAL_1="12" TOTAL_2="6" WEIGHT="9.516822951182732"/>
<CONT_DATA CI_END="0.7134875883073168" CI_START="-1.001985630241621" EFFECT_SIZE="-0.14424902096715214" ESTIMABLE="YES" MEAN_1="6.89" MEAN_2="8.49" MODIFIED="2015-05-29 09:31:53 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="142" SD_1="9.995" SD_2="11.33" SE="0.43762876054875793" STUDY_ID="STD-Kutner-2010" TOTAL_1="11" TOTAL_2="10" WEIGHT="9.833624953525934"/>
<CONT_DATA CI_END="1.84094759135064" CI_START="-0.021588700935392335" EFFECT_SIZE="0.9096794452076238" ESTIMABLE="YES" MEAN_1="0.25" MEAN_2="0.03" MODIFIED="2011-08-22 09:23:08 +0100" MODIFIED_BY="[Empty name]" ORDER="64" SD_1="0.17" SD_2="0.28" SE="0.47514554016744204" STUDY_ID="STD-Liao-2011" TOTAL_1="10" TOTAL_2="10" WEIGHT="9.653988270646636"/>
<CONT_DATA CI_END="3.0805827503809837" CI_START="2.115209313229128" EFFECT_SIZE="2.597896031805056" ESTIMABLE="YES" MEAN_1="6.31" MEAN_2="1.37" MODIFIED="2011-08-22 09:28:51 +0100" MODIFIED_BY="[Empty name]" ORDER="68" SD_1="1.68" SD_2="2.01" SE="0.24627325929624158" STUDY_ID="STD-Lo-2010" TOTAL_1="49" TOTAL_2="78" WEIGHT="10.586432147908681"/>
<CONT_DATA CI_END="1.0561774100325412" CI_START="-0.6616701356394454" EFFECT_SIZE="0.19725363719654784" ESTIMABLE="YES" MEAN_1="67.1" MEAN_2="65.5" ORDER="90" SD_1="7.96" SD_2="7.59" SE="0.43823446737341826" STUDY_ID="STD-Volpe-2008" TOTAL_1="11" TOTAL_2="10" WEIGHT="9.830791040422145"/>
<CONT_DATA CI_END="1.3400812297186222" CI_START="0.02105250408261261" EFFECT_SIZE="0.6805668669006174" ESTIMABLE="YES" MEAN_1="3.26" MEAN_2="-2.88" MODIFIED="2015-05-29 09:33:45 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="150" SD_1="7.16" SD_2="9.56" SE="0.33649310294483464" STUDY_ID="STD-Wu-2012" TOTAL_1="14" TOTAL_2="28" WEIGHT="10.270549684908932"/>
<CONT_DATA CI_END="0.8952070323354057" CI_START="-0.7767025872918843" EFFECT_SIZE="0.05925222252176064" ESTIMABLE="YES" MEAN_1="0.4" MEAN_2="0.1" MODIFIED="2015-05-29 09:33:45 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="151" SD_1="6.1" SD_2="3.2" SE="0.4265153933478114" STUDY_ID="STD-Yoo-2013" TOTAL_1="11" TOTAL_2="11" WEIGHT="9.885209192625995"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="46.80697724207178" CI_END="0.509739975014202" CI_START="0.18169251399010358" CI_STUDY="95" CI_TOTAL="95" DF="30" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.34571624450215277" ESTIMABLE="YES" I2="35.906991291386085" I2_Q="0.0" ID="CMP-001.03" MODIFIED="2015-06-02 10:59:04 +0100" MODIFIED_BY="Jan Mehrholz" NO="3" P_CHI2="0.025984424715987275" P_Q="1.0" P_Z="3.610989459514721E-5" Q="0.0" RANDOM="YES" SCALE="2.7852761969357442" SORT_BY="STUDY" STUDIES="31" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.07210376119254659" TOTALS="YES" TOTAL_1="553" TOTAL_2="525" UNITS="" WEIGHT="100.0" Z="4.131057048753608">
<NAME>Arm function at the end of intervention phase</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.905225283130183" CI_START="0.0215555863225656" EFFECT_SIZE="0.9633904347263743" ESTIMABLE="YES" MEAN_1="2.75" MEAN_2="1.0" MODIFIED="2015-05-18 08:46:12 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="132" SD_1="1.8" SD_2="1.69" SE="0.4805368138562146" STUDY_ID="STD-Abdullah-2011" TOTAL_1="9" TOTAL_2="11" WEIGHT="2.3112491673928086"/>
<CONT_DATA CI_END="1.545723328739264" CI_START="-0.2943955854666359" EFFECT_SIZE="0.625663871636314" ESTIMABLE="YES" MEAN_1="7.3" MEAN_2="4.9" MODIFIED="2015-05-18 08:33:50 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="131" SD_1="3.5" SD_2="4.1" SE="0.4694267161847164" STUDY_ID="STD-Ang-2014" TOTAL_1="15" TOTAL_2="7" WEIGHT="2.394655183065593"/>
<CONT_DATA CI_END="1.4324949099920308" CI_START="-0.8786487561458767" EFFECT_SIZE="0.276923076923077" ESTIMABLE="YES" MEAN_1="1.8" MEAN_2="1.2" MODIFIED="2015-03-24 10:15:17 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="119" SD_1="2.0" SD_2="2.0" SE="0.5895882996748699" STUDY_ID="STD-Brokaw-2014" TOTAL_1="7" TOTAL_2="5" WEIGHT="1.668627761865493"/>
<CONT_DATA CI_END="0.3081496460411424" CI_START="-0.8280085735289184" EFFECT_SIZE="-0.259929463743888" ESTIMABLE="YES" MEAN_1="10.6" MEAN_2="14.0" MODIFIED="2011-10-25 09:12:22 +0100" MODIFIED_BY="[Empty name]" ORDER="73" SD_1="11.56" SD_2="15.27" SE="0.2898416064101003" STUDY_ID="STD-Burgar-2011" TOTAL_1="36" TOTAL_2="18" WEIGHT="4.48622580103058"/>
<CONT_DATA CI_END="0.8561955186790654" CI_START="-0.202399634046594" EFFECT_SIZE="0.3268979423162357" ESTIMABLE="YES" MEAN_1="2.32" MEAN_2="1.19" MODIFIED="2011-08-22 14:25:32 +0100" MODIFIED_BY="[Empty name]" ORDER="67" SD_1="3.42" SD_2="3.4" SE="0.2700547461779203" STUDY_ID="STD-Conroy-2011" TOTAL_1="41" TOTAL_2="21" WEIGHT="4.82891296955401"/>
<CONT_DATA CI_END="0.9310498700010024" CI_START="-1.2548880687588093" EFFECT_SIZE="-0.16191909937890353" ESTIMABLE="YES" MEAN_1="8.17" MEAN_2="9.5" ORDER="1" SD_1="7.31" SD_2="8.02" SE="0.5576474761786979" STUDY_ID="STD-Daly-2005" TOTAL_1="7" TOTAL_2="6" WEIGHT="1.8282432562550028"/>
<CONT_DATA CI_END="2.6623609248578424" CI_START="0.9302855392658632" EFFECT_SIZE="1.7963232320618527" ESTIMABLE="YES" MEAN_1="5.53" MEAN_2="2.6" ORDER="1" SD_1="1.38" SD_2="1.77" SE="0.44186408506849323" STUDY_ID="STD-Fazekas-2007" TOTAL_1="15" TOTAL_2="15" WEIGHT="2.619635386731053"/>
<CONT_DATA CI_END="1.8465189666165394" CI_START="0.5530841717988703" EFFECT_SIZE="1.1998015692077049" ESTIMABLE="YES" MEAN_1="20.5" MEAN_2="2.82" ORDER="1" SD_1="19.85" SD_2="4.98" SE="0.3299639189852767" STUDY_ID="STD-Hesse-2005" TOTAL_1="22" TOTAL_2="22" WEIGHT="3.8697840183374415"/>
<CONT_DATA CI_END="0.2421653389643318" CI_START="-0.874040952640155" EFFECT_SIZE="-0.3159378068379116" ESTIMABLE="YES" MEAN_1="11.1" MEAN_2="14.6" MODIFIED="2015-05-18 08:53:38 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="133" SD_1="10.6" SD_2="11.2" SE="0.28475173534028675" STUDY_ID="STD-Hesse-2014" TOTAL_1="25" TOTAL_2="25" WEIGHT="4.571875472975729"/>
<CONT_DATA CI_END="1.0209936227256453" CI_START="-1.1608028334099776" EFFECT_SIZE="-0.06990460534216623" ESTIMABLE="YES" MEAN_1="3.4" MEAN_2="3.7" MODIFIED="2015-04-10 11:59:04 +0100" MODIFIED_BY="Bernhard Elsner" ORDER="259" SD_1="3.9" SD_2="4.1" SE="0.5565909560954576" STUDY_ID="STD-Hollenstein-2011" TOTAL_1="7" TOTAL_2="6" WEIGHT="1.8338788974615214"/>
<CONT_DATA CI_END="1.1102258266122658" CI_START="-0.25169977451996944" EFFECT_SIZE="0.42926302604614813" ESTIMABLE="YES" MEAN_1="3.3" MEAN_2="2.2" MODIFIED="2011-10-26 07:00:54 +0100" MODIFIED_BY="[Empty name]" ORDER="61" SD_1="2.4" SD_2="2.6" SE="0.3474363845139325" STUDY_ID="STD-Housman-2009" TOTAL_1="17" TOTAL_2="17" WEIGHT="3.6322402281315385"/>
<CONT_DATA CI_END="1.182490402424469" CI_START="-0.7830267711788745" EFFECT_SIZE="0.19973181562279718" ESTIMABLE="YES" MEAN_1="4.17" MEAN_2="2.83" MODIFIED="2011-08-15 12:07:57 +0100" MODIFIED_BY="[Empty name]" ORDER="58" SD_1="5.85" SD_2="7.44" SE="0.5014166558944685" STUDY_ID="STD-Hsieh-2011" TOTAL_1="12" TOTAL_2="6" WEIGHT="2.164775182239475"/>
<CONT_DATA CI_END="1.256066852120378" CI_START="0.02633557977746892" EFFECT_SIZE="0.6412012159489234" ESTIMABLE="YES" MEAN_1="7.31" MEAN_2="3.81" MODIFIED="2015-06-02 10:59:04 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="819" SD_1="5.53" SD_2="5.02" SE="0.3137127217752143" STUDY_ID="STD-Hsieh-2014" TOTAL_1="32" TOTAL_2="16" WEIGHT="4.107175950971884"/>
<CONT_DATA CI_END="1.5411350448323422" CI_START="-0.564551119498822" EFFECT_SIZE="0.48829196266676017" ESTIMABLE="YES" MEAN_1="3.5" MEAN_2="1.3" MODIFIED="2015-05-18 10:24:52 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="140" SD_1="4.19" SD_2="4.32" SE="0.5371747085509091" STUDY_ID="STD-Hwang-2012" TOTAL_1="9" TOTAL_2="6" WEIGHT="1.9418634777898114"/>
<CONT_DATA CI_END="0.9139431654975261" CI_START="0.008014735073424206" EFFECT_SIZE="0.46097895028547514" ESTIMABLE="YES" MEAN_1="3.25" MEAN_2="2.47" MODIFIED="2015-03-24 10:11:41 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="121" SD_1="1.68" SD_2="1.67" SE="0.23110843810650342" STUDY_ID="STD-Klamroth_x002d_Marganska-2014" TOTAL_1="39" TOTAL_2="38" WEIGHT="5.5798433030741075"/>
<CONT_DATA CI_END="1.4768483449093637" CI_START="-0.2821758660975854" EFFECT_SIZE="0.5973362394058892" ESTIMABLE="YES" MEAN_1="26.47" MEAN_2="14.85" MODIFIED="2015-05-18 13:32:03 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="143" SD_1="17.54" SD_2="19.86" SE="0.44873891175600866" STUDY_ID="STD-Kutner-2010" TOTAL_1="11" TOTAL_2="10" WEIGHT="2.560984244672761"/>
<CONT_DATA CI_END="1.6055435530865014" CI_START="-0.21249276415684137" EFFECT_SIZE="0.6965253944648301" ESTIMABLE="YES" MEAN_1="6.3" MEAN_2="1.3" MODIFIED="2011-08-15 10:17:47 +0100" MODIFIED_BY="[Empty name]" ORDER="51" SD_1="5.64" SD_2="7.92" SE="0.4637932971176464" STUDY_ID="STD-Liao-2011" TOTAL_1="10" TOTAL_2="10" WEIGHT="2.4384883229561196"/>
<CONT_DATA CI_END="0.936564544371069" CI_START="0.2078479042559952" EFFECT_SIZE="0.5722062243135321" ESTIMABLE="YES" MEAN_1="3.87" MEAN_2="-0.03" MODIFIED="2011-08-22 14:23:19 +0100" MODIFIED_BY="[Empty name]" ORDER="54" SD_1="7.35" SD_2="6.39" SE="0.18590051803581534" STUDY_ID="STD-Lo-2010" TOTAL_1="49" TOTAL_2="78" WEIGHT="6.56605257011757"/>
<CONT_DATA CI_END="1.1372647343252518" CI_START="-0.6566802193014193" EFFECT_SIZE="0.24029225751191627" ESTIMABLE="YES" MEAN_1="6.98" MEAN_2="6.5" ORDER="1" SD_1="1.8" SD_2="2.5" SE="0.4576474281612009" STUDY_ID="STD-Lum-2006" TOTAL_1="24" TOTAL_2="6" WEIGHT="2.4875365901052384"/>
<CONT_DATA CI_END="1.1942660946499475" CI_START="-0.15634433909086787" EFFECT_SIZE="0.5189608777795398" ESTIMABLE="YES" MEAN_1="15.8" MEAN_2="10.3" ORDER="1" SD_1="8.1" SD_2="12.1" SE="0.3445498091787038" STUDY_ID="STD-Masiero-2007" TOTAL_1="17" TOTAL_2="18" WEIGHT="3.6702622138518772"/>
<CONT_DATA CI_END="0.6809447060792966" CI_START="-1.0359319244142693" EFFECT_SIZE="-0.17749360916748635" ESTIMABLE="YES" MEAN_1="12.16" MEAN_2="13.87" MODIFIED="2011-10-25 09:42:36 +0100" MODIFIED_BY="[Empty name]" ORDER="82" SD_1="8.3" SD_2="10.2" SE="0.437986780378637" STUDY_ID="STD-Masiero-2011" TOTAL_1="11" TOTAL_2="10" WEIGHT="2.6534949159961347"/>
<CONT_DATA CI_END="2.133932848002897" CI_START="-0.7883144554155647" EFFECT_SIZE="0.6728091962936661" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="1.25" MODIFIED="2011-11-17 08:29:25 +0000" MODIFIED_BY="[Empty name]" ORDER="112" SD_1="2.94" SD_2="1.26" SE="0.7454849493329406" STUDY_ID="STD-Mayr-2008" TOTAL_1="4" TOTAL_2="4" WEIGHT="1.1154759291272027"/>
<CONT_DATA CI_END="0.33268540893651005" CI_START="-1.0372739184578856" EFFECT_SIZE="-0.3522942547606878" ESTIMABLE="YES" MEAN_1="7.7" MEAN_2="9.35" MODIFIED="2015-03-24 12:55:32 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="127" SD_1="3.84" SD_2="4.87" SE="0.3494858421380342" STUDY_ID="STD-McCabe-2015" TOTAL_1="12" TOTAL_2="27" WEIGHT="3.6055317001702036"/>
<CONT_DATA CI_END="0.6496554439606558" CI_START="-0.8697010151771357" EFFECT_SIZE="-0.11002278560824001" ESTIMABLE="YES" MEAN_1="3.05" MEAN_2="3.88" MODIFIED="2015-03-24 12:02:31 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="115" SD_1="8.12" SD_2="6.94" SE="0.3875980556587471" STUDY_ID="STD-Rabadi-2008" TOTAL_1="10" TOTAL_2="20" WEIGHT="3.1499769288603665"/>
<CONT_DATA CI_END="1.0818176867387777" CI_START="-0.015723027078641483" EFFECT_SIZE="0.5330473298300681" ESTIMABLE="YES" MEAN_1="8.65" MEAN_2="3.63" MODIFIED="2015-03-24 12:37:46 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="125" SD_1="7.52" SD_2="10.7" SE="0.2799900208561688" STUDY_ID="STD-Sale-2014" TOTAL_1="26" TOTAL_2="27" WEIGHT="4.6535668875357175"/>
<CONT_DATA CI_END="0.7987435476676239" CI_START="-1.0038276049828765" EFFECT_SIZE="-0.10254202865762635" ESTIMABLE="YES" MEAN_1="5.11" MEAN_2="5.7" MODIFIED="2015-05-18 14:22:52 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="149" SD_1="6.55" SD_2="4.35" SE="0.4598480295732349" STUDY_ID="STD-Susanto-2015" TOTAL_1="9" TOTAL_2="10" WEIGHT="2.4698247477737207"/>
<CONT_DATA CI_END="0.7610269452232925" CI_START="-0.9111528257790966" EFFECT_SIZE="-0.07506294027790202" ESTIMABLE="YES" MEAN_1="1.6" MEAN_2="3.5" MODIFIED="2015-05-18 13:49:19 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="145" SD_1="10.8" SD_2="32.7" SE="0.42658431078130254" STUDY_ID="STD-Timmermans-2014" TOTAL_1="11" TOTAL_2="11" WEIGHT="2.756450745240964"/>
<CONT_DATA CI_END="1.22032829423937" CI_START="0.1380767794858967" EFFECT_SIZE="0.6792025368626333" ESTIMABLE="YES" MEAN_1="6.0" MEAN_2="4.0" ORDER="1" SD_1="3.5" SD_2="2.0" SE="0.27608964330215635" STUDY_ID="STD-Volpe-2000" TOTAL_1="30" TOTAL_2="26" WEIGHT="4.721612921038082"/>
<CONT_DATA CI_END="1.0091858566316418" CI_START="-0.7065613610612295" EFFECT_SIZE="0.15131224778520622" ESTIMABLE="YES" MEAN_1="19.46" MEAN_2="17.7" ORDER="1" SD_1="13.27" SD_2="8.22" SE="0.4376986595739683" STUDY_ID="STD-Volpe-2008" TOTAL_1="11" TOTAL_2="10" WEIGHT="2.6560338851857526"/>
<CONT_DATA CI_END="0.6612941275915234" CI_START="-0.6218341101810183" EFFECT_SIZE="0.01973000870525251" ESTIMABLE="YES" MEAN_1="3.85" MEAN_2="3.71" MODIFIED="2015-05-19 07:49:10 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="150" SD_1="6.71" SD_2="7.08" SE="0.3273346469357839" STUDY_ID="STD-Wu-2012" TOTAL_1="14" TOTAL_2="28" WEIGHT="3.9070937026842847"/>
<CONT_DATA CI_END="1.0159481183404653" CI_START="-0.6595509237771858" EFFECT_SIZE="0.17819859728163975" ESTIMABLE="YES" MEAN_1="1.7" MEAN_2="0.3" MODIFIED="2015-05-19 08:04:07 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="151" SD_1="9.94" SD_2="3.93" SE="0.42743107917639656" STUDY_ID="STD-Yoo-2013" TOTAL_1="11" TOTAL_2="11" WEIGHT="2.748627637807964"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="53.03814752165133" CI_END="0.6972994512510928" CI_START="0.01387205280560977" CI_STUDY="95" CI_TOTAL="95" DF="15" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.3555857520283513" ESTIMABLE="YES" I2="71.7184692510675" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2015-05-19 08:04:51 +0100" MODIFIED_BY="Jan Mehrholz" NO="4" P_CHI2="3.8000825132167293E-6" P_Q="1.0" P_Z="0.041397181731651696" Q="0.0" RANDOM="YES" SCALE="3.2670441893017523" SORT_BY="STUDY" STUDIES="16" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.3265275468171086" TOTALS="YES" TOTAL_1="304" TOTAL_2="264" UNITS="" WEIGHT="100.00000000000003" Z="2.0395297846600853">
<NAME>Arm muscle strength at the end of intervention phase</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.5236581282261129" CI_START="-0.6080483368605797" EFFECT_SIZE="-0.042195104317233355" ESTIMABLE="YES" MEAN_1="14.85" MEAN_2="15.4" MODIFIED="2011-10-25 09:19:02 +0100" MODIFIED_BY="[Empty name]" ORDER="77" SD_1="11.2" SD_2="15.7" SE="0.28870593388793075" STUDY_ID="STD-Burgar-2011" TOTAL_1="36" TOTAL_2="18" WEIGHT="7.416060887538548"/>
<CONT_DATA CI_END="1.67985014422481" CI_START="0.4122721485450257" EFFECT_SIZE="1.0460611463849179" ESTIMABLE="YES" MEAN_1="12.09" MEAN_2="4.27" MODIFIED="2008-06-06 10:08:04 +0100" MODIFIED_BY="[Empty name]" ORDER="1236" SD_1="8.35" SD_2="6.17" SE="0.3233676755487034" STUDY_ID="STD-Hesse-2005" TOTAL_1="22" TOTAL_2="22" WEIGHT="7.051092589576425"/>
<CONT_DATA CI_END="0.4672732497429875" CI_START="-0.6420239454626022" EFFECT_SIZE="-0.08737534785980733" ESTIMABLE="YES" MEAN_1="7.5" MEAN_2="8.1" MODIFIED="2015-05-18 08:57:20 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="136" SD_1="7.1" SD_2="6.4" SE="0.28298917836133325" STUDY_ID="STD-Hesse-2014" TOTAL_1="25" TOTAL_2="25" WEIGHT="7.475669481843943"/>
<CONT_DATA CI_END="0.6722621005577868" CI_START="-0.6722621005577868" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="0.8" MEAN_2="0.8" MODIFIED="2011-08-15 12:49:15 +0100" MODIFIED_BY="[Empty name]" ORDER="62" SD_1="3.0" SD_2="2.3" SE="0.3429971702850177" STUDY_ID="STD-Housman-2009" TOTAL_1="17" TOTAL_2="17" WEIGHT="6.843446435921644"/>
<CONT_DATA CI_END="1.3131056407308523" CI_START="-0.6615955570341459" EFFECT_SIZE="0.3257550418483533" ESTIMABLE="YES" MEAN_1="3.53" MEAN_2="3.33" MODIFIED="2011-08-15 12:10:07 +0100" MODIFIED_BY="[Empty name]" ORDER="59" SD_1="0.53" SD_2="0.69" SE="0.5037595622524672" STUDY_ID="STD-Hsieh-2011" TOTAL_1="12" TOTAL_2="6" WEIGHT="5.238115817578579"/>
<CONT_DATA CI_END="1.088902005917945" CI_START="-0.9776020178197606" EFFECT_SIZE="0.05564999404909226" ESTIMABLE="YES" MEAN_1="1.7" MEAN_2="1.3" MODIFIED="2015-05-18 12:22:09 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="141" SD_1="7.04" SD_2="6.3" SE="0.5271790808499609" STUDY_ID="STD-Hwang-2012" TOTAL_1="9" TOTAL_2="6" WEIGHT="5.028883458129724"/>
<CONT_DATA CI_END="0.31186964781818277" CI_START="-0.5827187824600608" EFFECT_SIZE="-0.135424567320939" ESTIMABLE="YES" MEAN_1="1.4" MEAN_2="2.6" MODIFIED="2015-03-24 10:12:41 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="122" SD_1="8.0" SD_2="9.5" SE="0.22821552776853118" STUDY_ID="STD-Klamroth_x002d_Marganska-2014" TOTAL_1="39" TOTAL_2="38" WEIGHT="8.028541597005605"/>
<CONT_DATA CI_END="0.6946924702166966" CI_START="-1.0978462415592616" EFFECT_SIZE="-0.20157688567128254" ESTIMABLE="YES" MEAN_1="7.87" MEAN_2="9.3" MODIFIED="2008-06-06 09:48:10 +0100" MODIFIED_BY="[Empty name]" ORDER="49" SD_1="7.47" SD_2="3.18" SE="0.4572886864032387" STUDY_ID="STD-Lum-2006" TOTAL_1="24" TOTAL_2="6" WEIGHT="5.674860622594647"/>
<CONT_DATA CI_END="1.130282062238079" CI_START="-0.2148401012278081" EFFECT_SIZE="0.4577209805051354" ESTIMABLE="YES" MEAN_1="1.73" MEAN_2="1.2" MODIFIED="2008-06-06 10:14:10 +0100" MODIFIED_BY="[Empty name]" ORDER="1237" SD_1="1.23" SD_2="1.03" SE="0.3431497145039498" STUDY_ID="STD-Masiero-2007" TOTAL_1="17" TOTAL_2="18" WEIGHT="6.841834188582259"/>
<CONT_DATA CI_END="-0.028667928074597615" CI_START="-1.8542160485393169" EFFECT_SIZE="-0.9414419883069572" ESTIMABLE="YES" MEAN_1="0.77" MEAN_2="1.54" MODIFIED="2012-01-26 11:20:55 +0000" MODIFIED_BY="[Empty name]" ORDER="83" SD_1="0.64" SD_2="0.92" SE="0.4657096086623045" STUDY_ID="STD-Masiero-2011" TOTAL_1="11" TOTAL_2="10" WEIGHT="5.593692454679265"/>
<CONT_DATA CI_END="1.6488640121596752" CI_START="-1.1445627006805346" EFFECT_SIZE="0.2521506557395702" ESTIMABLE="YES" MEAN_1="3.63" MEAN_2="2.38" MODIFIED="2011-11-17 08:24:41 +0000" MODIFIED_BY="[Empty name]" ORDER="111" SD_1="4.39" SD_2="4.23" SE="0.712621949911938" STUDY_ID="STD-Mayr-2008" TOTAL_1="4" TOTAL_2="4" WEIGHT="3.6431443270703157"/>
<CONT_DATA CI_END="1.548535909755944" CI_START="-0.024981971697060068" EFFECT_SIZE="0.7617769690294419" ESTIMABLE="YES" MEAN_1="8.33" MEAN_2="1.24" MODIFIED="2015-03-24 12:26:46 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="116" SD_1="7.86" SD_2="9.57" SE="0.40141499891444743" STUDY_ID="STD-Rabadi-2008" TOTAL_1="10" TOTAL_2="20" WEIGHT="6.233185973553484"/>
<CONT_DATA CI_END="0.781640980982105" CI_START="-0.29965171695851783" EFFECT_SIZE="0.24099463201179355" ESTIMABLE="YES" MEAN_1="13.89" MEAN_2="9.26" MODIFIED="2015-03-24 12:38:41 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="126" SD_1="15.5" SD_2="21.72" SE="0.27584504268183535" STUDY_ID="STD-Sale-2014" TOTAL_1="26" TOTAL_2="27" WEIGHT="7.549798723023794"/>
<CONT_DATA CI_END="2.132446881878119" CI_START="0.9287355898247233" EFFECT_SIZE="1.530591235851421" ESTIMABLE="YES" MEAN_1="4.1" MEAN_2="1.7" MODIFIED="2008-06-06 10:15:53 +0100" MODIFIED_BY="[Empty name]" ORDER="1238" SD_1="1.4" SD_2="1.7" SE="0.30707484972890237" STUDY_ID="STD-Volpe-2000" TOTAL_1="30" TOTAL_2="26" WEIGHT="7.223199920537022"/>
<CONT_DATA CI_END="3.8735564448362148" CI_START="1.4088011254804826" EFFECT_SIZE="2.6411787851583486" ESTIMABLE="YES" MEAN_1="4.82" MEAN_2="3.37" MODIFIED="2008-06-06 10:26:27 +0100" MODIFIED_BY="[Empty name]" ORDER="48" SD_1="0.66" SD_2="0.32" SE="0.6287756659809587" STUDY_ID="STD-Volpe-2008" TOTAL_1="11" TOTAL_2="10" WEIGHT="4.210752807205096"/>
<CONT_DATA CI_END="1.1554919624393556" CI_START="-0.5284338971188725" EFFECT_SIZE="0.3135290326602416" ESTIMABLE="YES" MEAN_1="1.0" MEAN_2="0.1" MODIFIED="2015-05-19 08:04:42 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="152" SD_1="3.61" SD_2="1.49" SE="0.4295808170050114" STUDY_ID="STD-Yoo-2013" TOTAL_1="11" TOTAL_2="11" WEIGHT="5.947720715159656"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="13.067409080643772" CI_END="0.02526805191362545" CI_START="-0.020587922110874696" CI_STUDY="95" CI_TOTAL="95" DF="33" EFFECT_MEASURE="RD" EFFECT_SIZE="0.0023400649013753756" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="24" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="-1.597428239511645" LOG_CI_START="NaN" LOG_EFFECT_SIZE="-2.6307720973256186" METHOD="MH" MODIFIED="2015-06-02 12:32:36 +0100" MODIFIED_BY="Jan Mehrholz" NO="5" P_CHI2="0.9992489299850278" P_Q="1.0" P_Z="0.841451740028492" Q="0.0" RANDOM="YES" SCALE="0.57" SORT_BY="STUDY" STUDIES="34" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="593" TOTAL_2="567" WEIGHT="99.99999999999997" Z="0.20003687745162904">
<NAME>Acceptability: drop-outs during intervention period</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.35962918295906665" CI_START="-0.1374069607368444" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-03-31 09:12:06 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="129" O_E="0.0" SE="0.1267972645457949" STUDY_ID="STD-Abdullah-2011" TOTAL_1="9" TOTAL_2="11" VAR="0.016077546296296295" WEIGHT="0.8511692061709213"/>
<DICH_DATA CI_END="0.11712827820384197" CI_START="-0.11712827820384197" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="1239" O_E="0.0" SE="0.059760423726014804" STUDY_ID="STD-Amirabdollahian-2007" TOTAL_1="16" TOTAL_2="15" VAR="0.003571308243912833" WEIGHT="3.831848550603229"/>
<DICH_DATA CI_END="0.18815969265945354" CI_START="-0.18815969265945354" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-05-18 08:19:19 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="130" O_E="0.0" SE="0.09600160724566022" STUDY_ID="STD-Ang-2014" TOTAL_1="15" TOTAL_2="7" VAR="0.00921630859375" WEIGHT="1.4848366001410782"/>
<DICH_DATA CI_END="0.028661096932235564" CI_START="-0.8286610969322357" EFFECT_SIZE="-0.4" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-03-24 09:52:35 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="118" O_E="0.0" SE="0.21870866011491008" STUDY_ID="STD-Brokaw-2014" TOTAL_1="7" TOTAL_2="5" VAR="0.04783347800925926" WEIGHT="0.2860906814165962"/>
<DICH_DATA CI_END="0.08102235190295506" CI_START="-0.08102235190295506" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-10-25 09:19:27 +0100" MODIFIED_BY="[Empty name]" ORDER="78" O_E="0.0" SE="0.041338694252572514" STUDY_ID="STD-Burgar-2011" TOTAL_1="36" TOTAL_2="18" VAR="0.0017088876425076717" WEIGHT="8.007964934495872"/>
<DICH_DATA CI_END="0.1873215527306609" CI_START="-0.13389530418246112" EFFECT_SIZE="0.026713124274099886" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-08-22 13:39:47 +0100" MODIFIED_BY="[Empty name]" ORDER="72" O_E="0.0" SE="0.08194458149405795" STUDY_ID="STD-Conroy-2011" TOTAL_1="41" TOTAL_2="21" VAR="0.006714914436236305" WEIGHT="2.0379578099084465"/>
<DICH_DATA CI_END="0.47384270534000533" CI_START="-0.18812841962571963" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="1240" O_E="0.0" SE="0.1688732880265323" STUDY_ID="STD-Daly-2005" TOTAL_1="7" TOTAL_2="6" VAR="0.02851818740889213" WEIGHT="0.4798591201461767"/>
<DICH_DATA CI_END="0.12056853005506211" CI_START="-0.12056853005506211" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="1248" O_E="0.0" SE="0.061515686515717274" STUDY_ID="STD-Fazekas-2007" TOTAL_1="15" TOTAL_2="15" VAR="0.0037841796875" WEIGHT="3.6162955906661742"/>
<DICH_DATA CI_END="0.1626473548494195" CI_START="-0.07173826394032859" EFFECT_SIZE="0.045454545454545456" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="1242" O_E="0.0" SE="0.05979334840807074" STUDY_ID="STD-Hesse-2005" TOTAL_1="22" TOTAL_2="22" VAR="0.0035752445138489356" WEIGHT="3.827629764953461"/>
<DICH_DATA CI_END="0.14401372947138133" CI_START="-0.06401372947138134" EFFECT_SIZE="0.04" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-05-18 08:50:53 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="134" O_E="0.0" SE="0.053069204481219226" STUDY_ID="STD-Hesse-2014" TOTAL_1="25" TOTAL_2="25" VAR="0.0028163404642694585" WEIGHT="4.859040478880625"/>
<DICH_DATA CI_END="0.2540361136080607" CI_START="-0.2540361136080607" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-04-10 12:00:32 +0100" MODIFIED_BY="Bernhard Elsner" ORDER="260" O_E="0.0" SE="0.12961264370767278" STUDY_ID="STD-Hollenstein-2011" TOTAL_1="7" TOTAL_2="6" VAR="0.01679943740889213" WEIGHT="0.8145934881695074"/>
<DICH_DATA CI_END="0.24847386904608582" CI_START="-0.13082681022255643" EFFECT_SIZE="0.058823529411764705" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-08-22 13:34:18 +0100" MODIFIED_BY="[Empty name]" ORDER="70" O_E="0.0" SE="0.09676215539176168" STUDY_ID="STD-Housman-2009" TOTAL_1="17" TOTAL_2="17" VAR="0.009362914716059434" WEIGHT="1.461586774332409"/>
<DICH_DATA CI_END="0.217547235299985" CI_START="-0.217547235299985" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-08-22 13:34:59 +0100" MODIFIED_BY="[Empty name]" ORDER="71" O_E="0.0" SE="0.11099552696680644" STUDY_ID="STD-Hsieh-2011" TOTAL_1="12" TOTAL_2="6" VAR="0.012320007006639056" WEIGHT="1.110771472030842"/>
<DICH_DATA CI_END="0.09048579982142332" CI_START="-0.09048579982142332" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-06-02 10:23:48 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="613" O_E="0.0" SE="0.046167072729480625" STUDY_ID="STD-Hsieh-2014" TOTAL_1="32" TOTAL_2="16" VAR="0.0021313986044091534" WEIGHT="6.420531706216586"/>
<DICH_DATA CI_END="0.20159926948921522" CI_START="-0.20159926948921522" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-05-18 10:12:17 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="139" O_E="0.0" SE="0.1028586601995774" STUDY_ID="STD-Hwang-2012" TOTAL_1="9" TOTAL_2="8" VAR="0.010579903978052127" WEIGHT="1.293462808980451"/>
<DICH_DATA CI_END="0.1827544526427866" CI_START="-0.1827544526427866" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="1243" O_E="0.0" SE="0.09324378105124911" STUDY_ID="STD-Kahn-2006" TOTAL_1="10" TOTAL_2="9" VAR="0.008694402704733283" WEIGHT="1.5739680784218468"/>
<DICH_DATA CI_END="0.045747461042123065" CI_START="-0.15236014660217703" EFFECT_SIZE="-0.05330634278002699" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-03-24 10:07:26 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="120" O_E="0.0" SE="0.05053858366963567" STUDY_ID="STD-Klamroth_x002d_Marganska-2014" TOTAL_1="39" TOTAL_2="38" VAR="0.002554148439332765" WEIGHT="5.3578375114994055"/>
<DICH_DATA CI_END="0.5975633291981939" CI_START="0.002436670801806151" EFFECT_SIZE="0.3" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-03-31 09:06:48 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="128" O_E="0.0" SE="0.15182081484421928" STUDY_ID="STD-Kutner-2010" TOTAL_1="10" TOTAL_2="11" VAR="0.023049559819962713" WEIGHT="0.5937081846718273"/>
<DICH_DATA CI_END="0.17408193796294572" CI_START="-0.17408193796294572" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-08-22 13:35:45 +0100" MODIFIED_BY="[Empty name]" ORDER="56" O_E="0.0" SE="0.08881894735621768" STUDY_ID="STD-Liao-2011" TOTAL_1="10" TOTAL_2="10" VAR="0.007888805409466567" WEIGHT="1.734700199573068"/>
<DICH_DATA CI_END="0.07568584695640879" CI_START="-0.1536554963546296" EFFECT_SIZE="-0.03898482469911041" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-08-22 13:38:26 +0100" MODIFIED_BY="[Empty name]" ORDER="55" O_E="0.0" SE="0.058506519793234374" STUDY_ID="STD-Lo-2010" TOTAL_1="49" TOTAL_2="78" VAR="0.0034230128583161252" WEIGHT="3.9978559487289336"/>
<DICH_DATA CI_END="0.2800405189491249" CI_START="-0.1467071856157916" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-08-22 13:44:06 +0100" MODIFIED_BY="[Empty name]" ORDER="73" O_E="0.0" SE="0.10886621079036347" STUDY_ID="STD-Lum-2002" TOTAL_1="15" TOTAL_2="15" VAR="0.011851851851851853" WEIGHT="1.154647601847682"/>
<DICH_DATA CI_END="0.1985204422991016" CI_START="-0.1985204422991016" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="1245" O_E="0.0" SE="0.10128780113563592" STUDY_ID="STD-Lum-2006" TOTAL_1="24" TOTAL_2="6" VAR="0.010259218658892129" WEIGHT="1.3338942051238563"/>
<DICH_DATA CI_END="0.18140996707977655" CI_START="-0.279449182766051" EFFECT_SIZE="-0.04901960784313725" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="1246" O_E="0.0" SE="0.11756826999909839" STUDY_ID="STD-Masiero-2007" TOTAL_1="17" TOTAL_2="18" VAR="0.013822298110580897" WEIGHT="0.9900460986092592"/>
<DICH_DATA CI_END="0.16713734661541962" CI_START="-0.16713734661541962" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-10-25 09:38:35 +0100" MODIFIED_BY="[Empty name]" ORDER="79" O_E="0.0" SE="0.08527572339786735" STUDY_ID="STD-Masiero-2011" TOTAL_1="11" TOTAL_2="10" VAR="0.00727194900102958" WEIGHT="1.8818493248862496"/>
<DICH_DATA CI_END="0.371877019382737" CI_START="-0.371877019382737" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-08-22 13:38:49 +0100" MODIFIED_BY="[Empty name]" ORDER="69" O_E="0.0" SE="0.18973665961010275" STUDY_ID="STD-Mayr-2008" TOTAL_1="4" TOTAL_2="4" VAR="0.036" WEIGHT="0.380130897727632"/>
<DICH_DATA CI_END="0.11547423462165031" CI_START="-0.11547423462165031" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-03-24 12:57:05 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="128" O_E="0.0" SE="0.05891650843204076" STUDY_ID="STD-McCabe-2015" TOTAL_1="12" TOTAL_2="27" VAR="0.0034711549658227293" WEIGHT="3.9424089252526984"/>
<DICH_DATA CI_END="0.13929808382818423" CI_START="-0.13929808382818423" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-03-24 09:23:15 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="117" O_E="0.0" SE="0.07107175689295811" STUDY_ID="STD-Rabadi-2008" TOTAL_1="10" TOTAL_2="20" VAR="0.005051194627851738" WEIGHT="2.7092031343909686"/>
<DICH_DATA CI_END="0.07065490363040891" CI_START="-0.07065490363040891" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-06-02 12:32:36 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="123" O_E="0.0" SE="0.03604908262994921" STUDY_ID="STD-Sale-2014" TOTAL_1="26" TOTAL_2="27" VAR="0.0012995363584609055" WEIGHT="10.530457442839168"/>
<DICH_DATA CI_END="0.14366881988087293" CI_START="-0.34366881988087294" EFFECT_SIZE="-0.1" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-05-18 14:19:14 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="148" O_E="0.0" SE="0.12432311093617102" STUDY_ID="STD-Susanto-2015" TOTAL_1="9" TOTAL_2="10" VAR="0.015456235912847484" WEIGHT="0.8853845396355388"/>
<DICH_DATA CI_END="0.15989141359795075" CI_START="-0.15989141359795075" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-05-18 13:41:47 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="144" O_E="0.0" SE="0.08157875086438007" STUDY_ID="STD-Timmermans-2014" TOTAL_1="11" TOTAL_2="11" VAR="0.006655092592592593" WEIGHT="2.056276772681785"/>
<DICH_DATA CI_END="0.06747143798619011" CI_START="-0.06747143798619011" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="1247" O_E="0.0" SE="0.03442483561861147" STUDY_ID="STD-Volpe-2000" TOTAL_1="30" TOTAL_2="26" VAR="0.001185069307368421" WEIGHT="11.54760504985416"/>
<DICH_DATA CI_END="0.16713734661541962" CI_START="-0.16713734661541962" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="1249" O_E="0.0" SE="0.08527572339786735" STUDY_ID="STD-Volpe-2008" TOTAL_1="11" TOTAL_2="10" VAR="0.00727194900102958" WEIGHT="1.8818493248862496"/>
<DICH_DATA CI_END="0.10245247403883434" CI_START="-0.10245247403883434" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-05-18 14:08:03 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="146" O_E="0.0" SE="0.05227263094983703" STUDY_ID="STD-Wu-2012" TOTAL_1="14" TOTAL_2="28" VAR="0.00273242794641786" WEIGHT="5.008260999575503"/>
<DICH_DATA CI_END="0.15989141359795075" CI_START="-0.15989141359795075" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-05-18 14:09:13 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="147" O_E="0.0" SE="0.08157875086438007" STUDY_ID="STD-Yoo-2013" TOTAL_1="11" TOTAL_2="11" VAR="0.006655092592592593" WEIGHT="2.056276772681785"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser" NO="2">
<NAME>Sensitivity analysis: by trial methodology</NAME>
<CONT_OUTCOME CHI2="42.60614128351649" CI_END="0.4950241859455211" CI_START="0.22931402176247676" CI_STUDY="95" CI_TOTAL="95" DF="32" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.3621691038539989" ESTIMABLE="YES" I2="24.89345658631566" I2_Q="0.0" ID="CMP-002.01" MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser" NO="1" P_CHI2="0.0996124898172901" P_Q="0.7911471931329452" P_Z="9.144470612171754E-8" Q="0.4685429623537807" RANDOM="YES" SCALE="2.87" SORT_BY="STUDY" STUDIES="16" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.03726859159565271" TOTALS="SUB" TOTAL_1="654" TOTAL_2="655" UNITS="" WEIGHT="300.0" Z="5.342952551698292">
<NAME>Activities of daily living</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="9.009346658377543" CI_END="0.592841042982276" CI_START="0.2199275551545434" DF="10" EFFECT_SIZE="0.4063842990684097" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.01" MODIFIED="2015-05-29 09:49:12 +0100" MODIFIED_BY="Jan Mehrholz" NO="1" P_CHI2="0.5312168420515485" P_Z="1.939356320559664E-5" STUDIES="11" TAU2="0.0" TOTAL_1="244" TOTAL_2="237" WEIGHT="100.0" Z="4.271760695470365">
<NAME>All studies with description of randomisation procedure</NAME>
<CONT_DATA CI_END="1.0380024373648842" CI_START="-0.10814800700190896" EFFECT_SIZE="0.4649272151814876" ESTIMABLE="YES" MEAN_1="19.6" MEAN_2="15.9" MODIFIED="2015-05-29 09:47:42 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="74" SD_1="8.47" SD_2="6.36" SE="0.29239069018805486" STUDY_ID="STD-Burgar-2011" TOTAL_1="36" TOTAL_2="18" WEIGHT="10.586025330940704"/>
<CONT_DATA CI_END="1.1507506471231492" CI_START="0.07547143196899198" EFFECT_SIZE="0.6131110395460706" ESTIMABLE="YES" MEAN_1="3.98" MEAN_2="-3.19" MODIFIED="2015-05-29 09:47:48 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="62" SD_1="11.94" SD_2="10.72" SE="0.2743109627615156" STUDY_ID="STD-Conroy-2011" TOTAL_1="41" TOTAL_2="21" WEIGHT="12.027453344420222"/>
<CONT_DATA CI_END="0.9453307469415558" CI_START="-0.24643832635851426" EFFECT_SIZE="0.3494462102915208" ESTIMABLE="YES" MEAN_1="22.45" MEAN_2="17.27" ORDER="1" SD_1="15.14" SD_2="13.95" SE="0.30402830937216" STUDY_ID="STD-Hesse-2005" TOTAL_1="22" TOTAL_2="22" WEIGHT="9.791110698214359"/>
<CONT_DATA CI_END="1.2389432899259827" CI_START="0.09714309978213664" EFFECT_SIZE="0.6680431948540597" ESTIMABLE="YES" MEAN_1="25.2" MEAN_2="16.0" MODIFIED="2015-05-29 09:48:11 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="135" SD_1="11.0" SD_2="15.7" SE="0.29128091106525944" STUDY_ID="STD-Hesse-2014" TOTAL_1="25" TOTAL_2="25" WEIGHT="10.666844427976804"/>
<CONT_DATA CI_END="0.9520381577866032" CI_START="-0.3997153806708117" EFFECT_SIZE="0.27616138855789574" ESTIMABLE="YES" MEAN_1="0.2" MEAN_2="0.1" MODIFIED="2015-05-29 09:48:19 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="60" SD_1="0.4" SD_2="0.3" SE="0.3448414228832454" STUDY_ID="STD-Housman-2009" TOTAL_1="17" TOTAL_2="17" WEIGHT="7.610639536814739"/>
<CONT_DATA CI_END="1.265099905567385" CI_START="-0.7057379833459232" EFFECT_SIZE="0.2796809611107309" ESTIMABLE="YES" MEAN_1="0.13" MEAN_2="0.06" MODIFIED="2011-10-26 12:12:27 +0100" MODIFIED_BY="[Empty name]" ORDER="95" SD_1="0.19" SD_2="0.32" SE="0.502774006170273" STUDY_ID="STD-Hsieh-2011" TOTAL_1="12" TOTAL_2="6" WEIGHT="3.580258440812671"/>
<CONT_DATA CI_END="0.7134875883073168" CI_START="-1.001985630241621" EFFECT_SIZE="-0.14424902096715214" ESTIMABLE="YES" MEAN_1="6.89" MEAN_2="8.49" MODIFIED="2015-05-29 09:48:27 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="142" SD_1="9.995" SD_2="11.33" SE="0.43762876054875793" STUDY_ID="STD-Kutner-2010" TOTAL_1="11" TOTAL_2="10" WEIGHT="4.725505776168509"/>
<CONT_DATA CI_END="1.84094759135064" CI_START="-0.021588700935392335" EFFECT_SIZE="0.9096794452076238" ESTIMABLE="YES" MEAN_1="0.25" MEAN_2="0.03" MODIFIED="2015-05-29 09:48:35 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="49" SD_1="0.17" SD_2="0.28" SE="0.47514554016744204" STUDY_ID="STD-Liao-2011" TOTAL_1="10" TOTAL_2="10" WEIGHT="4.0087289761673555"/>
<CONT_DATA CI_END="0.7711305899067029" CI_START="0.04926402680540454" EFFECT_SIZE="0.4101973083560537" ESTIMABLE="YES" MEAN_1="6.31" MEAN_2="1.37" MODIFIED="2015-05-29 09:48:53 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="53" SD_1="11.76" SD_2="12.1" SE="0.18415301729911612" STUDY_ID="STD-Lo-2010" TOTAL_1="49" TOTAL_2="78" WEIGHT="26.687158293317616"/>
<CONT_DATA CI_END="1.5975928473079857" CI_START="-0.1799721623230024" EFFECT_SIZE="0.7088103424924916" ESTIMABLE="YES" MEAN_1="1.83" MEAN_2="1.0" MODIFIED="2011-10-26 12:44:54 +0100" MODIFIED_BY="[Empty name]" ORDER="115" SD_1="1.4" SD_2="0.7" SE="0.45346879423606606" STUDY_ID="STD-Masiero-2011" TOTAL_1="11" TOTAL_2="10" WEIGHT="4.4011401394250935"/>
<CONT_DATA CI_END="0.37113285169722676" CI_START="-1.162162290668966" EFFECT_SIZE="-0.3955147194858696" ESTIMABLE="YES" MEAN_1="25.49" MEAN_2="28.29" MODIFIED="2015-05-29 09:49:12 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="113" SD_1="7.23" SD_2="6.72" SE="0.39115390753621726" STUDY_ID="STD-Rabadi-2008" TOTAL_1="10" TOTAL_2="20" WEIGHT="5.915135035741927"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="6.047227117483353" CI_END="0.6729032980483659" CI_START="0.008314104157129187" DF="5" EFFECT_SIZE="0.34060870110274755" ESTIMABLE="YES" I2="17.3174762108021" ID="CMP-002.01.02" MODIFIED="2015-05-29 10:02:23 +0100" MODIFIED_BY="Jan Mehrholz" NO="2" P_CHI2="0.3016506649981958" P_Z="0.04453683318990919" STUDIES="6" TAU2="0.029935007303594885" TOTAL_1="85" TOTAL_2="103" WEIGHT="100.00000000000001" Z="2.009002833987115">
<NAME>All studies with adequate concealed allocation</NAME>
<CONT_DATA CI_END="0.9453307469415558" CI_START="-0.24643832635851426" EFFECT_SIZE="0.3494462102915208" ESTIMABLE="YES" MEAN_1="22.45" MEAN_2="17.27" MODIFIED="2011-10-26 12:14:09 +0100" MODIFIED_BY="[Empty name]" ORDER="99" SD_1="15.14" SD_2="13.95" SE="0.30402830937216" STUDY_ID="STD-Hesse-2005" TOTAL_1="22" TOTAL_2="22" WEIGHT="23.48993062178087"/>
<CONT_DATA CI_END="0.9520381577866032" CI_START="-0.3997153806708117" EFFECT_SIZE="0.27616138855789574" ESTIMABLE="YES" MEAN_1="0.2" MEAN_2="0.1" MODIFIED="2011-10-26 12:14:19 +0100" MODIFIED_BY="[Empty name]" ORDER="101" SD_1="0.4" SD_2="0.3" SE="0.3448414228832454" STUDY_ID="STD-Housman-2009" TOTAL_1="17" TOTAL_2="17" WEIGHT="19.310776899157194"/>
<CONT_DATA CI_END="1.265099905567385" CI_START="-0.7057379833459232" EFFECT_SIZE="0.2796809611107309" ESTIMABLE="YES" MEAN_1="0.13" MEAN_2="0.06" MODIFIED="2011-10-26 12:14:12 +0100" MODIFIED_BY="[Empty name]" ORDER="100" SD_1="0.19" SD_2="0.32" SE="0.502774006170273" STUDY_ID="STD-Hsieh-2011" TOTAL_1="12" TOTAL_2="6" WEIGHT="10.167142286289716"/>
<CONT_DATA CI_END="1.84094759135064" CI_START="-0.021588700935392335" EFFECT_SIZE="0.9096794452076238" ESTIMABLE="YES" MEAN_1="0.25" MEAN_2="0.03" MODIFIED="2011-10-26 12:14:25 +0100" MODIFIED_BY="[Empty name]" ORDER="102" SD_1="0.17" SD_2="0.28" SE="0.47514554016744204" STUDY_ID="STD-Liao-2011" TOTAL_1="10" TOTAL_2="10" WEIGHT="11.241455640545349"/>
<CONT_DATA CI_END="0.37113285169722676" CI_START="-1.162162290668966" EFFECT_SIZE="-0.3955147194858696" ESTIMABLE="YES" MEAN_1="25.49" MEAN_2="28.29" MODIFIED="2015-05-29 09:50:04 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="113" SD_1="7.23" SD_2="6.72" SE="0.39115390753621726" STUDY_ID="STD-Rabadi-2008" TOTAL_1="10" TOTAL_2="20" WEIGHT="15.712680538750595"/>
<CONT_DATA CI_END="1.3400812297186222" CI_START="0.02105250408261261" EFFECT_SIZE="0.6805668669006174" ESTIMABLE="YES" MEAN_1="3.26" MEAN_2="-2.88" MODIFIED="2015-05-29 09:50:12 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="150" SD_1="7.16" SD_2="9.56" SE="0.33649310294483464" STUDY_ID="STD-Wu-2012" TOTAL_1="14" TOTAL_2="28" WEIGHT="20.078014013476288"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="27.2545226921066" CI_END="0.5354294316256121" CI_START="0.07460132533921196" DF="15" EFFECT_SIZE="0.305015378482412" ESTIMABLE="YES" I2="44.96326290702471" ID="CMP-002.01.03" MODIFIED="2015-05-29 09:52:10 +0100" MODIFIED_BY="Jan Mehrholz" NO="3" P_CHI2="0.02672975003877942" P_Z="0.009471677932853471" STUDIES="16" TAU2="0.09350464286641613" TOTAL_1="325" TOTAL_2="315" WEIGHT="100.0" Z="2.5945429473645962">
<NAME>All studies with blinded assessors</NAME>
<CONT_DATA CI_END="1.0380024373648842" CI_START="-0.10814800700190896" EFFECT_SIZE="0.4649272151814876" ESTIMABLE="YES" MEAN_1="19.6" MEAN_2="15.9" MODIFIED="2015-05-29 09:52:10 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="74" SD_1="8.47" SD_2="6.36" SE="0.29239069018805486" STUDY_ID="STD-Burgar-2011" TOTAL_1="36" TOTAL_2="18" WEIGHT="7.7210451719919515"/>
<CONT_DATA CI_END="1.1507506471231492" CI_START="0.07547143196899198" EFFECT_SIZE="0.6131110395460706" ESTIMABLE="YES" MEAN_1="3.98" MEAN_2="-3.19" MODIFIED="2015-05-29 09:52:10 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="62" SD_1="11.94" SD_2="10.72" SE="0.2743109627615156" STUDY_ID="STD-Conroy-2011" TOTAL_1="41" TOTAL_2="21" WEIGHT="8.189832342394674"/>
<CONT_DATA CI_END="-0.3120300825451786" CI_START="-1.860101658277956" EFFECT_SIZE="-1.0860658704115673" ESTIMABLE="YES" MEAN_1="12.07" MEAN_2="25.53" MODIFIED="2015-05-29 09:52:10 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="9.26" SD_2="14.32" SE="0.39492347511070824" STUDY_ID="STD-Fazekas-2007" TOTAL_1="15" TOTAL_2="15" WEIGHT="5.5399369369638585"/>
<CONT_DATA CI_END="0.9453307469415558" CI_START="-0.24643832635851426" EFFECT_SIZE="0.3494462102915208" ESTIMABLE="YES" MEAN_1="22.45" MEAN_2="17.27" MODIFIED="2015-05-29 09:52:10 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="15.14" SD_2="13.95" SE="0.30402830937216" STUDY_ID="STD-Hesse-2005" TOTAL_1="22" TOTAL_2="22" WEIGHT="7.432825322809459"/>
<CONT_DATA CI_END="1.2389432899259827" CI_START="0.09714309978213664" EFFECT_SIZE="0.6680431948540597" ESTIMABLE="YES" MEAN_1="25.2" MEAN_2="16.0" MODIFIED="2015-05-29 09:52:10 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="135" SD_1="11.0" SD_2="15.7" SE="0.29128091106525944" STUDY_ID="STD-Hesse-2014" TOTAL_1="25" TOTAL_2="25" WEIGHT="7.749087238312088"/>
<CONT_DATA CI_END="0.9520381577866032" CI_START="-0.3997153806708117" EFFECT_SIZE="0.27616138855789574" ESTIMABLE="YES" MEAN_1="0.2" MEAN_2="0.1" MODIFIED="2015-05-29 09:52:10 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="60" SD_1="0.4" SD_2="0.3" SE="0.3448414228832454" STUDY_ID="STD-Housman-2009" TOTAL_1="17" TOTAL_2="17" WEIGHT="6.506176337198695"/>
<CONT_DATA CI_END="1.265099905567385" CI_START="-0.7057379833459232" EFFECT_SIZE="0.2796809611107309" ESTIMABLE="YES" MEAN_1="0.13" MEAN_2="0.06" MODIFIED="2015-05-29 09:52:10 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="57" SD_1="0.19" SD_2="0.32" SE="0.502774006170273" STUDY_ID="STD-Hsieh-2011" TOTAL_1="12" TOTAL_2="6" WEIGHT="3.9910427487745905"/>
<CONT_DATA CI_END="0.7134875883073168" CI_START="-1.001985630241621" EFFECT_SIZE="-0.14424902096715214" ESTIMABLE="YES" MEAN_1="6.89" MEAN_2="8.49" MODIFIED="2015-05-29 09:52:10 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="142" SD_1="9.995" SD_2="11.33" SE="0.43762876054875793" STUDY_ID="STD-Kutner-2010" TOTAL_1="11" TOTAL_2="10" WEIGHT="4.848874705072165"/>
<CONT_DATA CI_END="1.84094759135064" CI_START="-0.021588700935392335" EFFECT_SIZE="0.9096794452076238" ESTIMABLE="YES" MEAN_1="0.25" MEAN_2="0.03" MODIFIED="2015-05-29 09:52:10 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="49" SD_1="0.17" SD_2="0.28" SE="0.47514554016744204" STUDY_ID="STD-Liao-2011" TOTAL_1="10" TOTAL_2="10" WEIGHT="4.32878934910781"/>
<CONT_DATA CI_END="0.7711305899067029" CI_START="0.04926402680540454" EFFECT_SIZE="0.4101973083560537" ESTIMABLE="YES" MEAN_1="6.31" MEAN_2="1.37" MODIFIED="2015-05-29 09:52:10 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="53" SD_1="11.76" SD_2="12.1" SE="0.18415301729911612" STUDY_ID="STD-Lo-2010" TOTAL_1="49" TOTAL_2="78" WEIGHT="10.846620593097475"/>
<CONT_DATA CI_END="0.624373679078866" CI_START="-1.1709634921881498" EFFECT_SIZE="-0.27329490655464184" ESTIMABLE="YES" MEAN_1="2.85" MEAN_2="3.2" MODIFIED="2015-05-29 09:52:10 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="1.21" SD_2="1.4" SE="0.45800259224873674" STUDY_ID="STD-Lum-2006" TOTAL_1="24" TOTAL_2="6" WEIGHT="4.557123904482848"/>
<CONT_DATA CI_END="1.4561515539012915" CI_START="0.07671920946610333" EFFECT_SIZE="0.7664353816836974" ESTIMABLE="YES" MEAN_1="32.6" MEAN_2="25.5" MODIFIED="2015-05-29 09:52:10 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="7.2" SD_2="10.5" SE="0.3519024725239786" STUDY_ID="STD-Masiero-2007" TOTAL_1="17" TOTAL_2="18" WEIGHT="6.35890147739755"/>
<CONT_DATA CI_END="1.5975928473079857" CI_START="-0.1799721623230024" EFFECT_SIZE="0.7088103424924916" ESTIMABLE="YES" MEAN_1="1.83" MEAN_2="1.0" MODIFIED="2015-05-29 09:52:10 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="80" SD_1="1.4" SD_2="0.7" SE="0.45346879423606606" STUDY_ID="STD-Masiero-2011" TOTAL_1="11" TOTAL_2="10" WEIGHT="4.620077943893043"/>
<CONT_DATA CI_END="0.37113285169722676" CI_START="-1.162162290668966" EFFECT_SIZE="-0.3955147194858696" ESTIMABLE="YES" MEAN_1="25.49" MEAN_2="28.29" MODIFIED="2015-05-29 09:52:10 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="113" SD_1="7.23" SD_2="6.72" SE="0.39115390753621726" STUDY_ID="STD-Rabadi-2008" TOTAL_1="10" TOTAL_2="20" WEIGHT="5.606530786582247"/>
<CONT_DATA CI_END="1.3400812297186222" CI_START="0.02105250408261261" EFFECT_SIZE="0.6805668669006174" ESTIMABLE="YES" MEAN_1="3.26" MEAN_2="-2.88" MODIFIED="2015-05-29 09:52:10 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="150" SD_1="7.16" SD_2="9.56" SE="0.33649310294483464" STUDY_ID="STD-Wu-2012" TOTAL_1="14" TOTAL_2="28" WEIGHT="6.6851862484575735"/>
<CONT_DATA CI_END="0.8952070323354057" CI_START="-0.7767025872918843" EFFECT_SIZE="0.05925222252176064" ESTIMABLE="YES" MEAN_1="0.4" MEAN_2="0.1" MODIFIED="2015-05-29 09:52:10 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="151" SD_1="6.1" SD_2="3.2" SE="0.4265153933478114" STUDY_ID="STD-Yoo-2013" TOTAL_1="11" TOTAL_2="11" WEIGHT="5.017948893463973"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="84.5198753869295" CI_END="0.4633128703148888" CI_START="0.23039141396599155" CI_STUDY="95" CI_TOTAL="95" DF="57" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.3468521421404402" ESTIMABLE="YES" I2="32.560241317139095" I2_Q="0.0" ID="CMP-002.02" MODIFIED="2015-06-02 11:16:55 +0100" MODIFIED_BY="Jan Mehrholz" NO="2" P_CHI2="0.010417095302075241" P_Q="0.859491602130398" P_Z="5.304942530888582E-9" Q="0.3028284839156873" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="29" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.06005337596470257" TOTALS="SUB" TOTAL_1="1061" TOTAL_2="1004" UNITS="" WEIGHT="300.0" Z="5.837312862560151">
<NAME>Arm function</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="27.694167743191514" CI_END="0.5207702952587683" CI_START="0.14639703483645627" DF="20" EFFECT_SIZE="0.3335836650476123" ESTIMABLE="YES" I2="27.7826285105935" ID="CMP-002.02.01" MODIFIED="2015-06-02 11:16:43 +0100" MODIFIED_BY="Jan Mehrholz" NO="1" P_CHI2="0.11683910613904691" P_Z="4.7792213763751394E-4" STUDIES="21" TAU2="0.04924496959477873" TOTAL_1="386" TOTAL_2="351" WEIGHT="100.0" Z="3.49283476382186">
<NAME>All studies with description of randomisation procedure</NAME>
<CONT_DATA CI_END="1.905225283130183" CI_START="0.0215555863225656" EFFECT_SIZE="0.9633904347263743" ESTIMABLE="YES" MEAN_1="2.75" MEAN_2="1.0" MODIFIED="2015-05-29 09:55:01 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="132" SD_1="1.8" SD_2="1.69" SE="0.4805368138562146" STUDY_ID="STD-Abdullah-2011" TOTAL_1="9" TOTAL_2="11" WEIGHT="3.2557152417648747"/>
<CONT_DATA CI_END="1.545723328739264" CI_START="-0.2943955854666359" EFFECT_SIZE="0.625663871636314" ESTIMABLE="YES" MEAN_1="7.3" MEAN_2="4.9" MODIFIED="2015-05-29 09:55:01 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="131" SD_1="3.5" SD_2="4.1" SE="0.4694267161847164" STUDY_ID="STD-Ang-2014" TOTAL_1="15" TOTAL_2="7" WEIGHT="3.3831655841268504"/>
<CONT_DATA CI_END="1.4324949099920308" CI_START="-0.8786487561458767" EFFECT_SIZE="0.276923076923077" ESTIMABLE="YES" MEAN_1="1.8" MEAN_2="1.2" MODIFIED="2015-05-29 09:55:01 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="119" SD_1="2.0" SD_2="2.0" SE="0.5895882996748699" STUDY_ID="STD-Brokaw-2014" TOTAL_1="7" TOTAL_2="5" WEIGHT="2.2983537423603204"/>
<CONT_DATA CI_END="0.3081496460411424" CI_START="-0.8280085735289184" EFFECT_SIZE="-0.259929463743888" ESTIMABLE="YES" MEAN_1="10.6" MEAN_2="14.0" MODIFIED="2015-05-29 09:55:01 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="73" SD_1="11.56" SD_2="15.27" SE="0.2898416064101003" STUDY_ID="STD-Burgar-2011" TOTAL_1="36" TOTAL_2="18" WEIGHT="6.8450411420344635"/>
<CONT_DATA CI_END="0.8561955186790654" CI_START="-0.202399634046594" EFFECT_SIZE="0.3268979423162357" ESTIMABLE="YES" MEAN_1="2.32" MEAN_2="1.19" MODIFIED="2015-05-29 09:55:01 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="67" SD_1="3.42" SD_2="3.4" SE="0.2700547461779203" STUDY_ID="STD-Conroy-2011" TOTAL_1="41" TOTAL_2="21" WEIGHT="7.465738491075852"/>
<CONT_DATA CI_END="1.8465189666165394" CI_START="0.5530841717988703" EFFECT_SIZE="1.1998015692077049" ESTIMABLE="YES" MEAN_1="20.5" MEAN_2="2.82" MODIFIED="2015-05-29 09:55:47 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="19.85" SD_2="4.98" SE="0.3299639189852767" STUDY_ID="STD-Hesse-2005" TOTAL_1="22" TOTAL_2="22" WEIGHT="5.768507816181234"/>
<CONT_DATA CI_END="0.2421653389643318" CI_START="-0.874040952640155" EFFECT_SIZE="-0.3159378068379116" ESTIMABLE="YES" MEAN_1="11.1" MEAN_2="14.6" MODIFIED="2015-05-29 09:55:47 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="133" SD_1="10.6" SD_2="11.2" SE="0.28475173534028675" STUDY_ID="STD-Hesse-2014" TOTAL_1="25" TOTAL_2="25" WEIGHT="6.998645652560347"/>
<CONT_DATA CI_END="1.0209936227256453" CI_START="-1.1608028334099776" EFFECT_SIZE="-0.06990460534216623" ESTIMABLE="YES" MEAN_1="3.4" MEAN_2="3.7" MODIFIED="2015-05-29 09:55:47 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="259" SD_1="3.9" SD_2="4.1" SE="0.5565909560954576" STUDY_ID="STD-Hollenstein-2011" TOTAL_1="7" TOTAL_2="6" WEIGHT="2.5404607836013215"/>
<CONT_DATA CI_END="1.1102258266122658" CI_START="-0.25169977451996944" EFFECT_SIZE="0.42926302604614813" ESTIMABLE="YES" MEAN_1="3.3" MEAN_2="2.2" MODIFIED="2015-05-29 09:55:47 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="61" SD_1="2.4" SD_2="2.6" SE="0.3474363845139325" STUDY_ID="STD-Housman-2009" TOTAL_1="17" TOTAL_2="17" WEIGHT="5.366787329359793"/>
<CONT_DATA CI_END="1.182490402424469" CI_START="-0.7830267711788745" EFFECT_SIZE="0.19973181562279718" ESTIMABLE="YES" MEAN_1="4.17" MEAN_2="2.83" MODIFIED="2015-05-29 09:55:47 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="58" SD_1="5.85" SD_2="7.44" SE="0.5014166558944685" STUDY_ID="STD-Hsieh-2011" TOTAL_1="12" TOTAL_2="6" WEIGHT="3.0336995706138583"/>
<CONT_DATA CI_END="1.256066852120378" CI_START="0.02633557977746892" EFFECT_SIZE="0.6412012159489234" ESTIMABLE="YES" MEAN_1="7.31" MEAN_2="3.81" MODIFIED="2015-06-02 11:16:43 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="819" SD_1="5.53" SD_2="5.02" SE="0.3137127217752143" STUDY_ID="STD-Hsieh-2014" TOTAL_1="32" TOTAL_2="16" WEIGHT="6.177158136945734"/>
<CONT_DATA CI_END="1.5411350448323422" CI_START="-0.564551119498822" EFFECT_SIZE="0.48829196266676017" ESTIMABLE="YES" MEAN_1="3.5" MEAN_2="1.3" MODIFIED="2015-05-29 09:55:47 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="140" SD_1="4.19" SD_2="4.32" SE="0.5371747085509091" STUDY_ID="STD-Hwang-2012" TOTAL_1="9" TOTAL_2="6" WEIGHT="2.700173807169991"/>
<CONT_DATA CI_END="0.9139431654975261" CI_START="0.008014735073424206" EFFECT_SIZE="0.46097895028547514" ESTIMABLE="YES" MEAN_1="3.25" MEAN_2="2.47" MODIFIED="2015-05-29 09:55:47 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="121" SD_1="1.68" SD_2="1.67" SE="0.23110843810650342" STUDY_ID="STD-Klamroth_x002d_Marganska-2014" TOTAL_1="39" TOTAL_2="38" WEIGHT="8.885232464202454"/>
<CONT_DATA CI_END="1.4768483449093637" CI_START="-0.2821758660975854" EFFECT_SIZE="0.5973362394058892" ESTIMABLE="YES" MEAN_1="26.47" MEAN_2="14.85" MODIFIED="2015-05-29 09:55:47 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="143" SD_1="17.54" SD_2="19.86" SE="0.44873891175600866" STUDY_ID="STD-Kutner-2010" TOTAL_1="11" TOTAL_2="10" WEIGHT="3.6395889233557392"/>
<CONT_DATA CI_END="1.6055435530865014" CI_START="-0.21249276415684137" EFFECT_SIZE="0.6965253944648301" ESTIMABLE="YES" MEAN_1="6.3" MEAN_2="1.3" MODIFIED="2015-05-29 09:55:47 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="51" SD_1="5.64" SD_2="7.92" SE="0.4637932971176464" STUDY_ID="STD-Liao-2011" TOTAL_1="10" TOTAL_2="10" WEIGHT="3.4504479679357463"/>
<CONT_DATA CI_END="0.936564544371069" CI_START="0.2078479042559952" EFFECT_SIZE="0.5722062243135321" ESTIMABLE="YES" MEAN_1="3.87" MEAN_2="-0.03" MODIFIED="2015-05-29 09:55:47 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="54" SD_1="7.35" SD_2="6.39" SE="0.18590051803581534" STUDY_ID="STD-Lo-2010" TOTAL_1="49" TOTAL_2="78" WEIGHT="10.884008341938648"/>
<CONT_DATA CI_END="0.6809447060792966" CI_START="-1.0359319244142693" EFFECT_SIZE="-0.17749360916748635" ESTIMABLE="YES" MEAN_1="12.16" MEAN_2="13.87" MODIFIED="2015-05-29 09:55:58 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="82" SD_1="8.3" SD_2="10.2" SE="0.437986780378637" STUDY_ID="STD-Masiero-2011" TOTAL_1="11" TOTAL_2="10" WEIGHT="3.7835283303086262"/>
<CONT_DATA CI_END="2.133932848002897" CI_START="-0.7883144554155647" EFFECT_SIZE="0.6728091962936661" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="1.25" MODIFIED="2015-05-29 09:55:58 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="112" SD_1="2.94" SD_2="1.26" SE="0.7454849493329406" STUDY_ID="STD-Mayr-2008" TOTAL_1="4" TOTAL_2="4" WEIGHT="1.5076595353934108"/>
<CONT_DATA CI_END="0.6496554439606558" CI_START="-0.8697010151771357" EFFECT_SIZE="-0.11002278560824001" ESTIMABLE="YES" MEAN_1="3.05" MEAN_2="3.88" MODIFIED="2015-05-29 09:56:13 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="115" SD_1="8.12" SD_2="6.94" SE="0.3875980556587471" STUDY_ID="STD-Rabadi-2008" TOTAL_1="10" TOTAL_2="20" WEIGHT="4.5725678440727435"/>
<CONT_DATA CI_END="0.7987435476676239" CI_START="-1.0038276049828765" EFFECT_SIZE="-0.10254202865762635" ESTIMABLE="YES" MEAN_1="5.11" MEAN_2="5.7" MODIFIED="2015-05-29 09:56:21 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="149" SD_1="6.55" SD_2="4.35" SE="0.4598480295732349" STUDY_ID="STD-Susanto-2015" TOTAL_1="9" TOTAL_2="10" WEIGHT="3.4986766771587985"/>
<CONT_DATA CI_END="0.7610269452232925" CI_START="-0.9111528257790966" EFFECT_SIZE="-0.07506294027790202" ESTIMABLE="YES" MEAN_1="1.6" MEAN_2="3.5" MODIFIED="2015-05-29 09:56:21 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="145" SD_1="10.8" SD_2="32.7" SE="0.42658431078130254" STUDY_ID="STD-Timmermans-2014" TOTAL_1="11" TOTAL_2="11" WEIGHT="3.9448426178391793"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="11.368950321601726" CI_END="0.6911001333774396" CI_START="0.14201553453110366" DF="8" EFFECT_SIZE="0.41655783395427165" ESTIMABLE="YES" I2="29.632905644776258" ID="CMP-002.02.02" MODIFIED="2015-06-02 11:16:50 +0100" MODIFIED_BY="Jan Mehrholz" NO="2" P_CHI2="0.18165746460859578" P_Z="0.0029412114422421053" STUDIES="9" TAU2="0.05110281483072149" TOTAL_1="167" TOTAL_2="168" WEIGHT="99.99999999999999" Z="2.973816252518395">
<NAME>All studies with adequate concealed allocation</NAME>
<CONT_DATA CI_END="1.8465189666165394" CI_START="0.5530841717988703" EFFECT_SIZE="1.1998015692077049" ESTIMABLE="YES" MEAN_1="20.5" MEAN_2="2.82" ORDER="1" SD_1="19.85" SD_2="4.98" SE="0.3299639189852767" STUDY_ID="STD-Hesse-2005" TOTAL_1="22" TOTAL_2="22" WEIGHT="12.264768819529419"/>
<CONT_DATA CI_END="1.1102258266122658" CI_START="-0.25169977451996944" EFFECT_SIZE="0.42926302604614813" ESTIMABLE="YES" MEAN_1="3.3" MEAN_2="2.2" MODIFIED="2011-10-26 12:15:09 +0100" MODIFIED_BY="[Empty name]" ORDER="104" SD_1="2.4" SD_2="2.6" SE="0.3474363845139325" STUDY_ID="STD-Housman-2009" TOTAL_1="17" TOTAL_2="17" WEIGHT="11.419882587610827"/>
<CONT_DATA CI_END="1.182490402424469" CI_START="-0.7830267711788745" EFFECT_SIZE="0.19973181562279718" ESTIMABLE="YES" MEAN_1="4.17" MEAN_2="2.83" MODIFIED="2011-10-26 12:15:06 +0100" MODIFIED_BY="[Empty name]" ORDER="103" SD_1="5.85" SD_2="7.44" SE="0.5014166558944685" STUDY_ID="STD-Hsieh-2011" TOTAL_1="12" TOTAL_2="6" WEIGHT="6.485838621941786"/>
<CONT_DATA CI_END="1.256066852120378" CI_START="0.02633557977746892" EFFECT_SIZE="0.6412012159489234" ESTIMABLE="YES" MEAN_1="7.31" MEAN_2="3.81" MODIFIED="2015-06-02 11:16:50 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="819" SD_1="5.53" SD_2="5.02" SE="0.3137127217752143" STUDY_ID="STD-Hsieh-2014" TOTAL_1="32" TOTAL_2="16" WEIGHT="13.122828673602253"/>
<CONT_DATA CI_END="0.9139431654975261" CI_START="0.008014735073424206" EFFECT_SIZE="0.46097895028547514" ESTIMABLE="YES" MEAN_1="3.25" MEAN_2="2.47" MODIFIED="2015-05-29 09:59:16 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="121" SD_1="1.68" SD_2="1.67" SE="0.23110843810650342" STUDY_ID="STD-Klamroth_x002d_Marganska-2014" TOTAL_1="39" TOTAL_2="38" WEIGHT="18.77362737776081"/>
<CONT_DATA CI_END="1.6055435530865014" CI_START="-0.21249276415684137" EFFECT_SIZE="0.6965253944648301" ESTIMABLE="YES" MEAN_1="6.3" MEAN_2="1.3" MODIFIED="2011-10-26 12:15:17 +0100" MODIFIED_BY="[Empty name]" ORDER="105" SD_1="5.64" SD_2="7.92" SE="0.4637932971176464" STUDY_ID="STD-Liao-2011" TOTAL_1="10" TOTAL_2="10" WEIGHT="7.370599604248276"/>
<CONT_DATA CI_END="0.6496554439606558" CI_START="-0.8697010151771357" EFFECT_SIZE="-0.11002278560824001" ESTIMABLE="YES" MEAN_1="3.05" MEAN_2="3.88" MODIFIED="2015-05-29 09:59:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="115" SD_1="8.12" SD_2="6.94" SE="0.3875980556587471" STUDY_ID="STD-Rabadi-2008" TOTAL_1="10" TOTAL_2="20" WEIGHT="9.745473092250512"/>
<CONT_DATA CI_END="0.7610269452232925" CI_START="-0.9111528257790966" EFFECT_SIZE="-0.07506294027790202" ESTIMABLE="YES" MEAN_1="1.6" MEAN_2="3.5" MODIFIED="2015-05-29 09:59:44 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="145" SD_1="10.8" SD_2="32.7" SE="0.42658431078130254" STUDY_ID="STD-Timmermans-2014" TOTAL_1="11" TOTAL_2="11" WEIGHT="8.418271969953997"/>
<CONT_DATA CI_END="0.6612941275915234" CI_START="-0.6218341101810183" EFFECT_SIZE="0.01973000870525251" ESTIMABLE="YES" MEAN_1="3.85" MEAN_2="3.71" MODIFIED="2015-05-29 09:59:44 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="150" SD_1="6.71" SD_2="7.08" SE="0.3273346469357839" STUDY_ID="STD-Wu-2012" TOTAL_1="14" TOTAL_2="28" WEIGHT="12.398709253102115"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="44.99251251412514" CI_END="0.5067356336194915" CI_START="0.15275289808566636" DF="27" EFFECT_SIZE="0.32974426585257893" ESTIMABLE="YES" I2="39.99001502411427" ID="CMP-002.02.03" MODIFIED="2015-06-02 11:16:55 +0100" MODIFIED_BY="Jan Mehrholz" NO="3" P_CHI2="0.01629016572089248" P_Z="2.60696429837797E-4" STUDIES="28" TAU2="0.08454729965773129" TOTAL_1="508" TOTAL_2="485" WEIGHT="99.99999999999999" Z="3.651516417629916">
<NAME>All studies with blinded assessors</NAME>
<CONT_DATA CI_END="1.905225283130183" CI_START="0.0215555863225656" EFFECT_SIZE="0.9633904347263743" ESTIMABLE="YES" MEAN_1="2.75" MEAN_2="1.0" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="132" SD_1="1.8" SD_2="1.69" SE="0.4805368138562146" STUDY_ID="STD-Abdullah-2011" TOTAL_1="9" TOTAL_2="11" WEIGHT="2.584994702051691"/>
<CONT_DATA CI_END="1.545723328739264" CI_START="-0.2943955854666359" EFFECT_SIZE="0.625663871636314" ESTIMABLE="YES" MEAN_1="7.3" MEAN_2="4.9" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="131" SD_1="3.5" SD_2="4.1" SE="0.4694267161847164" STUDY_ID="STD-Ang-2014" TOTAL_1="15" TOTAL_2="7" WEIGHT="2.6744723565853015"/>
<CONT_DATA CI_END="1.4324949099920308" CI_START="-0.8786487561458767" EFFECT_SIZE="0.276923076923077" ESTIMABLE="YES" MEAN_1="1.8" MEAN_2="1.2" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="119" SD_1="2.0" SD_2="2.0" SE="0.5895882996748699" STUDY_ID="STD-Brokaw-2014" TOTAL_1="7" TOTAL_2="5" WEIGHT="1.8869559027112488"/>
<CONT_DATA CI_END="0.3081496460411424" CI_START="-0.8280085735289184" EFFECT_SIZE="-0.259929463743888" ESTIMABLE="YES" MEAN_1="10.6" MEAN_2="14.0" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="73" SD_1="11.56" SD_2="15.27" SE="0.2898416064101003" STUDY_ID="STD-Burgar-2011" TOTAL_1="36" TOTAL_2="18" WEIGHT="4.83799229997211"/>
<CONT_DATA CI_END="0.8561955186790654" CI_START="-0.202399634046594" EFFECT_SIZE="0.3268979423162357" ESTIMABLE="YES" MEAN_1="2.32" MEAN_2="1.19" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="67" SD_1="3.42" SD_2="3.4" SE="0.2700547461779203" STUDY_ID="STD-Conroy-2011" TOTAL_1="41" TOTAL_2="21" WEIGHT="5.17834792705287"/>
<CONT_DATA CI_END="0.9310498700010024" CI_START="-1.2548880687588093" EFFECT_SIZE="-0.16191909937890353" ESTIMABLE="YES" MEAN_1="8.17" MEAN_2="9.5" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="7.31" SD_2="8.02" SE="0.5576474761786979" STUDY_ID="STD-Daly-2005" TOTAL_1="7" TOTAL_2="6" WEIGHT="2.0617771766277584"/>
<CONT_DATA CI_END="2.6623609248578424" CI_START="0.9302855392658632" EFFECT_SIZE="1.7963232320618527" ESTIMABLE="YES" MEAN_1="5.53" MEAN_2="2.6" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="1.38" SD_2="1.77" SE="0.44186408506849323" STUDY_ID="STD-Fazekas-2007" TOTAL_1="15" TOTAL_2="15" WEIGHT="2.914566612095389"/>
<CONT_DATA CI_END="1.8465189666165394" CI_START="0.5530841717988703" EFFECT_SIZE="1.1998015692077049" ESTIMABLE="YES" MEAN_1="20.5" MEAN_2="2.82" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="19.85" SD_2="4.98" SE="0.3299639189852767" STUDY_ID="STD-Hesse-2005" TOTAL_1="22" TOTAL_2="22" WEIGHT="4.215982304292121"/>
<CONT_DATA CI_END="0.2421653389643318" CI_START="-0.874040952640155" EFFECT_SIZE="-0.3159378068379116" ESTIMABLE="YES" MEAN_1="11.1" MEAN_2="14.6" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="133" SD_1="10.6" SD_2="11.2" SE="0.28475173534028675" STUDY_ID="STD-Hesse-2014" TOTAL_1="25" TOTAL_2="25" WEIGHT="4.9234185439486655"/>
<CONT_DATA CI_END="1.0209936227256453" CI_START="-1.1608028334099776" EFFECT_SIZE="-0.06990460534216623" ESTIMABLE="YES" MEAN_1="3.4" MEAN_2="3.7" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="259" SD_1="3.9" SD_2="4.1" SE="0.5565909560954576" STUDY_ID="STD-Hollenstein-2011" TOTAL_1="7" TOTAL_2="6" WEIGHT="2.067932146257145"/>
<CONT_DATA CI_END="1.1102258266122658" CI_START="-0.25169977451996944" EFFECT_SIZE="0.42926302604614813" ESTIMABLE="YES" MEAN_1="3.3" MEAN_2="2.2" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="61" SD_1="2.4" SD_2="2.6" SE="0.3474363845139325" STUDY_ID="STD-Housman-2009" TOTAL_1="17" TOTAL_2="17" WEIGHT="3.9728764437703994"/>
<CONT_DATA CI_END="1.182490402424469" CI_START="-0.7830267711788745" EFFECT_SIZE="0.19973181562279718" ESTIMABLE="YES" MEAN_1="4.17" MEAN_2="2.83" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="58" SD_1="5.85" SD_2="7.44" SE="0.5014166558944685" STUDY_ID="STD-Hsieh-2011" TOTAL_1="12" TOTAL_2="6" WEIGHT="2.42723993378918"/>
<CONT_DATA CI_END="1.256066852120378" CI_START="0.02633557977746892" EFFECT_SIZE="0.6412012159489234" ESTIMABLE="YES" MEAN_1="7.31" MEAN_2="3.81" MODIFIED="2015-06-02 11:16:55 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="819" SD_1="5.53" SD_2="5.02" SE="0.3137127217752143" STUDY_ID="STD-Hsieh-2014" TOTAL_1="32" TOTAL_2="16" WEIGHT="4.457022062871231"/>
<CONT_DATA CI_END="1.5411350448323422" CI_START="-0.564551119498822" EFFECT_SIZE="0.48829196266676017" ESTIMABLE="YES" MEAN_1="3.5" MEAN_2="1.3" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="140" SD_1="4.19" SD_2="4.32" SE="0.5371747085509091" STUDY_ID="STD-Hwang-2012" TOTAL_1="9" TOTAL_2="6" WEIGHT="2.18563744226334"/>
<CONT_DATA CI_END="0.9139431654975261" CI_START="0.008014735073424206" EFFECT_SIZE="0.46097895028547514" ESTIMABLE="YES" MEAN_1="3.25" MEAN_2="2.47" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="121" SD_1="1.68" SD_2="1.67" SE="0.23110843810650342" STUDY_ID="STD-Klamroth_x002d_Marganska-2014" TOTAL_1="39" TOTAL_2="38" WEIGHT="5.910984343363132"/>
<CONT_DATA CI_END="1.4768483449093637" CI_START="-0.2821758660975854" EFFECT_SIZE="0.5973362394058892" ESTIMABLE="YES" MEAN_1="26.47" MEAN_2="14.85" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="143" SD_1="17.54" SD_2="19.86" SE="0.44873891175600866" STUDY_ID="STD-Kutner-2010" TOTAL_1="11" TOTAL_2="10" WEIGHT="2.8521522399263435"/>
<CONT_DATA CI_END="1.6055435530865014" CI_START="-0.21249276415684137" EFFECT_SIZE="0.6965253944648301" ESTIMABLE="YES" MEAN_1="6.3" MEAN_2="1.3" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="51" SD_1="5.64" SD_2="7.92" SE="0.4637932971176464" STUDY_ID="STD-Liao-2011" TOTAL_1="10" TOTAL_2="10" WEIGHT="2.721394487677889"/>
<CONT_DATA CI_END="0.936564544371069" CI_START="0.2078479042559952" EFFECT_SIZE="0.5722062243135321" ESTIMABLE="YES" MEAN_1="3.87" MEAN_2="-0.03" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="54" SD_1="7.35" SD_2="6.39" SE="0.18590051803581534" STUDY_ID="STD-Lo-2010" TOTAL_1="49" TOTAL_2="78" WEIGHT="6.84657306114786"/>
<CONT_DATA CI_END="1.1372647343252518" CI_START="-0.6566802193014193" EFFECT_SIZE="0.24029225751191627" ESTIMABLE="YES" MEAN_1="6.98" MEAN_2="6.5" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="1.8" SD_2="2.5" SE="0.4576474281612009" STUDY_ID="STD-Lum-2006" TOTAL_1="24" TOTAL_2="6" WEIGHT="2.773816284681847"/>
<CONT_DATA CI_END="1.1942660946499475" CI_START="-0.15634433909086787" EFFECT_SIZE="0.5189608777795398" ESTIMABLE="YES" MEAN_1="15.8" MEAN_2="10.3" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="8.1" SD_2="12.1" SE="0.3445498091787038" STUDY_ID="STD-Masiero-2007" TOTAL_1="17" TOTAL_2="18" WEIGHT="4.011918210889929"/>
<CONT_DATA CI_END="0.6809447060792966" CI_START="-1.0359319244142693" EFFECT_SIZE="-0.17749360916748635" ESTIMABLE="YES" MEAN_1="12.16" MEAN_2="13.87" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="82" SD_1="8.3" SD_2="10.2" SE="0.437986780378637" STUDY_ID="STD-Masiero-2011" TOTAL_1="11" TOTAL_2="10" WEIGHT="2.950542109716567"/>
<CONT_DATA CI_END="0.33268540893651005" CI_START="-1.0372739184578856" EFFECT_SIZE="-0.3522942547606878" ESTIMABLE="YES" MEAN_1="7.7" MEAN_2="9.35" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="127" SD_1="3.84" SD_2="4.87" SE="0.3494858421380342" STUDY_ID="STD-McCabe-2015" TOTAL_1="12" TOTAL_2="27" WEIGHT="3.945421928367545"/>
<CONT_DATA CI_END="0.6496554439606558" CI_START="-0.8697010151771357" EFFECT_SIZE="-0.11002278560824001" ESTIMABLE="YES" MEAN_1="3.05" MEAN_2="3.88" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="115" SD_1="8.12" SD_2="6.94" SE="0.3875980556587471" STUDY_ID="STD-Rabadi-2008" TOTAL_1="10" TOTAL_2="20" WEIGHT="3.4733433645616962"/>
<CONT_DATA CI_END="1.0818176867387777" CI_START="-0.015723027078641483" EFFECT_SIZE="0.5330473298300681" ESTIMABLE="YES" MEAN_1="8.65" MEAN_2="3.63" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="125" SD_1="7.52" SD_2="10.7" SE="0.2799900208561688" STUDY_ID="STD-Sale-2014" TOTAL_1="26" TOTAL_2="27" WEIGHT="5.0046731024311155"/>
<CONT_DATA CI_END="0.7987435476676239" CI_START="-1.0038276049828765" EFFECT_SIZE="-0.10254202865762635" ESTIMABLE="YES" MEAN_1="5.11" MEAN_2="5.7" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="149" SD_1="6.55" SD_2="4.35" SE="0.4598480295732349" STUDY_ID="STD-Susanto-2015" TOTAL_1="9" TOTAL_2="10" WEIGHT="2.7548963220614286"/>
<CONT_DATA CI_END="0.7610269452232925" CI_START="-0.9111528257790966" EFFECT_SIZE="-0.07506294027790202" ESTIMABLE="YES" MEAN_1="1.6" MEAN_2="3.5" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="145" SD_1="10.8" SD_2="32.7" SE="0.42658431078130254" STUDY_ID="STD-Timmermans-2014" TOTAL_1="11" TOTAL_2="11" WEIGHT="3.0596784141769633"/>
<CONT_DATA CI_END="0.6612941275915234" CI_START="-0.6218341101810183" EFFECT_SIZE="0.01973000870525251" ESTIMABLE="YES" MEAN_1="3.85" MEAN_2="3.71" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="150" SD_1="6.71" SD_2="7.08" SE="0.3273346469357839" STUDY_ID="STD-Wu-2012" TOTAL_1="14" TOTAL_2="28" WEIGHT="4.253991229590222"/>
<CONT_DATA CI_END="1.0159481183404653" CI_START="-0.6595509237771858" EFFECT_SIZE="0.17819859728163975" ESTIMABLE="YES" MEAN_1="1.7" MEAN_2="0.3" MODIFIED="2015-05-29 10:00:30 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="151" SD_1="9.94" SD_2="3.93" SE="0.42743107917639656" STUDY_ID="STD-Yoo-2013" TOTAL_1="11" TOTAL_2="11" WEIGHT="3.051399047119004"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser" NO="3">
<NAME>Subgroup analysis by treatment approach</NAME>
<CONT_OUTCOME CHI2="44.25906028687777" CI_END="0.6509045718983636" CI_START="0.19442318017726637" CI_STUDY="95" CI_TOTAL="95" DF="17" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.42266387603781497" ESTIMABLE="YES" I2="61.58978548164007" I2_Q="0.0" ID="CMP-003.01" MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser" NO="1" P_CHI2="3.1363488733560096E-4" P_Q="0.4723066865083453" P_Z="2.8394003709632725E-4" Q="0.516574383043507" RANDOM="YES" SCALE="1.2" SORT_BY="STUDY" STUDIES="18" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.18562939192331754" TOTALS="SUB" TOTAL_1="366" TOTAL_2="351" UNITS="" WEIGHT="200.0" Z="3.6295279046395925">
<NAME>Activities of daily living at the end of intervention phase: subgroup analysis comparing different device groups</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours [control]</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours [treatment]</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.9636373549493586" CI_END="0.7815036120459787" CI_START="0.19743725689596303" DF="5" EFFECT_SIZE="0.4894704344709709" ESTIMABLE="YES" I2="0.0" ID="CMP-003.01.01" MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser" NO="1" P_CHI2="0.5546631741874812" P_Z="0.0010196324300613057" STUDIES="6" TAU2="0.0" TOTAL_1="94" TOTAL_2="101" WEIGHT="100.0" Z="3.285052852646754">
<NAME>distal training (finger, hand and radio-ulnar joints)</NAME>
<CONT_DATA CI_END="0.9453307469415558" CI_START="-0.24643832635851426" EFFECT_SIZE="0.3494462102915208" ESTIMABLE="YES" MEAN_1="22.45" MEAN_2="17.27" MODIFIED="2015-08-25 12:35:55 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="15.14" SD_2="13.95" SE="0.30402830937216" STUDY_ID="STD-Hesse-2005" TOTAL_1="22" TOTAL_2="22" WEIGHT="24.01818341063187"/>
<CONT_DATA CI_END="1.2389432899259827" CI_START="0.09714309978213664" EFFECT_SIZE="0.6680431948540597" ESTIMABLE="YES" MEAN_1="25.2" MEAN_2="16.0" MODIFIED="2015-08-25 12:35:55 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="135" SD_1="11.0" SD_2="15.7" SE="0.29128091106525944" STUDY_ID="STD-Hesse-2014" TOTAL_1="25" TOTAL_2="25" WEIGHT="26.166410919094936"/>
<CONT_DATA CI_END="1.265099905567385" CI_START="-0.7057379833459232" EFFECT_SIZE="0.2796809611107309" ESTIMABLE="YES" MEAN_1="0.13" MEAN_2="0.06" MODIFIED="2015-08-25 12:35:55 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="57" SD_1="0.19" SD_2="0.32" SE="0.502774006170273" STUDY_ID="STD-Hsieh-2011" TOTAL_1="12" TOTAL_2="6" WEIGHT="8.782589283214229"/>
<CONT_DATA CI_END="0.7134875883073168" CI_START="-1.001985630241621" EFFECT_SIZE="-0.14424902096715214" ESTIMABLE="YES" MEAN_1="6.89" MEAN_2="8.49" MODIFIED="2015-08-25 12:36:23 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="142" SD_1="9.995" SD_2="11.33" SE="0.43762876054875793" STUDY_ID="STD-Kutner-2010" TOTAL_1="11" TOTAL_2="10" WEIGHT="11.591949875586089"/>
<CONT_DATA CI_END="1.84094759135064" CI_START="-0.021588700935392335" EFFECT_SIZE="0.9096794452076238" ESTIMABLE="YES" MEAN_1="0.25" MEAN_2="0.03" MODIFIED="2015-08-25 12:36:02 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="49" SD_1="0.17" SD_2="0.28" SE="0.47514554016744204" STUDY_ID="STD-Liao-2011" TOTAL_1="10" TOTAL_2="10" WEIGHT="9.833653275992624"/>
<CONT_DATA CI_END="1.3400812297186222" CI_START="0.02105250408261261" EFFECT_SIZE="0.6805668669006174" ESTIMABLE="YES" MEAN_1="3.26" MEAN_2="-2.88" MODIFIED="2015-08-25 12:36:06 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="150" SD_1="7.16" SD_2="9.56" SE="0.33649310294483464" STUDY_ID="STD-Wu-2012" TOTAL_1="14" TOTAL_2="28" WEIGHT="19.607213235480252"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="40.0016940889321" CI_END="0.6836734278748806" CI_START="-0.048062728328167326" DF="11" EFFECT_SIZE="0.3178053497733566" ESTIMABLE="YES" I2="72.50116463681586" ID="CMP-003.01.02" MODIFIED="2015-08-31 10:28:01 +0100" MODIFIED_BY="Hazel Fraser" NO="2" P_CHI2="3.5751416925022816E-5" P_Z="0.08866340028063771" STUDIES="12" TAU2="0.28910586345987616" TOTAL_1="272" TOTAL_2="250" WEIGHT="99.99999999999999" Z="1.7024908072933602">
<NAME>proximal training (shoulder and elbow joints)</NAME>
<CONT_DATA CI_END="1.0380024373648842" CI_START="-0.10814800700190896" EFFECT_SIZE="0.4649272151814876" ESTIMABLE="YES" MEAN_1="19.6" MEAN_2="15.9" MODIFIED="2015-08-25 12:34:12 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="74" SD_1="8.47" SD_2="6.36" SE="0.29239069018805486" STUDY_ID="STD-Burgar-2011" TOTAL_1="36" TOTAL_2="18" WEIGHT="9.302232584767902"/>
<CONT_DATA CI_END="1.1507506471231492" CI_START="0.07547143196899198" EFFECT_SIZE="0.6131110395460706" ESTIMABLE="YES" MEAN_1="3.98" MEAN_2="-3.19" MODIFIED="2015-08-25 12:34:12 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="62" SD_1="11.94" SD_2="10.72" SE="0.2743109627615156" STUDY_ID="STD-Conroy-2011" TOTAL_1="41" TOTAL_2="21" WEIGHT="9.563817054256953"/>
<CONT_DATA CI_END="-0.3120300825451786" CI_START="-1.860101658277956" EFFECT_SIZE="-1.0860658704115673" ESTIMABLE="YES" MEAN_1="12.07" MEAN_2="25.53" MODIFIED="2015-08-25 12:34:12 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="9.26" SD_2="14.32" SE="0.39492347511070824" STUDY_ID="STD-Fazekas-2007" TOTAL_1="15" TOTAL_2="15" WEIGHT="7.82932154942235"/>
<CONT_DATA CI_END="0.9520381577866032" CI_START="-0.3997153806708117" EFFECT_SIZE="0.27616138855789574" ESTIMABLE="YES" MEAN_1="0.2" MEAN_2="0.1" MODIFIED="2015-08-25 12:34:12 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="60" SD_1="0.4" SD_2="0.3" SE="0.3448414228832454" STUDY_ID="STD-Housman-2009" TOTAL_1="17" TOTAL_2="17" WEIGHT="8.540235358384644"/>
<CONT_DATA CI_END="0.7711305899067029" CI_START="0.04926402680540454" EFFECT_SIZE="0.4101973083560537" ESTIMABLE="YES" MEAN_1="6.31" MEAN_2="1.37" MODIFIED="2015-08-25 12:34:12 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="53" SD_1="11.76" SD_2="12.1" SE="0.18415301729911612" STUDY_ID="STD-Lo-2010" TOTAL_1="49" TOTAL_2="78" WEIGHT="10.787625645327006"/>
<CONT_DATA CI_END="0.624373679078866" CI_START="-1.1709634921881498" EFFECT_SIZE="-0.27329490655464184" ESTIMABLE="YES" MEAN_1="2.85" MEAN_2="3.2" MODIFIED="2015-08-25 12:34:12 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="1.21" SD_2="1.4" SE="0.45800259224873674" STUDY_ID="STD-Lum-2006" TOTAL_1="24" TOTAL_2="6" WEIGHT="6.984953507656574"/>
<CONT_DATA CI_END="1.4561515539012915" CI_START="0.07671920946610333" EFFECT_SIZE="0.7664353816836974" ESTIMABLE="YES" MEAN_1="32.6" MEAN_2="25.5" MODIFIED="2015-08-25 12:34:12 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="7.2" SD_2="10.5" SE="0.3519024725239786" STUDY_ID="STD-Masiero-2007" TOTAL_1="17" TOTAL_2="18" WEIGHT="8.438487788221094"/>
<CONT_DATA CI_END="1.5975928473079857" CI_START="-0.1799721623230024" EFFECT_SIZE="0.7088103424924916" ESTIMABLE="YES" MEAN_1="1.83" MEAN_2="1.0" MODIFIED="2015-08-25 12:34:12 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="80" SD_1="1.4" SD_2="0.7" SE="0.45346879423606606" STUDY_ID="STD-Masiero-2011" TOTAL_1="11" TOTAL_2="10" WEIGHT="7.043296925672423"/>
<CONT_DATA CI_END="0.37113285169722676" CI_START="-1.162162290668966" EFFECT_SIZE="-0.3955147194858696" ESTIMABLE="YES" MEAN_1="25.49" MEAN_2="28.29" MODIFIED="2015-08-25 12:34:12 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="113" SD_1="7.23" SD_2="6.72" SE="0.39115390753621726" STUDY_ID="STD-Rabadi-2008" TOTAL_1="10" TOTAL_2="20" WEIGHT="7.8817966565445134"/>
<CONT_DATA CI_END="2.285499037956927" CI_START="1.0547178671309285" EFFECT_SIZE="1.6701084525439278" ESTIMABLE="YES" MEAN_1="9.1" MEAN_2="4.4" MODIFIED="2015-08-25 12:34:12 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="3.3" SD_2="2.0" SE="0.31398055794245294" STUDY_ID="STD-Volpe-2000" TOTAL_1="30" TOTAL_2="26" WEIGHT="8.988115495151366"/>
<CONT_DATA CI_END="1.0561774100325412" CI_START="-0.6616701356394454" EFFECT_SIZE="0.19725363719654784" ESTIMABLE="YES" MEAN_1="67.1" MEAN_2="65.5" MODIFIED="2015-08-25 12:34:12 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="7.96" SD_2="7.59" SE="0.43823446737341826" STUDY_ID="STD-Volpe-2008" TOTAL_1="11" TOTAL_2="10" WEIGHT="7.242150928417791"/>
<CONT_DATA CI_END="0.8952070323354057" CI_START="-0.7767025872918843" EFFECT_SIZE="0.05925222252176064" ESTIMABLE="YES" MEAN_1="0.4" MEAN_2="0.1" MODIFIED="2015-08-25 12:34:12 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="151" SD_1="6.1" SD_2="3.2" SE="0.4265153933478114" STUDY_ID="STD-Yoo-2013" TOTAL_1="11" TOTAL_2="11" WEIGHT="7.397966506177387"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="46.806977242071795" CI_END="0.5109469004927698" CI_START="0.17870663080307367" CI_STUDY="95" CI_TOTAL="95" DF="30" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.34482676564792175" ESTIMABLE="YES" I2="35.906991291386106" I2_Q="0.0" ID="CMP-003.02" MODIFIED="2015-08-26 09:35:25 +0100" MODIFIED_BY="Jan Mehrholz" NO="2" P_CHI2="0.025984424715987275" P_Q="0.7495906916529032" P_Z="4.733109608076004E-5" Q="0.10187533216959505" RANDOM="YES" SCALE="1.23" SORT_BY="STUDY" STUDIES="31" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.07210376119254663" TOTALS="SUB" TOTAL_1="553" TOTAL_2="525" UNITS="" WEIGHT="200.0" Z="4.0684294062642365">
<NAME>Arm function at the end of intervention phase: subgroup analysis comparing different device groups</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours [control]</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours [treatment]</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="16.288200186687618" CI_END="0.722131439187649" CI_START="0.06066733201822522" DF="9" EFFECT_SIZE="0.39139938560293713" ESTIMABLE="YES" I2="44.74527635437757" ID="CMP-003.02.01" MODIFIED="2015-08-25 12:55:19 +0100" MODIFIED_BY="Jan Mehrholz" NO="1" P_CHI2="0.061101810482784735" P_Z="0.020368645111905875" STUDIES="10" TAU2="0.12298763544778386" TOTAL_1="159" TOTAL_2="140" WEIGHT="100.0" Z="2.3194870017531386">
<NAME>distal training (finger, hand and radio-ulnar joints)</NAME>
<CONT_DATA CI_END="1.545723328739264" CI_START="-0.2943955854666359" EFFECT_SIZE="0.625663871636314" ESTIMABLE="YES" MEAN_1="7.3" MEAN_2="4.9" MODIFIED="2015-08-25 12:54:51 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="131" SD_1="3.5" SD_2="4.1" SE="0.4694267161847164" STUDY_ID="STD-Ang-2014" TOTAL_1="15" TOTAL_2="7" WEIGHT="8.293168860660817"/>
<CONT_DATA CI_END="1.8465189666165394" CI_START="0.5530841717988703" EFFECT_SIZE="1.1998015692077049" ESTIMABLE="YES" MEAN_1="20.5" MEAN_2="2.82" MODIFIED="2015-08-25 12:54:57 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="19.85" SD_2="4.98" SE="0.3299639189852767" STUDY_ID="STD-Hesse-2005" TOTAL_1="22" TOTAL_2="22" WEIGHT="12.28070785710351"/>
<CONT_DATA CI_END="0.2421653389643318" CI_START="-0.874040952640155" EFFECT_SIZE="-0.3159378068379116" ESTIMABLE="YES" MEAN_1="11.1" MEAN_2="14.6" MODIFIED="2015-08-25 12:54:57 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="133" SD_1="10.6" SD_2="11.2" SE="0.28475173534028675" STUDY_ID="STD-Hesse-2014" TOTAL_1="25" TOTAL_2="25" WEIGHT="13.953228424727165"/>
<CONT_DATA CI_END="1.182490402424469" CI_START="-0.7830267711788745" EFFECT_SIZE="0.19973181562279718" ESTIMABLE="YES" MEAN_1="4.17" MEAN_2="2.83" MODIFIED="2015-08-25 12:55:04 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="58" SD_1="5.85" SD_2="7.44" SE="0.5014166558944685" STUDY_ID="STD-Hsieh-2011" TOTAL_1="12" TOTAL_2="6" WEIGHT="7.605245663851849"/>
<CONT_DATA CI_END="1.256066852120378" CI_START="0.02633557977746892" EFFECT_SIZE="0.6412012159489234" ESTIMABLE="YES" MEAN_1="7.31" MEAN_2="3.81" MODIFIED="2015-08-25 12:55:04 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="819" SD_1="5.53" SD_2="5.02" SE="0.3137127217752143" STUDY_ID="STD-Hsieh-2014" TOTAL_1="32" TOTAL_2="16" WEIGHT="12.860927470692232"/>
<CONT_DATA CI_END="1.5411350448323422" CI_START="-0.564551119498822" EFFECT_SIZE="0.48829196266676017" ESTIMABLE="YES" MEAN_1="3.5" MEAN_2="1.3" MODIFIED="2015-08-25 12:55:04 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="140" SD_1="4.19" SD_2="4.32" SE="0.5371747085509091" STUDY_ID="STD-Hwang-2012" TOTAL_1="9" TOTAL_2="6" WEIGHT="6.918943734342379"/>
<CONT_DATA CI_END="1.4768483449093637" CI_START="-0.2821758660975854" EFFECT_SIZE="0.5973362394058892" ESTIMABLE="YES" MEAN_1="26.47" MEAN_2="14.85" MODIFIED="2015-08-25 12:55:08 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="143" SD_1="17.54" SD_2="19.86" SE="0.44873891175600866" STUDY_ID="STD-Kutner-2010" TOTAL_1="11" TOTAL_2="10" WEIGHT="8.778833353296273"/>
<CONT_DATA CI_END="1.6055435530865014" CI_START="-0.21249276415684137" EFFECT_SIZE="0.6965253944648301" ESTIMABLE="YES" MEAN_1="6.3" MEAN_2="1.3" MODIFIED="2015-08-25 12:55:08 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="51" SD_1="5.64" SD_2="7.92" SE="0.4637932971176464" STUDY_ID="STD-Liao-2011" TOTAL_1="10" TOTAL_2="10" WEIGHT="8.422124963393498"/>
<CONT_DATA CI_END="0.7987435476676239" CI_START="-1.0038276049828765" EFFECT_SIZE="-0.10254202865762635" ESTIMABLE="YES" MEAN_1="5.11" MEAN_2="5.7" MODIFIED="2015-08-25 12:55:14 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="149" SD_1="6.55" SD_2="4.35" SE="0.4598480295732349" STUDY_ID="STD-Susanto-2015" TOTAL_1="9" TOTAL_2="10" WEIGHT="8.513889123563446"/>
<CONT_DATA CI_END="0.6612941275915234" CI_START="-0.6218341101810183" EFFECT_SIZE="0.01973000870525251" ESTIMABLE="YES" MEAN_1="3.85" MEAN_2="3.71" MODIFIED="2015-08-25 12:55:19 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="150" SD_1="6.71" SD_2="7.08" SE="0.3273346469357839" STUDY_ID="STD-Wu-2012" TOTAL_1="14" TOTAL_2="28" WEIGHT="12.372930548368828"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="30.50723475327297" CI_END="0.5212246896336925" CI_START="0.13700084260971285" DF="20" EFFECT_SIZE="0.32911276612170265" ESTIMABLE="YES" I2="34.44178024737461" ID="CMP-003.02.02" MODIFIED="2015-08-25 13:00:01 +0100" MODIFIED_BY="Jan Mehrholz" NO="2" P_CHI2="0.06204106491788919" P_Z="7.860131753448369E-4" STUDIES="21" TAU2="0.06391793093073626" TOTAL_1="394" TOTAL_2="385" WEIGHT="99.99999999999999" Z="3.357673780256713">
<NAME>proximal training (shoulder and elbow joints)</NAME>
<CONT_DATA CI_END="1.905225283130183" CI_START="0.0215555863225656" EFFECT_SIZE="0.9633904347263743" ESTIMABLE="YES" MEAN_1="2.75" MEAN_2="1.0" MODIFIED="2015-08-25 12:39:49 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="132" SD_1="1.8" SD_2="1.69" SE="0.4805368138562146" STUDY_ID="STD-Abdullah-2011" TOTAL_1="9" TOTAL_2="11" WEIGHT="3.2586336785939456"/>
<CONT_DATA CI_END="1.4324949099920308" CI_START="-0.8786487561458767" EFFECT_SIZE="0.276923076923077" ESTIMABLE="YES" MEAN_1="1.8" MEAN_2="1.2" MODIFIED="2015-08-25 12:39:49 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="119" SD_1="2.0" SD_2="2.0" SE="0.5895882996748699" STUDY_ID="STD-Brokaw-2014" TOTAL_1="7" TOTAL_2="5" WEIGHT="2.3345788007631914"/>
<CONT_DATA CI_END="0.3081496460411424" CI_START="-0.8280085735289184" EFFECT_SIZE="-0.259929463743888" ESTIMABLE="YES" MEAN_1="10.6" MEAN_2="14.0" MODIFIED="2015-08-25 12:39:49 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="73" SD_1="11.56" SD_2="15.27" SE="0.2898416064101003" STUDY_ID="STD-Burgar-2011" TOTAL_1="36" TOTAL_2="18" WEIGHT="6.494828493081382"/>
<CONT_DATA CI_END="0.8561955186790654" CI_START="-0.202399634046594" EFFECT_SIZE="0.3268979423162357" ESTIMABLE="YES" MEAN_1="2.32" MEAN_2="1.19" MODIFIED="2015-08-25 12:39:49 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="67" SD_1="3.42" SD_2="3.4" SE="0.2700547461779203" STUDY_ID="STD-Conroy-2011" TOTAL_1="41" TOTAL_2="21" WEIGHT="7.020622163518511"/>
<CONT_DATA CI_END="0.9310498700010024" CI_START="-1.2548880687588093" EFFECT_SIZE="-0.16191909937890353" ESTIMABLE="YES" MEAN_1="8.17" MEAN_2="9.5" MODIFIED="2015-08-25 12:39:49 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="7.31" SD_2="8.02" SE="0.5576474761786979" STUDY_ID="STD-Daly-2005" TOTAL_1="7" TOTAL_2="6" WEIGHT="2.5627732359235678"/>
<CONT_DATA CI_END="2.6623609248578424" CI_START="0.9302855392658632" EFFECT_SIZE="1.7963232320618527" ESTIMABLE="YES" MEAN_1="5.53" MEAN_2="2.6" MODIFIED="2015-08-25 12:39:49 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="1.38" SD_2="1.77" SE="0.44186408506849323" STUDY_ID="STD-Fazekas-2007" TOTAL_1="15" TOTAL_2="15" WEIGHT="3.707161191446563"/>
<CONT_DATA CI_END="1.0209936227256453" CI_START="-1.1608028334099776" EFFECT_SIZE="-0.06990460534216623" ESTIMABLE="YES" MEAN_1="3.4" MEAN_2="3.7" MODIFIED="2015-08-25 12:39:49 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="259" SD_1="3.9" SD_2="4.1" SE="0.5565909560954576" STUDY_ID="STD-Hollenstein-2011" TOTAL_1="7" TOTAL_2="6" WEIGHT="2.570846138241278"/>
<CONT_DATA CI_END="1.1102258266122658" CI_START="-0.25169977451996944" EFFECT_SIZE="0.42926302604614813" ESTIMABLE="YES" MEAN_1="3.3" MEAN_2="2.2" MODIFIED="2015-08-25 12:39:49 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="61" SD_1="2.4" SD_2="2.6" SE="0.3474363845139325" STUDY_ID="STD-Housman-2009" TOTAL_1="17" TOTAL_2="17" WEIGHT="5.203676076965018"/>
<CONT_DATA CI_END="0.9139431654975261" CI_START="0.008014735073424206" EFFECT_SIZE="0.46097895028547514" ESTIMABLE="YES" MEAN_1="3.25" MEAN_2="2.47" MODIFIED="2015-08-25 12:39:49 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="121" SD_1="1.68" SD_2="1.67" SE="0.23110843810650342" STUDY_ID="STD-Klamroth_x002d_Marganska-2014" TOTAL_1="39" TOTAL_2="38" WEIGHT="8.18854872195836"/>
<CONT_DATA CI_END="0.936564544371069" CI_START="0.2078479042559952" EFFECT_SIZE="0.5722062243135321" ESTIMABLE="YES" MEAN_1="3.87" MEAN_2="-0.03" MODIFIED="2015-08-25 12:39:49 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="54" SD_1="7.35" SD_2="6.39" SE="0.18590051803581534" STUDY_ID="STD-Lo-2010" TOTAL_1="49" TOTAL_2="78" WEIGHT="9.756138163531212"/>
<CONT_DATA CI_END="1.1372647343252518" CI_START="-0.6566802193014193" EFFECT_SIZE="0.24029225751191627" ESTIMABLE="YES" MEAN_1="6.98" MEAN_2="6.5" MODIFIED="2015-08-25 12:39:49 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="1.8" SD_2="2.5" SE="0.4576474281612009" STUDY_ID="STD-Lum-2006" TOTAL_1="24" TOTAL_2="6" WEIGHT="3.514624431734204"/>
<CONT_DATA CI_END="1.1942660946499475" CI_START="-0.15634433909086787" EFFECT_SIZE="0.5189608777795398" ESTIMABLE="YES" MEAN_1="15.8" MEAN_2="10.3" MODIFIED="2015-08-25 12:39:49 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="8.1" SD_2="12.1" SE="0.3445498091787038" STUDY_ID="STD-Masiero-2007" TOTAL_1="17" TOTAL_2="18" WEIGHT="5.26058921233399"/>
<CONT_DATA CI_END="0.6809447060792966" CI_START="-1.0359319244142693" EFFECT_SIZE="-0.17749360916748635" ESTIMABLE="YES" MEAN_1="12.16" MEAN_2="13.87" MODIFIED="2015-08-25 12:39:49 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="82" SD_1="8.3" SD_2="10.2" SE="0.437986780378637" STUDY_ID="STD-Masiero-2011" TOTAL_1="11" TOTAL_2="10" WEIGHT="3.7566109560004874"/>
<CONT_DATA CI_END="2.133932848002897" CI_START="-0.7883144554155647" EFFECT_SIZE="0.6728091962936661" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="1.25" MODIFIED="2015-08-25 12:39:49 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="112" SD_1="2.94" SD_2="1.26" SE="0.7454849493329406" STUDY_ID="STD-Mayr-2008" TOTAL_1="4" TOTAL_2="4" WEIGHT="1.550440030063974"/>
<CONT_DATA CI_END="0.33268540893651005" CI_START="-1.0372739184578856" EFFECT_SIZE="-0.3522942547606878" ESTIMABLE="YES" MEAN_1="7.7" MEAN_2="9.35" MODIFIED="2015-08-25 12:39:49 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="127" SD_1="3.84" SD_2="4.87" SE="0.3494858421380342" STUDY_ID="STD-McCabe-2015" TOTAL_1="12" TOTAL_2="27" WEIGHT="5.163729046582819"/>
<CONT_DATA CI_END="0.6496554439606558" CI_START="-0.8697010151771357" EFFECT_SIZE="-0.11002278560824001" ESTIMABLE="YES" MEAN_1="3.05" MEAN_2="3.88" MODIFIED="2015-08-25 12:39:49 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="115" SD_1="8.12" SD_2="6.94" SE="0.3875980556587471" STUDY_ID="STD-Rabadi-2008" TOTAL_1="10" TOTAL_2="20" WEIGHT="4.486358839343701"/>
<CONT_DATA CI_END="1.0818176867387777" CI_START="-0.015723027078641483" EFFECT_SIZE="0.5330473298300681" ESTIMABLE="YES" MEAN_1="8.65" MEAN_2="3.63" MODIFIED="2015-08-25 12:39:49 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="125" SD_1="7.52" SD_2="10.7" SE="0.2799900208561688" STUDY_ID="STD-Sale-2014" TOTAL_1="26" TOTAL_2="27" WEIGHT="6.75102771278561"/>
<CONT_DATA CI_END="0.7610269452232925" CI_START="-0.9111528257790966" EFFECT_SIZE="-0.07506294027790202" ESTIMABLE="YES" MEAN_1="1.6" MEAN_2="3.5" MODIFIED="2015-08-25 12:39:49 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="145" SD_1="10.8" SD_2="32.7" SE="0.42658431078130254" STUDY_ID="STD-Timmermans-2014" TOTAL_1="11" TOTAL_2="11" WEIGHT="3.90722007514523"/>
<CONT_DATA CI_END="1.22032829423937" CI_START="0.1380767794858967" EFFECT_SIZE="0.6792025368626333" ESTIMABLE="YES" MEAN_1="6.0" MEAN_2="4.0" MODIFIED="2015-08-25 12:39:49 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="3.5" SD_2="2.0" SE="0.27608964330215635" STUDY_ID="STD-Volpe-2000" TOTAL_1="30" TOTAL_2="26" WEIGHT="6.855509558122717"/>
<CONT_DATA CI_END="1.0091858566316418" CI_START="-0.7065613610612295" EFFECT_SIZE="0.15131224778520622" ESTIMABLE="YES" MEAN_1="19.46" MEAN_2="17.7" MODIFIED="2015-08-25 12:39:49 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1" SD_1="13.27" SD_2="8.22" SE="0.4376986595739683" STUDY_ID="STD-Volpe-2008" TOTAL_1="11" TOTAL_2="10" WEIGHT="3.760320592729545"/>
<CONT_DATA CI_END="1.0159481183404653" CI_START="-0.6595509237771858" EFFECT_SIZE="0.17819859728163975" ESTIMABLE="YES" MEAN_1="1.7" MEAN_2="0.3" MODIFIED="2015-08-25 12:39:49 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="151" SD_1="9.94" SD_2="3.93" SE="0.42743107917639656" STUDY_ID="STD-Yoo-2013" TOTAL_1="11" TOTAL_2="11" WEIGHT="3.8957628811346563"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram. Please note that several studies have been published in multiple full-text articles. Hence the number of assessed full-text articles and the number of identified studies may differ.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAvsAAAP5CAYAAACIPuDxAACAAElEQVR42uydAURf3///vySTJB+S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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2015-10-30 14:13:22 +0000" MODIFIED_BY="Hazel Fraser" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAASMAAAUjCAIAAAACDdRpAAA3tElEQVR42u3dsY4cx9WG4QUMGA4Y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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2015-10-30 09:52:21 +0000" MODIFIED_BY="[Empty name]" NO="3" REF_ID="CMP-001.01" SETTINGS="SHOW_CI_LINES:NO;SHOW_STUDY_NAMES:NO;SHOW_AUTOGENERATED_NUM_FOR_STUDY_NAMES:NO;SHOW_EFFECT_ESTIMATE:YES;DISTINGUISH_SUBGROUPS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Electromechanical and robotic assisted training versus all other intervention, outcome: 1.1 Activities of daily living at the end of intervention phase.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2015-10-30 09:52:21 +0000" MODIFIED_BY="[Empty name]" NO="4" REF_ID="CMP-001.03" SETTINGS="SHOW_CI_LINES:NO;SHOW_STUDY_NAMES:NO;SHOW_AUTOGENERATED_NUM_FOR_STUDY_NAMES:NO;SHOW_EFFECT_ESTIMATE:YES;DISTINGUISH_SUBGROUPS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Electromechanical and robotic assisted training versus all other intervention, outcome: 1.3 Arm function at the end of intervention phase.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2015-10-30 09:52:21 +0000" MODIFIED_BY="[Empty name]" NO="5" REF_ID="CMP-001.04" SETTINGS="SHOW_CI_LINES:NO;SHOW_STUDY_NAMES:NO;SHOW_AUTOGENERATED_NUM_FOR_STUDY_NAMES:NO;SHOW_EFFECT_ESTIMATE:YES;DISTINGUISH_SUBGROUPS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Electromechanical and robotic assisted training versus all other intervention, outcome: 1.4 Arm muscle strength at the end of intervention phase.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser">
<APPENDIX ID="APP-01" MODIFIED="2015-07-31 11:31:12 +0100" MODIFIED_BY="Bernhard Elsner" NO="1">
<TITLE MODIFIED="2015-06-03 12:04:14 +0100" MODIFIED_BY="Bernhard Elsner">CENTRAL search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2015-06-03 12:06:14 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Cochrane Central Register of Controlled Trials (CENTRAL) The Cochrane Library </P>
<P>#1 [mh ^"cerebrovascular disorders"] or [mh "basal ganglia cerebrovascular disease"] or [mh "brain ischemia"] or [mh "carotid artery diseases"] or [mh "cerebral small vessel diseases"] or [mh "intracranial arterial diseases"] or [mh "intracranial embolism and thrombosis"] or [mh "intracranial hemorrhages"] or [mh ^stroke] or [mh "brain infarction"] or [mh ^"stroke, lacunar"] or [mh ^"vasospasm, intracranial"] or [mh ^"vertebral artery dissection"] or [mh ^"brain injuries"] or [mh ^"brain injury, chronic"]</P>
<P>#2 (stroke* or poststroke or apoplex* or cerebral next vasc* or brain next vasc* or cerebrovasc* or cva* or SAH):ti,ab</P>
<P>#3 ((brain or cerebr* or cerebell* or vertebrobasil* or hemispher* or intracran* or intracerebral or infratentorial or supratentorial or "middle cerebral artery" or MCA* or "anterior circulation" or "posterior circulation" or "basilar artery" or "vertebral artery" or "space-occupying") near/5 (isch*emi* or infarct* or thrombo* or emboli* or occlus* or hypoxi*)):ti,ab</P>
<P>#4 ((brain* or cerebr* or cerebell* or intracerebral or intracran* or parenchymal or intraparenchymal or intraventricular or infratentorial or supratentorial or basal next gangli* or putaminal or putamen or "posterior fossa" or hemispher* or subarachnoid) near/5 (hemorrhag* or haemorrhage* or hematoma* or haematoma* or bleed*)):ti,ab</P>
<P>#5 [mh ^hemiplegia] or [mh paresis]</P>
<P>#6 (hemipleg* or hemipar* or paresis or paretic or brain next injur*):ti,ab</P>
<P>#7 #1 or #2 or #3 or #4 or #5 or #6</P>
<P>#8 [mh "upper extremity"]</P>
<P>#9 (upper next limb* or upper next extremit* or arm or arms or shoulder or shoulders or hand or hands or axilla* or elbow* or forearm* or finger* or wrist*):ti,ab</P>
<P>#10 #8 or #9</P>
<P>#11 [mh robotics] or [mh automation] or [mh "orthotic devices"]</P>
<P>#12 [mh "equipment and supplies"] or [mh "self-help devices"]</P>
<P>#13 [mh "physical therapy modalities"] or [mh "occupational therapy"]</P>
<P>#14 [mh "therapy, computer-assisted"] or [mh "man-machine systems"]</P>
<P>#15 [mh "exercise movement techniques"] or [mh exercise] or [mh "exercise therapy"] or [mh "muscle stretching techniques"] or [mh "motion therapy, continuous passive"]</P>
<P>#16 (robot* or orthos* or orthotic or automat* or computer next aided or computer next assisted or device*):ti,ab</P>
<P>#17 (electromechanical or "electro-mechanical" or mechanical or mechanised or mechanized or driven):ti,ab</P>
<P>#18 ((continuous passive or cpm) near/3 therap*):ti,ab</P>
<P>#19 (MIT-Manus or ARM guide or Bi-Manu-Track or ARMtrainer or MIME or Mirror-Image Motion Enabler or InMOTION or REHAROB or NeReBot or "GENTLE/S" or ARMin):ti,ab</P>
<P>#20 (assist* near/5 (train* or aid* or rehabilitat* or re-educat*)):ti,ab</P>
<P>#21 #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20</P>
<P>#22 #7 and #10 and #21</P>
<P>Number of hits: n=930</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2015-07-31 12:03:01 +0100" MODIFIED_BY="Bernhard Elsner" NO="2">
<TITLE MODIFIED="2015-07-31 12:03:01 +0100" MODIFIED_BY="Bernhard Elsner">MEDLINE (Ovid) search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2015-06-03 12:06:31 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Medline (Ovid) Revised March 2015</P>
<P>1. cerebrovascular disorders/ or exp basal ganglia cerebrovascular disease/ or exp brain ischemia/ or exp carotid artery diseases/ or exp cerebral small vessel diseases/ or exp intracranial arterial diseases/ or exp "intracranial embolism and thrombosis"/ or exp intracranial hemorrhages/ or stroke/ or exp brain infarction/ or stroke, lacunar/ or vasospasm, intracranial/ or vertebral artery dissection/ or brain injuries/ or brain injury, chronic/</P>
<P>2. (stroke$ or poststroke or apoplex$ or cerebral vasc$ or brain vasc$ or cerebrovasc$ or cva$ or SAH).tw.</P>
<P>3. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or intracerebral or infratentorial or supratentorial or middle cerebral artery or MCA$ or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$ or hypoxi$)).tw.</P>
<P>4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or intraparenchymal or intraventricular or infratentorial or supratentorial or basal gangli$ or putaminal or putamen or posterior fossa or hemispher$ or subarachnoid) adj5 (h?emorrhag$ or h?ematoma$ or bleed$)).tw.</P>
<P>5. hemiplegia/ or exp paresis/</P>
<P>6. (hemipleg$ or hemipar$ or paresis or paretic or brain injur$).tw.</P>
<P>7. or/1-6</P>
<P>8. exp upper extremity/</P>
<P>9. (upper limb$ or upper extremit$ or arm or arms or shoulder or shoulders or hand or hands or axilla$ or elbow$ or forearm$ or finger$ or wrist$).tw.</P>
<P>10. 8 or 9</P>
<P>11. robotics/ or automation/ or orthotic devices/</P>
<P>12. "equipment and supplies"/ or self-help devices/</P>
<P>13. physical therapy modalities/ or occupational therapy/</P>
<P>14. therapy, computer-assisted/ or man-machine systems/</P>
<P>15. exercise movement techniques/ or exercise/ or exercise therapy/ or muscle stretching techniques/ or motion therapy, continuous passive/</P>
<P>16. (robot$ or orthos$ or orthotic or automat$ or computer aided or computer assisted or device$).tw.</P>
<P>17. (electromechanical or electro-mechanical or mechanical or mechanised or mechanized or driven).tw.</P>
<P>18. ((continuous passive or cpm) adj3 therap$).tw.</P>
<P>19. (MIT-Manus or ARM guide or Bi-Manu-Track or ARMtrainer or MIME or Mirror-Image Motion Enabler or InMOTION or REHAROB or NeReBot or "GENTLE/S" or ARMin).tw.</P>
<P>20. (assist$ adj5 (train$ or aid$ or rehabilitat$ or re-educat$)).tw.</P>
<P>21. or/11-20</P>
<P>22. Randomized Controlled Trials as Topic/</P>
<P>23. random allocation/</P>
<P>24. Controlled Clinical Trials as Topic/</P>
<P>25. control groups/</P>
<P>26. clinical trials as topic/ or clinical trials, phase i as topic/ or clinical trials, phase ii as topic/ or clinical trials, phase iii as topic/ or clinical trials, phase iv as topic/</P>
<P>27. double-blind method/</P>
<P>28. single-blind method/</P>
<P>29. Placebos/</P>
<P>30. placebo effect/</P>
<P>31. cross-over studies/</P>
<P>32. randomized controlled trial.pt.</P>
<P>33. controlled clinical trial.pt.</P>
<P>34. (clinical trial or clinical trial phase i or clinical trial phase ii or clinical trial phase iii or clinical trial phase iv).pt.</P>
<P>35. (random$ or RCT or RCTs).tw.</P>
<P>36. (controlled adj5 (trial$ or stud$)).tw.</P>
<P>37. (clinical$ adj5 trial$).tw.</P>
<P>38. ((control or treatment or experiment$ or intervention) adj5 (group$ or subject$ or patient$)).tw.</P>
<P>39. (quasi-random$ or quasi random$ or pseudo-random$ or pseudo random$).tw.</P>
<P>40. ((control or experiment$ or conservative) adj5 (treatment or therapy or procedure or manage$)).tw.</P>
<P>41. ((singl$ or doubl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).tw.</P>
<P>42. (cross-over or cross over or crossover).tw.</P>
<P>43. (placebo$ or sham).tw.</P>
<P>44. trial.ti.</P>
<P>45. (assign$ or allocat$).tw.</P>
<P>46. controls.tw.</P>
<P>47. or/22-46</P>
<P>48. 7 and 10 and 21 and 47</P>
<P>49. exp animals/ not humans.sh.</P>
<P>50. 48 not 49</P>
<P>Number of hits: n=552</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2015-07-31 12:03:13 +0100" MODIFIED_BY="Bernhard Elsner" NO="3">
<TITLE MODIFIED="2015-07-31 12:03:13 +0100" MODIFIED_BY="Bernhard Elsner">EMBASE (Ovid) search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2015-06-03 12:06:42 +0100" MODIFIED_BY="Bernhard Elsner">
<P>EMBASE (Ovid) Revised March 2015</P>
<P>1. cerebrovascular disease/ or exp basal ganglion hemorrhage/ or exp brain hematoma/ or exp brain hemorrhage/ or exp brain infarction/ or exp brain ischemia/ or exp carotid artery disease/ or cerebral artery disease/ or exp cerebrovascular accident/ or exp intracranial aneurysm/ or exp occlusive cerebrovascular disease/ or stroke unit/ or stroke patient/ or brain injury/ or acquired brain injury/</P>
<P>2. (stroke$ or poststroke or apoplex$ or cerebral vasc$ or brain vasc$ or cerebrovasc$ or cva$ or SAH).tw.</P>
<P>3. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or intracerebral or infratentorial or supratentorial or middle cerebral artery or MCA$ or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$ or hypoxi$)).tw.</P>
<P>4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or intraparenchymal or intraventricular or infratentorial or supratentorial or basal gangli$ or putaminal or putamen or posterior fossa or hemispher$ or subarachnoid) adj5 (h?emorrhag$ or h?ematoma$ or bleed$)).tw.</P>
<P>5. hemiparesis/ or hemiplegia/ or paresis/</P>
<P>6. (hemipleg$ or hemipar$ or paresis or paretic or brain injur$).tw.</P>
<P>7. 1 or 2 or 3 or 4 or 5 or 6</P>
<P>8. exp arm/ or arm weakness/ or arm exercise/ or arm movement/</P>
<P>9. (upper limb$ or upper extremit$ or arm or arms or shoulder or shoulders or hand or hands or axilla$ or elbow$ or forearm$ or finger$ or wrist$).tw.</P>
<P>10. 8 or 9</P>
<P>11. robotics/ or automation/ or orthotics/</P>
<P>12. man machine interaction/ or biomedical engineering/ or device/ or machine/ or assistive technology/ or assistive technology device/ or computer assisted therapy/</P>
<P>13. passive movement/ or movement therapy/ or kinesiotherapy/ or exp exercise/ or muscle stretching/ or muscle training/</P>
<P>14. (robot$ or orthos$ or orthotic or automat$ or computer aided or computer assisted or computeri?ed or device$).tw.</P>
<P>15. (electromechanical or electro-mechanical or mechanical or mechanised or mechanized or driven).tw.</P>
<P>16. ((continuous passive or cpm) adj3 therap$).tw.</P>
<P>17. (MIT-Manus or ARM guide or Bi-Manu-Track or ARMtrainer or MIME or Mirror-Image Motion Enabler or InMOTION or REHAROB or NeReBot or "GENTLE/S" or ARMin).tw.</P>
<P>18. (assist$ adj5 (train$ or aid$ or rehabilitat$ or re-educat$)).tw.</P>
<P>19. or/11-18</P>
<P>20. Randomized Controlled Trial/ or "randomized controlled trial (topic)"/</P>
<P>21. Randomization/</P>
<P>22. Controlled clinical trial/ or "controlled clinical trial (topic)"/</P>
<P>23. control group/ or controlled study/</P>
<P>24. clinical trial/ or "clinical trial (topic)"/ or phase 1 clinical trial/ or phase 2 clinical trial/ or phase 3 clinical trial/ or phase 4 clinical trial/</P>
<P>25. Crossover Procedure/</P>
<P>26. Double Blind Procedure/</P>
<P>27. Single Blind Procedure/ or triple blind procedure/</P>
<P>28. placebo/ or placebo effect/</P>
<P>29. (random$ or RCT or RCTs).tw.</P>
<P>30. (controlled adj5 (trial$ or stud$)).tw.</P>
<P>31. (clinical$ adj5 trial$).tw.</P>
<P>32. ((control or treatment or experiment$ or intervention) adj5 (group$ or subject$ or patient$)).tw.</P>
<P>33. (quasi-random$ or quasi random$ or pseudo-random$ or pseudo random$).tw.</P>
<P>34. ((control or experiment$ or conservative) adj5 (treatment or therapy or procedure or manage$)).tw.</P>
<P>35. ((singl$ or doubl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).tw.</P>
<P>36. (cross-over or cross over or crossover).tw.</P>
<P>37. (placebo$ or sham).tw.</P>
<P>38. trial.ti.</P>
<P>39. (assign$ or allocat$).tw.</P>
<P>40. controls.tw.</P>
<P>41. or/20-40</P>
<P>42. 7 and 10 and 19 and 41</P>
<P>43. (exp animals/ or exp invertebrate/ or animal experiment/ or animal model/ or animal tissue/ or animal cell/ or nonhuman/) not (human/ or normal human/ or human cell/)</P>
<P>44. 42 not 43</P>
<P>Number of hits: n=1265</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2015-06-03 12:06:54 +0100" MODIFIED_BY="Bernhard Elsner" NO="4">
<TITLE MODIFIED="2012-01-26 12:50:59 +0000" MODIFIED_BY="[Empty name]">CINAHL (Ebsco) search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2015-06-03 12:06:54 +0100" MODIFIED_BY="Bernhard Elsner">
<P>CINAHL (Ebsco) Revised March 2015</P>
<P>S1 .(MH "Cerebrovascular Disorders") OR (MH "Basal Ganglia Cerebrovascular Disease+") OR (MH "Carotid Artery Diseases+") OR (MH "Cerebral Ischemia+") OR (MH "Cerebral Vasospasm") OR (MH "Intracranial Arterial Diseases+") OR (MH "Intracranial Embolism and Thrombosis") OR (MH "Intracranial Hemorrhage+") OR (MH "Stroke") OR (MH "Vertebral Artery Dissections") OR .(MH "Brain Injuries")</P>
<P>S2 .(MH "Stroke Patients") OR (MH "Stroke Units")</P>
<P>S3 .TI ( stroke* or poststroke or apoplex* or cerebral vasc* or brain vasc* or cerebrovasc* or cva* or SAH ) or AB ( stroke* or poststroke or apoplex* or cerebral vasc* or brain vasc* or cerebrovasc* or cva* or SAH )</P>
<P>S4 .TI ( brain or cerebr* or cerebell* or vertebrobasil* or hemispher* or intracran* or intracerebral or infratentorial or supratentorial or middle cerebral artery or MCA* or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying ) or AB ( brain or cerebr* or cerebell* or vertebrobasil* or hemispher* or intracran* or intracerebral or infratentorial or supratentorial or middle cerebral artery or MCA* or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying )</P>
<P>S5 .TI ( ischemi* or ischaemi* or infarct* or thrombo* or emboli* or occlus* or hypoxi* ) or AB ( ischemi* or ischaemi* or infarct* or thrombo* or emboli* or occlus* or hypox* )</P>
<P>S6 .S4 and S5</P>
<P>S7 .TI ( brain* or cerebr* or cerebell* or intracerebral or intracran* or parenchymal or intraparenchymal or intraventricular or infratentorial or supratentorial or basal gangli* or putaminal or putamen or posterior fossa or hemispher* or subarachnoid ) or AB ( brain* or cerebr* or cerebell* or intracerebral or intracran* or parenchymal or intraparenchymal or intraventricular or infratentorial or supratentorial or basal gangli* or putaminal or putamen or posterior fossa or hemispher* or subarachnoid )</P>
<P>S8 .TI ( haemorrhage* or hemorrhage* or haematoma* or hematoma* or bleed* ) or AB ( haemorrhage* or hemorrhage* or haematoma* or hematoma* or bleed* )</P>
<P>S9 .S7 and S8</P>
<P>S10 ..(MH "Hemiplegia")</P>
<P>S11 .TI ( hemipleg* or hemipar* or paresis or paretic or brain injur* ) or AB ( hemipleg* or hemipar* or paresis or paretic or brain injur*)</P>
<P>S12 .S1 OR S2 OR S3 OR S6 OR S9 OR S10 OR S11</P>
<P>S13 .(MH "Upper Extremity+")</P>
<P>S14 .TI ( upper limb* or upper extremit* or arm or arms or shoulder or shoulders or hand or hands or axilla* or elbow* or forearm* or finger* or wrist* ) or AB ( upper limb* or upper extremit* or arm or arms or shoulder or shoulders or hand or hands or axilla* or elbow* or forearm* or finger* or wrist* )</P>
<P>S15 .S13 or S14</P>
<P>S16 ..(MH "Therapeutic Exercise") OR (MH "Motion Therapy, Continuous Passive") OR (MH "Muscle Strengthening+") OR (MH "Neuromuscular Facilitation") OR (MH "Upper Extremity Exercises+")</P>
<P>S17 .(MH "Exercise+")</P>
<P>S18 .(MH "Movement+")</P>
<P>S19 .(MH "Assistive Technology") OR (MH "Automation") OR (MH "Robotics")</P>
<P>S20 .(MH "Orthoses") OR (MH "Orthoses Design")</P>
<P>S21 .(MH "Biomedical Engineering") OR (MH "Assistive Technology Services")</P>
<P>S22 .(MH "Assistive Technology Devices") OR (MH "Equipment and Supplies")</P>
<P>S23 .(MH "Therapy, Computer Assisted</P>
<P>S24 .(MH "Biomechanics")</P>
<P>S25 .TI ( robot* or orthos* or orthotic or automat* or computer aided or computer assisted or device* ) OR AB ( robot* or orthos* or orthotic or automat* or computer aided or computer assisted or device* )</P>
<P>S26 .TI ( electromechanical or electro-mechanical or mechanical or mechanised or mechanized or driven ) OR AB ( electromechanical or electro-mechanical or mechanical or mechanised or mechanized or driven )</P>
<P>S27 .TI ( continuous passive or cpm ) OR AB ( continuous passive or cpm )</P>
<P>S28 .TI therap* OR AB therap*</P>
<P>S29 .S27 and S28</P>
<P>S30 .TI ( MIT-Manus or ARM guide or Bi-Manu-Track or ARMtrainer or MIME or Mirror-Image Motion Enabler or InMOTION or REHAROB or NeReBot or "GENTLE/S" or ARMin) OR AB ( MIT-Manus or ARM guide or Bi-Manu-Track or ARMtrainer or MIME or Mirror-Image Motion Enabler or InMOTION or REHAROB or NeReBot or "GENTLE/S" or ARMin)</P>
<P>S31 .TI assist* OR AB assist*</P>
<P>S32 .TI ( train* or aid* or rehabilitat* or re-educat* ) OR AB ( train* or aid* or rehabilitat* or re-educat* )</P>
<P>S33 .S31 AND S32</P>
<P>S34 .S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S29 OR S30 OR S33</P>
<P>S35 .(MH "Randomized Controlled Trials") or (MH "Random Assignment") or (MH "Random Sample+")</P>
<P>S36 .(MH "Clinical Trials") or (MH "Intervention Trials") or (MH "Therapeutic Trials")</P>
<P>S37 .(MH "Double-Blind Studies") or (MH "Single-Blind Studies") or (MH "Triple-Blind Studies")</P>
<P>S38 .(MH "Control (Research)") or (MH "Control Group") or (MH "Placebos") or (MH "Placebo Effect")</P>
<P>S39 .(MH "Crossover Design") OR (MH "Quasi-Experimental Studies")</P>
<P>S40 .PT (clinical trial or randomized controlled trial)</P>
<P>S41 .TI (random* or RCT or RCTs) or AB (random* or RCT or RCTs)</P>
<P>S42 .TI (controlled N5 (trial* or stud*)) or AB (controlled N5 (trial* or stud*))</P>
<P>S43 .TI (clinical* N5 trial*) or AB (clinical* N5 trial*)</P>
<P>S44 .TI ((control or treatment or experiment* or intervention) N5 (group* or subject* or patient*)) or AB ((control or treatment or experiment* or intervention) N5 (group* or subject* or patient*))</P>
<P>S45 .TI ((control or experiment* or conservative) N5 (treatment or therapy or procedure or manage*)) or AB ((control or experiment* or conservative) N5 (treatment or therapy or procedure or manage*))</P>
<P>S46 .TI ((singl* or doubl* or tripl* or trebl*) N5 (blind* or mask*)) or AB ((singl* or doubl* or tripl* or trebl*) N5 (blind* or mask*))</P>
<P>S47 .TI (cross-over or cross over or crossover) or AB (cross-over or cross over or crossover)</P>
<P>S48 .TI (placebo* or sham) or AB (placebo* or sham)</P>
<P>S49 .TI trial</P>
<P>S50 .TI (assign* or allocat*) or AB (assign* or allocat*)</P>
<P>S51 .TI controls or AB controls</P>
<P>S52 .TI (quasi-random* or quasi random* or pseudo-random* or pseudo random*) or AB (quasi-random* or quasi random* or pseudo-random* or pseudo random*)</P>
<P>S53 .S35 OR S36 OR S37 OR S38 OR S39 OR S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 OR S48 OR S49 OR S50 OR S51 OR S52</P>
<P>S54 .S12 AND S15 AND S34 AND S53</P>
<P>Number of hits: n=298</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2015-06-03 12:07:05 +0100" MODIFIED_BY="Bernhard Elsner" NO="5">
<TITLE MODIFIED="2012-01-26 12:50:59 +0000" MODIFIED_BY="[Empty name]">AMED (Ovid) search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2015-06-03 12:07:05 +0100" MODIFIED_BY="Bernhard Elsner">
<P>1. cerebrovascular disorders/ or cerebral hemorrhage/ or cerebral infarction/ or cerebral ischemia/ or cerebrovascular accident/ or stroke/ or brain injuries/</P>
<P>2. (stroke$ or poststroke or apoplex$ or cerebral vasc$ or brain vasc$ or cerebrovasc$ or cva$ or SAH).tw.</P>
<P>3. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or intracerebral or infratentorial or supratentorial or middle cerebral artery or MCA$ or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$ or hypoxi$)).tw.</P>
<P>4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or intraparenchymal or intraventricular or infratentorial or supratentorial or basal gangli$ or putaminal or putamen or posterior fossa or hemispher$ or subarachnoid) adj5 (h?emorrhag$ or h?ematoma$ or bleed$)).tw.</P>
<P>5. hemiplegia/</P>
<P>6. (hemipleg$ or hemipar$ or paresis or paretic or brain injur$).tw.</P>
<P>7. or/1-6</P>
<P>8. exp arm/</P>
<P>9. (upper limb$ or upper extremit$ or arm or arms or shoulder or shoulders or hand or hands or axilla$ or elbow$ or forearm$ or finger$ or wrist$).tw.</P>
<P>10. 8 or 9</P>
<P>11. robotics/ or orthotic devices/ or biomechanics/ or equipment design/ or equipment/ or biomechanics equipment/ or therapy computer assisted/</P>
<P>12. exercise/ or exercise movement techniques/ or exercise therapy/ or exp movement/ or continuous passive motion/</P>
<P>13. engineering/ or technology/ or technology medical/</P>
<P>14. (robot$ or orthos$ or orthotic or automat$ or computer aided or computer assisted or device$).tw.</P>
<P>15. (electromechanical or electro-mechanical or mechanical or mechanised or mechanized or driven).tw.</P>
<P>16. ((continuous passive or cpm) adj3 therap$).tw.</P>
<P>17. (MIT-Manus or ARM guide or Bi-Manu-Track or ARMtrainer or MIME or Mirror-Image Motion Enabler or InMOTION or REHAROB or NeReBot or "GENTLE/S" or ARMin).tw.</P>
<P>18. (assist$ adj5 (train$ or aid$ or rehabilitat$ or re-educat$)).tw.</P>
<P>19. or/11-18</P>
<P>20. clinical trials/ or randomized controlled trials/ or random allocation/</P>
<P>21. research design/ or comparative study/</P>
<P>22. double blind method/ or single blind method/</P>
<P>23. placebos/</P>
<P>24. (random$ or RCT or RCTs).tw.</P>
<P>25. (controlled adj5 (trial$ or stud$)).tw.</P>
<P>26. (clinical$ adj5 trial$).tw.</P>
<P>27. ((control or treatment or experiment$ or intervention) adj5 (group$ or subject$ or patient$)).tw.</P>
<P>28. (quasi-random$ or quasi random$ or pseudo-random$ or pseudo random$).tw.</P>
<P>29. ((control or experiment$ or conservative) adj5 (treatment or therapy or procedure or manage$)).tw.</P>
<P>30. ((singl$ or doubl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).tw.</P>
<P>31. (cross-over or cross over or crossover).tw.</P>
<P>32. (placebo$ or sham).tw.</P>
<P>33. trial.ti.</P>
<P>34. (assign$ or allocat$).tw.</P>
<P>35. controls.tw.</P>
<P>36. or/20-35</P>
<P>37. 7 and 10 and 19 and 36</P>
<P>Number of hits: n=117<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-06" MODIFIED="2015-06-03 12:07:16 +0100" MODIFIED_BY="Bernhard Elsner" NO="6">
<TITLE MODIFIED="2012-01-26 12:50:59 +0000" MODIFIED_BY="[Empty name]">SPORTDiscus (Ebsco) search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2015-06-03 12:07:16 +0100" MODIFIED_BY="Bernhard Elsner">
<P>SportDISCUS (Ebsco) Revised march 2015</P>
<P>S1 .DE "CEREBROVASCULAR disease" OR DE "BRAIN -- Hemorrhage" OR DE "CEREBRAL embolism &amp; thrombosis" OR DE "STROKE" OR DE "BRAIN -- Wounds &amp; injuries" OR DE "BRAIN damage"</P>
<P>S2 .DE "CEREBROVASCULAR disease -- Patients"</P>
<P>S3 .TI ( stroke* or poststroke or apoplex* or cerebral vasc* or brain vasc* or cerebrovasc* or cva* or SAH ) or AB ( stroke* or poststroke or apoplex* or cerebral vasc* or brain vasc* or cerebrovasc* or cva* or SAH )</P>
<P>S4 .TI ( brain or cerebr* or cerebell* or vertebrobasil* or hemispher* or intracran* or intracerebral or infratentorial or supratentorial or middle cerebral artery or MCA* or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying ) or AB ( brain or cerebr* or cerebell* or vertebrobasil* or hemispher* or intracran* or intracerebral or infratentorial or supratentorial or middle cerebral artery or MCA* or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying )</P>
<P>S5 .TI ( ischemi* or ischaemi* or infarct* or thrombo* or emboli* or occlus* or hypoxi* ) or AB ( ischemi* or ischaemi* or infarct* or thrombo* or emboli* or occlus* or hypox* )</P>
<P>S6 .S4 AND S5</P>
<P>S7 .TI ( brain* or cerebr* or cerebell* or intracerebral or intracran* or parenchymal or intraparenchymal or intraventricular or infratentorial or supratentorial or basal gangli* or putaminal or putamen or posterior fossa or hemispher* or subarachnoid ) or AB ( brain* or cerebr* or cerebell* or intracerebral or intracran* or parenchymal or intraparenchymal or intraventricular or infratentorial or supratentorial or basal gangli* or putaminal or putamen or posterior fossa or hemispher* or subarachnoid )</P>
<P>S8 .TI ( haemorrhage* or hemorrhage* or haematoma* or hematoma* or bleed* ) or AB ( haemorrhage* or hemorrhage* or haematoma* or hematoma* or bleed* )</P>
<P>S9 .S7 AND S8</P>
<P>S10 .DE "HEMIPLEGIA" OR DE "HEMIPLEGICS"</P>
<P>S11 .TI ( hemipleg* or hemipar* or paresis or paretic or brain injur* ) or AB ( hemipleg* or hemipar* or paresis or paretic or brain injur*)</P>
<P>S12 .S1 OR S2 OR S3 OR S6 OR S9 OR S10 OR S11</P>
<P>S13 .DE "ARM" OR DE "BICEPS brachii" OR DE "ELBOW" OR DE "FOREARM" OR DE "HAND" OR DE "HUMERUS" OR DE "TRICEPS" OR DE "WRIST" OR DE "ARM exercises" OR DE "HAND exercises" OR DE "SHOULDER exercises"</P>
<P>S14 .TI ( upper limb* or upper extremit* or arm or arms or shoulder or shoulders or hand or hands or axilla* or elbow* or forearm* or finger* or wrist* ) or AB ( upper limb* or upper extremit* or arm or arms or shoulder or shoulders or hand or hands or axilla* or elbow* or forearm* or finger* or wrist* )</P>
<P>S15 .S13 OR S14</P>
<P>S16 .DE "EXERCISE" OR DE "EXERCISE therapy" OR DE "STRENGTH training" OR DE "MOVEMENT therapy&#8221; OR DE "SELF-help devices for people with disabilities" OR DE "ROBOTICS in sports"</P>
<P>S17 .DE "ORTHOPEDIC apparatus" OR DE "EQUIPMENT &amp; supplies" OR DE "ORTHOPEDIC braces" OR DE "ORTHOPEDIC slings"</P>
<P>S18 .DE "BIOMEDICAL engineering"</P>
<P>S19 .DE "ELECTRONIC games" OR DE "COMPUTER games" OR DE "INTERNET games" OR DE "VIDEO games"</P>
<P>S20 .DE "BIOMECHANICS"</P>
<P>S21 .TI ( robot* or orthos* or orthotic or automat* or computer aided or computer assisted or device* ) OR AB ( robot* or orthos* or orthotic or automat* or computer aided or computer assisted or device* )</P>
<P>S22 .TI ( electromechanical or electro-mechanical or mechanical or mechanised or mechanized or driven ) OR AB ( electromechanical or electro-mechanical or mechanical or mechanised or mechanized or driven )</P>
<P>S23 .TI ( continuous passive or cpm ) OR AB ( continuous passive or cpm )</P>
<P>S24 .TI therap* OR AB therap*</P>
<P>S25 .S23 AND S24</P>
<P>S26 .TI ( MIT-Manus or ARM guide or Bi-Manu-Track or ARMtrainer or MIME or Mirror-Image Motion Enabler or InMOTION or REHAROB or NeReBot or "GENTLE/S" or ARMin) OR AB ( MIT-Manus or ARM guide or Bi-Manu-Track or ARMtrainer or MIME or Mirror-Image Motion Enabler or InMOTION or REHAROB or NeReBot or "GENTLE/S" or ARMin)</P>
<P>S27 .TI assist* OR AB assist*</P>
<P>S28 .TI ( train* or aid* or rehabilitat* or re-educat* ) OR AB ( train* or aid* or rehabilitat* or re-educat* )</P>
<P>S29 .S27 AND S28</P>
<P>S30 .S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S25 OR S26 OR S29</P>
<P>S31 .S12 AND S15 AND S30</P>
<P>Number of hits: n=773<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-07" MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser" NO="7">
<TITLE MODIFIED="2015-10-30 14:18:34 +0000" MODIFIED_BY="Hazel Fraser">Compendex and Inspec (Engineering Village) search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2015-06-03 12:08:20 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Compendex and Inspec (Engineering Village)<BR/>
<A HREF="http://www.engineeringvillage.com.ezproxy.is.ed.ac.uk/search/results/quick.url?CID=quickSearchCitationFormat&amp;RERUN=2150625eMf521M420cMa42bMf50719d0057d&amp;database=3&amp;STEP=1">((((robot* or orthos* or orthotic or automat* or computer aided or computer assisted or device* or electromechanical or electro-mechanical or mechanical or mechanised or mechanized or driven or MIT-Manus or ARM guide or Bi-Manu-Track or ARMtrainer or MIME or Mirror-Image Motion Enabler or InMOTION or REHAROB or NeReBot or "GENTLE/S" or ARMin) WN KY) AND ((stroke or cerebrovascular or poststroke or post-stroke or hemipleg*) WN TI)) AND ((upper limb* or upper extremit* or arm* or shoulder* or hand* or axilla* or elbow* or forearm* or finger* or wrist*) WN KY))</A>
</P>
<P>Number of hits Compendex: n=718</P>
<P>Number of hits Inspec: n=655</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>



<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;34 studies included in quantitative synthesis (meta-analysis)&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;34 studies included in qualitative synthesis&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;19 studies included in previous version of review&lt;/p&gt;"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;15 new studies (30 full texts) included&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;49 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;4471 records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;5311 records identified&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;5308 records identified through database searching (2011-2015)&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;3 additional records identified through other sources&lt;/p&gt;" WIDTH="120"/>
<OUT TEXT="&lt;p&gt;840 duplicates removed&lt;/p&gt;"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;4422 records excluded&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;19 full-text articles excluded (11 studies excluded)&lt;/p&gt;&lt;p&gt;Did not fit to PICOS: irrelevant participants&amp;#160;(n = 0), irrelevant intervention&amp;#160;(n = 7), irrelevant comparison (n = 4), irrelevant outcome (n = 0), irrelevant study type&amp;#160;(n = 8)&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
<EXTENSION ID="AFF_D2C58DF182E26AA201E74FE96B163441_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS"><ALIAS ALIAS_ID="D2C58DF182E26AA201E74FE96B163441"><ADDRESS><DEPARTMENT>Sektion Therapiewissenschaften</DEPARTMENT><ORGANISATION>SRH Fachhochschule für Gesundheit Gera gGmbH</ORGANISATION><CITY>07548 Gera</CITY><COUNTRY CODE="DE">Germany</COUNTRY></ADDRESS></ALIAS></EXTENSION><EXTENSION ID="AFF_D2C58DF182E26AA201E74FE96B163441_2" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS"><ALIAS ALIAS_ID="D2C58DF182E26AA201E74FE96B163441"><ADDRESS><DEPARTMENT>Department of Public Health, Dresden Medical School</DEPARTMENT><ORGANISATION>Technical University Dresden</ORGANISATION><CITY>Dresden</CITY><COUNTRY CODE="DE">Germany</COUNTRY></ADDRESS></ALIAS></EXTENSION><EXTENSION ID="AFF_B5C90D8D82E26AA200F0756D4FD96716_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS"><ALIAS ALIAS_ID="B5C90D8D82E26AA200F0756D4FD96716"><ADDRESS><DEPARTMENT>Neurowissenschaften</DEPARTMENT><ORGANISATION>Ernst-Moritz-Arndt-Universität</ORGANISATION><CITY>Greifswald</CITY><COUNTRY CODE="DE">Germany</COUNTRY></ADDRESS></ALIAS></EXTENSION></EXTENSIONS>
</COCHRANE_REVIEW>